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This PhD thesis is focused on the development of novel carbon(II) and carbon(0) catalysis for organic
synthesis. More specifically, the major objective has been to explore and design non-toxic and
effective catalysts based on: an unusual Bertrand carbene type, a so-called
bis(dialkylamino)cyclopropenylidene (BAC), and the carbodicarbene (CDC) framework; the central
carbon atom in these molecules is in the formal low-oxidation state ‘+II’ and ‘0’, respectively. These
species may be used in base catalysis or as ligands in metal catalysis, and in the context of frustrated
Lewis pair (FLP) or dual catalysis. Prior to catalysis studies, the Lewis basicity of such carbon-based
compounds has been assessed with 11B NMR analysis using various boron-based Lewis acids. Boron
binding has been detected in all cases with a BAC, thereby confirming its strongly nucleophilic
character and decreased steric demand. In contrast, only few ate complexes have been identified with
CDCs (or precursors thereof), which means that CDCs may be more suitable for FLP catalysis. A
preliminary electrophile binding study with a BAC has provided interesting data, based on which
unprecedented aldimine Umpolung may be developed in the future. In the context of organocatalysis,
BAC-mediated C–C bond formations between various Michael acceptors and N-tosyl imines have
been developed (aza-Morita–Baylis–Hillman chemistry). In addition, C–N or C–Hal bond formations
between various Michael acceptors and azodicarboxylates or electrophilic halogen reagents have been
developed. The characteristic features of these unprecedented BAC catalyses include low catalyst
loading, mild reaction conditions, and broad substrate scopes. Importantly, several novel chiral BACs
have been synthesized and characterized, and excellent results have been achieved in BAC-catalysed
asymmetric aza-MBH reactions (ee up to 97%). To the best of our knowledge, these data represent the
first highly enantioselective BAC catalysis; chiral N-heterocyclic carbenes (NHCs) have proved to be
substantially less effective in this context (ee up to 38%). In the same line, BAC-catalysed
asymmetric borylations and silylations of Michael acceptors have been developed (preliminary ee up
to 69%). These results demonstrate the high potential of the newly developed chiral BACs in
asymmetric organocatalysis. Meanwhile, several BAC–gallium and BAC–iron complexes have been
synthesized and characterized. These novel complexes may be used in Lewis acid catalysis after
appropriate activation of the corresponding metal sites. Finally, the exploration of the catalysis
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1 ORGANOCATALYSIS WITH AN UNUSUAL CARBENE
1.1 Introduction
1.1.1 General Introduction to Carbene Chemistry
A carbene is a divalent, neutral carbon species with the central carbon atom bearing six valence
electrons. Generally, carbenes may exist in two states: the singlet and the triplet state (Figure 1.1).[1]
Singlet carbenes have a vacant p orbital and a lone pair in a non-bonding sp2 orbital. In contrast,
triplet carbenes have two unpaired electrons, one in a p orbital and another one in an sp2 orbital.[1] The
population of a specific carbene type is influenced by the substituents L bound to the carbon atom: π
donation from an adjacent electron-rich heteroatom into the vacant p orbital favors the singlet state,
whereas the associated decreased electron–electron repulsion favors the triplet state.
Figure 1.1 Schematic representation of singlet and triplet carbenes[1]
An electronic stabilization of carbenes is required. Singlet carbenes are stabilized through a so-called
‘push–pull’ effect: π donation of lone pair electron density from an adjacent heteroatom into the vacant
p orbital of the carbon atom, and σ withdrawal by an adjacent electronegative heteroatom along an sp2
hybridized orbital axis (Figure 1.2).[1] The π donation effect dominates over the σ withdrawal effect.
Meanwhile, a steric stabilization of carbenes is optional.[1] Sterically demanding substituents on the
adjacent nitrogen atom(s) provide kinetic stabilization of carbenes, which means the access to the
carbene center is rendered more difficult.
Figure 1.2 Schematic representation of ‘push–pull’ effect[1]
Since the first isolation of a singlet carbene, phosphinosilyl carbene 1–1, by Bertrand et al. in 1988
(Figure 1.3),[2] a variety of carbenes have been investigated.[3] Among these, N-heterocyclic carbenes
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(NHCs) have proved to be the most popular species. The adjacent heteroatoms serve to stabilize the
carbon center through the described ‘push–pull’ effect. Thus, NHCs are neutral electron-rich species,
and thus considered as strong σ donors with easily tunable electronic and steric properties making
them good nucleophilic organocatalysts,[4] and ligands in metal catalysis.[5] After the first isolation of
NHC 1–2 by Arduengo et al. in 1991 (Figure 1.3),[6] remarkable catalytic transformations have been
triggered by NHCs in recent years.
Figure 1.3 The first isolated singlet and N-heterocyclic carbenes
1.1.2 Introduction to CAAC and BAC Chemistry
In addition to ‘classic’ NHCs, a few other types of more recently reported carbenes such as cyclic
(alkyl)(amino)carbenes (CAACs)[7] and bis(dialkylamino)cyclopropenylidenes (BACs)[8] have been
investigated (Figure 1.4). Both species do not show the usual N–C–N motif present in NHCs. In the
case of a CAAC, a quaternary carbon adjacent to the carbene site replaces one nitrogen atom in the
structure of classic NHCs. In a BAC, two dialkylamino groups are located at the β positions relative
to the carbene centre. Thus, these novel carbenes are expected to display distinct reactivity. Unlike
the popular use of NHCs in organocatalysis, only few examples involving CAACs and BACs in
catalysis have been reported. At the outset of our study, BAC organocatalysis had not been reported.
In addition, although metal complexes –using a BAC as a ligand– had been synthesized, only two
examples of metal catalysis have been reported.[14,15]
Figure 1.4 Examples of various types of carbenes
1.1.3 Synthesis of CAACs and BACs
In 2005, Bertrand et al. reported the first synthesis of CAACs (Scheme 1.1).[7] The reaction between
an imine precursor and lithium diisopropylamide (LDA) afforded the corresponding azaenolate, which
triggered regioselective ring-opening of 1,2-epoxy-2-methylpropane to give the corresponding imino
alkoxide 1–3. Subsequent addition of triflic anhydride at –78 °C and warming to room temperature
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afforded –through an intramolecular C–N bond formation– aldiminium salt 1–4 in up to 58% yield.
This direct carbene precursor was then deprotonated with a second equivalent of LDA to form the free
CAAC, which proved to be isolable.
Scheme 1.1 CAAC preparation through epoxide ring-opening[7]
In 2007, Bertrand et al. reported a second synthetic route involving a hydroiminiumation of alkenes
(Scheme 1.2).[9] First, an aldimine was deprotonated using LDA to provide the corresponding
azaenolate, which reacted with 3-bromo-2-methylpropene to give alkenyl aldimine 1–5. The addition
of one equivalent of hydrochloric acid in diethyl ether to a solution of 1–5 in toluene afforded alkenyl
aldiminium salt 1–6. Heating a solution of this salt in acetonitrile at 50 °C for 18 h resulted in the
formation of the corresponding direct CAAC precursor, which was deprotonated in the usual way to
form the free CAAC. This synthesis offers advantages over the earlier method (Scheme 1.1), as it
avoids expensive and toxic reagents.
Scheme 1.2 CAAC preparation through intramolecular hydroiminiumation[9]
In 2006, Bertrand et al. reported the first synthesis of a BAC (Scheme 1.3).[8] An excess of
diisopropyl amine was added to a solution of tetrachlorocyclopropene in dichloromethane at 0 °C,
followed by an anion metathesis using sodium tetraphenylborate to afford a cyclopropenium
tetraphenylborate, pre-BAC–1. This direct BAC precursor was then deprotonated with potassium
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hexamethyldisilazide at –78 °C to generate the corresponding free BAC. NMR spectroscopic analysis
confirmed the presence of the BAC; crystals thereof were obtained in an overall yield of 20%.
Scheme 1.3 pre-BAC–1 and BAC–1 preparation[8]
In contrast to previously isolated carbenes, this BAC does not require a heteroatom adjacent to the
electron-deficient carbene center to confer stability. Indeed, a BAC contains two dialkylamino groups
located at the β positions relative to the carbene site, which itself is situated at the apex of a
cyclopropene unit. This distance between the amino groups and the carbene center indicates that this
new BAC species is sterically less demanding compared to normal NHCs. Despite the presence of the
dialkylamino groups, the geometric parameters of this cyclic skeleton –revealed by X-ray
crystallography[8]– proved to be only slightly perturbed compared to the calculated structure of the
non-substituted cyclopropenylidene (Figure 1.5).
Figure 1.5 3D-view of pre-BAC–1 and BAC–1[8]
1.1.4 Comparison of Properties: CAAC vs. BAC
Electronic Properties
The structural differences of NHCs, CAACs, and BACs result in different electronic and steric
properties. In case of a CAAC, the replacement of one electron-withdrawing nitrogen atom by a σ
donating alkyl group decreases the σ withdrawal effect, and thus increases the electron density at the
carbene site. This modification renders a CAAC more basic compared to an NHC.[7] Likewise, in
case of a BAC, the dialkylamino groups are located at a more distant position relative to the carbene
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site, which renders this species also more basic than an NHC.[10] These considerations have been
confirmed experimentally by IR studies measuring the average wavenumbers of the CO ligand in the
corresponding cis-Ir and cis-Rh complexes (Figure 1.6). Indeed, for cis-[IrCl(CO)2L] complexes (L =
CAAC or NHC), the IR spectra showed a decrease in the average CO wavenumbers when CAAC was
used (1–7; ṽ = 2013 cm–1) compared to the use of an NHC (1–8; ṽ = 2017–2020 cm–1).[7] Similarly,
for cis-[RhCl(CO)2L] complexes (L = BAC or NHC), the IR spectra showed a decrease in the average
CO wavenumbers when BAC was used (1–9; ṽ = 2031 cm–1) compared to the use of an NHC (1–10; ṽ
= 2038–2041 cm–1).[10] In both cases, these observations indicated a stronger σ donor property, i.e., a
stronger basicity of a CAAC or a BAC compared to their NHC counterparts. A direct comparison
between CAAC and BAC was not drawn as different metal complexes were used.
Figure 1.6 Donor ability–comparison between NHC, CAAC, and BAC[7,10]
Despite the fact that CAACs and BACs may act as strong σ donors, the electrophilic component in
these species cannot be ignored.[11] This π acceptor ability is possible through donation of external
electron density into the vacant p orbital of the central carbon atom. This phenomenon was confirmed
experimentally by 31P NMR spectroscopy of the corresponding phosphinidene complexes through
comparison of the relative chemical shift of the phosphorous atom: a stronger electrophile gives a
higher chemical shift due to a de-shielding effect (Figure 1.7). Accordingly, when the corresponding
L=PPh adducts were examined (L = NHC, CAAC, BAC), the NHC proved to display a moderate
electrophilicity (1–11; δ = –10 ppm) whereas the CAAC was found to be substantially more
electrophilic (1–12; δ = 69 ppm). On the other hand, the BAC was shown to be the weakest π acceptor
(1–13; δ = –35 ppm).[11] Based on these data, the electrophilicity order was suggested to be as follows:
CAAC > NHC > BAC.
Figure 1.7 π acceptor ability–comparison between NHC, CAAC, and BAC[11]
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Steric Properties
Compared to NHCs and CAACs, BACs have a significantly decreased steric bulk due to their unique
cyclopropene-based structure. In 2011, a direct comparison of the steric demand between NHCs,
CAACs, and BACs was described in a seminal study, reported by Grubbs et al., on the carbene-
triggered aggregation of bis(cyclooctatetraene)iron, Fe(cot)2 (Schemes 1.4 ~ 1.6).[12]
In the reactions between different NHCs and Fe(cot)2, surprising results were obtained.[12] The
addition of one equivalent of a bulky NHC to Fe(cot)2 at room temperature provided tri-nuclear iron
cluster 1–14 [Scheme 1.4 a)]. On the other hand, the interaction between a less sterically demanding
NHC and Fe(cot)2 yielded tetra-nuclear iron complex 1–15 [Scheme 1.4 b)]. Although the mechanistic
details of these transformations were not fully elucidated, it is supposedly the steric bulk of the NHC
that prevented the formation of the dimer with release of the free NHC in the first case.
Scheme 1.4 Synthesis of tri- and tetranuclear NHC–iron clusters[12]
In contrast, the reaction between Fe(cot)2 and a bulky CAAC at 45 °C gave a substantially different
result (Scheme 1.5).[12] Indeed, the formal [4+1] cycloaddition product 1–16 was formed in 52% yield;
this complex was found to be thermally stable at 120 °C for at least two days.
7
Scheme 1.5 Synthesis of an [Fe(cot)2(CAAC)] complex[12]
Finally, the use of a BAC gave a different result as well (Scheme 1.6).[12] The reaction of the free
BAC with Fe(cot)2 at –78 °C generated the “mono-substituted” Fe(cot)2(BAC) complex 1–17.
However, the addition of another equivalent of BAC at room temperature resulted in the formation of
the “di-substituted” Fe(cot)(BAC)2 complex 1–18.
Scheme 1.6 Synthesis of [Fe(cot)2(BAC)] and [Fe(cot)(BAC)2] complexes[12]
The above studies clearly emphasize the steric differences between these three carbenes. Compared
with an NHC and a CAAC, the decreased size of the BAC ligand has allowed for a single
‘substitution’ of Fe(cot)2 without displacement of one of the COT ligands. Considering the ease of
preparation and bearing in mind the distinct electronic and steric properties of NHCs, CAACs, and
BACs, we decided to investigate BACs in the context of various types of catalysis.
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1.1.5 BAC–Metal Complexes in Literature
A few transition metal complexes have been prepared from the free cyclopropenylidene,[10] which may
be facilitated by its minimal steric bulk (Scheme 1.7). The used metals include rhodium, palladium,
and nickel.[10] Indeed, BAC–1 has proved to react with [RhCl2(CO)2]2 to afford RhCl(CO)2(BAC) (1–
19), which was typically used to assess the σ donor ability of BACs. BAC–1 was also shown to react
with [RhCl(cod)]2 to give a salt, Rh(cod)(BAC)2+ RhCl2(cod)– (1–20); such a species has been rarely
obtained with normal NHCs. BAC–1 was also demonstrated to displace standard or neutral bidentate
ligands, as shown through the formation of RhCl(PPh3)2(BAC) (1–21) and PdMe2(BAC)2 (1–22),
respectively. Such a ligand-exchange was found to be also efficient for metal(0) complexes, as
evidenced by the synthesis of Ni(cod)(BAC)2+ COD– (1–23).
Scheme 1.7 Literature-reported BAC–metal complexes[10]
Furthermore, BACs have also been shown to react with elemental phosphorous as a main group non-
metal. For example, in 2009 Bertrand et al. reported the reaction between BAC–1 and white
phosphorous to give the corresponding P1 fragment 1–24 in 74% yield (Scheme 1.8).[13]
Scheme 1.8 BAC-facilitated formation of a P1 fragment[13]
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1.1.6 Catalysis with BAC–Metal Complexes
At the outset of our investigations, only two examples of metal–BAC catalysis have been reported. In
1988, Yoshida et al. reported the exothermic isomerization of quadricyclane to norbornadiene
catalysed by Pd–BAC complex 1–25 (Scheme 1.9).[14]
Scheme 1.9 A single example of a Pd–BAC-catalysed isomerization[14]
In 2010, Montgomery et al. introduced a general strategy for the nickel-catalysed regioselective
reductive coupling between aldehydes and alkynes, including aliphatic or aromatic internal,
conjugated, and terminal alkynes (Scheme 1.10).[15] The corresponding major regioisomer was
obtained with a selectivity of up to 98:2 through the use of in situ-formed BAC–1 as a ligand.
Interestingly, the use of in situ-formed NHC–1 displayed the opposite regioselectivity.
Scheme 1.10 Ni–carbene-catalysed reductive cross-coupling[15]
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1.1.7 Aims
The aims of this project were focused on the development of novel catalysis using new BACs as
potential catalysts (Figure 1.9). After the synthesis of these species, their Lewis basicity or
nucleophilicity had to be assessed by 11B NMR spectroscopy using various boron Lewis acids.
Figure 1.9 Aims for Chapter 1
If a boron–ate complex is detected with a specific boron Lewis acid, direct BAC Lewis base catalysis
would be envisaged provided the boron reagent bears a transferable organic group. If such a boron–
carbene binding is not observed, the couple would be considered as a frustrated Lewis pair (FLP) in
view of strong-bond activation in small molecules, i.e., CO2 or N2O.
Another goal was to examine the unprecedented catalytic umpolung of aldimines. In this scenario, the
nucleophilic BAC may add to the initially electrophilic site to form –after proton transfer– a
nucleophilic Breslow-type intermediate. The latter may add to a suitable electrophile and –following
another proton transfer– the functionalized ketimine product would be formed with concomitant
regeneration of the BAC catalyst.
Finally, metal–BAC Lewis acid or redox catalysis was another potential application. The metal Lewis
acid center would coordinate to a suitably basic electrophile, thus facilitating the nucleophilic addition
of another reagent. Here, due to the unique properties of BAC ligands –compared with NHCs and
CAACs– a distinct activity and selectivity for metal–BAC-catalysed processes may be anticipated.
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1.2 Results and Discussions
1.2.1 Synthesis of a Pre-BAC and a BAC
BAC–1 was synthesized on a gram-scale according to the literature procedures (Scheme 1.11).[8] The
reaction of an excess of diisopropylamine and tetrachlorocyclopropene in DCM –followed by
successive treatment of the reaction mixture with sodium tetrafluoroborate, triphenyl phosphine, and
water– afforded pre-BAC–1 in 90% yield.
Scheme 1.11 Preparation of pre-BAC–1 and BAC–1[8]
This precursor was then deprotonated by using one equivalent of potassium hexamethyldisilazide in
THF at –78 oC. After warming to room temperature the mixture was stirred for 30 min, and the
solvents were evaporated to yield BAC in its crude form. This in situ formation of BAC–1 was
verified in the presence of a boron Lewis acid through 11B NMR spectroscopy (see Section 1.2.2; P11).
1.2.2 Evaluation of Lewis Basicity: BAC vs. Other Carbenes
Generally speaking, the Lewis basicity or nucleophilicity of molecules may be examined by reacting
these with tri-coordinate boron Lewis acids. Potentially, a tetra-coordinate boron species, i.e., a so-
called boron–ate complex, may be formed in situ; boron compounds can be detected by 11B NMR
spectroscopy, and so the reaction between the boron Lewis acid and the corresponding Lewis base can
be monitored easily. In this context, the general chemical shifts of boron compounds can be
summarized as shown in Chart 1.1.
11B NMR spectroscopy can be considered as a scale for the Lewis acidity of boron compounds; the
chemical shift of the boron signal decreases with an increasing number of bound heteroatoms, i.e.,
oxygen or nitrogen.[16] This effect can be ascribed to the fact that e.g. an oxygen atom can partially
donate electron density to the vacant p orbital of the adjacent boron center. Typically, a tri-coordinate
boron compound would give a signal in the range from +90 ppm to +15 ppm. In contrast, tetra-
coordinate species, such as boron–ate complexes, have a much higher electron density around the
boron atom and hence display a signal in the range from +10 ppm to –40 ppm.
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Chart 1.1 11B NMR spectroscopy as a Lewis acidity scale[16]
All boron Lewis acids used in this study and their corresponding chemical shifts in 11B NMR
spectroscopy are shown in Figure 1.10. The general goal in this part of study was to detect whether a
boron–ate complex was generated by combining an in situ-formed BAC and the corresponding boron
reagent. As BACs are considerably more basic than the traditional NHCs and less sterically
demanding than CAACs, the carbene’s lone pair was anticipated to more easily attack the electrophilic
boron atom. According to the experimental procedure, a solution of the in situ-formed BAC in
benzene was reacted with the various boron reagents at room temperature, and the resulting mixture
was transferred into an NMR tube for 11B NMR spectroscopic analysis. A new signal appearing in the
range from –40 ppm to +10 ppm would show the formation of a boron–ate complex, and thus
demonstrate the nucleophilicity of the BAC towards a specific boron species.
Figure 1.10 Boron reagents examined and their chemical shifts
The spectra for these boron binding experiments are illustrated in Charts 1.2a–g). In case of
triethylborane (B–1), the starting material displayed a signal at ~ +87 ppm [Chart 1.2a)]. The reaction
of BAC–1 with B–1 afforded a carbene boron–ate complex, as evidenced by a signal at –13.3 ppm. In
this context, a control experiment has also been carried out using B–1 in the presence of KHMDS; an
amide boron–ate complex was detected at –1.7 ppm. This result confirmed that the signal at –13.3
ppm was indeed the complex formed through addition of BAC–1 to B–1.
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Chart 1.2a) 11B NMR spectra for B–1 and the corresponding BAC boron–ate complexes
In case of Bn–B(9BBN) (B–2), the starting material showed a signal at ~ +77 ppm [Chart 1.2b)]. The
reaction of BAC–1 with B–2 provided a carbene boron–ate complex, as evidenced by a signal at –12.6
ppm. The signal at ~ +56 ppm may be an impurity [HO–B(9BBN)] formed from B–2 and water
present in the starting material. In this context, a control experiment has also been carried out using
B–2 in the presence of KHMDS; an amide boron–ate complex was detected at –6.2 ppm. This result
confirmed that the signal at –12.6 ppm was the complex formed between BAC–1 and B–2.
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Chart 1.2b) 11B NMR spectra for B–2 and the corresponding BAC boron–ate complexes
In case of MeO–B(9BBN) (B–3), the starting material showed a signal at ~ +57 ppm [Chart 1.2c)].
The reaction of BAC–1 with B–3 gave a carbene boron–ate complex, which displayed a signal at +1.4
ppm. The control experiment between B–3 and KHMDS formed an amide boron–ate complex, which
was detected at +5.0 ppm. This result confirmed that the signal at +1.4 ppm ppm was the complex
formed between BAC–1 and B–3.
Chart 1.2c) 11B NMR spectra for B–3 and the corresponding BAC boron–ate complexes
In case of allyl–B(pin) (B–4), the starting material showed a signal at ~ +33 ppm [Chart 1.2d)]. The
reaction of BAC–1 with B–4 gave a carbene boron–ate complex, which displayed a singlet at –2.1
ppm. Here, the control experiment using B–4 and KHMDS gave a signal at ~ +26 ppm, which could
be ascribed to an equilibrium between B–4 and an amide boron–ate complex. This result also
confirmed that the signal at –2.1 ppm was the complex formed between BAC–1 and B–4.
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Chart 1.2d) 11B NMR spectra for B–4 and the corresponding BAC boron–ate complexes
In case of B2(pin)2 (B–5), the starting material displayed a signal at ~ +31 ppm [Chart 1.2e)]. The
reaction between BAC–1 and B–5 afforded a carbene boron–ate complex, as evidenced by a signal at
+7.5 ppm. The control experiment using B–5 and KHMDS led to an amide boron–ate complex that
was detected at –3.1 ppm. This result confirmed that the signal at +7.5 ppm corresponded to the
complex between BAC–1 and B–5.
Chart 1.2e) 11B NMR spectra for B–5 and the corresponding BAC boron–ate complexes
In case of H–B(9BBN) (B–6), the starting material displayed a signal at ~ +28 ppm [Chart 1.2f)]. The
reaction of BAC–1 with B–6 afforded a carbene boron–ate complex, as evidenced by a signal at –16.0
ppm. The control experiment using B–6 and KHMDS generated an amide boron–ate complex
detectable at –14.8 ppm, and thus confirmed the formation of the carbene boron–ate complex with
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BAC–1 (–16.0 ppm).
Chart 1.2f) 11B NMR spectra for B–6 and the corresponding BAC boron–ate complexes
In case of H3B•SMe2 (B–7), the starting material displayed a signal at –19 ppm [q; Chart 1.2g)]. The
reaction of BAC–1 with B–7 afforded a carbene boron–ate complex, as evidenced by a quartet at –35
ppm. The control experiment between B–7 and KHMDS formed a signal at +40 ppm, which may be
ascribed to an equilibrium between the amide boron–ate complex and a “BH2 species” generated
through intramolecular hydride transfer from boron-to-silicon. This result confirmed that the signal at
–35.0 ppm was indeed the complex formed through addition of BAC–1 to B–7.
Chart 1.2g) 11B NMR spectra for B–7 and the corresponding BAC boron–ate complexes
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In summary, as shown in all spectra [Charts 1.2a–g)], BAC–1 formed ate complexes with all boron
Lewis acids examined; control experiments using KHMDS alone confirmed these data. The ability of
BAC–1 to generate adducts with virtually any boron electrophile may be due to its highly nucleophilic
and non-sterically demanding character. Overall, these results indicated that a cyclopropenylidene
may act as a potential nucleophilic catalyst for electrophilic metalloid reagents.
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1.2.3 Synthesis of Novel BAC–Metal Complexes
In 2007, Bertrand et al. reported the first complexes of cyclopropenylidenes with transition metals
such as Rh, Pd, and Ni.[10] Those well-defined air- and moisture-stable BAC–M adducts may have a
significant potential in π Lewis acid catalysis. Here, we were rather interested in non-precious metals
such as main group and first-row transition metals; typically, these metals are considered as both less
expensive and less toxic. In our study, gallium(III), iron(II), and iron(III) were reacted in the presence
of a BAC to generate the corresponding complexes. These adducts were synthesized according to
literature procedures (Scheme 1.12).[8,10]
Scheme 1.12 Preparation of BAC–metal complexes[8,10]
Free BAC–1 was prepared in situ (see Scheme 1.11; P11), and subsequently reacted with the
corresponding metal chloride at room temperature. After filtration, evaporation, and washing with
anhydrous methanol, the corresponding BAC–metal adducts were obtained in high yields [gallium(III)
(1–26): 96%; iron(II) (1–27): 86%; iron(III) (1–28): 80%]. The identity of these new complexes were
confirmed by NMR spectroscopy and high-resolution mass spectroscopy (HRMS), as well as by
comparison with reported data for analogous species.[10,17] In the 1H NMR spectrum of pre-BAC–1,
the cyclopropenium hydrogen atom displayed a signal at 7.42 ppm and the CH hydrogen atoms of two
non-equivalent isopropyl groups showed signals at 4.03 ppm and 3.86 ppm, respectively [Chart 1.3a)
above]. After deprotonation to form BAC–1 (see Scheme 1.11; P11), the signal of the cyclopropenium
hydrogen atom obviously disappeared, and CH hydrogen atoms of the equivalent isopropyl groups
showed one signal only at 3.69 ppm [Chart 1.3a) below].
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Chart 1.3a) 1H NMR spectra of pre-BAC–1 and BAC–1
Chart 1.3b) 1H NMR and 71Ga NMR spectra of BAC–GaCl3 complex 1–26
In the 1H NMR spectrum of the BAC–Ga(III) complex 1–26, the CH hydrogen atoms of two non-
pre-BAC–1 [1H NMR (C6D6)]
BAC–1 [1H NMR (C6D6)]
Ga complex (1H NMR )
Ga complex (71Ga NMR)
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equivalent isopropyl groups displayed signals at 4.14 ppm and 4.08 ppm, respectively [Chart1.3b) left].
While the spectrum looked similar to the one recorded for pre-BAC–1 [see Chart1.3a) above], the
chemical shifts were clearly distinct, which suggested the formation of a BAC–gallium complex.
Likewise, 71Ga NMR spectroscopy indicated the formation of a “molecular” tetra-coordinated gallium
complex rather than an “ionic” three-coordinated gallium species. Indeed, a singlet at ~ +249 ppm
was observed [Chart1.3b) right], which is consistent with Gandon’s data on related NHC–gallium
complexes (+249 ~ +257 ppm).[17a] In addition, the anionic gallium halide species (L–GaCl2+X¯)
displayed a signal at +365 ppm ~ +740 ppm,[17b] in which area no signals were detected in our 71Ga
NMR. Finally, gallium complex 1–26 was analyzed as well by high-resolution mass spectroscopy
(HRMS), and the molecular (non-ionic) structure has been unambiguously confirmed by HRMS
analysis, i.e., the corresponding “molecular gallium complex–Na+“ species was detected. In analogy,
iron complexes 1–27 and 1–28 were characterized by 1H and 13C NMR spectroscopy, and the
molecular (non-ionic) structures have been confirmed by HRMS analysis.
All three complexes seem to be bench-stable, and their use in Lewis acid catalysis will be investigated
in the presence of an anion metathesis trigger.
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1.2.4 Attempted Classic Umpolung by a BAC
After having confirmed the high degree of nucleophilicity of BAC–1 in Section 1.2.2 (P11), a variety
of reactions with different electrophilic substrates were performed in order to see whether umpolung
catalysis using aldehyde or aldimine pro-nucleophiles was feasible.
1.2.4.1 Benzaldehyde as a Potential Pro-Nucleophile
Benzaldehyde (1–29) was first used to react with the in situ-formed BAC–1 to see whether this
compound was suitable to convert 1–29 to an acylanion equivalent for subsequent intermolecular C–C
bond formation with a suitable electrophile (Scheme 1.13). To date, analytical data regarding adduct
1–30 were not reported in literature. After a C-to-O proton transfer a so-called Breslow-intermediate,
species 1–31¸ would be formed. This acylanion equivalent may react with an electrophile; here,
benzaldehyde may be the electrophile to undergo C–C bond formation, i.e., generation of
homobenzoin adduct 1–32 (Scheme 1.14).
Scheme 1.13 Proposed pathway for BAC-catalysed aldehyde umpolung chemistry
Regarding the experimental procedure, one equivalent of benzaldehyde (1–29) was reacted with 30
mol% of in situ-formed BAC–1 in THF at room temperature; both consumption of benzaldehyde and
product formation were monitored by 1H NMR spectroscopy (use of DBE as an internal standard;
Scheme 1.14).
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Scheme 1.14 BAC-catalysed homo-benzoin formation
According to related literature data, the relevant signals detectable in 1H NMR spectroscopy would
appear at 4.5 ppm and 6.0 ppm, respectively.[18,19] In our initial trial, homo-benzoin 1–32 was formed
in ~60 %yield, which showed the potential of a BAC in umpolung catalysis. A presentative example
of an aliquot NMR for this homo-benzoin formation displayed the benzylic hydrogen atom in 1–32 at
~ 5.0 ppm (d, J = 8.2 Hz; Chart 1.4).
Chart 1.4 1H NMR spectroscopic analysis for homo-benzoin formation[18,19]
1.2.4.2 An Aldimine as a Potential Pro-Nucleophile
In addition, a benzaldehyde-derived N-Boc-imine was examined. Despite the fact that NHCs have
proved to be good catalysts for the catalytic umpolung of aldehydes, these species were found to
inactive in the umpolung of aldimines. As BACs have been shown to be stronger bases/nucleophiles
than NHCs, we anticipated that a BAC may activate a suitable aldimine in the context of umpolung
catalysis [Scheme 1.15a)]. The corresponding experiment was conducted using the benzaldehyde-
derived N-Boc-imine in the presence of 10 mol% of in situ-formed BAC–1 in THF at room
temperature [Scheme 1.15b)]. Both consumption of N-Boc-imine as well as product formation were
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monitored by 1H NMR spectroscopy (use of DBE as an internal standard).
Scheme 1.15 Proposed pathway for BAC-catalysed umpolung of an aldimine for homo-aza-benzoin formation
The consumption of the electrophile, i.e., the benzaldehyde-derived N-Boc-imine, proceeded smoothly
thus indicating an initial nucleophilic addition of BAC–1 to the imine’s C=N double bond, which is
facilitated by the electron-withdrawing carbamate protecting group. Literature data have not been
reported for this initial adduct nor for the final homo-aza-benzoin product. In our case, a new singlet
at around 5.9 ppm was identified (Chart 1.5), and the consumption of imine was also detected.
However, a dimeric product was not detected, which may be ascribed to the electron withdrawing
group decreasing the basicity of the amide intermediate, i.e., a proton transfer may not occur and thus
no umpolung. In conclusion, this preliminary experiment revealed that an initial adduct between the
cyclopropenylidene and the imine was likely formed, but it did not react further in a productive
pathway.
Chart 1.5 1H NMR spectroscopic analysis of the umpolung reaction using an aldimine (aliquot)
1H NMR (CDCl3)
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1.2.5 Umpolung of Michael Acceptors by a BAC
C–C Bond formations are among the most important reactions in organic chemistry, and represent thus
an important area of organic synthesis and catalysis.[20] Among the various C–C bond-forming
reactions, the Morita–Baylis–Hillman (MBH) reaction is one of the most useful and popular reactions
due to its atom-economy and its high synthetic potential.[21]
The classic MBH reaction represents the formation of a C–C bond between the α-position of a
Michael acceptor –such as an α,β-unsaturated aldehyde, ketone, or carboxylic acid derivative– and a
carbonyl electrophile –such as an aldehyde or a ketone– in the presence of a nucleophilic catalyst, i.e.,
a tertiary amine or a phosphine (Scheme 1.16).[22] The first MBH reaction was reported in 1968 by
Morita, using aldehydes and methyl acrylate or acrylonitrile as substrates, in the presence of a
phosphine catalyst; the corresponding MBH adducts were obtained with low conversions [Scheme
1.16a)].[23] In 1972, Baylis and Hillman used cheaper and less toxic amine catalysts to carry out
similar transformations [Scheme 1.16b)].[24]
Scheme 1.16 First examples and commonly accepted mechanism of the MBH reaction[23,24]
The commonly accepted mechanism of the MBH reaction is shown in Scheme 1.16c).[22] The catalytic
cycle is initiated by the conjugate addition of the Lewis basic catalyst to an electron-deficient alkene to
generate zwitterionic enolate I. This nucleophile may add to the carbonyl group of the electrophile to
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generate the C–C bond with adduct II. The following intermolecular proton transfer would lead to
another zwitterionic intermediate III, which may undergo β-elimination to regenerate the initial C=C
double bond thereby releasing the nucleophilic catalyst.
In addition, aldimines were shown to participate –as electrophiles– in this transformation provided
these are sufficiently activated by an electron-withdrawing N-protecting group; in turn, this process
has been called the aza-Morita–Baylis–Hillman (aza-MBH) reaction (Scheme 1.17).[22] The first aza-
MBH reaction was reported in 1984 by Perlmutter and Teo using aromatic N-tosyl aldimines and ethyl
acrylate as substrates in the presence of a cyclic tertiary amine, DABCO, as a catalyst [Scheme
1.17a)].[25] Subsequently, aliphatic aldimines and various Michael acceptors have been explored
[Scheme 1.17b)]; the key to the imine’s reactivity has proved to be the corresponding N-protecting
group, which must be of sufficient electron-withdrawing character.
Scheme 1.17 First example and general scheme of the aza-MBH reaction[25]
Catalytic (aza-)MBH reactions have evolved substantially over the past few years. The reasons for
this fast growth may be attributed to the advantages of these transformations:[26] (i) the starting
materials are commercially available or easily accessible, and the reactions are suitable for large-scale
production; (ii) the reactions are atom-economic – waste is not generated; (iii) the products are flexible
and multi-functional, thus facilitating further chemical transformations; (iv) a metal-free nucleophilic
organocatalyst is typically sufficient for activity; (v) fairly mild reaction conditions may be used.
1.2.5.1 Aza-Morita–Baylis–Hillman Reactions in Literature
After the discovery of the first aza-MBH reaction more than 30 years ago [see Scheme 1.17a)],
organocatalytic aza-MBH reactions were investigated in more detail in order to achieve high yields for
a broad variety of electrophiles and pro-nucleophiles.
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Acrylates, acryl amides, and acrylonitrile as pro-nucleophiles
In 2004, Shi et al. used two different Lewis basic catalysts, PPh2Me or DABCO, to catalyze the aza-
MBH reaction between aromatic N-tosyl aldimines and aromatic acrylates (Scheme 1.18).[27] The
corresponding aza-MBH adducts were obtained in 56–91% yields.
Scheme 1.18 aza-MBH reactions between aromatic N-tosyl aldimines and aromatic acrylates[27]
Similarly, in 2002 and 2004, Shi et al. reported catalytic aza-MBH reactions between N-phosphinoyl
aldimines and acrylates or acrylonitrile (Scheme 1.19).[28,29] The corresponding aza-MBH adducts
were obtained in 19–99% yields. It is important to note that the use of a less reactive pro-nucleophile,
acrylamide, required a stoichiometric amount of the catalyst.
Scheme 1.19 aza-MBH reactions between N-phosphinoyl aldimines and different Michael acceptors[28,29]
α,β-Unsaturated ketones as pro-nucleophiles
In 2002, Shi et al. reported phosphine-catalysed aza-MBH-type reactions between N-tosyl aldimines
and methyl vinyl ketone (Scheme 1.20).[30] The corresponding “normal” aza-MBH adducts were
obtained in 45–92% yields when PPh3 was used as a catalyst. On the other hand, two cyclized
products were observed in moderate yields when a more nucleophilic catalyst, PBu3, was used.
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Scheme 1.20 PPh3 vs. PBu3 catalysis in aza-MBH-type reactions with methyl vinyl ketone[30]
In 2003, Shi et al. reported catalytic aza-MBH-type reactions between aromatic N-tosyl aldimines and
phenyl vinyl ketone (Scheme 1.21).[31] The corresponding “normal” aza-MBH adducts were obtained
in 68–99% yields when PPh3 was used as a catalyst. However, when DABCO was used a “dimeric”
aza-MBH product was obtained 54–85% yields as a single diastereoisomer (anti).
Scheme 1.21 PPh3 vs. DABCO catalysis in aza-MBH-type reactions with phenyl vinyl ketone[31]
In 2004, Shi et al. reported a similar phosphine-catalysed aza-MBH-type reaction between N-
phosphinoyl aldimines and phenyl vinyl ketone (Scheme 1.22); here, the “dimeric” aza-MBH adduct
was obtained in 23–62% yields.[32]
Scheme 1.22 aza-MBH-type reaction between N-phosphinoyl aldimines and phenyl vinyl ketone[32]
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Acrolein as a pro-nucleophile
In 2004, Shi et al. developed a catalytic aza-MBH reaction between aromatic N-tosyl aldimines and
acrolein (Scheme 1.23).[27] The corresponding aza-MBH adducts were obtained in 58–94% yields.
Scheme 1.23 PPh2Me vs. DABCO catalysis in aza-MBH reaction with acrolein[27]
An α,β-unsaturated sulfone as a pro-nucleophile
In 2005, Back et al. reported a dual catalytic aza-MBH reaction between aromatic N-tosyl aldimines
and a buta-1,3-diene sulfone (Scheme 1.24).[34] 3-HQD was used as a dual acid–base catalyst to give
the corresponding aza-MBH adducts in 31–86% yields as a mixture of E and Z geometric isomers.
Scheme 1.24 aza-MBH reaction between N-tosyl aldimines and sulfone[34]
β-Substituted Michael acceptors as pro-nucleophiles
In 2004 and 2006, Shi et al. developed also phosphine-catalysed aza-MBH reactions between aromatic
N-tosyl aldimines and different types of β-substituted Michael acceptors (Scheme 1.25).[35,36] The
corresponding aza-MBH adducts were obtained in 12–91% yields as a mixture of E and Z geometric
isomers.
Scheme 1.25 aza-MBH reaction of aromatic imines with β-substituted Michael acceptors[35,36]
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α,β-Unsaturated cyclic ketones as pro-nucleophiles
In 2002, Shi et al. reported catalytic aza-MBH-type reactions between aromatic N-tosyl aldimines and
cycloalkenones (Scheme 1.26).[37] With cyclopentenone the corresponding aza-MBH adducts were
obtained in 54–99% yields. The outcome for the use of cyclohexanone and cycloheptenone was
shown to depend on the nature of the catalyst. With DMAP the corresponding aza-MBH adducts were
obtained in 30–60% yields; on the other hand, the catalytic use of PBu3 or DBU afforded the aza-
MBH adducts in only up to 40% yield together with aza-Diels–Alder side-products in up to overall
50% yield. In case of cyclooctenone, various distinct products were observed selectively depending
on the nature of the nucleophilic catalyst.
Scheme 1.26 aza-MBH-type reactions between aromatic N-tosyl aldimines and α,β-unsaturated cycloalkenones[37]
In 2004, Shi et al. reported phosphine-catalysed aza-MBH reactions between N-phosphinoyl imines
and cycloalkenones (Scheme 1.27).[38] The corresponding aza-MBH adducts were obtained in 42–
97% yields depending on the ring size of the Michael acceptor and the phosphine catalyst.
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Scheme 1.27 aza-MBH reactions of N-phosphinoyl aldimines and cyclic ketones[38]
Allenic esters as pro-nucleophiles
In 2003, Shi et al. reported catalytic aza-MBH-type reactions between aromatic N-tosyl aldimines and
various allenic esters (Scheme 1.28).[39] When DABCO was used as the catalyst, the corresponding
azetidine products were formed in 42–99% yields through a formal [2+2] cycloaddition. In contrast,
with DMAP as a catalyst, dihydropyridine products were observed in 31–60% yields. Interestingly,
Shi et al. reported the formation of [3+2] cycloaddition products in 28–95% yields starting from a β-
substituted allenic ester in the presence of a phosphine catalyst.[42] The observed diastereoselectivities
proved to be synthetically useful.
Scheme 1.28 aza-MBH-type reactions of aromatic N-tosyl imine with allenic esters[39,42]
In 2005, Shi et al. also reported catalytic aza-MBH-type reactions between aromatic N-tosyl aldimines
and an α-substituted allenic ester (Scheme 1.29).[40] In the presence of DMAP as a catalyst at room
temperature, the corresponding aza-MBH adducts were formed in 40–81% yields as an equimolar
mixture of diastereoisomers. On the other hand, the catalytic use of PBu3 at 80 oC afforded two
distinct tetrahydropyridine products in up to 67% yield through a formal [4+2] cycloaddition.
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Scheme 1.29 aza-MBH-type reactions of aromatic N-tosyl imines with α-substituted allenic esters[40]
Miscellaneous examples
In 2005, Shi et al. used DMAP to catalyze the aza-MBH-type reaction between aromatic N-tosyl
aldimines and but-3-yn-2-one (Scheme 1.30).[42] Here again, instead of the classic aza-MBH adduct
two distinct tetrahydropyridine products were obtained in up to 45% yield through formal [4+2]
cycloaddition pathways.
Scheme 1.30 aza-MBH-type reactions of aromatic N-tosyl aldimines with an alkynyl ketone[42]
In 2001, Burger and Cyrener reported DABCO-catalysed aza-MBH-type reactions between an
activated N-benzoyl ketimine and various Michael acceptors (Scheme 1.31).[33] The corresponding
aza-MBH adducts were obtained in 27–89% yields together with traces of formal [4+2] cycloaddition
side-products.
Scheme 1.31 aza-MBH type reactions between hexafluoroacetone-derived N-benzoylimine and Michael acceptors[33]
In addition to all phosphine and amine catalyses summarized above, Ye et al. reported in 2007 that an
NHC was also apt to catalyze an aza-MBH reaction between a variety of aromatic N-tosyl aldimines
32
and two cycloalkenones (Scheme 1.32).[44] This transformation represents the first example of a
carbene-catalysed aza-MBH reaction; the corresponding adducts were obtained in 72–99% yields.
Drawbacks of this NHC catalysis include a limited scope (only two cyclic enones and only a limited
number of aromatic N-tosyl aldimines; no aliphatic imines), rather harsh conditions (10–20 mol%
catalyst loading and up to 50 oC), and the lack of an asymmetric version using an enantiopure NHC
catalyst.
Scheme 1.32 First carbene-catalysed aza-MBH reaction[44]
In light of this work and considering the distinct properties of BACs (stronger σ donor, less sterically
demanding carbene), we anticipated that a BAC may be a more efficient catalyst for this important C–
C bond formation. Overall, advantages may include: (i) the access to additional classes of Michael
acceptors including α,β-unsaturated aldehydes, acyclic ketones, and carboxylic acid derivatives; (ii) a
broader variety of accessible imines including various aliphatic N-tosyl aldimines, ketimines, and
imines containing important functional groups; (iii) a substantially lower catalyst loading; (iv) the
possibility of an asymmetric version using an enantiopure BAC catalyst.
1.2.5.2 Initial Experiments in BAC Catalysis
In order to test the feasibility of this BAC-catalysed C–C bond formation, a BAC was formed in situ
according to Bertrand’s method (see Scheme 1.11; P11) through deprotonation of a BAC precursor,
pre-BAC–1, using one equivalent of a potassium amide (KHMDS) in THF at –78 oC (Scheme 1.33).
The successful generation of BAC–1 was confirmed by its subsequent reaction with triethyl borane
(B–1) and 11B NMR spectroscopic analysis of the formed boron–ate complex IV. The spectra of B–1
and IV are displayed in Chart 1.6; an up-field shift from +87 ppm (tri-coordinate boron) to –13 ppm
(tetra-coordinate boron) was observed, which confirmed the clean production of boron–ate complex
IV. It is noted that a control reaction was also carried out using KHMDS and B–1 resulting in the
formation of a distinct boron–ate complex (–1.7 ppm). Hence, the successful in situ formation of the
potential Lewis base catalyst, BAC–1, was demonstrated.
Scheme 1.33 In situ preparation of a BAC and subsequent formation of a boron–ate complex
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Chart 1.6 Comparison of 11B NMR spectra for BEt3 and the boron–ate complex involving a BAC
Next, a preliminary set of aza-MBH reactions was carried out using 10 mol% of the in situ-generated
BAC–1 (Scheme 1.34). The benzaldehyde-derived N-tosyl imine, Imine–1, and a variety of
commercially available Michael acceptors –including cyclic and acyclic α,β-unsaturated ketones as
well as carboxylic acid derivatives– were used as model substrates in this screening at 30 °C; the
NMR yields were determined using dibenzyl ether (DBE) as an internal standard (1H NMR
spectroscopy of reaction aliquots taken after 16 h).
Scheme 1.34 Initial experiments of a BAC-catalysed aza-MBH reaction
The intended C–C bond formations proceeded with both cyclic and acyclic ketones and esters, albeit
in only 21–31% yields – however, a catalyst turnover was demonstrated (TON = 2–3). The only
unreactive substrate proved to be acrylonitrile (1–38). It is important to point out that control
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experiments were carried out using KHMDS and HMDS as potential catalysts under otherwise
identical conditions (Scheme 1.35). Here, the aza-MBH adduct was not observed, which confirmed
that the in situ-formed cyclopropenylidene, BAC–1, was the real catalyst in the experiments above.
Scheme 1.35 Control experiments for catalytic aza-MBH reaction
Interestingly, in the case of the α,β-unsaturated ester and lactone, the observed products were formed
through a BAC-catalysed a3d2 umpolung pathway [Scheme 1.36a)], which is clearly distinct from
reported NHC catalysis with these types of pro-nucleophiles. Typically, under NHC catalysis these
substrates undergo an a3d3 umpolung pathway to generate the corresponding homoenolate rather than a
classic enolate [Scheme 1.36b)].[45]
Scheme 1.36 BAC vs. NHC catalysis in case of α,β-unsaturated carboxylic acid pro-nucleophiles[45]
As mentioned, the formation of the products was monitored by 1H NMR spectroscopic analysis of
reaction aliquots; a presentative example is shown for the reaction with cyclopentenone; the benzylic
hydrogen atom in the aza-MBH adduct appeared at ~ 5.2 ppm (d, J = 8.4 Hz; Chart 1.7).
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Chart 1.7 1H NMR spectroscopy of the aza-MBH product (DBE as an internal standard)
A plausible mechanism for this BAC-catalysed aza-MBH reaction is shown below (Scheme 1.37); it
represents the classic pathway. As a nucleophile, BAC–1 would add to the electrophilic β-position of
MA–1 to form zwitterionic enolate V. The latter would then add as a nucleophile to the electrophilic
C=N double bond of Imine–1 to generate the intended C–C bond in intermediate VI. The following
intermolecular C-to-N proton transfer would lead to another zwitterionic enolate VII, which would
undergo β-elimination to regenerate the C=C double bond in product 1–33 with concomitant
regeneration the carbene catalyst, BAC–1.
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Scheme 1.37 Proposed mechanism for the BAC-catalysed aza-MBH reaction
The proposed catalytic cycle is consistent with the commonly accepted mechanism published by
Hoffman and supported by a kinetic study by Hill and Isaacs in the late-1980s.[46] They suggested that
the C–C bond formation was the rate-determining step. In 2005 however, McQuade et al.[47,48] and
Aggarwal et al.[49] independently re-evaluated the mechanism and demonstrated that the proton
transfer, rather than C–C bond formation, was the rate-determining step.
Our promising early results encouraged us to further investigate this BAC catalysis. However, the
yields had to be substantially improved in order to develop an appropriate novel synthetic method.
One issue may be the use of a metal amide in the in situ BAC generation because a secondary amine
(HMDS) was formed as a by-product (Scheme 1.37). Despite the fact that HMDS itself does not
catalyze this C–C bond formation, the presence of a secondary amine may hamper the catalyst
turnover. The structural differences between the BAC and HMDS result in different electronic and
steric properties. In case of HMDS, the two bulky trimethylsilyl groups are located adjacent to the
basic nitrogen atom. On the other hand, the bulky diisopropylamino groups in the BAC are located at
a more distant position relative to the basic carbon atom. Thus, a BAC is considered to be sterically
less hindered than HMDS; in turn, a BAC may add more easily to electrophiles than HMDS.
Moreover, once the BAC is added to an electrophile, a 2π aromatic system (cyclopropenium) ion is
formed (Scheme 1.38, left); therefore, the generated zwitterionic enolate should be well stabilized.
Both BAC and HMDS can be considered as good leaving groups. A lower pKa value represents a
weaker conjugate base, i.e., a better leaving group, the corresponding pKa value may account for the
observed experimental results. The significantly lower pKa value of an ammonium ion (~9–12 in
DMSO)[50] compared with a cyclopropenium ion (estimated to be ~20 in DMSO)[51] indicates that
HMDS should be a substantially better leaving group than a BAC. Thus, the HMDS-based
zwitterionic enolate should be significantly less stable (Scheme 1.38, right).
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Scheme 1.38 BAC vs. HMDS in the activation of cyclopentenone
Under certain conditions, HMDS may also potentially act as a weak BrØnsted acid. Indeed, both the
formed enolate or the BAC may deprotonate HMDS to liberate a basic amide, which may hamper the
normal reaction pathway (Scheme 1.39).
Scheme 1.39 Deprotonation of HMDS
In conclusion, although the catalyst turnover was low and acrylonitrile (1–38) proved to be unreactive,
we established a proof-of-principle for BAC catalysis. The presence of a catalytic amount of HMDS
in the reaction mixture may be a potential reason for the observed low yields. In turn, the reaction
conditions for this BAC-catalysed aza-MBH reaction had to be optimized in order to obtain
synthetically useful results.
1.2.5.3 Optimization and Control Experiments
First, a solvent screening was conducted for the model reaction between Imine–1 and MA–1 using
solvents of different polarity at 30 oC (Table 1.1). Here again, BAC–1 was pre-formed in THF
according to Bertrand’s method[8] (see Scheme 1.11; P11).
Table 1.1: Solvent and temperature screening
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Entry Solvent (Ɛ) Temp (oC) NMR yield (%)[a] Mass Balance(Imine–1) / (MA–1) (%)[b]
1 dioxane (2.3) 30 10 98 / 97
2 toluene (2.4) 30 21 97 / 98
3 TBME (2.6) 30 31 96 / 96
4 Et2O (4.3) 30 26 100 / 98
5 EtOAc (6.0) 30 19 93 / 88
6 DME (7.2) 30 38 97 / 98
7 TCE (7.3) 30 10 99 / 97
8 THF (7.5) 30 40 96 / 99
9 DCE (10.4) 30 9 102 / 100
10 MeCN (37.5) 30 18 95 / 99
11 TBME (2.6) 40 38 98 / 96
12 Et2O (4.3) 40 45 92 / 100
13 DME (7.2) 40 43 97 / 99
14 THF (7.5) 40 61 96 / 95
[a]The yield was determined by 1H NMR spectroscopic analysis of the reaction mixture; internal standard: dibenzyl ether (25
mol%). [b] Mass balance: the amount of product formed plus the amount of starting material remained.
First, different apolar solvents –including ethers, aromatic or chlorinated solvents, and an ester– were
examined (entries 1–9). Among the ethers, TBME, Et2O, DME, and THF provided product 1–33 in
31–40% yields (entries 3, 4, 6 and 8); the use of THF proved to be most effective (40%; entry 8). In
literature, MBH and aza-MBH reactions typically rely on the use of a polar aprotic solvent,[34,37,42]
which may stabilize the critical zwitterionic enolate. Interestingly however, the use of acetonitrile –a
highly polar aprotic solvent with a high dielectric constant Ɛ[52]– proved to be less effective (entry 10).
When the reaction in the most promising ethers was carried out at 40 oC, yields of 1–33 were slightly
improved (entries 11–14); here again, THF was most efficient (61%; entry 14). Considering that a
fairly high yield was obtained in a low-toxic solvent, THF was selected for further optimizations.
Optimization of the base co-catalyst
The role of the base co-catalyst is to deprotonate pre-BAC–1 in order to generate in situ the reactive
carbene catalyst, BAC–1; this step delivers as well the corresponding conjugate acid, which is
expected to influence the reaction rate (Scheme 1.40).
Scheme 1.40 General method for the deprotonation of the BAC precursor
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As mentioned, the obtained low yields of product 1–33 may be caused by the presence of HMDS, the
conjugate acid of the base co-catalyst. In turn, next we examined the use of different base co-catalysts
for the deprotonation of pre-BAC–1; a base screening for the model reaction in THF at 30 °C was
carried out using a variety of organic and inorganic bases (Table 1.2). Here, BAC–1 was prepared in
situ in the presence of both substrates; the product yields were determined using DBE as the internal
standard (1H NMR spectroscopy).
Table 1.2: Brønsted base screening for the BAC-catalysed aza-MBH model reaction
Entry Pre-BAC BrØnsted base NMR yield (%)[a]
1 + ─ NR[b]
2 + KHMDS 26
3 + NaHMDS 17
4 + LiHMDS 10
5 + LDA 12
6 + LTMP 33
7 + NaOtBu NR[b]
8 + KOtBu 24
9 + Li2CO3 NR[b]
10 + Na2CO3 26
11 + K2CO3 36
12 + Cs2CO3 57
13 + DBU 79
14 ─ DBU NR[b]
15 + TMG 60
16 + proton sponge® NR[b]
17 + DBU (5 mol%) 76[c]
18 + DBU (2 mol%) 64[d]
19 + DBU (1 mol%) 90[e]
[a] The yield was determined by 1H NMR spectroscopic analysis of the reaction mixture; internal standard: dibenzyl ether (25
mol%). [b] NR = no reaction; the desired product was not detectable, only unreacted starting materials were detected (1H
NMR analysis of the reaction mixture). [c] Reaction was carried out for 30 h. [d] Reaction was carried out for 48 h. [e]Reaction
was carried out for 72 h.
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Expectedly, the use of pre-BAC–1 alone –in the absence of a base co-catalyst– did not afford aza-
MBH product 1–33 (entry 1). Three types of metal–base co-catalysts were used in this screening;
regarding amide bases (entries 2–6), the use of LTMP showed a better reactivity compared with
MHMDS and LDA, but the yield of 1–33 was rather low (33%; entry 6). Regarding alkoxide bases
(entries 7 and 8), the use of KOtBu displayed low reactivity, whereas product 1–33 was not detected
when NaOtBu was used (entries 7 and 8). Among carbonate bases (entries 9–12), the use of Cs2CO3
afforded 1–33 in the highest yield (57%; entry 12). Next, several organic bases were examined
(entries 13–16). The use of DBU as a base co-catalyst afforded 1–33 in a 79% yield (entry 13),
whereas DBU alone displayed no activity (entry 14). In addition to the amidine base (DBU), a
guanidine (TMG) and a diamine (proton sponge®) were used but proved less effective (entries 15 and
16). Overall, DBU was found to be the most effective base co-catalyst. It is important to note that the
reaction still proceeded smoothly when a lower catalyst loading was used (1–5 mol%; entries 17–19).
For instance, aza-MBH adduct 1–33 was obtained in 90% yield at 1 mol% carbene loading although a
longer reaction time was required (entry 19).
Several factors may be considered to rationalize the efficiency of the base co-catalyst in this
cyclopropenylidene-catalysed aza-MBH reaction: (i) solubility: according to our observation, DBU
displayed a better solubility in THF than metal–base co-catalysts; when metal–base co-catalysts were
used, a small amount of a solid at the bottom of the reaction vessel was observed, which may be only
partially MBF4; (ii) basicity: the acidity of the corresponding conjugate acid may play a role; a lower
pKa value represents a stronger conjugate acid, which means that the used base co-catalyst is weaker.
The pKa value of DBU–H+ is high, which means that DBU is a strong base co-catalyst and therefore
more of the active BAC catalyst should be formed in situ. In spite of the fact that the pKa value of
tBuOH is also high, the solubility issue may be one of the reason of low efficiency (iii) hydrogen
bonding effect: despite its high pKa value, DBU–H+ may act as a hydrogen bond donor in order to
stabilize the formed zwitterionic enolate and/or to increase the electrophilicity of the imine (Scheme
1.41); other conjugate acids may be less effective in this context.
Scheme 1.41 Nucleophilic addition of enolate intermediate to an imine electrophile
With DBU as the best base co-catalyst, the effect of various solvents was re-examined; these
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experiments confirmed that THF was the most effective solvent in this racemic transformation.
Interestingly, in contrast to literature reports,[74,75] the use of a polar aprotic solvent, acetonitrile, was
substantially less efficient. Finally, the concentration of MA–1 was optimized for the best reaction
system (5 mol% DBU as base co-catalyst in THF at 30 oC; Chart 1.8).
Chart 1.8 Optimization of the concentration ofMA–1
A variety of concentrations were tested (0.05–1.0 M). It was found that 0.3 M was the best
concentration leading to a maximum product yield of 94%. The yield increased with an increasing
concentration; however, if the concentration was too high, a detrimental effect was observed.
Control experiments with other carbenes
Next, we compared the developed BAC catalysis with the use of other carbenes: in situ-formed NHCs,
a CAAC, and other BACs. All control reactions were carried out under the optimized conditions
(Table 1.3).
Table 1.3: Pre-BAC–1 vs. other pre-carbene salts
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Several commercially available NHC precursors (pre-NHC–2 ~ pre-NHC–10) proved to be tolerated
pre-catalysts although the maximum yield of product 1–33 dropped to 68%. Interestingly, the in situ-
generated CAAC did not display any catalytic activity under the mild conditions, which may be due to
the steric demand of this carbene species. In addition, two other BAC pre-catalysts, pre-BAC–2 and
pre-BAC–3, proved to be rather ineffective. Potential reasons for this decreased catalytic activity
include different steric demand (Et or Cy vs. iPr) and counteranion (BPh4– vs. BF4–), which may result
in differences regarding nucleophilicity (of the zwitterionic enolate) and solubility (of the conjugate
acid). Overall, the initially used cyclopropenylidene precursor, pre-BAC–1, was shown to be the best
pre-catalyst for the aza-MBH model reaction.
1.2.5.4 Substrate Scope
With the optimized BAC catalysis protocol in hand, the effect of the N-protecting group of
benzaldehyde-derived imines was examined (Table 1.4).
Table 1.4 Influence of N-protecting group on the BAC-catalysed aza-MBH model reaction
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All imines with N-tosyl (Imine–1), N-nosyl (Imine–2), and N-nasyl (Imine–3) protecting groups gave
product 1–33 in high yields. Imine–1 was found to be slightly more reactive than the two other imines.
On the other hand, less electrophilic imines with less activating N-protecting groups, such as phenyl
(Imine–4), para-methoxyphenyl (Imine–5), benzyl (Imine–6), and tert-butyl (Imine–7), were
unreactive even at 60 °C; only starting materials were recovered. Considering the price of the
commercially available sulfonyl amide precursors and the obtained yields, only the N-tosyl protecting
group was considered for substrate scope. N-Tosyl aldimines were easily prepared from commercially
available aldehydes, N-tosyl amide, and tetraethyl orthosilicate according to a literature method
(Scheme 1.42).[54]
Scheme 1.42 Preparation of N-tosyl aldimines[54]
With a broad variety of aromatic, heteroaromatic, and aliphatic N-tosyl aldimines in hand, the scope of
the BAC-catalysed aza-MBH reaction was investigated using cyclopentenone (MA–1) under the
optimized conditions (Table 1.5).
Table 1.5: Substrate imine scope for the BAC-catalysed aza-MBH reaction[a]
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[a] Isolated yield of products after purification by preparative thin-layer chromatography (PTLC).
Interestingly, all aromatic imines with either electron-donating groups (Me, OMe, OH, NH2, NMe2) or
electron-withdrawing groups (F, Cl, Br, CO2Me, CF3, CN, NO2) were smoothly converted to the
corresponding aza-MBH adducts in 84–95% isolated yields. In case of electron-withdrawing groups
with a higher Hammett constant σ (CF3: 0.54; CN: 0.66; NO2: 0.78),[55] the reactions gave the
corresponding products 1–49 ~ 1–51 in high yields after a short time reaction. It was found that some
challenging functional groups such as unprotected OH and NH2 groups (low σ values; OH: –0.37; NH2:
–0.66)[55] were also tolerated. Importantly, various heterocyclic imines with distinct electron demand
also proved to be excellent substrates giving products 1–52 ~ 1–59 in 64–92% yields. It is noted that
the cyclopropenylidene catalyst was also found to be compatible with primary, secondary, and tertiary
aliphatic imines. In summary, the BAC-catalysed aza-MBH reaction between cyclopentenone (MA–1)
and various aromatic, heteroaromatic, and aliphatic imines has proceeded under mild conditions.
Important functionalities such as amino and hydroxy groups have been tolerated. The electrophile
scope for this BAC catalysis proved to be very broad and went far beyond the NHC catalysis reported
by Ye.[44]
Next, we explored the scope of pro-nucleophiles for this aza-MBH reaction using Imine–1 as
electrophile (Table 1.6). Various types of Michael acceptors –including α,β-unsaturated aldehydes,
cyclic or acyclic α,β-unsaturated ketones, and α,β-unsaturated carboxylic acid derivatives– were used
at 30–60 oC.
45
Table 1.6: Pro-nucleophile scope for the catalytic aza-MBH reaction using pre-BAC–1
Michael acceptors such as α,β-unsaturated aldehydes, ketones, esters, amides, and acrylonitrile, were
shown to be compatible to give the corresponding aza-MBH adducts 1–34 ~ 1–36, 1–38, and 1–63 ~
1–69 in 43–92% yields even though in most cases a higher catalyst loading (10 mol%) and a higher
temperature (60 oC) were required. Remarkably, the use of the two α,β-unsaturated aldehydes under
BAC catalysis conditions resulted in a MBH-type a3d2 umpolung [Scheme 1.43a)]. Usually, under
NHC catalysis these pro-nucleophiles undergo a “classic” a1d3 umpolung [Scheme 1.43b)].[56] In
contrast to the initial trial (see Scheme 1.34; P33), even acrylonitrile (1–38) proved to be a successful
substrate although under rather harsh conditions.
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Scheme 1.43 BAC vs. NHC catalysis for Michael aldehyde pro-nucleophiles
Although a decent variety of pro-nucleophiles proved to react, the conditions were rather harsh (up to
60 oC). In turn, a less sterically demanding pre-catalyst, pre-BAC–2, was used with the aim to
improve the results under milder conditions (Table 1.7).
Table 1.7: Pro-nucleophile scope for the catalytic aza-MBH reaction using pre-BAC–2
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Here, it was found that all Michael acceptors displayed good reactivity at 40 oC to give the
corresponding aza-MBH adducts in 60–96% yields. This tendency may be due to the fact that the less
sterically demanding cyclopropenylidene catalyst (Et vs. iPr) was more apt to activate more
challenging pro-nucleophiles.
Finally, even more challenging pro-nucleophiles were examined using the most efficient catalyst
systems (Table 1.8). β-Substituted cycloalkenones MA–2, MA–3, and MA–4, and cycloheptenone
(MA–5) were found to be unreactive even at 80 oC; this lack of reactivity may be ascribed to the steric
demand at the electrophilic site and the larger ring size, respectively. More sterically bulky Michael
esters, such as ethyl and tert-butyl acrylate (MA–6 and MA–7), proved to be unreactive even under
forcing conditions.
Table 1.8: Unsuccessful pro-nucleophiles in the BAC-catalysed aza-MBH reaction
Next, we turned our attention to the reaction mechanism of this BAC catalysis with the aim to
potentially detect reaction intermediates.
Detection of reaction intermediates
In Ye’s work regarding the NHC-catalysed aza-MBH reaction,[44] a catalytic cycle was proposed that
basically followed the classic aza-MBH mechanism (Scheme 1.44). The reaction between Imine–1
and NHC–1 resulted in the formation of the corresponding adduct, which was isolated in 82% yield.
The reaction between this adduct and MA–1 still afforded aza-MBH product 1–33, which indicated
that the addition of NHC–1 to Imine–1 was reversible, and the adduct represented a resting state of the
carbene catalyst. In turn, a typical aza-MBH mechanism was proposed. The free NHC was would add
as a nucleophile to the electrophilic β-position of cyclopentenone (MA–1) to form zwitterionic enolate
VIII. The latter would add to the C=N double bond of the N-tosyl imine to form a C–C bond. The
following intermolecular C-to-N proton transfer in intermediate IX would lead to another zwitterionic
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enolate X, which would undergo β-elimination to form the C=C double bond in product 1–33 with
concomitant regeneration of the NHC catalyst.
Scheme 1.44 Proposed catalytic cycle for the NHC-catalysed aza-MBH reaction[44]
In order to provide further evidence for the proposed cycle, Ye et al. also conducted a reaction with an
equimolar mixture of NHC–1 and cyclopentenone (MA–1) at room temperature. Although the thin-
layer chromatography (TLC) showed the consumption of MA–1, the isolation of the anticipated
intermediate VIII failed, and “only some unidentified compounds were detectable”.[44]
With these literature results in mind, we attempted to trap critical reaction intermediates (Scheme 1.45).
In stoichiometric experiments, cyclopentenone (MA–1) and N-tosyl imine (Imine–1) were separately
reacted with pre-BAC–1 in the presence of DBU in THF. In case of MA–1, the proposed BAC-based
enolate V was not detected in the reaction mixture; only a decreased amount of MA–1 was observed
(1H NMR spectroscopy). In case of Imine–1, although a new singlet at ~ 5.0 ppm was observed (1H
NMR spectroscopy), efforts to isolate a potential adduct failed to date. At this stage, we assumed a
classic aza-Morita–Baylis–Hillman mechanism (Scheme 1.45).
Scheme 1.45 Proposed catalytic cycle for the BAC-catalysed aza-MBH reaction
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In this context, it is noted that Bertrand et al. reported a reactivity study using different stable cyclic
and acyclic mono- and diamino carbenes in the presence of organic substrates such as methyl acrylate
or benzaldehyde.[41] Similarly, transient species were not isolated, only the corresponding reaction
products.
After the initial success with BAC-catalysed aza-MBH reactions, we were interested in extending this
novel methodology to the use of other electrophiles, such as azodicarboxylates and halogenation
reagents, in view of catalytic C–N and C–Hal bond formations (Scheme 1.46).
Scheme 1.46 Possibility for BAC-catalysed C–N and C–Hal bond formations
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1.2.6 α-Hydrazination of Michael Acceptors
1.2.6.1 Literature: Azodicarboxylates in MBH-Type Reactions
Although the coupling of the α-position of activated alkenes (vinyl anion equivalents) with various
carbon electrophiles has emerged as an important C–C bond formation in organic synthesis, the
equally important C–X bond formation through a similar strategy has received less attention.[57] In
fact, the electrophilic amination of carbanion equivalents is an important C–N bond-forming strategy
offering a convenient entry into both natural and non-natural amino acids and other synthetically and
biologically useful building blocks.[58] Commonly used electrophiles for this purpose are
azodicarboxylates, azides, oxaziridines etc.
In 1998, Kamimura et al. used DABCO to mediate an aza-MBH-type reaction between diethyl
azodicarboxylate (DEAD) or di-tert-butyl azodicarboxylate and α,β-unsaturated ketones in THF
(Scheme 1.47).[59] The corresponding products were obtained in high yields. Most of these reactions
required a high catalyst loading or even a stoichiometric amount of DABCO. In contrast, the
corresponding reaction between DEAD and different acrylates, under otherwise identical conditions,
did not proceed. In order to overcome this limitation, Shi et al. investigated the same DABCO-
triggered aza-MBH-type reaction in DMF, which proved to be successful even for acrylates (Scheme
1.47).[60] The corresponding products were obtained in moderate to good yields.
Scheme 1.47 First DABCO-catalysed α-hydrazination
In contrast to the well-developed MBH reaction of terminal alkenes, such as acrylates and vinyl
ketones, β-substituted alkenes remain challenging substrates for both the MBH and the aza-MBH
reaction. In 2006, Namboothiri et al. reported the first aza-MBH-type coupling between
azodicarboxylates and various β-nitro styrenes mediated by imidazole or DMAP [Scheme 1.48a)].[61]
The corresponding products were obtained in up to quantitative yield.
51
Scheme 1.48 Stoichiometric and catalytic α-hydrazination of α-nitro alkenes
In 2013, Shi et al. reported an efficient NHC-catalysed coupling between azodicarboxylates and
various β-nitro alkenes [Scheme 1.48b)].[62] Importantly, aromatic and aliphatic Michael acceptors
proved to be applicable, and only 5 mol% of pre-NHC–12 were required in the presence of DMAP as
a base co-catalyst; the use of DMAP alone proved to be ineffective.
1.2.6.2 BAC-Catalysed α-Hydrazination of Michael Acceptors
In light of the limited earlier work on catalytic α-hydrazination of Michael acceptors,[59-62] and
encouraged by the success regarding the BAC-catalysed aza-MBH reaction, we envisioned the
developed BAC catalysis to be applicable to α-hydrazination. Although the N=N double bond of
azodicarboxylates is not polarized, based on the bond energies of C=N (615 kJ/mol) and N=N (418
kJ/mol) double bonds,[63] we expected a cyclopropenylidene to be active enough to trigger C–N cross-
coupling with Michael acceptors in an aza-MBH-type fashion (Scheme 1.49).
Scheme 1.49 Proposed pathway for the BAC-catalysed α-hydrazination of cyclopentenone
The critical zwitterionic enolate V would be formed through conjugate addition of the BAC catalyst to
cyclopentenone. Subsequent C–N bond formation would occur between V and DEAD to generate the
corresponding adduct XII. The following intermolecular C-to-N proton transfer followed by β-
elimination would form the C=C double bond in the product with regeneration of the catalyst.
In an initial experiment, we used the commercially available substrates DIAD and MA–1 in the
presence of pre-BAC–1 and DBU in THF (Scheme 1.50).
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Scheme 1.50 Initial trials of BAC-catalysed C–N bond formation
While the experiment at 30 oC failed to give the expected product 1–70, heating to 40 oC resulted in
the formation of 1–70 in 78% NMR yield. In this context, the separate use of pre-BAC–1 and DBU
failed to give 1–70. Likewise, the use of other metal-free and metal–base co-catalysts or other
solvents proved to be less effective. Finally, the concentration of MA–1 was optimized under the best
reaction conditions, i.e., the use of 5 mol% DBU as base co-catalyst in THF at 40 oC (24 h; Chart 1.9).
Chart 1.9 Optimization of concentration ofMA–1
A variety of concentrations of MA–1 were tested (0.05–1.0 M). According to our observation, the
product yields increased with an increasing concentration of MA–1. It was found that 1.0 M was the
best concentration ofMA–1 leading to a maximum yield of 95% for 1–70.
With the optimized BAC catalysis protocol in hand, the scope of pro-nucleophiles for this α-
hydrazination was investigated (Scheme 1.51). α,β-Unsaturated cyclic and acyclic ketones, acrylates,
acrylonitrile, and β-nitro styrene were used. It was found that all pro-nucleophiles were tolerated
under the optimized conditions; the corresponding products 1–70 ~ 1–78 were obtained in 75–98%
yields.
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Scheme 1.51 Scope for the BAC-catalysed α-hydrazination of Michael Acceptors
In summary, we developed a general BAC-catalysed α-hydrazination of different types of Michael
acceptors using an azodicarboxylate at low catalyst loading (5 mol%). The corresponding products
were obtained in high yields under mild conditions. This simple carbene catalysis has provided a
substantial advance with respect to the current state-of-the-art in literature.
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1.2.7 α-Halogenation of Michael Acceptors
In light of the earlier BAC-catalysed C–C and C–N bond formations, we anticipated that C–Hal bond-
forming reactions using electrophilic halogenation reagents may be feasible.
1.2.7.1 Literature: “Electrophilic Halogen” in MBH-Type Reactions
α-Halo enones and derivatives are versatile intermediates, which have been used for the generation of
α-carbon-substituted enones. Specifically, α-iodinated α,β-unsaturated carbonyl compounds have
proved to be useful substrates in organic synthesis, especially in transition metal-mediated
reactions.[64a] Although transition metal-mediated halogenations have been reported by Hardy,[64b]
Ritter,[64c] and Cramer,[64d] a convenient general procedure for the synthesis of α-halo enones does not
exist. Here, only metal-free protocols for α-halogenation are discussed in more detail.
In 1992, Johnson et al. reported a pyridine-mediated synthesis of α-iodo cycloalkenones using
molecular iodine in tetrachloromethane [Scheme 1.52a)].[43] The intended products were obtained in
up to quantitative yield. Compared to previous routes using iodo azides[65] or a combination of iodine
and ceric ammonia nitrate,[66] Johnson’s method represents the most common approach. The proposed
mechanism follows a Morita–Baylis–Hillman-type pathway [Scheme 1.52b)].
Scheme 1.52 A pyridine-mediated direct α-iodination and mechanism
In 2005, Krafft et al. reported a more convenient protocol for the C–I bond formation between α,β-
unsaturated carbonyl compounds and molecular iodine (Scheme 1.53).[67] The corresponding products
were obtained 16–99% yields. Here, a more nucleophilic catalyst, DMAP, was used; the aqueous
media may stabilize the zwitterionic intermediate through solvation. This method required the use of a
stoichiometric amount of a base, K2CO3, to neutralize the in situ formed HI. It is noted that the
reactions proceeded slowly in the absence of K2CO3 if a stoichiometric amount of DMAP was used.
In the absence of DMAP, an iodination was not detected.
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Scheme 1.53 DMAP-catalysed α-iodination of α,β-unsaturated carbonyl compounds[67]
Although some progress has been made in α-iodination, the conditions explored have proved to be not
suitable for α-chlorination and α-bromination. Indeed, such transformations would not be practical
due to the handling difficulty as well as the toxicity of both molecular bromine and chlorine.
In 2007, Bovonsombat et al. reported a stoichiometric method for the formation of cyclic α-bromo
enones and linear α-bromo enals, which are useful templates for organic synthesis (Scheme 1.54).[68]
Here, the combination of a nucleophilic mediator, pyridine-N-oxide, and an electrophilic bromination
reagent, N-bromosuccinimide (NBS), were used in MeCN at room temperature. The corresponding
products were obtained in up to quantitative yield.
Scheme 1.54 Pyridine-N-oxide-mediated α-bromination of α,β-unsaturated carbonyl compounds[68]
When these conditions were applied to the α-chlorination using N-bromosuccinimide (NCS), the
conversion to the corresponding products was only up to 16% even though two equivalents of NCS
were used. In 2009, Lupton et al. reported a stoichiometric method for the α-chlorination using
bisacetoxyiodobenzene (BAIB) and the HCl salt of pyridine (Scheme 1.55).[69] A number of α,β-
unsaturated carbonyls proved to be tolerated, and the corresponding products were obtained in 24–
94% yields.
Scheme 1.55 α-Chlorination of α,β-unsaturated carbonyl compounds[69]
1.2.7.2 BAC-Catalysed α-Halogenation of Michael Acceptors
Based on the fact that a stoichiometric amount of mediator was required in most α-halogenations of
Michael acceptors, we became interested in exploring a cyclopropenylidene catalyst in combination
with a suitable halogen electrophile. A mechanistic scenario for this anticipated BAC catalysis is
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shown in Scheme 1.56.
Scheme 1.56 Proposed cycle for the BAC-catalysed α-halogenation of cyclopentenone
The BAC catalyst would undergo conjugate addition to the Michael acceptor to form zwitterionic
enolate V. The latter would add to an “electrophilic halogen” reagent, i.e., N-halogenosuccinimide.
This C–X bond formation would liberate the cationic intermediate XIII together with the succinimide
anion. The latter would deprotonate XIII to form succinimide, as a stoichiometric by-product, and
another zwitterionic enolate, XIV. This intermediate would undergo β-elimination to form the C=C
double bond in the final product with concomitant regeneration of the catalyst.
Bromination
First, we explored electrophilic bromination using commercially available N-bromosuccinimide (NBS)
and cyclopentenone (MA–1) as substrates under standard BAC catalysis conditions (Scheme 1.57).
The catalytic C–Br bond formation to generate product 1–77 was observed, and the product was
isolated in 56% yield (59% NMR yield). In this context, the sole use of DBU as a potential catalyst
failed to give 1–77. Thus, the proof-of-principle for BAC catalysis was realized in the very first
attempt.
Scheme 1.57 Initial trial for BAC-catalysed α-bromination
Next, a base co-catalyst screening was carried out but all alternatives proved to be less effective. It is
important to note that the reaction still proceeded smoothly when a lower catalyst loading was used.
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For instance, the product was obtained in 46% yield after 24 hours when virtually 2 mol% of the in
situ-formed BAC catalyst were used. THF was found to be the most suitable solvent. The conditions
were further optimized in terms of temperature and substrate concentration. A variety of
concentrations ofMA–1 (0.2–1.0 M) were tested at 25 oC, 30 oC, and 40 oC (Chart 1.10).
Chart 1.10 Optimization of the concentration ofMA–1 and of the temperature for α-bromination
The yields of product 1–77 at 25 oC (0–22%), 30 oC (34–79%), and 40 oC (53–98%) revealed that a
slightly higher temperature was critical for reacticity. In addition, it was found that an increasing
substrate concentration from 0.2 M to 1.0 M also provided substantially increased product yields. The
optimal conditions were determined to be a concentration of 1.0 M of MA–1 at 40 °C giving product
1–77 in 98% yield.
Chlorination and Iodination
Based on the postulated catalytic formation of enolate V (Scheme 1.58), we also explored electrophilic
chlorinating and iodinating reagents.
Scheme 1.58 Possible extension to BAC-catalysed C–Cl and C–I bond formations
A preliminary set of experiments was carried out using N-chlorosuccinimide (NCS) and
cyclopentenone (MA–1) under standard BAC catalysis conditions (Scheme 1.59).
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Scheme 1.59 Initial trials for BAC-catalysed C–Cl bond formation
The C–Cl bond formation proceeded smoothly, and product 1–78 was isolated in 54% yield (57%
NMR yield); the catalytic use of DBU alone failed to give 1–78. The use of 5 mol% catalyst loading
provided product 1–78 in 82% yield. In analogy, we used commercially available N-iodosuccinimide
(NIS) under standard BAC catalysis conditions (Scheme 1.60).
Scheme 1.60 Initial trials for BAC-catalysed C–I bond formations
Unfortunately, only a trace amount of product 1–79 was detected, and the use of 5 mol% catalyst
loading gave 1–79 in only 38% yield. Eventually, product 1–79 was obtained in 91% yield when 10
mol% of the BAC catalyst were used for 48 h.
With these optimized BAC catalysis conditions in hand, the scope of pro-nucleophiles was explored
(Scheme 1.61). It was found that cyclic and acyclic α,β-unsaturated ketones as well as methyl acrylate
were tolerated. At 5 mol% catalyst loading, the chlorinated products 1–78 and 1–80 ~ 1–82 were
obtained in 65–82% yields. At 2 mol% catalyst loading, the brominated products 1–77 and 1–83 ~ 1–
85 were obtained in 81–98% yields. The iodinated products 1–79 and 1–86 ~ 1–88 were obtained in
74–91% yields, but 10 mol% catalyst loading and a reaction time of 48 h were required.
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Scheme 1.61 Scope for BAC-catalysed α-halogenations of Michael acceptors




In this chapter, novel BAC pre-catalysts, such as pre-BAC–1, were synthesized and characterized. In
11B NMR studies the nucleophilicity of the in situ-formed BAC–1 was assessed using a variety of
boron electrophiles (Figure 1.10). In all cases, the corresponding boron–ate complexes were detected,
which indicated that BAC–1 may be a suitable metal-free catalyst for the nucleophilic transfer of
organic fragments or hydride to suitable electrophiles.
Figure 1.10 Results for boron binding study
Next, three novel BAC–metal complexes have been successfully synthesized and characterized (Figure
1.11). In all cases, both NMR spectroscopic analysis (1H, 13C, and 71Ga) and high-resolution mass
spectroscopy (HRMS) confirmed the formation of these non-precious metal-based BAC complexes
(“molecular” structure rather than “ionic”).
Figure 1.11 Synthesized BAC–metal complexes
In preliminary experiments, in situ-formed BAC–1 (30 mol%) was shown to trigger catalytic
umpolung of benzaldehyde to afford the homo-benzoin product in ~ 60% yield (Scheme 1.60). In case
of the corresponding N-Boc-imine, the initial adduct formation was confirmed; further
experimentation will be required in order to exploit this chemistry in the context of useful bond
transformations.
Scheme 1.60 BAC-catalysed C=X umpolung reactions
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Most significantly, a rare BAC catalysis was accomplished at low catalyst loading under mild reaction
conditions (Scheme 1.61). Regarding aza-MBH reactions, a variety of substrates including aromatic,
heteroaromatic, and aliphatic imines, as well as acyclic or cyclic α,β-unsaturated ketones and
carboxylic acid derivatives were tolerated; intriguingly, functionalities such as unprotected amino and
hydroxy groups were tolerated. This novel catalytic method for C–C bond formations was
subsequently applied to α-hydrazination and α-halogenations of Michael acceptors.
Scheme 1.61 Summary of BAC-catalysed aza-MBH(-type) reactions
In light of these promising results regarding racemic BAC catalysis, investigations into asymmetric
BAC catalysis were the next logical stage of this project.
In 2007, Tamm et al. reported the synthesis of the first enantiopure BAC precursor, for which an
application in asymmetric organocatalysis seemed challenging:[70] “… our initial studies on the
benzoin condensation of benzaldehyde employing (BAC*–H)BF4 in combination with KOtBu as the
catalyst system … only up to 18% ee could be observed”. Nonetheless, we have been interested in
exploring asymmetric organocatalysis with these types of chiral non-NHC species (Figure 1.12).
Figure 1.12 First enantiopure acyclic BAC precursor
In 2013, during our cyclopropenylidene studies, Gravel et al. reported the first organocatalytic BAC-
catalysed intermolecular Stetter reactions.[71] In their work, an enantiopure bicyclic BAC precursor
was synthesized for the first time (Scheme 1.62). Its combined use with Cs2CO3 as a base co-catalyst
was shown to induce asymmetry in one example of an intermolecular Stetter reaction (36% ee).
Scheme 1.62 BAC-catalysed asymmetric Stetter reaction reported by Gravel[71]
Inspired by this seminal study, we envisioned the development of an asymmetric version for BAC-
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catalysed aza-MBH reactions (Scheme 1.63).
Scheme 1.63 Possibility of BAC-catalysed asymmetric aza-MBH reactions
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2 BAC-CATALYSED ASYMMETRIC AZA-MBH REACTIONS
2.1 Introduction
Parallel to the emerging concept of bifunctional asymmetric catalysis, the development of asymmetric
versions of the aza-Morita–Baylis–Hillman reaction has remarkably evolved over the past decade.[72]
Indeed, various acid–base catalysts have been newly introduced in order to achieve high asymmetric
induction for a broad variety of pro-nucleophiles.
2.1.1 Use of a Single Catalyst System in Literature
Catalyst system composed of an amine Lewis base and a hydrogen bond donor in one molecule
Initially, enantiopure tertiary amine catalysts based on the quinidine framework have been investigated.
In 1999, Hatakeyama et al. used the modified cinchona alkaloid β-ICD (N*/OH–1) to catalyze the first
highly enantioselective MBH reaction between aldehydes and acrylate MA–8 (Scheme 2.1).[73] The
corresponding MBH adducts were obtained with 91% to >99% ee; other quinidine derivatives have
proved to be inefficient. This seminal report has initiated further studies into catalytic asymmetric
MBH and aza-MBH reactions.
Scheme 2.1 First catalytic asymmetric MBH reaction using the Hatakeyama catalyst[73]
In 2002, Shi et al. reported the first highly enantioselective aza-MBH reactions between aromatic N-
tosyl aldimines and a variety of Michael acceptors, including methyl acrylate (MA–9), methyl vinyl
ketone (MVK; MA–10), and acrylonitrile (MA–11; Scheme 2.2).[74] Using the Hatakeyama catalyst
(N*/OH–1), the corresponding aza-MBH adducts were obtained with 34–99% ee. However, under the
explored conditions the use of aliphatic imines gave unidentified side-products. Furthermore, it was
found that the absolute configuration of the products varied depending on the nature of the pro-
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nucleophiles. The use of an α,β-unsaturated ketone (MA–10) afforded the (R)-adducts, whereas the
use of an acrylate (MA–9) and acrylonitrile (MA–11) provided the (S)-adducts.
Scheme 2.2 First catalytic asymmetric aza-MBH reactions with various Michael acceptors[74]
After identifying this difference in the stereochemical outcome, Shi et al. used the same catalyst to
reinvestigate systematically the aza-MBH reaction between aromatic N-tosyl aldimines and various
Michael acceptors (Scheme 2.3).[75] It was found that when α,β-unsaturated ketonesMA–10 and MA–
12 were used, the corresponding (R)-adducts were formed [Scheme 2.3a)]. Here again, the
corresponding (S)-adducts were obtained when acrylates MA–9, MA–13, MA–14, acrolein (MA–15),
and acrylonitrile (MA–11) were used [Scheme 2.3b),c)]. The corresponding products were obtained
with 43–94% ee.
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Scheme 2.3 Catalytic asymmetric aza-MBH reactions with various Michael acceptors[75]
Despite the fact that catalyst N*/OH–1 has proved to be highly efficient in asymmetric aza-MBH
reactions, the scope remained limited to aromatic aldimines. In turn, several novel bifunctional
catalysts derived from N*/OH–1 have been developed in order to achieve high asymmetric induction
for the use of both aromatic and aliphatic aldimines.
In 2008, Zhu and Masson et al. developed a new β-ICD-type bifunctional compound, N*/NH–1, that
served –in combination with 2-naphthol– as a highly effective dual catalyst for the enantioselective
aza-MBH reaction between various N-tosyl aldimines and acrylate MA–16 (Scheme 2.4).[76] It is
noted that the reaction proceeded smoothly even for aliphatic aldmines to give the corresponding
adducts with 84–87% ee. Considering the role of the dual catalyst, it was proposed that a pairing of
cooperative hydrogen bonds was critical for asymmetric induction; these non-covalent interactions
favor nucleophilic addition of the zwitterionic enolate to the imine from the Re face in a less crowded
transition state, which accounts for the observed absolute configuration.
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Scheme 2.4 Catalytic asymmetric aza-MBH reactions with 2-naphthyl acrylate (MA–16)[76]
Based on this mechanistic assumption, Zhu et al. anticipated that this type of dual catalytic system
should favor the formation of (S)-adducts regardless of the nature of the Michael acceptor used.
Therefore, a new β-ICD-type catalyst, N*/NH–2, was used in aza-MBH reactions of N-tosyl imines
with Michael ketones MA–10 and MA–12 (Scheme 2.5).[77] It was found that the presence 2-naphthol
as an achiral protic additive was critical to provide the products with (S)-configuration. In contrast, in
the absence of 2-naphthol or when N*/OH–1 was used, (R)-adducts were formed. The corresponding
products were obtained with 78–98% ee.
Scheme 2.5 Catalytic asymmetric aza-MBH reactions with alkyl vinyl ketones[77]
Soon after this discovery, Zhu et al. reported bifunctional compound N*/NH–3, which served –in
combination with 2-naphthol– as an effective catalyst for highly enantioselective aza-MBH reactions
between aliphatic amidosulfones and Michael acceptorsMA–10,MA–14, andMA–15 (Scheme 2.6).[78]
Here, the absolute configuration of the corresponding adducts proved to be the same for each pro-
nucleophile (87–94% ee).
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Scheme 2.6 Catalytic asymmetric aza-MBH reactions between α-amidosulfones and various Michael acceptors[78]
In 2005, Sasai et al. designed the bifunctional organocatalyst N*/OH–2 for enantioselective aza-MBH
reactions between aromatic N-tosyl aldimines and Michael acceptors MA–10, MA–12, and MA–15
(Scheme 2.7).[79] The corresponding adducts were obtained with 87–95% ee. It was found that the
stereochemical outcome was influenced to a large extent by the critical factors: (1) the position of the
Lewis base attached to the BINOL skeleton; (2) the acid–base functionalities (basic site for the
nucleophilic addition to the Michael acceptor, and acidic site for pairing of cooperative hydrogen
bonds) for the activation of both substrates; (3) the fixed conformation of the organocatalyst.
Scheme 2.7 Catalysed asymmetric aza-MBH reactions with various Michael acceptors[79]
Catalyst system composed of a phosphine Lewis base and a hydrogen bond donor in one molecule
In 2003, Shi et al. used the enantiopure bifunctional phosphine P*/OH–1 to catalyze asymmetric aza-
MBH reactions between aromatic N-tosyl aldimines and Michael acceptors MA–10, MA–12, MA–13,
MA–14, MA–15, and MA–16 (Scheme 2.8).[80] The corresponding adducts were obtained with 49–
92% ee. It was found that the presence of the hydroxy group in the catalyst was critical for the
reactivity; a simple phosphine did not catalyze this reaction. It is noted that in all cases the absolute
configuration of the products did not depend on the nature of the Michael acceptor.
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Scheme 2.8 Catalytic asymmetric aza-MBH reactions with various Michael acceptors[80]
A detailed mechanism was proposed to rationalize the absolute configuration of the aza-MBH adducts
(Scheme 2.9).[80] The catalytic pathway was proposed to be initiated by conjugate addition of the
Lewis basic phosphorus atom of P*/OH–1 to the corresponding Michael acceptor (e.g. methyl vinyl
ketone) to form zwitterionic enolate I, which may be stabilized through hydrogen bonding to the
aromaticic hydroxy group within P*/OH–1. Intermediate I was detected by 1H and 31P NMR
spectroscopic analysis. I would add to the C=N double bond of the imine to form adduct II. A
subsequent intermolecular proton transfer followed by β-elimination would from the C=C double bond
in the product with concomitant release of the catalyst.
Scheme 2.9 Proposed mechanism of the asymmetric aza-MBH reaction catalysed by P*/OH–1[80]
In 2005, Shi et al. synthesized an enantiopure phosphine catalyst, P*/OH–2, bearing long
perfluoroalkyl chains (Scheme 2.10).[83] This idea was inspired by the observation that long
perfluoroalkyl chains in a variety of chiral ligands improved the asymmetric induction in specific
cases.[82] Catalyst P*/OH–2 was shown to catalyze an asymmetric aza-MBH reaction between N-tosyl
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aldimines and methyl vinyl ketone (MA–10).[83] The corresponding (S)-adducts were obtained with
71–95% ee.
Scheme 2.10 Catalytic asymmetric aza-MBH reaction with methyl vinyl ketone (MA–10)[83]
In 2006, Shi et al. developed another enantiopure phosphine catalyst, P*/OH–3, bearing three hydroxy
groups.[84] It was used to catalyze asymmetric aza-MBH reactions between N-sulfonyl aldimines and
vinyl ketones MA–10 and MA–12 (Scheme 2.11).[84] The corresponding (S)-adducts were obtained
with 72–99% ee.
Scheme 2.11 Catalytic asymmetric aza-MBH reactions with α,β-unsaturated ketonesMA–10 andMA–12[84]
In 2011, Sasai et al. developed bifunctional spiro-type phosphine P*/OH–4 (Scheme 2.12).[86] It was
used to catalyze highly enantioselective aza-MBH reactions between aromatic N-tosyl aldimines and
vinyl ketones MA–10 and MA–12.[86] The corresponding products were obtained with 85–98% ee; it
is noted that the absolute configuration observed for the adducts, (R), was opposite Shi’s previous
work[80,83,84] [(S); see Scheme 2.8, 2.10, and 2.11).
Scheme 2.12 Catalytic asymmetric aza-MBH reactions with α,β-unsaturated ketonesMA–10 andMA–12[86]
Having studied in detail these bifunctional P*/OH catalysts for the asymmetric aza-MBH reaction, Shi
et al. continued exploring the potential of this dual catalysis. The aromatic hydroxy group in the
catalyst was replaced by another hydrogen bond donor such as a thiourea, i.e., P*/NH–1 (Scheme
2.13).[81] Shi et al. used P*/NH–1 –combined with benzoic acid– to catalyze highly enantioselective
aza-MBH reactions between N-tosyl aldimines and Michael acceptors MA–10, MA–12, MA–15, and
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MA–17. The corresponding products were obtained with 67–97% ee. This study represented the first
example of synthesis and application of a bifunctional thiourea in asymmetric catalysis.
Scheme 2.13 Catalytic asymmetric aza-MBH reactions with various Michael acceptors[81]
In 2008, Shi et al. developed another enantiopure phosphine catalyst, P*/NH–2, bearing an aromatic
amide hydrogen atom (Scheme 2.14).[82a] P*/NH–2 was used to catalyze asymmetric aza-MBH
reactions between aromatic N-tosyl aldimines and vinyl ketones MA–10 and MA–12. The
corresponding products were obtained with 51–91% ee.
Scheme 2.14 Catalytic asymmetric aza-MBH reactions withMA–10 andMA–12[82a]
In 2011, Lu et al. designed another novel bifunctional phosphine sulfonamide catalyst, P*/NH–3,
derived from L-threonine.[85] P*/NH–3 was used to catalyze an asymmetric aza-MBH reaction
between aromatic N-sulfonyl imines and acrylate MA–16 (Scheme 2.15). The corresponding products
were obtained with 88–97% ee. It is noted that ortho-substituted aromatic imines were found to be
suitable substrates, while these proved to be challenging in aza-MBH chemistry.
Scheme 2.15 Catalytic asymmetric aza-MBH reaction with 2-naphthyl acrylate (MA–16)[85]
2.1.2 Use of a Two-Catalyst Component System in Literature
Beside catalysts with Lewis base and hydrogen bond donor in one molecule, two-catalyst component
systems with an achiral Lewis base and an enantiopure hydrogen bond donor were also developed.
In 2005, Jacobsen et al. used enantiopure Thiourea*, together with a stoichiometric amount of
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DABCO, to catalyze an asymmetric aza-MBH reaction between aromatic N-nosyl aldimines and
methyl acrylate (MA–9; Scheme 2.16).[87] The corresponding products were obtained with 87–99% ee.
Scheme 2.16 DABCO-mediated asymmetric aza-MBH reaction catalysed by an enantiopure thiourea[87]
In 2010, Shibasaki et al. found that the combined use of a La alkoxide, a linked BINOL, an aromatic
carboxylic acid, and DABCO effectively catalysed an aza-MBH reaction between various N-
phosphinoyl imines and methyl acrylate (MA–9; Scheme 2.17).[88] The corresponding products were
obtained with 81–98% ee.
Scheme 2.17 Asymmetric aza-MBH reaction catalysed by DABCO and an enantiopure La complex [88]
In 2012, Shibata et al. used an enantiopure Pd Lewis acid catalyst together with a catalytic amount of
DABCO as a Lewis base to catalyze an asymmetric aza-MBH reaction between aromatic N-tosyl
aldimines and acrylonitrile (MA–11; Scheme 2.18).[89] The corresponding products were obtained
with 76–98% ee.
Scheme 2.18 Asymmetric aza-MBH reaction catalysed by DABCO and an enantiopure Pd complex[89]
2.1.3 Aims
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We aimed to develop novel enantiopure BAC catalysts for general asymmetric aza-MBH reactions
(Scheme 2.19). A highly asymmetric BAC catalysis had not been reported. Although several catalytic
asymmetric aza-MBH reactions have been reported using different types of enantiopure (dual)
catalysts, several drawbacks were apparent, including the lack of generality (limited substrate scope),
the necessity of a very low reaction temperature, and the use of rather complex (dual) catalyst systems.
We wanted to develop a general method that could tolerate a broad variety of aromatic and aliphatic
imines as well as different types of Michael acceptors (α,β-unsaturated aldehydes, ketones, esters,
amides, and nitriles), including sterically demanding substrates.
Scheme 2.19 Potential for asymmetric BAC catalysis?
In order to achieve this goal, different types of enantiopure BAC precursors were considered (Figure
2.1): bicyclic diamine-derived pre-BAC*–1 ~ pre-BAC*–3; [71] acyclic species pre-BAC*–4;[70]
bicyclic BINOL-derived pre-BAC*–4; acyclic imidazolidinone-derived pre-BAC*–6.
Figure 2.1 Envisaged enantiopure BAC precursors
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2.2 Results and Discussion
2.2.1 Synthesis of Enantiopure BAC Precursors
In 2007, Tamm et al. reported the synthesis of an acyclic ennatiopure BAC precursor from a
commercially available diamine, (+)-bis[(R)-1-phenylethyl]amine (Scheme 2.20).[70]
Scheme 2.20 Synthesis of pre-BAC*–4 by Tamm[70]
The commercially available diamine and tetrachlorocyclopropene were reacted in dichloromethane to
afford intermediate III. Upon treatment with tetrafluoroboric acid intermediate IV was formed
through an anion exchange. Successive reactions with triphenyl phosphine and water the enantiopure
cyclopropenylidene precursor pre-BAC*–4 as a colorless solid.
In 2013, Gravel et al. reported the synthesis of a bicyclic enantiopure BAC precursor bearing an 8-
membered ring as a chiral backbone (Scheme 2.21).[71] The treatment of commercially available (S)-(–
)-α-methylbenzyl amine and succinic anhydride afforded the ring-opened condensate (acid), which
was reacted with another equivalent of (S)-(–)-α-methylbenzyl amine in the presence of stoichiometric
amounts of DMAP and 1,3-dicyclohexylcarbodiimide to form chiral bis(amide) 2–1.[90] The latter was
fully reduced using an excess of LiAlH4 to afford the corresponding chiral bis(amine) 2–2.[90]
Tetrachlorocyclopropene and 2–2 were reacted in the presence of an excess of Hünig’s base to form
chlorocyclopropenium salt V. Treatment of V with polystyrene-supported triphenyl phosphine gave
the corresponding BAC intermediate VI, which was in situ treated with water and sodium
tetraphenylborate to give cyclopropenylidene precursor pre-BAC*–1 as a colorless solid.
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Scheme 2.21 Synthesis of pre-BAC*–1 by Gravel[71,90]
Based on the synthesis of achiral BAC precursors (see Scheme 1.11), and the literature reports
(Schemes 2.20 and 2.21), a general scheme was considered for the synthesis of a variety of
enantiopure cyclopropenylidene precursors (Scheme 2.22). An enantiopure diamine had to be
synthesized from the corresponding commercially available chiral amine. The reaction between this
diamine and tetrachlorocyclopropene, followed by successive treatment of the reaction mixture with
sodium tetrafluoroborate, polymer-supported triphenyl phosphine, and water, should afford the
corresponding enantiopure BAC precursor.
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Scheme 2.22 Proposed synthetic procedure for enantiopure BAC precursors
Gravel’s pre–catalyst bearing an 8-membered ring, pre-BAC*–1, as well as its 7- and 6-membered
ring analogs, pre-BAC*–2 and pre-BAC*–3, were successfully synthesized according to this
procedure (Scheme 2.22). The corresponding enantiopure BAC precursors were obtained in 80–86%
yields over three steps (Figure 2.2). The 1H NMR spectroscopic data and molecular models for these
compounds are shown in Chart 2.1.
Figure 2.2 Overview for the (attempted) synthesis of enantiopure BAC precursors
Attempts were also made to prepare the other enantiopure BAC precursors (Figure 2.2). We tried to
synthesize Tamm’s salt pre-BAC*–4.[70] However, after successful preparation of intermediates III
and IV (see Scheme 2.20) –as confirmed by 1H, 11B, and 19F NMR spectroscopic analysis– the final
proto-dechlorination step of IV failed in our hands. Regarding the synthesis of pre-BAC*–5 and pre-
BAC*–6, the first double condensation between tetrachlorocyclopropene and the corresponding
enantiopure secondary amine proved to be too challenging. The intended reactions did not occur
under mild conditions, and messy reaction mixtures were obtained under more forcing conditions.
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Chart 2.1 1H NMR spectra for pre-BAC*–1 ~ pre-BAC*–3 and molecular models for the corresponding BACs
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2.2.2 Asymmetric BAC Catalysis – Initial Experiments
With the three enantiopure BAC precursors in hand, a first set of asymmetric aza-MBH reactions was
carried out between benzaldehyde-derived N-tosyl imine Imine–1 and cyclopentenone (MA–1) under
“racemic BAC catalysis” conditions (Scheme 2.23).
Scheme 2.23 Initial trials in asymmetric catalysis with the ennatiopure BAC pre-catalysts
The intended C–C bond formation proceeded smoothly in each case. The use of Gravel’s pre-BAC*–1
(8-membered ring backbone) gave product 2–3 in 78% isolated yield with 35% ee. Importantly, the
use of the novel BAC precursor pre-BAC*–2 (7-membered ring backbone) gave product 2–3 in 86%
isolated yield with 67% ee. The use of the third pre-catalyst, pre-BAC*–3 (6-membered ring
backbone), did not allow to further improve this result (75% y, 58% ee). At this stage, the absolute
configuration of the enantiomerically enriched product 2–3 was determined. By analogy with a
literature report,[74] chiral HPLC analysis determined the absolute configuration of all three samples to
be R (Chart 2.2).
Chart 2.2 Comparison of chiral HPLC analyses of product 2–3
Since the pre-BAC*–2 proved to be substantially more selective than the two analogs, further
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optimizations were carried out using this novel pre-catalyst.
2.2.3 Optimization of Reaction Parameters
First, a base co-catalyst screening was carried out under otherwise identical conditions (Table 2.1).
The yields were determined after purification by preparative thin-layer chromatography (PTLC), and
the optical purity (ee) was determined by chiral HPLC analysis.
Table 2.1: Base co-catalyst screening for the BAC-catalysed asymmetric aza-MBH reaction
Entry pre-BAC*–2 BrØnsted base Yield (%)[a] ee (%)[c]
1 + DBU 82 67
2 + ─ NR[b] ─
3 + TMG 62 56
4 + proton sponge® NR[b] ─
5 + KHMDS 25 45
6 + NaHMDS 17 41
7 + LiHMDS 10 37
8 + LDA 10 32
9 + LTMP 30 38
10 + LiOtBu 15 18
11 + NaOtBu 23 19
12 + KOtBu 35 18
13 + Li2CO3 NR[b] ─
14 + Na2CO3 NR[b] ─
15 + K2CO3 NR[b] ─
16 + Cs2CO3 75 80
17 ─ Cs2CO3 NR[b] ─
[a] Yields were determined after purification by preparative thin-layer chromatography (PTLC). [b] NR = no reaction; the
desired product was not detectable, only unreacted starting materials were detected (1H NMR analysis of the reaction
mixture). [c] The ee was determined by chiral HPLC analysis.
In contrast to the initial benchmark result in asymmetric catalysis with DBU as a base co-catalyst
(82% y, 67% ee; entry 1), the sole use of pre-BAC*–2 as a potential catalyst did not give product 2–3
(entry 2). The use of other metal-free base co-catalysts proved to be less effective in terms of both
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reactivity and asymmetric induction (entries 3 and 4). Next, several metal–base co-catalysts were
examined (entries 5–16). Among amide and alkoxide bases (entries 5–12), the use of KHMDS as a
co-catalyst gave product 2–3 with the best optical purity (45% ee; entry 5). Among carbonates (entries
13–16), only the use of the Cs2CO3 co-catalyst gave product 2–3 (75%; entry 16); in addition, the
optical purity of product 2–3 proved to be best among all base co-catalysts examined (80% ee). In this
context, in the absence of pre-BAC*–2, the use of Cs2CO3 alone did not catalyze this reaction; only
starting materials were recovered (entry 17). The HPLC charts of the enantiomerically enriched
product 2–3 obtained using DBU and Cs2CO3 as co-catalyst are displayed in Chart 2.3.
Chart 2.3 Chiral HPLC charts for the use of DBU and Cs2CO3 as co-catalyst
The base screening revealed DBU and Cs2CO3 to be the most effective co-catalysts for the in situ
generation of the enantiopure BAC catalyst. Thus, both base co-catalysts were used to examine the
solvent effect (Table 2.2).
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Table 2.2: Solvent screening for the BAC-catalysed asymmetric aza-MBH reaction
Entry Base Solvent (Ɛ) Yield (%)[a] ee (%)[c]
1
DBU
dioxane (2.3) 70 40
2 toluene (2.4) 74 67
3 TBME (2.6) 28 20
4 Et2O (4.3) 15 15
5 THF (7.5) 82 67
6 DCM (9.1) NR[b] ─
7 tBuOH (18.0) 70 42
8 EtOH (24.6) 69 48
9 MeOH (33) 52 53
10 MeCN (37.5) 24 35
11 DMF (38.0) 48 50
12
Cs2CO3
dioxane (2.3) 72 37
13 toluene (2.4) 70 35
14 TBME (2.6) 19 30
15 Et2O (4.3) NR[b] ─
16 THF (7.5) 76 81
17 DCM (9.1) NR[b] ─
18 tBuOH (18.0) 68 48
19 EtOH (24.6) 70 50
20 MeOH (33) 55 58
21 MeCN (37.5) 28 40
22 DMF (38.0) 50 62
[a] Yields were determined after purification by preparative thin-layer chromatography (PTLC). [b] NR = no reaction; the
desired product was not detectable, only unreacted starting materials were detected (1H NMR analysis of the reaction
mixture). [c] The ee was determined by chiral HPLC analysis.
First, aromatic and etheral solvents were examined (entries 1–5 and 12–16). Among these, the use of
THF provided the best results regarding reactivity and asymmetric induction, although toluene proved
to be competitive when DBU was used as a co-catalyst (entries 2, 5, and 16). Usually, in catalytic
asymmetric aza-MBH reactions, THF or a more polar solvent (e.g. MeCN) have been used.
Interestingly however, the use of more polar aprotic and protic solvents provided product 2–3 with a
substantially lower asymmetric induction (entries 6–11 and 17–22). In turn, the system pre-BAC*–2 /
Cs2CO3 / THF was used for further optimizations.
Next, the substrate concentration, the amount of Cs2CO3, and the reaction temperature were optimized
(Table 2.3).
81
Table 2.3: Further optimization of the BAC-catalysed asymmetric aza-Morita–Baylis–Hillman reaction




2 0.075 51 83
3 0.1 57 84
4 0.125 66 81
5 0.2 75 79
6 0.3 81 80
7 0.5 80 69
8 2.5 32 76
9 4.5 52 78
10 0.1 5.0 30 55 84
11 5.5 79 85
12 6.0 75 84




15 10 NR[b] ─
16 20 39 84
17 25 54 86
18 30 79 85
[a] Yield were determined after purification by preparative thin-layer chromatography (PTLC). [b] NR = no reaction; the
desired product was not detectable, only unreacted starting materials were detected (1H NMR analysis of the reaction
mixture). [c] The ee was determined by chiral HPLC analysis.
At 5 mol% loading of pre-BAC*–2 and Cs2CO3 in THF at 30 oC, several substrate concentrations
(0.05–0.5 M) were tested (entries 1–7). It was found that 0.1 M was the optimal concentration of MA–
1; product 2–3 was obtained in 57% yield with 84% ee (entry 3). Using this substrate concentration in
the presence of 5 mol% of pre-BAC*–2, the amount of Cs2CO3 (2.5–7.5 mol%) was examined (entries
8–13). These experiments revealed that a slight excess of the base co-catalyst was required; the use of
5.5 mol% of Cs2CO3 gave product 2–3 in 79% yield with 85% ee (entry 11). With these optimized
conditions in hand, the effect of the reaction temperature (0–30 oC) was investigated (entries 14–18).
All starting materials, including pre-BAC*–2 and Cs2CO3, were reacted at the corresponding
temperature; the enantiopure BAC was not pre-formed. At 0–10 oC the reaction did not proceed at all
(entries 14 and 15). These results are likely to be ascribed to the failed in situ formation of the BAC
catalyst at these lower temperatures. The experiments at 20–30 oC revealed that 25 oC was the optimal
temperature (entries 16–18); product 2–3 was formed in a lower yield (54%), but with a slightly
increased asymmetric induction (86% ee; entry 17).
As bicyclic pre-BAC*–2 with the 7-membered ring backbone displayed the best potential for
asymmetric catalysis, several analogues with the same ring size were synthesized (see Scheme 2.22;
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P75, Figure 2.3): salt pre-BAC*–7 contains a distinct counteranion, BF4– instead of BPh4–; analogue
pre-BAC*–8 bears a more sterically demanding alkyl substituent, Et instead of Me; analogues pre-
BAC*–9 and pre-BAC*–10 vary regarding the corresponding aromatic substituent, 1- and 2-naphthyl
instead phenyl.
Figure 2.3 A variety of enantiopure BAC precursors
With these novel enantiopure BAC precursors and the optimized BAC catalysis protocol in hand, the
effect on the asymmetric induction was investigated at 25 oC (48; Scheme 2.24).
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Scheme 2.24 Comparison of various enantiopure BAC precursors
It was found in that product 2–3 was obtained in high yields in all cases. The use of Gravel’s pre-
catalyst (pre-BAC*–1), bearing an 8-membered ring backbone, gave 2–3 with 54% ee. The use of
novel BAC precursors pre-BAC*–2 and pre-BAC*–3, bearing 7- and 6-membered ring backbones,
afforded 2–3 with 86% ee and 84% ee, respectively. When the counteranion in pre-BAC*–2 was
changed from BPh4– to BF4–, the resulting pre-catalyst (pre-BAC*–7) gave 2–3 only with 67% ee.
Likewise, when the aromatic substituent in pre-BAC*–2 was changed from phenyl to 1-naphthyl and
2-napthyl, the resulting pre-catalysts (pre-BAC*–9 and pre-BAC*–10) gave 2–3 only with 73% ee and
78% ee, respectively. Importantly, when the aliphatic substituent in pre-BAC*–2 was changed from
methyl to ethyl, the resulting pre-catalyst (pre-BAC*–8) gave 2–3 with 87% ee, which represented the
highest asymmetric induction of all BAC precursors used in this context.
2.2.4 Asymmetric Carbene Catalysis: Enantiopure BAC vs. NHC Precursors
Next, we compared the potential of the best enantiopure BAC pre-catalyst (pre-BAC*–8) with various
enantiopure NHC pre-catalysts under otherwise identical conditions (Table 2.4). Several of these
NHC precursors, pre-NHC*–1 ~ pre-NHC*–5, are commercially available while others were donated
by Professor Andrew Smith’s laboratory at the University of St Andrews.
Table 2.4:Asymmetric catalysis – enantiopure BAC vs. NHC precursors
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The use of in situ generated enantiopure NHCs gave product 2–3 in 22–91% yields. However, the
asymmetric induction in this aza-MBH adduct proved to be low for all these non-BAC pre-catalysts
(0–38% ee). The best asymmetric induction was obtained with NHC precursor pre-NHC*–11 bearing
a hydroxy group in proximity to the carbene site (38% ee). In light of these results, the excellent
asymmetric induction displayed by the novel enantiopure BAC pre-catalyst pre-BAC*–8 must be
regarded therefore even more remarkable (87% ee). Next, we investigated the substrate scope for this
catalytic asymmetric aza-MBH reaction.
2.2.5 Scope for 1st Generation Asymmetric BAC Catalysis
With the optimized asymmetric BAC catalysis protocol in hand, we briefly examined the effect of the
N-protecting group of benzaldehyde-derived substrates: Imine–1a (PG = Ts), Imine–2a (PG = Ns),
and Imine–3a (PG = Nas; Scheme 2.25).
Scheme 2.25 Refinement of the N-protecting group in the imine
It was found that under the optimized conditions (25 oC), only the N-tosyl imine (Imine–1a) reacted
smoothly whereas the use of Imine–2a (PG = Ns) and Imine–3a (PG = Nas) gave product 2–3 only in
trace amounts. In turn, the experiments were conducted at 35 oC, and this modification gave 2–3 in
high yields for all imines (82–94%). In case of Imine–1a (PG = Ts), the asymmetric induction in
product 2–3 was found to be slightly decreased from 87% ee (25 oC) to 86% ee (35 oC); the same
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result was observed for the use of Imine–2a (PG = Ns; 86% ee). Importantly however, the use of
Imine–3a (PG = Nas) gave product 2–3 with 88% ee, which turned out to be the best enantiomeric
excess at this stage of the study.
Next, the scope was investigated with aromatic, heteroaromatic, and aliphatic N-Nas imines using
MA–1 as the pro-nucleophile (Table 2.5).
Table 2.5: Imine scope for the BAC-catalysed asymmetric aza-MBH reaction
It was found that all aromatic imines were smoothly converted to the corresponding aza-MBH adducts
in 72–97% yields with 58–93% ee. Several tendencies regarding the asymmetric induction were
observed. It is found that the use of o-substituted imines gave products 2–7 ~ 2–12 with a higher
asymmetric induction (66–93% ee) than p-substituted imines; here, products 2–13 ~ 2–21 were formed
with 58–90% ee. It is also noted that the use of electron-poor imines (R = F, Cl, Br, CN, CO2Me, CF3,
NO2) gave aza-MBH-adducts with a higher asymmetric induction (69–90% ee) than electron-rich
imines (R = Me, OMe; 58–76% ee). The best result was obtained with o-phenol-based imine, which
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gave product 2–9 with 93% ee. Interestingly, the use of electron-rich heteroaromatic imines (furan,
thiophene, pyrrole) provided the corresponding products 2–22 ~ 2–24 with 90–91% ee, while the
eletron-poor pyridine derivatives proved to be less effective (2–25 ~ 2–27; 76–89% ee). Finally, it is
noted that this novel methodology proved to be compatible with less reactive primary, secondary, and
tertiary aliphatic imines although the asymmetric induction dropped substantially (2–28 ~ 2–30; 34–
64% ee). Among all three aliphatic imines used, the use of the tertiary substrate gave the highest
asymmetric induction (64% ee).
Next, we explored the scope of pro-nucleophiles for the BAC-catalysed asymmetric aza-MBH
reaction using o-phenol-derived N-Nas imine, Imine–3h, as the electrophile (Table 2.6). Various
Michael acceptors were examined, including α,β-unsaturated aldehydes, ketones, esters, and amides,
as well as acrylonitrile.
Table 2.6 Pro-nucleophile scope for BAC-catalysed asymmetric aza-MBH reaction
It was found that all Michael acceptors reacted smoothly under the optimized conditions to give the
corresponding aza-MBH adducts in 60–89% yields with 66–93% ee. Interestingly, alike the racemic
version, both α,β-unsaturated aldehydes underwent an a3d2 umpolung exclusively to give products 2–
31 and 2–32 with 81% and 76% ee, respectively – the typical NHC-catalysed a1d3 umpolung was not
observed.[56] The use of α,β-unsaturated ketones afforded products 2–33 ~ 2–35 with up to 93% ee.
Importantly, the α,β-unsaturated carboxylic acid derivatives were shown to undergo an unusual a3d2
umpolung exclusively to give products 2–36 ~ 2–39 with 66–75% ee, whereas the NHC-catalysed a3d3
umpolung was not detected.[45]
At this stage of the study, several enantiopure BAC pre-catalysts were successfully synthesized and
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exploited in asymmetric aza-MBH reactions (Scheme 2.26). To the best of our knowledge, these data
represent the first highly enantioselective BAC catalysis. Compared to “classic” NHC pre-catalysts
these novel cyclopropenylidene precursors displayed a substantially higher asymmetric induction in
the model reaction (87% ee vs. 0–38% ee). Remarkably, this unprecedented asymmetric BAC
catalysis went beyond the asymmetric catalysis using established NHCs.
Scheme 2.26 Summary of BAC-catalysed asymmetric aza-MBH reactions
The skeleton of our new carbene catalyst bears only a Lewis base site without a supporting hydrogen
bond donor fragment (Scheme 2.27). Therefore, the high asymmetric induction observed for a broad
variety of both imines and Michael acceptors seems surprising.
Scheme 2.27 Deprotonation of an enantiopure BAC pre-catalyst using cesium carbonate
The optical purity for most aza-MBH adducts proved to be slightly lower compared to the best dual
catalyst systems reported in literature.[72] Remarkably, the use of an enantiopure cyclopropenylidene –
as a simple Lewis base catalyst– at ambient temperature represents a very distinct feature; a hydrogen
bond donor assistance was not required for high asymmetric induction. It is noted that in our hands,
all products were formed with an R configuration; an inversion of absolute configuration was not
detected, which is another difference to certain dual catalyst systems.[72] Typically, a bifunctional acid–
base catalyst system was required; both a Lewis base and a hydrogen bond donor site have been
crafted in the chiral backbone of such cooperative organocatalyst (Figure 2.4). The Lewis base
functionality serves to activate the Michael acceptor, while the hydrogen bond donor was thought to
stabilize zwitterionic intermediates through charge–dipole interactions. Both Hatakeyama’s catalyst[73-
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78] and Shi’s catalyst[80-84] were the most representative metal-free catalysts, and proved to tolerate
various Michael acceptors. However, N*/OH–1 and P*/OH–1 had to be used at a rather low reaction
temperature, –55 oC and –30 oC, respectively. Shibata’s N/Pd* system was shown to rely on the
combined use of an enantiopure palladium Lewis acid and an achiral Lewis base at –10 oC. However,
only acrylonitrile was tolerated by this metal-based catalyst.
Figure 2.4 Most effective bifunctional catalyst systems for asymmetric aza-MBH chemistry
In Aggarwal’s mechanism study,[49] two mechanisms were proposed for the proton-transfer process: (i)
an alcohol-catalysed mechanism, in which the alcohol acts as a shuttle for transferring a proton from
the α-position to alkoxide of int2; (ii) the addition of another equivalent aldehyde would facilitate the
formation of a hemiacetal alkoxide. Their results gave the first time a clear understanding of the rate
enhancement. The hydrogen-bond donors activate the reaction through a concerted lower-energy
mechanism, in which the alcohol works as a shuttle to transfer the proton.
Although a high asymmetric induction was obtained in most cases (Tables 2.5 and 2.6), it was found
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that the enantiomeric excess of products obtained from aromatic imines (58–93% ee) was substantially
higher compared to products obtained from aliphatic imines (34–64% ee). This tendency suggested
that π stacking interactions[91] might be critical. In literature, three types of π stacking interactions
have been reported: edge–to–face, face–to–face, and parallel displaced (Figure 2.5).[92-94]
Figure 2.5 Edge–to–face, face–to–face, and parallel displaced π stacking interactions[92-94]
The benzene dimer has been the prototypical system for studying π stacking interactions. In case of an
edge–to–face π stacking, the two benzene rings were perpendicular to each other with a distance of 5.0
Å between the two centres.[93] In the other two cases, a distance of 3.9 Å between the centers was
measured.[93] Several specific examples of π stacking interactions have been reported. In 1994,
Wilcox et al. reported on the effect of intramolecular edge–to–face interactions on conformational
preferences. The X-ray crystallography analysis confirmed the edge–to–face interactions for the
folded esters (Figure 2.6).[95]
Figure 2.6 First example of edge–to–face conformational study[95]
Such interactions may offer great potential in drug design. For example, the existence of π–π, cation–
π, and OH–π interactions was proposed to facilitate binding of a drug to the active site of the targeted
enzyme (Figure 2.7).
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Figure 2.7 Binding of Eisai’s anti-Alzheimer drug Aricept to the active site of acetylcholine esterase
Considering our catalyst system, the high asymmetric induction may be a result of the o-hydroxy
group of aromatic Imine–8. Indeed, the hydroxy group may act as a hydrogen bond donor for the
basic imine nitrogen atom (Figure 2.8). Cooperative hydrogen bonding may be important as these
non-covalent interactions may favor a nucleophilic addition of the zwitterionic enolate to the imine.
Considering a potential π stacking effect, a face–to–face interaction may not be possible as the two
aromatic rings seem to be too distant to each other. However, edge–to–face interactions seem feasible
as shown in the transition state model. Accordingly, the nucleophilic enolate may attack the imine
from its Re face to provide the corresponding products predominantly with an R configuration.
Figure 2.8 Proposed transition state for the 1st generation asymmetric BAC catalysis
2.2.6 Low-Temperature Experiments
In general, the temperature is considered as a critical factor for the level of asymmetric induction.[96]
Despite the fact that up to 93% ee were observed at 35 oC without BAC pre-formation (Section 2.2.5;
P84), the reaction temperature was re-examined after BAC pre-formation (Table 2.7).
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Table 2.7: Low-temperature effect on the BAC-catalysed asymmetric aza-MBH reaction
Entry Temp (oC) Yield (%)[a] ee (%)[b]
1 35 90 93
2 20 87 93
3 0 80 94
4 –20 78 95
5 –40 70 95
[a] Yields were determined after purification by preparative thin-layer chromatography (PTLC). [b] The ee was determined by
chiral HPLC analysis.
The most effective enantiopure BAC precursor, pre-BAC*–8, was reacted with Cs2CO3 at 35 °C to
pre-form in situ the corresponding enantiopure BAC. To this catalyst solution at a specific
temperature (+35 oC ~ –40 oC) were added the two reagents, Imine–8 and MA–1. The experiments
revealed that decreasing the reaction temperature increased the asymmetric induction for product 2–9:
from 93% ee (+35 °C) to 95% ee (–20 °C), although the yield slightly dropped (from 90% to 78%).
In conclusion, we have prepared a 1st generation of enantiopure BAC pre-catalysts and exploited these
in asymmetric aza-MBH reactions. A variety of imines and Michael acceptors proved to be tolerated;
the products were obtained with up to 95% ee.
2.2.7 2nd Generation Asymmetric BAC Catalysis
The presence of a hydrogen bond donor within the Lewis base catalyst has proved critical in
asymmetric aza-MBH reactions.[74,75,79,80,83,84,86,87,88] In turn, we have attempted to synthesize an
enantiopure cyclopropenylidene scaffold that contains hydroxy groups to examine the effect of such a
potential dual catalyst in asymmetric aza-MBH reactions.[97] According to the earlier synthesis of the
simple enantiopure BAC precursors (Scheme 2.22; P75), an appropriate synthetic scheme was used for
the preparation of the bifunctional pre-catalyst pre-BAC*–11 (Scheme 2.28).
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Scheme 2.28 Synthesis of enantiopure cyclopropenylidene precursor pre-BAC*–11[71,90,97]
Double condensation of (S)-(+)-2-phenylglycinol and 1,3-dibromopropane gave bis(amine) 2–40.[97]
The latter was reacted with tetrachlorocyclopropene in the presence of an excess of Hünig’s base to
form chlorocyclopropenium salt VII. Compound VII was treated with polystyrene-supported
triphenyl phosphine, and the resulting intermediate VIII was reacted with water and sodium
tetraphenylborate to give cyclopropenylidene precursor pre-BAC*–11 as a colorless solid.[71]
With pre-BAC*–11 in hand, this enantiopure “2nd generation” pre-catalyst was evaluated against the
most effective “1st generation” pre-catalyst, pre-BAC*–8 (Scheme 2.29). Compared to the use of pre-
BAC*–8, the use of the OH-containing pre-BAC*–11 gave product 2–4 with an increased asymmetric
induction (90% ee vs. 88% ee); an inversion of absolute configuration was not detected. Based on this
significant improvement, the substrate scope was re-investigated using pre-BAC*–11.
Scheme 2.29 Comparison between pre-BAC*–8 and pre-BAC*–11
First, the scope for imines was re-examined (Table 2.8).
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Table 2.8: Imine scope for the 2nd generation BAC-catalysed asymmetric aza-MBH reaction[a]
[a] The asymmetric induction was displayed as follows: % ee [at +35 oC] / % ee [at –20 oC].
It was found that all aromatic imines were smoothly converted to the corresponding aza-MBH adducts
with 72–92% ee (+35 oC) and 79–97% ee (–20 oC), respectively. For benchmark products 2–4, 2–5,
and 2–41 the asymmetric induction proved to be high: 79–90% ee (+35 oC) vs. 85–94% ee (–20 oC).
Similar general tendencies were observed with respect to data in Section 2.2.5 (P84). Here again, the
best result was obtained with the o-phenol-based imine: product 2–9 was obtained with 97% ee. Most
importantly, the asymmetric induction for primary, secondary, and tertiary aliphatic imines were
significantly increased to 59–84% ee for products 2–28 ~ 2–30.
Next, the scope for Michael acceptors was re-examined (Table 2.9).
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Table 2.9:Michael acceptor scope for the 2nd generation BAC-catalysed asymmetric aza-MBH reaction
[a] enantiomeric excess were displayed as: (+35 oC) / (–20 oC) ee.
Here again, all Michael acceptors reacted smoothly to give the corresponding aza-MBH adducts with
67–92% ee (+35 oC) and 82–97% ee (–20 oC), respectively. Both Michael aldehydes underwent an
a3d2 umpolung to give products 2–31 and 2–32 with 88–91% ee (–20 oC); an NHC-catalysed a1d3
umpolung was not detected.[56] The use of Michael ketones gave products 2–33 ~ 2–35 with up to 97%
ee (–20 oC). The α,β-unsaturated carboxylic acid derivatives were shown to undergo an a3d2 umpolung
to give products 2–36 ~ 2–39 with 82–94% ee (–20 oC); an NHC-catalysed a3d3 umpolung was not
detected.[45] An inversion of the absolute configuration was not detected.
In conclusion, the OH-containing cyclopropenylidene precursor pre-BAC*–11 was successfully
exploited in asymmetric aza-MBH reactions with the best results being obtained at –20 oC. The
corresponding products were obtained with 59–97% ee, which represents a substantial advance
compared to pre-BAC*–8 (34–93% ee). The higher levels of asymmetric induction may be the result
of the hydroxy groups in both certain aromatic imines and the catalyst. Specifically, the hydroxy
group in the imine may act as a hydrogen bond donor to the imine nitrogen atom, whereas the hydroxy
group in the catalyst may act as a hydrogen bond donor to an oxygen atom of the sulfone N-protecting
group (Figure 2.9). Such pairing of cooperative hydrogen bonds may be critical to favor the facial
approach of the zwitterionic enolate to the imine. In addition, edge–to–face π interactions may be
anticipated as shown in the transition state model. Accordingly, the zwitterionic enolate may attack
the imine through its Re face (from top to bottom) to give the corresponding products with an R
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configuration.
Figure 2.9 Proposed transition state for 2nd generation asymmetric BAC catalysis
During the course of our studies …
Two additional examples of BAC-catalysed umpolung reactions using simple aldehydes as pro-
nucleophiles were published.
In 2014, Gravel et al. reported BAC-catalysed aza-benzoin reactions between aromatic aldehydes and
aromatic N,S-aminals as imine surrogates (Scheme 2.30).[98] The corresponding products were
obtained in 27–96% yields. However, the asymmetric version using Gravel’s enantiopure pre-catalyst,
pre-BAC*–1, gave product 2–40 with 0% ee.
Scheme 2.30 BAC-catalysed aza-benzoin condensation by Gravel[98]
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In 2015, Anand et al. reported BAC-catalysed vinylogous Stetter reactions between various aromatic
aldehydes and para-quinone methides (Scheme 2.31).[99] The corresponding α,α’-diarylated ketones
were obtained in 20–98% yields. An asymmetric version was not reported.
Scheme 2.31 BAC-catalysed vinyloguous Stetter reaction by Anand[99]
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2.3 Summary
We have accomplished the first highly enantioselective BAC catalysis. Two generations of novel
enantiopure BAC pre-catalysts were developed and applied in catalytic asymmetric aza-MBH
reactions. Importantly, it was found that a variety of naphthalene-sulfonated imines and various types
of Michael acceptors were tolerated by this novel method. The use of pre-BAC*–8 (without OH
groups) gave the products with 34–93% ee (+35 oC), whereas the use of pre-BAC*–11 (with OH
groups) gave the products with 52–92% ee (+35 oC) and 59–97% ee (–20 oC), respectively.
Scheme 2.32 Summary of asymmetric BAC-catalysed aza-MBH chemistry
In light of the outlined synthetic potential of this innovative catalyst in asymmetric aza-MBH reactions,
we next explored other electrophiles, such as diboron reagents, in asymmetric catalysis.
Scheme 2.33 Possibility of BAC-catalysed asymmetric conjugate borylation
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3 TOWARDS BAC-catalysed ASYMMETRIC BORYLATION
3.1 Introduction
3.1.1 Literature-Reported Organocatalytic Conjugate Borylation
The development of metal-free catalysis is crucial for the ecological synthesis of organic
compounds.[100] In addition to C–C bond formation, C–B bond-forming reactions are also an
important area of organic synthesis including catalysis.[101] Within C–B bond formation, the conjugate
borylation of Michael acceptors using diboron reagents has recently attracted a lot of attention in the
synthetic community (Scheme 3.1).[102] The C–B bond thus formed in the product can be exploited in
C–C cross-coupling chemistry.[103] Alternatively, the C–B bond can be oxidized to generate
compounds bearing new C–O[104] or C–N bonds.[105]
Scheme 3.1 Conjugate borylation of Michael acceptors and subsequent C–B bond transformations
Classically, the conjugate borylation of Michael acceptors has been facilitated through metal catalysis
involving metal complexes based on transition metals such as Pt,[106] Rh,[107] Ni,[102a] and Cu.[108] This
methodology includes asymmetric catalysis as well. In 2009, the first metal-free C–B bond formation
using (pin)B–B(pin) (B–5) was reported by Hoveyda et al. (Scheme 3.2).[109] In the presence of an
NHC as a catalyst –pre-formed from pre-NHC–11 and NaOtBu– acyclic and cyclic α,β-unsaturated
ketones and esters were smoothly converted to the corresponding secondary and tertiary boronic esters
in 44–98% yields.
Scheme 3.2 First NHC-catalysed conjugate borylation[109]
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The mechanism for this unusual NHC catalysis was proposed to involve initial nucleophilic addition
of the Lewis basic carbene to a Lewis acidic boron atom of the diboron reagent to form boron–ate
complex I (Scheme 3.3). The B–B bond of this boron–ate complex should thus be sufficiently
activated for nucleophilic addition of the tri-coordinate boryl group to the electrophilic β-carbon of
cyclohexenone, and subsequent transfer of the second boryl group to the nucleophilic α-carbon. This
bond transformation would result in the generation of C-boron enolate II (Scheme 3.3) and recycle the
NHC catalyst. This C-boron enolate may be in equilibrium with the corresponding O-boron enolate
III (Scheme 3.3), and the hydrolysis of these basic intermediates would result in the formation of the
corresponding β-boryl cyclohexanone (3–1; Scheme 3.3). Overall, this process has been monitored by
11B NMR spectroscopy; the (pin)B–B(pin) reagent (B–5) displays a signal at 30.1 ppm, whereas
boron–ate complex I (Scheme 3.3) was shown to resonate at 1.8 ppm (tetra-coordinate boron) and 36.3
ppm (tri-coordinate boron), respectively.
Scheme 3.3 Hoveyda’s proposed mechanism for the NHC-catalysed conjugate borylation[109]
In 2010, Fernández et al. reported a phosphine-catalysed C–B bond formation between various α,β-
unsaturated ketones or acrylates and (pin)B–B(pin) (B–5; Scheme 3.4).[110] Interestingly, Cs2CO3 as a
base and methanol as a protic additive proved to be critical for reactivity; the products were obtained
in 54–99% yields. The proposed mechanism was very similar to the pathway published by
Hoveyda.[109]
Scheme 3.4 First phosphine-catalysed conjugate borylation[110]
In 2012, Hoveyda et al. developed the first NHC-catalysed asymmetric conjugate borylation of α,β-
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unsaturated aldehydes, ketones, esters, and amides using (pin)B–B(pin) [B–5; Scheme 3.5 a)].[111]
Specifically, enantiopure NHC –pre-formed from pre-NHC*–12 and DBU– bearing two phenyl
groups in the chiral backbone and a non-symmetric N–Ar moiety, afforded the products with 71–96%
ee. It is important to note that a large excess of methanol was required for high efficiency, and a
ligand exchange at boron was suggested to explain this phenomenon [Scheme 3.5 b)].[111] Indeed,
DBU should deprotonate methanol to form the corresponding amidinium methoxide [IV; Scheme 3.5
b)], two equivalents of which may replace one pinacolato ligand at a boron center. The generated
intermediate, (pin)B–B(OMe)2, may then undergo facilitated nucleophilic addition of the enantiopure
NHC to the less hindered boron atom to generate the postulated critical key intermediate, chiral
boron–ate complex V [Scheme 3.5 b)].
Scheme 3.5 First NHC-catalysed asymmetric conjugate borylation[111]
Although this successful asymmetric C–B bond-forming method resulted in the efficient formation of
different types of optically enriched secondary boronic esters, the analogous synthesis of the
corresponding tertiary boronic esters was not mentioned in this initial report. In 2014, Hoveyda et al.
applied this approach to the formation of enantiomerically enriched tertiary boronic esters using α,β-
unsaturated cyclic or acyclic ketones and (pin)B–B(pin) (B–5; Scheme 3.6).[112] These products were
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obtained with 82–99% ee. Interestingly, this asymmetric NHC catalysis proved to be applicable to the
total synthesis of a natural product bearing an optically pure tertiary alcohol moiety.
Scheme 3.6 NHC-catalysed asymmetric formation of tertiary boronic esters[112]
In 2010, Fernández at el. developed the first phosphine-catalysed asymmetric conjugate borylation of
α,β-unsaturated ketones and acrylates using (pin)B–B(pin) (B–5; Scheme 3.7).[110] In this context, (R)-
BINAP (P*–1) and (R,S)-Josiphos-type (P*–2) ligands proved to be most efficient; the corresponding
secondary boronic esters were obtained with 34−93% ee.
Scheme 3.7 First phosphine-catalysed asymmetric conjugate borylation[110]
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3.1.2 Aims
In light of the state-of-the-art of asymmetric conjugate borylation (see Section 3.1.1), and encouraged
by our earlier success regarding asymmetric BAC catalysis, we aimed to develop BAC-catalysed
asymmetric conjugate borylation. In our anticipated scenario, the asymmetric C–B bond formation
may proceed between an in situ-formed enantiomerically enriched zwitterionic MBH-type enolate and
the B–B substrate.
This scenario would be substantially different compared to Hoveyda’s suggested mechanism (Scheme
3.3).[109] Interestingly however, based on our earlier 11B NMR binding study, a Hoveyda-type boron–
ate complex was shown to be generated between a BAC and (pin)B–B(pin) (B–5) under mild
conditions (see Section 1.2.2; P11). In turn, we were intrigued to see whether a BAC was apt to
catalyze such a conjugate borylation, and which reaction pathway would be viable. Based on the
unique electronic and steric features of the BACs, the major goals were (Scheme below):
Scheme 3.8 Possibility of BAC-catalysed asymmetric conjugate borylation
(i) to explore a broad variety of Michael acceptors (α,β-unsaturated aldehydes, ketones, esters, amides,
and nitriles), including sterically demanding substrates; (ii) to examine potentially diastereoselective
transformations using α,β-disubstituted Michael acceptors; (iii) to attempt an asymmetric conjugate
borylation based on our earlier success in the asymmetric aza-MBH chemistry.
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3.2 Results and Discussion
3.2.1 BAC-catalysed Conjugate Borylation
In order to test the feasibility of this BAC-catalysed C–B bond formation, a preliminary set of
experiments at 10 mol% catalyst loading was carried out using cyclopentenone and cyclohexenone in
combination with (pin)B–B(pin) (B–5) in THF (Scheme 3.9).
Scheme 3.9 Initial experiments for BAC-catalysed conjugate borylation of cyclopentenone and -hexenone
Unfortunately, the initial experiments at 30 oC failed to give the expected products. However, heating
to 40 oC resulted in the smooth formation of the β-boryl products 3–1 and 3–2 in 82% and 89%
isolated yields, respectively. These reactions were monitored by 11B NMR spectroscopy. The signals
of the used diboron reagent, (pin)B–B(pin) (B–5), and the β-borylated O-boron enolate (III; see
Scheme 3.3) prior to hydrolysis, are shown in the corresponding 11B NMR charts in Scheme 3.9
(middle). The single resonance of the starting material, (pin)B–B(pin) (B–5), at 30 ppm (left)
disappeared, and two new signals of intermediate III appeared at 31 ppm [C–B(pin)] and 21 ppm [O–
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B(pin)], respectively (right). As expected, these new signals were found to be roughly in a 1:1 molar
ratio. After hydrolysis, the corresponding product was isolated thus leading to the displayed 1H and
11B NMR charts of β-boryl cyclohexanone (3–1; Scheme 3.9, below).
Since the use of cyclohexenone provided a slightly higher yield, further optimization of the reaction
parameters were carried out using this substrate. First, a brief BrØnsted base screening in THF at
40 °C was conducted using various organic and inorganic bases together with precursor pre-BAC–1.
Generally speaking, metal-based bases such as amides, alkoxides, and carbonates were shown to be
more efficient than metal-free bases such as tetramethyl guanidine and proton sponge®. Nevertheless,
none of these bases was found to be more effective than DBU, in turn, this amidine base was selected
as a base co-catalyst for the solvent screening (Table 3.1).
Table 3.1: Solvent screening for BAC-catalysed conjugate borylation
[a] Isolated yield of products after purification by preparative thin-layer chromatography (PTLC).
With a few exceptions, all examined solvents were found to give the corresponding borylated product
3–1 (Table 3.1, entries 1–18). THF proved to be most appropriate (89%; entry 8). Interestingly, it was
found that the use of polar protic solvents such as various alcohols gave decent yields (39–50%;
entries 12–15). This fact may be important considering that –with reference to Hoveyda’s work[111]– a
protic source may be required as an additive in a potential asymmetric version of this transformation.
Polar aprotic solvents such as acetonitrile and DMF failed to give high yields (18–24%; entries 16 and
17). Remarkably, the in situ generated BAC catalyst was found to tolerate an aqueous solvent mixture
(THF/H2O = 1:1; 72%; entry 18). Typically, carbenes have been considered unstable in aqueous
media. However, this result indicated that carbene catalysis might be conducted as well in aqueous
media or pure water.
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With this preliminary BAC catalysis protocol in hand, we also examined two acyclic α,β-unsaturated
ketones that proved to be less reactive (Scheme 3.10). However, when the reactions were carried out
in the presence of two equivalents of methanol the desired products were obtained in 65–76% isolated
yields.
Scheme 3.10 Preliminary scope for BAC-catalysed conjugate borylation
3.2.2 Towards an Asymmetric Version
In light of the reported earlier work on NHC-catalysed asymmetric conjugate borylation (see Section
3.1),[111,112] and encouraged by our success in asymmetric BAC catalysis, we attempted to apply our
novel enantiopure BAC catalysts to asymmetric C–B bond formation. The first experiment was
conducted in THF at 40 oC using cyclohexenone and (pin)B–B(pin) (B–5), in the presence of our best
1st generation precursor pre-BAC*–8 and DBU as the catalyst system (Scheme 3.11). The reaction
proceeded smoothly, and the product 3–5 was formed in 80% yield albeit as a racemic mixture.
Scheme 3.11 Initial attempts of asymmetric BAC catalysis
However, when the same experiment was carried out in the presence of two equivalents of methanol,
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product 3–5 was obtained in 90% yield with 25% ee (Scheme 3.11 and Chart 3.1). While the observed
asymmetric induction proved to be rather low, the proof-of-principle for asymmetric BAC catalysis
was established.
Chart 3.1 Chiral HPLC analysis for asymmetric BAC catalysis (2.0 equiv of MeOH)
The use of such a protic additive in asymmetric carbene catalysis paralleled the earlier studies by
Hoveyda in this context.[111] Similarly, it seemed that the use of methanol in the presence of a catalytic
amount of DBU played an important role for the asymmetric induction. Indeed, the combined use of
the amidine base and methanol should lead to the irreversible formation of the corresponding
conjugate acid–base pair, i.e., amidinium methoxide IV (Scheme 3.12, upper equation). The Lewis
basic methoxide may then add to a Lewis acidic boron atom of (pin)B–B(pin) (B–5) to generate
boron–ate complex VI (Scheme 3.12, lower equation). An activated B–O bond of the pinacolato
moiety of VI may then undergo protonation to form the corresponding diboron intermediate VII,
which may react with a second equivalent of methoxide to generate –after protonation and loss of
pinacol– diboron species VIII. It is conceivable that the Lewis acidic B(OMe)2 center of VIII may be
less sterically hindered, which may be of critical importance for a higher reactivity and a better
asymmetric induction. Further experiments will be required to clarify this effect.
Scheme 3.12 Plausible role of DBU and MeOH in B–B bond activation[111]
Starting from the diboron species VIII, two plausible mechanistic pathways may be anticipated. The
first route may follow the MBH-type mechanism [Scheme 3.13 a)], which would involve an initial
nucleophilic addition of the chiral BAC to the electrophilic β-position of the Michael acceptor to form
an enantiomerically enriched zwitterionic enolate. The latter may then add to the more accessible
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boron center of (MeO)2B–B(pin) (VIII; Scheme 3.13), thus triggering B(pin) transfer to the β-carbon;
this scenario would regenerate the chiral BAC catalyst. The other plausible route may follow a direct
addition of the enantiopure BAC to the more accessible boron center of VIII [Scheme 3.13 b)]. Such
a scenario was proposed by Hoveyda et al. and has been discussed earlier [see Section 3.1.1, Scheme
3.3].[109,111]
Scheme 3.13 Two plausible mechanistic pathways for the carbene-catalysed asymmetric conjugate borylation
Since the presence of methanol seemed to be critical for an asymmetric induction, we attempted to
optimize this reaction system by varying the amount of methanol (2–60 equiv) under otherwise
identical conditions (Table 3.2). These experiments revealed that a large excess of this protic additive
was required to induce a higher optical purity of the product. Indeed, the asymmetric induction in
product 3–5 was found to increase from 25% ee, when using 2 equiv of MeOH (entry 1), to 62% ee,
when using 25 equiv of MeOH (entry 6). When an even larger amount of methanol (30–60 equiv) was
used, an erosion of the asymmetric induction was observed (entries 7–9).
Table 3.2: Effect of MeOH stoichiometrically on BAC-catalysed asymmetric conjugate borylation
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[a] Isolated yield of products after purification by preparative thin-layer chromatography (PTLC). [b] The ee was determined
by chiral HPLC analysis.
While an asymmetric induction of 62% ee was good but not excellent, we wondered whether the
combined use of DBU and methanol could result in a racemic background reaction. We carried out
the same reaction as in entry 6, but in the absence of the enantiopure BAC precursor (Scheme 3.14,
equation).
Scheme 3.14 Control experiment using DBU/MeOH in the conjugate borylation
In the event, the intended C–B bond formation did not proceed. Indeed, potential reaction products
involving the Michael acceptor were not detected in the 1H NMR spectroscopic analysis of a reaction
aliquot, or by TLC analysis. Interestingly, the 11B NMR spectroscopic analysis of a reaction aliquot
(CDCl3) revealed the detection of five signals in the chart (Scheme 3.14, chart). Assuming the
irreversible formation of DBU–H+ –OMe (IV; see Scheme 3.12, upper equation), several boron species
may have been formed through an initial reaction between –OMe and (pin)B–B(pin) (B–5), followed
by a series of subsequent acid–base reactions. The initial starting material, (pin)B–B(pin) (B–5),
displays a signal at 33 ppm. Based on our experience in 11B NMR spectroscopy, the other signals may
be ascribed to the following boron-based species: (MeO)2B–B(pin) at 30 ppm; (MeO)B(pin) at 21 ppm;
(MeO)3B at 18 ppm; various plausible ate complexes of the type L4B– at 8 ppm. These data revealed
that –in the absence of a suitably reactive electrophile/nucleophile pair– the activated B–B bond of a
boron–ate complex may be cleaved through simple protonation, and the resulting H–BL2 species may
generate subsequently MeO–BL2 and molecular hydrogen. These results may suggest that a BAC-
catalysed reductive aldol or Mannich reaction may be conceivable if a Michael acceptor and H–B(pin)
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could be used as reagents under specific conditions.
This experiment supported our assumption that the enantiopure BAC catalyst was the real catalytically
active species for C–B bond formation; based on the control experiment, a racemic background
reaction was excluded. In turn, another set of experiments dealt with the optimization of the reaction
temperature under otherwise identical conditions (40 oC ~ –20 oC; Table 3.3). A preformation of
catalyst using pre-BAC*–8 and Cs2CO3 was carried out under room temperature for 20 hours before
moving to a lower temperature.
Table 3.3: Temperature effect on the BAC-catalysed asymmetric conjugate borylation
Entry Temp (oC) y (%)[a] ee (%)[b]
1 40 96 62
2 30 87 63
3 25 79 66
4 0 56 67
5 –20 45 69
[a] Isolated yield of products after purification by preparative thin-layer chromatography (PTLC). [b] The ee was determined
by chiral HPLC analysis.
Expectedly, compared to the benchmark result at 40 oC (62% ee; entry 1), all other experiments
resulted in a lower reactivity but a slightly increased asymmetric induction in product 3–5 (63–69% ee;
entries 2–5). To date, the best selectivity was obtained at –20 oC (69% ee), albeit the isolated yield for
3–5 proved to be insufficient (45%; entry 5).
These optimized conditions were subsequently applied to the use of cyclopentenone (Scheme 3.15).
The corresponding product 3–6 was obtained in 46% yield with 63% ee.
Scheme 3.15 BAC-catalysed asymmetric conjugate borylation of cyclopentenone
Overall, further experimentation will be required in order to attain a synthetically useful asymmetric
induction for this type of transformation.
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3.3 Summary
We have successfully achieved BAC-catalysed C–B bond formation under mild conditions using a
commercially available diboron reagent, (pin)B–B(pin) (B–5), and different Michael ketones. This
transformation was shown to be applicable to asymmetric BAC catalysis (up to 69% ee). It was found
that both reactivity and enantioselectivity were improved in the presence of an excess of methanol.
Expectedly, the asymmetric induction has proved to be optimal at low temperature.
Scheme 3.16 Summary of BAC-catalysed asymmetric conjugate borylation
This chemistry seems to require a substantial modification of the structure of the enantiomerically
enriched BAC in order to obtain very high asymmetric induction.
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4 THE CHEMISTRY OF CARBONES
4.1 Introduction
In parallel to our investigations into carbene [C(II)] catalysis, carbones [C(0)] were also examined in
view of potential applications in base and dual catalysis, which may have a significant impact on
“Green” Chemistry. Carbones, i.e., molecules with the central carbon atom in the formal “0”
oxidation state, include so-called “bent” allenes or carbodicarbenes.[113]
4.1.1 Classic or “Bent” Allenes vs. Carbodicarbenes
Classic allenes are organic compounds with a linear three-carbon-based structure that contain an sp
hybridised central carbon atom, which forms a C=C double bond to both adjacent carbon fragments,[1]
i.e., the central carbon shares its four valence electrons to form two covalent bonds each with the
orthogonal pairs of substituents (Figure 4.1).
+
Figure 4.1 Classic allenes[1]
However, in certain allenes deviations from linearity (180 °) of a few or more degrees have also been
observed. In 1995, Weber et al. reported the crystal structure of allene 4–1 with an unusually large
bent at the central carbon due to so-called packing effects.[114,121] Indeed, this “bent” acyclic allene has
a C=C=C bond angle of 170.1 ° (Figure 4.2).
Figure 4.2 Examples of a bent allene and its heavier homologues[114,115,121]
In addition to the studies of all-carbon allenes (C=C=C), several research groups explored the
chemistry of allene analogues involving heavier group 14 elements (E=E=E; E = Si, Ge; Figure
4.2).[115] These “heavier” allenes have been shown to display a highly flexible, non-linear structure
(Si=Si=Si: 136.5°; Ge=Ge=Ge: 122.6°).[115] The difference between all-carbon allenes and silicon or
germanium analogues may arise from the weakness of the π bonds in the latter. Unlike first long-row
elements (carbon), which tend to form hybrids from s and p orbitals, second and higher-row elements
114
can largely avoid hybridization; those heavier elements are generally reluctant to form multiple bonds
as their π bonds are rather weak. This phenomenon has been coined as the “first long-row anomaly”
by Grützmacher.[116] Based on this analysis, Bertrand et al. made the conclusion that weakening the π
bonds in C=C=C allenes could make them more flexible and lead to a higher degree of bending of the
linear C=C=C skeleton.[117] In this context, polarization seems to be the only possible way to weaken
the C=C π bonds of allenes; it can be realized by push–pull or push–push substitution patterns (Figure
4.3).[118] Push–pull substitution means one terminal carbon atom is bound to two donor groups (D),
while the other terminal carbon is connected to two acceptor groups (A). Push–pull-substituted
allenes show partial carbene character at the central carbon and tend to dimerize. However, so-called
push–push allenes may contain a double carbanion character at the central carbon atom that is
connected with two formally positively charged donor groups; this pattern may be the best choice for
the synthesis of “bent” allenes.
Figure 4.3 Resonance structures for push–pull and push–push allenes[118]
Several chemists synthesized and analyzed “bent” allenes according to the push–push substitution
pattern. In these cases, the central carbon atom is no longer sp hybridized like in classic allenes; rather,
it should be considered to have two lone pairs of electrons. Thus, the bonding situation is likely best
described as a carbene–C donor–acceptor interaction (Figure 4.4). This bonding model is usually
prevalent in the “classic” complexation of a metal center by ligands (e.g. ligand–metal donor–acceptor
complex). Thus, the non-metal element carbon may be considered to behave “metal-like”, as it acts as
the central atom of a “non-classic” coordination compound.
Figure 4.4 General structure of carbodicarbenes (CDCs)
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4.1.2 Carbenes [C(II)] vs. Carbones [C(0)]
As a consequence, these compounds have been described as “carbodicarbenes” (CDCs).[119] A
carbodicarbene is a strongly basic compound featuring “a divalent carbon(0)” centre coordinated by
two carbene ligands. The central carbon of a carbodicarbene is sp2-like hybridized with both
substituents being a strong σ donor and a weak π acceptor. A high proton affinity was calculated for
these carbon(0) species (carbodicarbenes), which are considered to be stronger bases than “classic”
carbon(II) compounds (carbenes).[120]
As carbodicarbenes feature a divalent central atom with two carbene ligands, the difference between
classic carbenes [carbon(II)] and carbodicarbenes [carbon(0)] should be recognized (Figure 4.5).
Figure 4.5 A comparison between carbenes and carbones
In carbenes, such as N-heterocyclic carbenes (NHCs), the central carbon atom is in the oxidation state
“+II”. It has only one lone pair in the σ orbital and a vacant π orbital. In contrast, in carbodicarbenes
the central carbon atom is divalent and does not form “classic” double bonds, but formally owns two
lone pairs. Thus, the formal oxidation state of the central carbon atom is considered to be “0”. These
low-oxidation state carbon compounds have been calculated to be substantially stronger Lewis or
Brønsted bases than carbenes.
4.1.3 Carbodicarbenes in Literature
In this section, the chemistry of “bent” allenes or carbodicarbenes will be summarized including their
properties and synthetic methods. The first two “bent” allenes were prepared by two different research
groups, respectively, although both compounds were not defined as “carbodicarbenes” per se. In 1964,
Fischer et al. reported the synthesis and isolation of an acyclic allene, 4–1, with a C=C=C bond angle
of 170.1 ° (Scheme 4.1).[114] This compound was prepared on a gram-scale in four steps in 12%
overall yield. This species was shown to be stable at room temperature, and its crystal structure was
reported by Weber et al. in 1995.[121]
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Scheme 4.1 Synthesis of the first bent allene[114]
The “bent” allene 4–2 was prepared by Liebenow et al. in 1980 (Scheme 4.2).[122] It was synthesized
on a gram-scale from commercially available starting materials in two steps in 79% overall yield. The
desired product was isolated as colorless crystals storable at –78 °C under argon.
Scheme 4.2 Synthesis of bent allene 4–2[122]
Several studies focusing on tetraaminoallenes have been carried out in view of their coordination
chemistry. In 2009, Fürstner et al. reported a new method for the preparation of
tetrakis(dimethylamino)allene (4–3; Scheme 4.3).[123] This compound was synthesized on a gram-
scale in three steps from commercially available starting materials in 64% overall yield. The product
was isolated as a colorless oil that can be stored at –20 °C under argon for months without
decomposition. The C=C=C bond angle in this compound was measured to be 172 °.
Scheme 4.3 Synthesis of acyclic carbodicarbene 4–3[123]
In 2007, Frenking et al. carried out a computational study on “bent” allene 4–4 and coined the
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expression “carbodicarbene” for the first time (Figure 4.6).[120] The allene framework and the π
system in this allene were both shown to be severely perturbed with a C=C=C bond angle of 131.8 °,
and the C–C bond lengths involving the central carbon atom were measured as 1.359 Ǻ, which are
shorter than “normal” single C–C bonds. The central carbon atom is no longer sp hybridized as in
typical allenes, but rather considered to have two lone pairs.
Figure 4.6 Resonance forms of carbodicarbene 4–4[120]
Similarly in 2008, Bertrand et al. reported the synthesis and isolation of the aromatic acyclic
carbodicarbene 4–5 with a C=C=C bond angle of 134.8 ° (Scheme 4.4, above).[117] This compound
was synthesized on a gram-scale in three steps from N-methyl-1,2-phenylenediamine in 32% overall
yield. Although this product was found to be extremely water-sensitive, it was demonstrated to be
stable –under an inert atmosphere– at room temperature both in solution and in the solid state. During
the course of our studies, Ong et al. synthesized –based on the same methodolgy– acyclic
carbodicarbenes 4–6 ~ 4–8 bearing more sterically demanding N-substituents such as isopropyl,
cyclohexyl, and 2-pyridyl (Scheme 4.4, below).[124,125]
Scheme 4.4 Synthesis of acyclic “symmetric” carbodicarbenes 4–5 ~ 4–8[117,124,125]
In addition, in 2015 Ong et al. synthesized “non-symmetric” carbodicarbenes 4–9 ~ 4–11 bearing
different substituents on the two lateral carbon atoms (Scheme 4.5).[126] Compound 4–9 was
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synthesized in five steps from the corresponding enediamine in 73% overall yield. Although this
product was shown to be extremely air-sensitive, it was demonstrated to be stable –under an inert
atmosphere– at room temperature both in solution and in the solid state. However, suitable single
crystals for X-ray diffraction were not obtained.
Scheme 4.5 Synthesis of acyclic “non-symmetric” carbodicarbenes 4–9 ~ 4–11[126]
In addition, several cyclic carbodicarbenes, within relatively small ring systems, were also synthesized.
Suitable donor groups were chosen (e.g. aryloxy groups), which were considered to be weaker π donor
and more electronegative in order to make the central carbon atom slightly less basic. In 2008,
Bertrand et al. reported the synthesis and isolation of five-membered ring allene 4–12 with a C=C=C
bond angle of 97.5 ° (Scheme 4.6).[127] This compound was synthesized on a gram-scale in two steps
in 47% overall yield as a pale yellow solid; it was shown to be stable at room temperature and up to
95 °C.
119
Scheme 4.6 Synthesis of cyclic five-membered ring allene 4–12[127]
In 2009, Bertrand et al. investigated the synthesis of an even smaller allene-containing ring system,
1,2-cyclobutadiene (Scheme 4.7).[128] Final product 4–13 displays a C=C=C bond angle of 85 °. This
compound was synthesized on a gram-scale in three steps starting from cyclohexane carbonyl chloride,
ethoxyacetylene, and triethyl amine. The desired product was found to be stable at –20 °C, but readily
decomposed above –5 °C. For the direct precursor, the overall yield was 58% over two steps.
Scheme 4.7 Synthesis of cyclic four-membered ring allene 4–13[128]
To date, different types of “bent” allenes or “carbodicarbenes” were synthesized including acyclic and
cyclic structures (Figure 4.7). Compound 4–1 displayed a pull–pull substitution pattern, and was
considered as an electron-poor (Lewis acidic) allene rather than a carbodicarbene. In 2010, Alcarazo
et al. showed its non-reactivity towards a very bulky N-heterocyclic carbene to generate a frustrated
Lewis pair (FLP), which was exploited in the heterolytic S–S bond cleavage of disulfides.[136] In
contrast, compound 4–2 showed a push–pull substitution pattern, and may display a “hidden carbene”
character rather than that of a carbodicarbene. All other “bent” allenes, compounds 4–3 ~ 4–13,
demonstrated a push–push substitution pattern. Based on the unique structure and properties of these
formal carbon(0) species, a variety of studies were carried out in literature.
120
Figure 4.7 Examples of “bent” allenes or carbodicarbenes 4–1 ~ 4–13[117,121-128]
4.1.4 Carbodicarbene–Metal Complexes: Preparation and Properties
With the successful synthesis of various carbodicarbenes being accomplished, several investigations
were carried out to see whether these bases bind to metal centers; according to calculations these
strongly basic carbon(0) compounds should be excellent ligands for metals. Thus, various metal
complexes have been prepared in order to study the ligand properties of C(0) species. Frenking et al.
concluded that because the C(NHC)2 can be electronically modified in many ways through variation of
the NHC skeleton, these molecules should be promising ligands for metal complexes.[120] In mono-
metallated complexes, the central carbon atom of the carbodicarbene ligand would coordinate to one
metal centre. Among these complexes, rhodium proved to be the most popular metal used in order to
evaluate the σ donor ability of C(0) ligands. The general method for metal complex formation with
various carbones is shown in Scheme 4.8.
Scheme 4.8 General method for the preparation of CDC–metal complexes[120]
The method used to study the donor property was the classic evaluation, which relies on the carbonyl
wave numbers of the corresponding trans-carbonyl (CO) ligand in the rhodium complex formed. The
trans effect concerns the electronic effect of one ligand (e.g. carbodicarbene) on another ligand (e.g.
CO) when these are trans (opposite) to one another. Considering the π back-bonding effect, electrons
are partially transferred from a metal d orbital to the π* (anti-bonding) orbital of CO. This electron
transfer –which relies on the σ donor strength of the anti-ligand– would strengthen and weaken the
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corresponding anti metal–CO and C–O bonds, respectively. The strengthening of the M–CO bond is
reflected by an increased vibrational frequency for the M–CO bond; the weakening of the C–O bond is
indicated by a decreased carbonyl stretching frequency for the C–O bond. By comparison of the data
collected for both carbenes and carbodicarbenes, the relative σ donor ability of these species can be
“measured”; the lower the wavenumber for the carbonyl ligand, the stronger donating is the anti
carbon-based ligand (Figure 4.8).
Figure 4.8 Carbonyl wavenumbers of CDC–metal vs. NHC–metal and BAC–metal complexes[117,124-128]
The carbonyl wavenumbers for carbone-based [RhCl(CO)2(L)] complexes 4–14 ~ 4–18[117,124-128] were
shown to be significantly lower than the ones recorded for the corresponding carbene-based
[RhCl(CO)2(L)] complexes 4–19 and 4–20. This tendency indicated that carbones were stronger σ
donors and weaker π acceptors than carbenes.
In case of the four-membered ring carbodicarbene 4–13, its iridium complex 4–21 has also been
evaluated (Figure 4.9).[128] The average value of the carbonyl wavenumbers for Ir–carbone complex
4–21 (ṽ = 2002 cm-1) was also at the lower end of the range observed for literature-known Ir–carbene
complexes (ṽ = 1999–2020 cm-1).
Figure 4.9 CDC–iridium and CDC–gold complexes
Fürstner et al. also used acyclic carbodicarbene 4–3 as a ligand for a gold(I) species to form 4–22
(Figure 4.9).[123] The metalated carbon atom was shown to exhibit a trigonal-planar coordination with
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the in-plane lone pair of the ligand binding to the gold centre. Hence, gold complex 4–22 was shown
to contain a η1-coordinated “allene” ligand, whereas “classic” allenes react with metal fragments to
give η2 complexes involving one of the C=C π bonds.
4.1.5 Carbodicarbenes: Carbene vs. Carbone Character
As shown, mono-metallated complexes have been formed based on various carbodicarbenes. The next
question was whether both lone pairs at the central carbon of CDCs can be chemically exploited or not.
Do date, all metal salts and carbodicarbenes explored in this context proved to be unsuitable for
dimetallation, which may be ascribed to steric reasons (Figure 4.10).[117,123,127,128]
Figure 4.10 Carbodicarbenes and metal salts involved in attempted CDC dimetallation[117,123,127,128]
Despite the fact that dimetallation was not realized yet, Bertrand et al. investigated the potential
chemical usage of both lone pairs at the central carbon atom of “bent” allene 4–13; indeed, a double
protonation of 4–13 was conducted using tetrafluoroboric acid under mild conditions to form
bis(iminium) salt 4–23 as colorless crystals in 90% yield (Scheme 4.9).[128]
Scheme 4.9 Double protonation of cyclic four-membered ring allene 4–13[128]
The fact that compound 4–13 was protonated twice proved the hypothesis that this compound
potentially displayed a carbon(0) character and that this compound may be employed in dual catalysis.
Similarly, a double protonation was realized using “bent” allene 4–3 in the presence two equivalents of
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HClO4 (Scheme 4.10);[123] the corresponding bis(iminium) salt 4–24 was isolated in 89% yield.
Scheme 4.10 Double protonation of acyclic allene 4–3[123]
Despite the fact that several “bent” allenes or carbodicarbenes have been successfully synthesized, at
the outset of our project a catalytic application had not been reported.
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4.1.6 Aims for Unprecedented Carbone [C(0)] Catalysis
Carbones, such as carbodicarbenes (CDCs) or “bent” allenes, bear two lone pairs and were reported to
be more basic than carbenes [C(II)]; both lone pairs may be exploited for chemical reactivity.
Carbones may be used to trigger catalytic umpolung of aldimines for subsequent intermolecular C–C
bond formation with suitable electrophiles (Scheme 4.11).
Scheme 4.11 Proposed C(0)-catalysed umpolung of aldimines
Carbones may also be used to activate electrophilic boron-based pro-nucleophiles for subsequent
intermolecular C–C bond formation with suitable electrophiles (Scheme 4.12).
Scheme 4.12 Proposed C(0) nucleophilic catalysis using an electrophilic boron pro-nucleophile
Metal–carbone complexes could be used as potential acid–base dual catalysts to activate both
electrophiles and pro-nucleophiles for subsequent bond formations (Scheme 4.13).
Scheme 4.13 Proposed metal–carbone dual catalysis
In the presence of a sterically demanding Lewis acid, carbones may act the Lewis base part of a
frustrated Lewis pair (FLP), which may be exploited for small molecule activation (Scheme 4.14).
Scheme 4.14 Proposed carbone-based frustrated Lewis pair (FLP) catalysis
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4.2 RESULTS AND DISCUSSION
4.2.1 Synthesis of Carbodicarbene Precursors 4–27, 4–28 and Carbodicarbene 4–5
We started our investigations with the synthesis of an acyclic carbodicarbene, which was prepared on a
gram-scale in four steps from N-methyl-1,2-phenylenediamine (4–25; Scheme 4.15). The first step
involved a double condensation using diethyl malonate, according to Field’s method,[129] to give
bis(amidine) 4–26 as a beige solid in 70% yield. Double N-methylation of the latter using methyl
triflate (2 equiv) in acetonitrile gave bis(amidinium) salt 4–27 as a colorless solid in 65% yield.
Scheme 4.15 Synthesis of double salt 4–27[117,129]
Next, the deprotonation of double salt 4–27 was conducted to form carbodicarbene precursor 4–28.[124]
The use of three different bases was examined (Scheme 4.16).[124] The reactions were monitored by 1H
NMR spectroscopic analysis of the reaction mixture through the detection of product formation and
substrate consumption.
Scheme 4.16 Synthesis of mono salt 4–28 through deprotonation of 4–27[124]
The solubility of silver(I) oxide in DCE was rather low, which may be the reason for the low yield of
4–28 (20%). The product identity was confirmed by both 1H and 13C NMR spectroscopy. The use of a
stronger base, KHMDS, gave 4–28 in 60% yield. In our hands however, the use of NaOMe proved to
be most effective (90% yield). Thus, CDC precursor 4–28 was synthesized in three steps in 41%
overall yield.
Next, we examined the complete deprotonation of both double salt 4–27 and CDC precursor 4–28 in
order to prepare carbodicarbene 4–5 (Scheme 4.17).[117,124] Two methods were used in this case. The
first one –double deprotonation of double salt 4–27 using KHMDS (2.2 equiv)– gave product 4–5 as a
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yellow solid in 75% yield. The second one –single deprotonation of CDC precursor 4–28 using
KHMDS (1.1 equiv)– gave product 4–5 in 80% yield. The identity of product 4–5 was confirmed by
both 1H and 13C NMR spectroscopy. The 1H NMR charts are displayed in Chart 4.1.
Scheme 4.17 Synthesis of carbodicarbene 4–5 through deprotonation using KHMDS
Pre-CDC (1H NMR, CD2Cl2)
Double salt (1H NMR, CD3CN)
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Chart 4.1 1H NMR spectra of isolated double salt 4-27, CDC precursor 4-28, and CDC 4-5
Next, we turned our attention to the preparation of cyclic four-membered ring carbodicarbene 4–13.[128]
In order to prepare this species, the corresponding precursor needs to be synthesized. CDC precursor
4–30 was synthesized in two steps from cyclohexane carbonyl chloride and ethoxyacetylene (Scheme
4.18).
Scheme 4.18 Synthesis of CDC precursor 4–30[128]
In the first step, cyclohexane carbonyl chloride and ethoxyacetylene in diethyl ether were reacted in
the presence of triethyl amine under reflux. Spirobicyclic cyclobutenone 4–29 was obtained as a
brown oil in 81% yield. In the second step, O-alkylation using Meerwein’s reagent, followed by
double amination of the cationic four-membered carbocycle with piperidine afforded CDC precursor
4–30 as light yellow crystals in 72% yield.
CDC (1H NMR, CDCl3)
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4.2.2 Evaluation of Nucleophilicity in 11B NMR Spectroscopy
4.2.2.1 Examination of Carbodicarbene Precursor 4–28
In order to determine the nucleophilicity of CDC precursor 4–28, it was reacted with a variety of
electrophilic boron reagents to see whether the corresponding boron–ate complex can be formed. The
boron reagents used are the same as in the earlier BAC study (Figure 4.11).
Figure 4.11 Boron reagents used and their chemical shifts in 11B NMR spectroscopy
As CDC precursor 4–28 was isolated, it was just dissolved in dichloroethane (DCE) followed by the
addition of the corresponding boron reagent (1.2 equiv) at room temperature (Table 4.1).
Table 4.1 11B NMR study using CDC precursor 4–28 and boron Lewis acids B–1 ~ B–7
Entry Boron Reagent 11B NMR (ppm) New 11B signal (ppm) Complex?
1 BEt3 (B–1) ~ +87 –13.2 +
2 Bn–B(9BBN) (B–2) +77.6 –14.5 +
3 MeO–B(9BBN) (B–3) +57.0 –1.0 +
4 allyl–B(pin) (B–4) +33.2 no change -
5 (pin)B–B(pin) (B–5) +32.1 no change -
6 H–B(9BBN) (B–6) +27.9 no change -
7 H3B•SMe2 (B–7) –19.0 +25.2 (minor) +/-
The 11B NMR spectra of boron observed binding including BEt3 (B–1), Bn–B(9BBN) (B–2), MeO–
B(9BBN) (B–3), H3B•SMe2 (B–7), were shown below in Chart 4.2. Compared to the earlier 11B NMR
study carried out with an in situ-formed BAC (see Section 1.2.2), CDC precursor 4–28 seemed to be
less nucleophilic, which may be ascribed to the higher steric demand of this species. While boron–ate
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complexes were detected with BEt3 (B–1), Bn–B(9BBN) (B–2), MeO–B(9BBN) (B–3), and to some
extent H3B•SMe2 (B–7), other trials failed to give a detectable donor–acceptor interaction. The boron–
ate complexes were identified with a signal in the tetravalent boron area (–40 to 10 ppm) in 11B NMR
spectra (Chart 4.2).
In case of BEt3 (B–1), the starting material displayed a signal at ~ +87 ppm [Chart 4.2a), above]. The
reaction between B–1 and CDC precursor 4–28 gave a new signal at –13.2 ppm, which can be
ascribed to the corresponding boron–ate complex [Chart 4.2a), below].
Chart 4.2a) 11B NMR spectra for B–1 and the corresponding boron–ate complex
In case of Bn–B(9BBN) (B–2), the starting material showed a signal at +77.6 ppm [Chart 4.2b), above].
The reaction between B–2 and CDC precursor 4–28 gave a new signal at –14.5 ppm, which can be
ascribed to the corresponding boron–ate complex [Chart 4.2b), middle]. The signal at ~ +57 ppm was
assigned to a minor impurity [HO–B(9BBN)] present in B–2 [Chart 4.2b), below].
Chart 4.2b) 11B NMR spectra for B–2 and the corresponding boron–ate complex
In case of MeO–B(9BBN) (B–3), the starting material displayed a signal at +57 ppm [Chart 4.2c),
above]. The reaction between B–3 and CDC precursor 4–28 gave a new signal at –1.0 ppm, which can
be ascribed to the corresponding boron–ate complex [Chart 4.2c), below].
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Chart 4.2c) 11B NMR spectra for B–3 and the corresponding boron–ate complex
If a boron–ate complex was not stable, it may further react in an intra- or intermolecular fashion.
Indeed, in case of H3B•SMe2 (B–7), a new minor signal at ~ +25 ppm was observed (Chart 4.3).
Chart 4.3 11B NMR spectrum for B–7 and the new species
The starting material, H3B•SMe2 (B–7), displayed a signal at –19 ppm. If a stable boron–ate complex
was formed, a signal in the range –40 ppm ~ +10 ppm would be expected. Here however, an
intramolecular boron-to-carbon hydride transfer within the ate complex may have occurred to give a
“carbon-ligated BH2” species; a signal at ~ +80 ppm would have been expected for such compound
(Scheme 4.19). In turn, the observed signal at ~ +25 ppm has been ascribed to a rapid equilibrium
between the initially formed boron–ate complex and the corresponding “carbon-ligated BH2” species.
Scheme 4.19 Intramolecular hydride transfer within the initially formed boron–ate complex
4.2.2.2 Examination of Carbodicarbene 4–5
In analogy to the study with CDC precursor 4–28, the isolated carbone 4–5 was also used with the
boron reagents (Table 4.2). 4–5 was dissolved in DCE and reacted with the corresponding boron
reagent (1.2 equiv) followed by 11B NMR spectroscopic analysis.
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Table 4.2 11B NMR study using carbone 4–5 and boron Lewis acids B–1 ~ B–7
Entry Boron Reagent 11B NMR (ppm) New 11B signal (ppm) Complex?
1 BEt3 (B–1) ~ +87 –6.2 +
2 Bn–B(9BBN) (B–2) +77.6 –9.0 +
3 MeO–B(9BBN) (B–3) +57.0 –2.5 +
4 allyl–B(pin) (B–4) +33.2 no change -
5 (pin)B–B(pin) (B–5) +32.1 no change -
6 H–B(9BBN) (B–6) +27.9 no change -
7 H3B•SMe2 (B–7) –19.0 +25.1 (minor) +/-
Here again, boron–ate complexes were not detected in all the cases. With BEt3 (B–1), Bn–B(9BBN)
(B–2), MeO–B(9BBN) (B–3), and H3B•SMe2 (B–7), boron–ate complexes were formed (Table 4.2,
entries1–3 and 7).
Here again, we propose that an intramolecular boron-to-carbon hydride transfer within the initially
formed ate complex must have occurred to form a “carbon-ligated BH2” species, which should display
a signal at ~ +80 ppm. The observed signal at ~ +25 ppm has been ascribed to a rapid equilibrium
between the initially formed boron–ate complex and the corresponding “carbon-ligated BH2” species
(Scheme 4.20).
Scheme 4.20 Intramolecular hydride transfer within the initially formed boron–ate complex
During the course of our studies, Ong et al. reported the formation of three-coordinate dicationic
hydrido–boron complex 4–31 using carbodicarbene 4–6 and H3B•THF (2.0 equiv; Scheme 4.21).[130]
The corresponding product signals in 11B NMR spectroscopy were detected at –38.6 ppm and –25.4
ppm, respectively. In our case, we did not observe these types of signals.
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Scheme 4.21 Formation of three-coordinate dicationic hydrido–boron complex 4–31[130]
With all other boron Lewis acids such as allyl–B(pin) (B–4), (pin)B–B(pin) (B–5), and H–B(9BBN)
(B–6), boron–ate complexes were not detected even upon heating (60 °C). The steric hindrance of
carbone 4–5 may be one reason for this rather low nucleophilicity; only less sterically demanding
Lewis acids may be attacked by the bulky carbon centre of 4–5. In cases where we observed boron–
ate complex formation, direct Lewis base catalysis may be applicable in view of nucleophilic transfer
of an organic group to a suitable electrophile. In cases where carbone 4–5 did not react with Lewis
acidic boron reagents, both reagents are considered to form a so-called frustrated Lewis pair (FLP),
which could be exploited in the activation of strong  bonds in small molecules.
During the Course of Our Studies: Applications in Catalysis
Despite the fact that a variety types of carbodicarbenes were synthesized in literature, catalytic
applications were only reported very recently. In 2014, Meek et al. developed novel cyclic
bis(phosphino)carbodicarbene–rhodium complexes of type 4–32 and exploited these in the
intermolecular hydroamination of dienes using secondary amines or anilines (Scheme 4.22).[131] The
corresponding products were obtained in 6–96% yields. It is important to note that this chemistry
represented the first example for the catalytic use of well-defined carbodicarbene–metal complexes.
Scheme 4.22 CDC–Rh-catalysed intermolecular hydroamination[131]
Similarily, Meek et al. developed a styrene-stabilized cationic bis(phosphino)carbodicarbene–rhodium
complex, 4–33 (Scheme 4.23).[132] Here, it was exploited in catalytic hydroheteroarylation between
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dienes and various N-heteroarenes. The corresponding products were obtained in 33–98% yields with
excellent regioselectivity (γ:α = >98:2). It is noted that the reactions were shown to be compatible
with a variety of terminal and internal dienes, and tolerant of ester, alkyl halide, and boronic ester
functional groups.
Scheme 4.23 CDC–Rh styrene complex-catalysed intermolecular hydroheteroarylation[132]
In 2015 –as mentioned in 5.1.4– Ong et al. synthesized the first isolable pincer-carbodicarbene 4–8
with a C=C=C bond angle of 143 o.[125] The corresponding tridentate pincer-CDC–Pd complex 4–34
was shown to catalyze Mizoroki–Heck and Suzuki–Miyaura cross-coupling reactions, respectively
(Schemes 4.24 and 4.25).
Scheme 4.24 CDC–Pd-catalysed Mizoroki–Heck cross-coupling reactions[125]
Scheme 4.25 CDC–Pd-catalysed Suzuki–Miyaura cross-coupling reactions[125]
In 2015, Ong et al. reported the first organocatalytic application using a carbodicarbene (Scheme
4.26).[126] In this work, carbodicarbene 4–35 was used for the reductive N-methylation of amines in
the presence of CO2 and H–B(9BBN) (B–6). The corresponding products were obtained in 24–97%
yields.
134
Scheme 4.26 First organocatalytic application of a carbodicarbene[126]
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4.3 Summary
In the final part of this thesis project, an acyclic bis(amidinium) salt (4–27), an acyclic carbodicarbene
precursor (4–28), an acyclic carbodicarbene (4–5), and a cyclic carbodicarbene precursor (4–30) were
synthesized and characterized. In subsequent 11B NMR studies, the nucleophilicity of the isolated
species 4–28 and 4–5 have been assessed using a variety of boron electrophiles (Figure 4.12). For
both carbon-based nucleophiles, stable boron–ate complexes were detected using three boron
electrophiles: BEt3 (B–1), Bn–B(9BBN) (B–2), and MeO–B(9BBN) (B–3). This promising data may
suggest that a direct Lewis base catalysis using 4–28 and 4–5 might be applicable in view of
transferring an organic group to a suitable electrophile. In case of H3B•SMe2 (B–7), a minor signal was
observed at +25 ppm, which has been ascribed to a rapid equilibrium between tetra- and tri-
coordinated boron species. For boron reagents B–4 ~ B–6 that did not react with 4–28 and 4–5, the
corresponding acid/base combinations represent potential candidates for frustrated Lewis Pair (FLP)
catalysis in view of the activation of strong σ bonds in small molecules.




The synthesized metal–BAC complexes 1–26 ~ 1–28 should be examined in Lewis acid catalysis in
the presence of an anion metathesis trigger (e.g. silver or sodium salt); the non-sterically demanding
BAC ligand may induce interesting selectivity. In metal-free BAC catalysis, further base-catalysed
reactions may be uncovered; if a hydrogen bond donor is included in the catalyst structure dual
catalysis may be developed (e.g. ring-opening reactions). In asymmetric BAC catalysis, other
important asymmetric reactions should be examined. Regarding the catalyst structure, the chiral
backbone of the enantiopure catalyst may be re-investigated, and another hydrogen bond donor may
be introduced. Such modifications may be critical to improve the level of asymmetric induction in the
conjugate borylation (or silylation) chemistry. In addition, as mentioned earlier, an application to
reductive aldol or Mannich reactions may be conceivable using H–B(pin). Finally, the synthesized
carbodicarbene, and some analogues thereof, may be exploited in Lewis base catalysis using boron-
based reagents. Likewise, catalytic umpolung chemistry of aldehydes or other suitable pro-




5.1 General Experimental Section
Nuclear Magnetic Resonance (NMR) spectra were recorded on Bruker AVA 400, Bruker AVA 500,
Bruker PRO 500, and Bruker AVA 600 spectrometers, respectively. These spectrometers operate at the
following frequencies: 400 MHz, 500 MHz, or 600 MHz for 1H NMR; 100 MHz, 125 MHz, or 150
MHz for 13C NMR; 128 MHz or 160 MHz for 11B NMR; 128 MHz for 19F NMR. Chemical shifts (δ)
were quoted in parts per million (ppm) down-field to tetramethylsilane (TMS; δ = 0 ppm), or in the
scale relative to the corresponding NMR solvent used as an internal reference. Coupling constants (J)
are quoted to the nearest 0.1 Hz. Abbreviations used in the description of resonances are: s (singlet), d
(doublet), t (triplet), q (quartet), sept (septet), m (multiplet), and br (broad). Infrared (IR) spectra were
recorded on a Shimadzu IR Affinity–1 instrument using the corresponding isolated NMR sample in
CDCl3 (attenuated total reflectance sampling technique). High-resolution mass spectra (HRMS) were
recorded on a Finnigan MAT 900 XLT spectrometer [electrospray ionization (ESI) technique]. Thin
layer chromatography (TLC) was carried out on pre-coated silica gel plates from Merck (DF
ALufolien 60F254; 0.2 mm). Preparative thin-layer Chromatography (PTLC) was carried out on self-
prepared plates using silica gel from Wakogel (B–5F; particle size: 45 µm). Flash column
chromatography was carried out using silica gel from Fisher Scientific (60 Å; particle size: 40–63 µm).
Product spots were visualized by UV light at 254 nm or with an appropriate stain solution. Melting
points were recorded on a Gallenkamp melting point apparatus (uncorrected).
All bases for base screening were purchased with the highest available purity. LiHMDS (97%,
Aldrich), NaHMDS (99%, Aldrich), KHMDS (0.5 M in toluene, Aldrich), LDA (97%, Aldrich), LTMP
(97%, Aldrich), NaOtBu (99.9%, Aldrich), KOtBu (99.99%, Aldrich), NaOtBu (99.9%, Aldrich),
Li2CO3 (≥99.0%, Aldrich), Na2CO3 (≥99.0%, Aldrich), K2CO3 (99.9995%, Aldrich), Cs2CO3
(99.9995%, Aldrich), 1,8-Diazabicyclo[5.4.0]undec-7-ene (≥99.0%, Aldrich), N,N,N,N-
tetramethylguanidine (TMG, ≥99.0%, Aldrich) and proton sponge (≥99.0%, Aldrich) were purchased.
All NHC precursors for control experiments were purchased with the highest available purity. NHC
precursors pre-NHC–2 (95%, Aldrich), pre-NHC–3 (96%, Aldrich), pre-NHC–4 (97%, Aldrich), pre-
NHC–5 (97%, Aldrich), pre-NHC–6 (97%, Aldrich), pre-NHC–7 (95%, Aldrich), pre-NHC–8 (98%,
Aldrich), pre-NHC–9 (≥98%, Aldrich) and pre-NHC–10 (98%, Aldrich) were purchased. CAAC
precursor pre-CAAC was donated from Rhodia, Marseille in France.
Bis(dialkylamino)cyclopropenylidene precursors pre-BAC–1,[8] 2,[71] and 3 were prepared according to
literature methods with slight modifications. Imines 1a, j, l, s, t, u,[54] 1b,[35] 1c-e, h, k, b’,[36] 1f, p,[53]
1g,[134] 1m, q,[135] 1n–o,[137] 1r,[138] 1v,[139] 1w, x, y,[140] 1z, a’,[141] are literature-known and were
prepared accordingly. Imine 1h was unknown and prepared according to literature method.[54]
Michael acceptors MA–1 (98%, Aldrich), MA–2 (99%, Aldrich), MA–3 (98%, Aldrich), MA–4 (98%,
Aldrich), MA–5 (98%, Aldrich), MA–6 (98%, Aldrich), MA–7 (98%, Aldrich), MA–9 (99%, Aldrich),
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MA–10 (99%, Aldrich), MA–11 (99%, Aldrich), MA–15 (99%, Aldrich) and MA–16 (90%, Aldrich)
were purchased and distilled before use, and stored over molecular sieves (4 Å) in a nitrogen glove
box. The obtained analytical data were in full agreement with the reported data. Unless otherwise
stated, all reagents purchased from commercial suppliers were used directly without further
purification. THF, toluene, and diethyl ether were distilled over sodium–benzophenone and stored
over molecular sieves (4 Å) in a nitrogen glove box. All other solvents –including dioxane, DME,
DCM, DCE, and MeCN– were used non-distilled, but stored over molecular sieves (4 Å) in a nitrogen
glove box. Solvent dryness was confirmed using a Karl–Fischer apparatus.
All catalytic reactions were carried out in in oven-dried glassware (typically sealed screw-caped test
tubes) under an inert atmosphere. Conventional stirring and heating was carried out using a magnetic
stirring bar and a hot plate magnetic stirrer (sand bath).
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5.2 ORGANOCATALYSIS WITH AN UNUSUAL CARBENE
5.2.1 Preparation of Bis(dialkylpropylamino)cyclopropenium precursors
Various bis(dialkylamino)cyclopropenium salts were synthesized according to previously reported
procedures. [8,71]
Bis(diisopropylamino)cyclopropenium tetrafluoroborate (pre-BAC–1)
The compound was prepared according to Bertrand’s reported literature procedure.[8] Diisopropyl
amine (11.1 g, 110 mmol, 5.00 equiv) was added drop-wise to a stirred solution of
tetrachlorocyclopropene (3.87 g, 22.0 mmol, 1.00 equiv) in CH2Cl2 (150 mL) at 0 °C under a nitrogen
atmosphere. After 6 hours at 0 °C, the solution was warmed to room temperature and sodium
tetrafluoroborate (7.50 g, 22.0 mmol, 1.00 equiv) was added. The suspension was stirred overnight,
and then refluxed for 4 hours. After cooling to room temperature were added successively triphenyl
phosphine (5.71 g, 22.0 mmol, 1.00 equiv) and water (100 mL), and the mixture was stirred overnight
(open air). The organic layer was washed with water (3 x 250 mL), dried (MgSO4), and concentrated
in vacuo. After washing with pentane (100 mL), and drying in vacuo, the cyclopropenium salt was
obtained as a pale-yellow solid. Recrystallization from CH2Cl2/Et2O at –20 °C afforded the final
product as yellow needle-like crystals.
Yellow needle-like crystals (mp 132–134 °C).
Yield: 10.6 g (90%).
1H NMR (CDCl3, 600 MHz): δ = 7.46 (s, 1H), 4.05 (sept, J = 11.3 Hz, 2H), 3.86 (sept, J = 11.3 Hz,
2H), 1.41 (d, J = 11.3 Hz, 12H), 1.38 (d, J = 11.3 Hz, 12H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 133.8 (2C), 99.3, 56.9 (2C), 49.2 (2C), 20.8 (4C), 20.7 (4C) ppm.
11B NMR (CDCl3, 128 MHz): δ = –1.70 ppm.
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19F NMR (CDCl3, 128 MHz): δ = –152.3 ~ –152.2 (m) ppm.
IR (CH2Cl2): ν = 3122, 2983, 2268, 1880, 1566, 1055, 1033, 912, 727 cm-1.
HRMS (ESI+): calculated for C15H29N2+ = [M]+: m/z = 237.2319, found: m/z = 237.2325.
Bis(diethylamino)cyclopropenium tetraphenylborate (pre-BAC–2)
The compound was prepared according to reported literature procedures.[71] Diethyl amine (4.70 mL,
45.0 mmol, 4.50 equiv) was added dropwise to a stirred solution of tetrachlorocyclopropene (1.38 mL,
12.0 mmol, 1.00 equiv) in CH2Cl2 (200 mL) at –78 °C under a nitrogen atmosphere. The reaction
mixture was warmed to room temperature over 3 hours, and then cooled to –78 °C. Triphenyl
phosphine (2.96 g, 12.0 mmol, 1.00 equiv) was then quickly added and the mixture was warmed to
room temperature. At that stage, distilled water (40 mL) was added and the two-phase mixture was
stirred vigorously for 16 hours before adding sodium tetraphenylborate (3.86 g, 12.0 mmol, 1.00
equiv). The organic layer was successively washed with aqueous HCl (0.5 M; 15 mL), aqueous
NaHCO3 (saturated; 15 mL), and water (10 mL), then dried over Na2SO4 and concentrated in vacuo to
provide the crude as a light yellow oil (4.50 g, 96% yield). Recrystallization from hot MeOH afforded
the final product. The obtained analytical data fit accurately with the reported data.[71]
White wedge-shaped crystals
Mp. 132–134 °C (132–133 °C).[71]
Yield: 4.50 g (96%).
1H NMR (CDCl3, 500 MHz): δ = 7.51 (br s, 8H), 7.03 (t, J = 7.1 Hz, 8H), 6.86 (t, J = 7.1 Hz, 4H),
4.46 (br s, 1H), 3.20 (q, J = 7.5 Hz, 4H), 3.10 (q, J = 7.5 Hz, 4H), 1.21 (t, J = 7.5 Hz, 6H), 1.11 (t, J =
7.5 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.4 (q, J = 49.0 Hz, 4C), 136.2 (4C), 135.4 (2C), 125.9 (8C),
122.0 (8C), 98.2, 48.1 (2C), 46.9 (2C), 14.2 (2C), 12.9 (2C) ppm.
Bis(dicyclohexylamino)cyclopropenium tetrafluoroborate (pre-BAC–3)
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The compound was prepared according to a modified literature procedure.[71] Dicyclohexylamine
(5.14 mL, 45.0 mmol, 4.50 equiv) was added drop-wise to a stirred solution of
tetrachlorocyclopropene (1.38 mL, 12.0 mmol, 1.00 equiv) in CH2Cl2 (200 mL) at –78 °C under a
nitrogen atmosphere. The reaction mixture was warmed to room temperature over 3 hours, and then
distilled water (40 mL) was added and the two-phase mixture was stirred vigorously for 16 hours
before adding sodium tetraphenylborate (3.86 g, 12.0 mmol, 1.00 equiv). The organic layer was
successively washed with aqueous HCl (0.5 M; 15 mL), aqueous NaHCO3 (saturated; 15 mL), and
water (10 mL), then dried over Na2SO4 and concentrated in vacuo to provide the crude as a light-
yellow solid. Recrystallization from hot MeOH afforded the final product as a colorless solid (mp
132–133 °C). The chlorocyclopropenium salt (1.00 g, 1.30 mmol, 1.00 equiv) was dissolved in DCM
(50 mL) and cooled to –78 °C. Triphenyl phosphine (0.35 g, 1.30 mmol, 1.00 equiv) was then quickly
added and the mixture was warmed to room temperature. At that stage, distilled water (10 mL) was
added and the two-phase mixture was stirred vigorously for 16 hours. The organic layer was
successively washed with aqueous HCl (0.5 M; 20.0 mL), aqueous NaHCO3 (saturated; 20.0 mL), and
water (15.0 mL), then dried over Na2SO4 and concentrated in vacuo to obtain the crude.
Recrystallization from DCM/Et2O afforded the final product.
Light yellow star-like crystals (mp 152–153 °C).
Yield: 0.81 g (85%)
1H NMR (CDCl3, 600 MHz): δ = 7.57 (br s, 8H), 7.09 (t, J = 8.5 Hz, 8H), 6.63 (t, J = 8.5 Hz, 4H),
4.61 (br s, 1H), 3.39 (q, J = 7.5 Hz, 2H), 3.36 (q, J = 7.5 Hz, 2H), 1.92-1.89 (m, 15H), 1.77-1.75 (m,
2H), 1.53-1.52 (m, 15H), 1.38-1.35 (m, 8H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 167.5 (q, J = 44.3 Hz, 4C), 138.9 (4C), 138.1 (2C), 127.5 (8C),
122.5 (8C), 99.2, 57.3 (4C), 31.2 (4C), 25.9 (8C), 25.4 (8C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –6.14 ppm.
IR (CH2Cl2): ν = 3110, 3045, 2984, 1620, 1593, 1567 cm-1.
HRMS (ESI+): calculated for C27H45N2+ = [M]+: m/z = 397.6578, found: m/z = 397.6581.
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5.2.2 Preparation of Novel BAC–Metal Complexes
Bis(diisopropylamino)cyclopropenylidene–metal complexes were synthesized according to previously
reported procedures.[3,8,17]
General Procedure A [Preparation of BAC-Metal Complexes]
To an oven-dried 5 mL test tube with a magnetic stirring bar in a nitrogen glove box were added pre-
BAC–1 (16.0 mg, 0.05 mmol, 1.00 equiv) and THF (450 µL). After stirring the reaction mixture at –
78 °C for 15 minutes, KHMDS (1.0M in THF; 50 µL, 0.05 mmol, 1.00 equiv) was added drop-wise to
the test tube. The reaction mixture was kept at –78 °C for another 15 minutes before warming to room
temperature. After stirring at room temperature for 30 minutes, the reaction mixture was introduced to
the glove box, where the corresponding metal chloride salt (0.06 mmol, 1.2 equiv) was added in one
portion. The reaction mixture was stirred at room temperature overnight. The solvent was then
evaporated and the residue was washed with methanol (2 mL). The corresponding complex was
obtained after filtration and dried in vacuo.
[Bis(diisopropylamino)cyclopropenium]gallium(III) Chloride (1–26)
Prepared from pre-BAC–1 (16.0 mg, 0.05 mmol, 1.00 equiv) and GaCl3 (10.6 mg, 0.06 mmol, 1.20
equiv) according to General Procedure A. 1–26 was washed with methanol (2 mL).
Light yellow solid (mp 220–223 °C).
Yield: 20.0 mg (96%).
1H NMR (CDCl3, 500 MHz): δ = 4.16 (sept, J = 6.7 Hz, 2H), 4.07 (sept, J = 6.7 Hz, 2H), 1.40 (d, J =
7.8 Hz, 12H), 1.36 (d, J = 7.8 Hz, 12H) ppm.
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13C NMR (CDCl3, 125 MHz): δ = 143.2 (2C), 140.8, 53.1 (2C), 51.4 (2C), 21.6 (4C), 20.9 (4C) ppm.
71Ga NMR (CDCl3, 244 MHz): δ = 249.8 ppm.
IR (CH2Cl2): ν = 2980, 2937, 2877, 1847, 1523, 1454, 1375, 1340, 1151, 904, 727, 650 cm–1.
HRMS (ESI+): calculated for C15H28Cl3GaNaN2 = [M+Na]+: m/z = 434.6871, found: m/z = 434.6876.
[Bis(diisopropylamino)cyclopropenium]iron(II) Chloride (1–27)
Prepared from pre-BAC–1 (16.0 mg, 0.05 mmol, 1.00 equiv) and FeCl2 (9.70 mg, 0.06 mmol, 1.20
equiv) according to General Procedure A. 1–27 was washed with methanol (2 mL).
Light purple solid (mp 110–113 °C).
Yield: 15.2 mg (80%).
1H NMR (CDCl3, 500 MHz): δ = 4.08 (sept, J = 7.2 Hz, 2H), 4.00 (sept, J = 7.2 Hz, 2H), 1.45 (d, J =
7.8 Hz, 12H), 1.42 (d, J = 7.8 Hz, 12H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 149.2 (2C), 133.8, 56.2 (2C), 49.7 (2C), 21.1 (4C), 21.0 (4C) ppm.
IR (CH2Cl2): ν = 3120, 2981, 2933, 2880, 2268, 1880, 1566, 1348, 1051, 1033, 908, 727, 648 cm–1.
HRMS (ESI+): calculated for C15H28Cl2FeNaN2 = [M+Na]+: m/z = 385.3203, found: m/z = 385.3210.
[Bis(diisopropylamino)cyclopropenium]iron(III) Chloride (1–28)
Prepared from pre-BAC–1 (16.0 mg, 0.05 mmol, 1.00 equiv) and FeCl3 (9.80 mg, 0.06 mmol, 1.20
equiv) according to General Procedure A. 1–28 was washed with methanol (2 mL).
Brown solid (mp 116–120 °C).
Yield: 19.0 mg (86%).
1H NMR (CDCl3, 500 MHz): δ = 4.06 (sept, J = 7.2 Hz, 2H), 3.98 (sept, J = 7.2 Hz, 2H), 1.33 (d, J =
8.0 Hz, 12H), 1.29 (d, J = 8.0 Hz, 12H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 149.9 (2C), 143.6, 57.9 (2C), 51.4 (2C), 21.9 (4C), 21.3 (4C) ppm.
IR (CH2Cl2): ν = 3128, 2939, 2880, 1600, 1577, 1541, 1394, 1347, 1215, 1136, 1014, 904, 848, 727,
650 cm–1.
HRMS (ESI+): calculated for C15H28Cl3FeNaN2 = [M+Na]+: m/z = 420.5323, found: m/z = 420.5319.
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5.2.3 Preparation of Imines
General Procedure B [Preparation of Imines]
To an oven-dried 50 mL round-bottom flask with a magnetic stirring bar under an argon atmosphere
were added p-toluenesulfonamide (1.00 equiv), tetraethyl orthosilicate (1.10 equiv), and the respective
aldehyde (1.00 equiv). The flask was connected to a short distillation head (approximately 3–4 cm
long) and a receptor flask. The reaction mixture was heated at 140–160 °C for 8–16 hours; the by-
product, ethanol, was collected in the receptor flask. After confirming the end-point of the reaction by
1H NMR spectroscopic analysis, the reaction mixture was cooled to room temperature, and washed
with hexane (10 mL). The mixture was filtered, and volatiles were removed in vacuo to give the crude
imine, which was recrystallized from ethyl acetate to yield the corresponding pure imine, which was
powdered and dried over 4 Å MS in DCM prior to use in catalysis.
4-Methyl-N-(phenylmethylene)benzenesulfonamide (Imine–1a)
Prepared from benzaldehyde (6.10 g, 55.0 mmol, 1.10 equiv), tosyl amide (8.60 g, 50.0 mmol, 1.00
equiv), and Si(OEt)4 (11.5 g, 55.0 mmol, 1.10 equiv) according to General Procedure B at 160 oC for
8 h. Imine–1a was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [54]
Colorless needle–like crystals.
Mp. 109−111 oC (110−111 oC) [54]
Yield: 12.7 g (98%).
1H NMR (CDCl3, 500 MHz): δ = 9.06 (s, 1H), 7.96–7.91 (m, 4H), 7.62–7.53 (m, 1H), 7.51–7.46 (m,
2H), 7.37 (d, J = 8.1 Hz, 2H), 2.46 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 170.1, 144.6, 135.2, 134.9, 132.1, 131.3 (2C), 129.8 (2C), 129.2
(2C), 128.1 (2C), 21.7 ppm.
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4-Methyl-N-[(2-tolyl)methylene]benzenesulfonamide (Imine–1b)
Prepared from 2-methylbenzaldehyde (2.48 g, 17.7 mmol, 1.10 equiv), tosyl amide (3.10 g, 16.1 mmol,
1.00 equiv), and Si(OEt)4 (3.70 g, 17.7 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 12 h. Imine–1b was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [35]
Colorless star–like crystals.
Mp. 89−90 oC (88−90 oC) [35]
Yield: 4.21 g (96%).
1H NMR (CDCl3, 500 MHz): δ = 9.37 (s, 1H), 8.06–8.04 (m, 1H), 7.92 (d, J = 7.6 Hz, 2H), 7.51–7.47
(m, 1H), 7.37 (d, J = 7.6 Hz, 2H), 7.31–7.28 (m, 2H), 2.64 (s, 3H), 2.47 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.7, 144.5, 142.3, 135.5, 134.6, 131.6, 130.7, 130.5, 129.8 (2C),
128.0 (2C), 126.6, 21.7, 19.7 ppm.
4-Methyl-N-[(3-tolyl)methylene]benzenesulfonamide (Imine–1c)
Prepared from 3-methylbenzaldehyde (2.48 g, 17.7 mmol, 1.10 equiv), tosyl amide (3.10 g, 16.1 mmol,
1.00 equiv), and Si(OEt)4 (3.70 g, 17.7 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 12 h. Imine–1c was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [36]
Colorless star–like crystals.
Mp. 88−90 oC (88−89 oC) [36]
Yield: 4.30 g (98%).
1H NMR (CDCl3, 500 MHz): δ = 9.00 (s, 1H), 7.89 (d, J = 8.0 Hz, 2H), 7.76–7.75 (m, 1H), 7.67 (d, J
= 8.0 Hz, 2H), 7.40–7.31 (m, 3H), 2.43 (s, 3H), 2.39 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 170.4, 144.5, 139.1, 135.9, 135.3, 132.4, 131.4, 129.8 (2C), 128.8,
128.7, 128.1 (2C), 21.7, 21.2 ppm.
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4-Methyl-N-[(4-tolyl)methylene]benzenesulfonamide (Imine–1d)
Prepared from 4-methylbenzaldehyde (2.48 g, 17.7 mmol, 1.10 equiv), tosyl amide (3.10 g, 16.1 mmol,
1.00 equiv), and Si(OEt)4 (3.70 g, 17.7 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 12 h. Imine–1d was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [36]
Colorless star–like crystals.
Mp. 111−113 oC (110−112 oC) [36]
Yield: 4.10 g (93%).
1H NMR (CDCl3, 500 MHz): δ = 8.99 (s, 1H), 7.88 (d, J = 8.0 Hz, 2H), 7.77 (d, J = 8.4 Hz, 2H), 7.36
(d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 2.43 (s, 3H), 2.43 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.9, 146.4, 144.4, 135.5, 131.4, 129.9 (2C), 129.4 (2C), 129.0
(2C), 128.1 (2C), 22.0, 21.7 ppm.
4-Methyl-N-[(naphthalen-1-yl)methylene]benzenesulfonamide (Imine–1e)
Prepared from 1-naphthaldehyde (2.62 g, 17.9 mmol, 1.10 equiv), tosyl amide (3.20 g, 16.4 mmol,
1.00 equiv), and Si(OEt)4 (3.73 g, 17.9 mmol, 1.10 equiv) according to General Procedure B at 180 oC
for 12 h. Imine–1e was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [36]
Brown feather–like crystals.
Mp. 136−139 oC (135−140 oC) [36]
Yield: 4.30 g (94%).
1H NMR (CDCl3, 500 MHz): δ = 9.62 (s, 1H), 8.99 (d, J = 10.8 Hz, 1H), 8.15 (d, J = 9.0 Hz, 1H),
8.07 (d, J = 9.0 Hz, 1H), 7.95 (d, J = 10.8 Hz, 2H), 7.90 (d, J = 10.8 Hz, 1H), 7.68–7.64 (m, 1H),
7.59–7.54 (m, 2H), 7.34 (d, J = 10.8 Hz, 2H), 2.44 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.8, 144.5, 136.1, 135.8, 135.1, 133.8, 131.9, 129.8 (2C), 129.1,
128.1 (2C), 127.9, 127.8, 126.9, 125.1, 124.3, 21.7 ppm.
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4-Methyl-N-[(naphthalen-2-yl)methylene]benzenesulfonamide (Imine–1f)
Prepared from 2-naphthaldehyde (2.62 g, 17.9 mmol, 1.10 equiv), tosyl amide (3.20 g, 16.4 mmol,
1.00 equiv), and Si(OEt)4 (3.73 g, 17.9 mmol, 1.10 equiv) according to General Procedure B at 180 oC
for 12 h. Imine–1f was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [53]
Brown wedge−shaped crystals.
Mp. 122−125 oC (124−126 oC) [53]
Yield: 4.28 g (94%).
1H NMR (CDCl3, 500 MHz): δ = 9.18 (s, 1H), 8.34–8.32 (m, 1H), 7.95 (d, J = 8.3 Hz, 1H), 7.93–7.88
(m, 5H), 7.59 (d, J = 7.6 Hz, 2H), 7.37 (d, J = 7.6 Hz, 2H), 2.44 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 170.0, 144.6, 136.6, 136.1, 135.2, 132.7, 131.8, 130.0, 129.8 (2C),
129.4, 129.1, 128.1 (2C), 127.8, 127.3, 124.2, 21.7 ppm.
4-Methyl-N-(4-methoxybenzylidene)benzenesulfonamide (Imine–1g)
Prepared from 4-methoxy benzaldehyde (2.59 g, 19.0 mmol, 1.10 equiv), tosyl amide (3.00 g, 17.3
mmol, 1.00 equiv), and Si(OEt)4 (3.96 g, 19.0 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 8 h. Imine–1g was recrystallized from EtOAc (10 mL). The obtained analytical data were
in full agreement with the reported data. [134]
Colorless needle–like crystals.
Mp. 125−128 oC (126−127 oC) [134]
Yield: 4.40 g (95%).
1H NMR (CDCl3, 500 MHz): δ = 8.97 (s, 1H), 7.92–7.89 (m, 4H), 7.36 (d, J = 8.4 Hz, 2H), 6.99 (d, J
= 8.4 Hz, 2H), 3.91 (s, 3H), 2.46 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.2, 165.3, 144.2, 135.8, 133.7 (2C), 129.7 (2C), 127.9 (2C),
125.3, 114.7 (2C), 55.7, 21.6 ppm.
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4-Methyl-N-[(4-dimethylamino)benzylidene]benzenesulfonamide (Imine–1h)
Prepared from 4-dimethylamino benzaldehyde (2.71 g, 18.1 mmol, 1.10 equiv), tosyl amide (2.80 g,
16.7 mmol, 1.00 equiv), and Si(OEt)4 (3.77 g, 18.1 mmol, 1.10 equiv) according to General Procedure
B at 160 oC for 8 h. Imine–1h was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [36]
Yellow hexagon−shaped crystals.
Mp. 172−177 oC (173−175 oC) [36]
Yield: 4.00 g (92%).
1H NMR (CDCl3, 500 MHz): δ = 8.82 (s, 1H), 7.86 (d, J = 8.4 Hz, 2H), 7.77 (d, J = 9.0 Hz, 2H), 7.29
(d, J = 8.4 Hz, 2H), 6.65 (d, J = 9.0 Hz, 2H), 3.09 (s, 6H), 2.41 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.0, 154.8, 143.5, 136.9, 133.9, 129.6 (2C) 129.5 (2C), 127.6
(2C), 119.9 (2C), 40.1 (2C), 21.6 ppm.
4-Methyl-N-[(4-amino)benzylidene]benzenesulfonamide (Imine–1i)
Prepared from 4-amino benzaldehyde (2.44 g, 20.0 mmol, 1.10 equiv), tosyl amide (3.10 g, 18.2 mmol,
1.00 equiv), and Si(OEt)4 (4.17 g, 20.0 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 8 h. Imine–1i was recrystallized from EtOAc (10 mL).
Colorless oil.
1H NMR (CDCl3, 500 MHz): δ = 9.72 (s, 1H), 7.73 (d, J = 7.0 Hz, 2H), 7.49 (d, J = 7.6 Hz, 2H), 7.33
(d, J = 7.0 Hz, 2H), 7.19 (d, J = 7.6 Hz, 2H), 6.39 (br s, NH2, 2H), 2.32 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 168.1, 149.1, 144.3, 138.2, 132.7, 130.1 (2C), 129.7 (2C), 127.2
(2C), 114.3 (2C), 21.6 ppm.
IR (CH2Cl2): ν = 3408, 2978, 2882, 1618, 1460, 1376, 1325, 1148, 856 cm-1.
HRMS (ESI): calculated for C14H14NaN2O2S = [M+Na]+: m/z = 297.0801, found: m/z = 297.0810.
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4-Methyl-N-[(4-hydroxy)benzylidene]benzenesulfonamide (Imine–1j)
Prepared from 4-hydroxy benzaldehyde (2.42 g, 20.0 mmol, 1.10 equiv), tosyl amide (3.10 g, 18.2
mmol, 1.00 equiv), and Si(OEt)4 (4.17 g, 20.0 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 8 h. Imine–1j was recrystallized from EtOAc (10 mL). The obtained analytical data were
in full agreement with the reported data. [54]
Pink lens−shaped crystals.
Mp. 110−113 oC (109−111 oC) [54]
Yield: 3.80 g (87%).
1H NMR (CDCl3, 500 MHz): δ = 9.76 (s, 1H), 9.24 (br s, OH, 1H), 7.81 (d, J = 9.0 Hz, 2H), 7.76 (d, J
= 6.0 Hz, 2H), 7.37 (d, J = 6.0 Hz, 2H), 7.03 (d, J = 9.0 Hz, 2H), 2.98 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.0, 157.8, 144.3, 138.2, 132.7, 129.7 (2C), 128.5 (2C), 127.3
(2C), 115.0 (2C), 21.3 ppm.
4-Methyl-N-[(4-fluoro)benzylidene]benzenesulfonamide (Imine–1k)
Prepared from 4-fluoro benzaldehyde (2.53 g, 20.4 mmol, 1.10 equiv), tosyl amide (3.50 g, 18.5 mmol,
1.00 equiv), and Si(OEt)4 (4.25 mL, 20.4 mmol, 1.10 equiv) according to General Procedure B at 160
oC for 8 h. Imine–1k was recrystallized from EtOAc (10 mL). The obtained analytical data were in
full agreement with the reported data. [36]
Colorless feather−shaped crystals.
Mp. 111−113 oC (111−112 oC) [36]
Yield: 4.80 g (96%).
1H NMR (CDCl3, 500 MHz): δ = 9.00 (s, 1H), 7.97–7.95 (m, 2H), 7.88 (d, J = 8.1 Hz, 2H), 7.35 (d, J
= 7.8 Hz, 2H), 7.18–7.16 (m, 2H), 2.44 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.5, 166.8 (d, J = 257.1 Hz), 144.7, 135.1, 133.8 (d, J = 9.7 Hz,
2C), 129.8 (2C), 128.6 (d, J = 2.6 Hz), 128.1 (2C), 116.6 (d, J = 22.2 Hz, 2C), 21.7 ppm.
19F NMR (CDCl3, 128 MHz): δ = – 101.2 ~ – 101.1 (m) ppm.
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4-Methyl-N-[(4-chloro)benzylidene]benzenesulfonamide (Imine–1l)
Prepared from 4-chloro benzaldehyde (2.32 g, 19.7 mmol, 1.10 equiv), tosyl amide (3.00 g, 17.9 mmol,
1.00 equiv), and Si(OEt)4 (4.11 g, 19.7 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 8 h. Imine–1l was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [54]
Colorless feather−shaped crystals.
Mp. 173−175 oC (174−175 oC) [54]
Yield: 4.50 g (92%).
1H NMR (CDCl3, 500 MHz): δ = 8.99 (s, 1H), 7.89 (d, J = 8.8 Hz, 2H), 7.86 (d, J = 8.0 Hz, 2H), 7.46
(d, J = 8.8 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 2.44 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.6, 144.7, 141.4, 134.9, 132.4 (2C), 130.9, 129.8 (2C), 129.6
(2C), 128.2 (2C), 22.2 ppm.
4-Methyl-N-[(4-bromo)benzylidene]benzenesulfonamide (Imine–1m)
Prepared from 4-bromo benzaldehyde (1.30 g, 6.50 mmol, 1.10 equiv), tosyl amide (1.30 g, 5.90 mmol,
1.00 equiv), and Si(OEt)4 (1.36 g, 6.50 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 8 h. Imine–1m was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [135]
Colorless feather−shaped crystals.
Mp. 196−197 oC (196−197 oC) [135]
Yield: 2.00 g (99%).
1H NMR (CDCl3, 500 MHz): δ = 8.98 (s, 1H), 7.89 (d, J = 8.0 Hz, 2H), 7.78 (d, J = 7.6 Hz, 2H), 7.64
(d, J = 8.0 Hz, 2H), 7.35 (d, J = 7.6 Hz, 2H), 2.44 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.8, 144.8, 134.9, 132.6 (2C), 132.4 (2C), 130.0, 131.9, 129.9
(2C), 128.2 (2C), 21.7 ppm.
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4-Methyl-N-[(4-methoxycarbonyl)benzylidene]benzenesulfonamide (Imine–1n)
Prepared from methyl 4-formylbenzoate (1.11 g, 6.80 mmol, 1.10 equiv), tosyl amide (1.60 g, 6.20
mmol, 1.00 equiv), and Si(OEt)4 (1.42 g, 6.80 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 8 h. Imine–1n was recrystallized from EtOAc (10 mL). The obtained analytical data were
in full agreement with the reported data. [137]
Colorless needle−like crystals.
Mp. 184−185 oC (183−185 oC) [137]
Yield: 1.70 g (94%).
1H NMR (CDCl3, 500 MHz): δ = 9.07 (s, 1H), 8.13 (d, J = 8.4 Hz, 2H), 7.99 (d, J = 8.5 Hz, 2H), 7.89
(d, J = 8.4 Hz, 2H), 7.36 (d, J = 8.5 Hz, 2H), 3.95 (s, 3H), 2.45 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.8, 165.9, 144.9, 135.9, 135.3, 134.7, 131.0 (2C), 130.1 (2C),
129.9 (2C), 128.2 (2C), 52.6, 21.7 ppm.
4-Methyl-N-[(4-trifluoromethyl)benzylidene]benzenesulfonamide (Imine–1o)
Prepared from 4-trifluoromethyl benzaldehyde (0.99 g, 5.70 mmol, 1.10 equiv), tosyl amide (1.50 g,
5.20 mmol, 1.00 equiv), and Si(OEt)4 (1.19 g, 5.70 mmol, 1.10 equiv) according to General Procedure
B at 160 oC for 8 h. Imine–1o was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [137]
Colorless needle−like crystals.
Mp. 158−160 oC (159−160 oC) [137]
Yield: 1.81 g (90%).
1H NMR (CDCl3, 500 MHz): δ = 9.08 (s, 1H), 8.05 (d, J = 8.4 Hz, 2H), 7.90 (d, J = 8.4 Hz, 2H), 7.76
(d, J = 8.1 Hz, 2H), 7.39 (d, J = 8.1 Hz, 2H), 2.45 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.3, 145.0, 135.7 (q, J = 257.0 Hz), 134.5 (2C), 131.4 (2C), 129.9
(q, J = 72.9 Hz), 128.3 (q, J = 23.4 Hz, 2C), 126.1, 126.0 (q, J = 7.6 Hz, 2C), 123.4 (q, J = 3.8 Hz),
21.7 ppm.
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19F NMR (CDCl3, 128 MHz): δ = – 63.3 (s) ppm.
4-Methyl-N-[(4-cyano)benzylidene]benzenesulfonamide (Imine–1p)
Prepared from 4-cyano benzaldehyde (2.16 g, 18.2 mmol, 1.10 equiv), tosyl amide (2.90 g, 16.5 mmol,
1.00 equiv), and Si(OEt)4 (3.79 g, 18.2 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 8 h. Imine–1p was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [53]
Colorless hexagon−shaped crystals.
Mp. 172−173 oC (171−173 oC) [53]
Yield: 3.80 g (87%).
1H NMR (CDCl3, 500 MHz): δ = 9.05 (s, 1H), 8.03 (d, J = 8.4 Hz, 2H), 7.89 (d, J = 8.1 Hz, 2H), 7.78
(d, J = 8.1 Hz, 2H), 7.37 (d, J = 8.4 Hz, 2H), 2.45 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 167.8, 145.3, 135.9, 134.0, 132.7 (2C), 131.3 (2C), 129.9 (2C),
128.3 (2C), 117.6, 117.5, 21.6 ppm.
4-Methyl-N-[(4-nitro)benzylidene]benzenesulfonamide (Imine–1q)
Prepared from 4-nitro benzaldehyde (2.76 g, 18.1 mmol, 1.10 equiv), tosyl amide (2.80 g, 16.5 mmol,
1.00 equiv), and Si(OEt)4 (3.77 g, 18.1 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 10 h. Imine–1q was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [135]
Colorless hexagon−shaped crystals.
Mp. 211−213 oC (211−212 oC) [135]
Yield: 4.30 g (92%).
1H NMR (CDCl3, 500 MHz): δ = 9.10 (s, 1H), 8.33 (d, J = 9.0 Hz, 2H), 8.11 (d, J = 8.7 Hz, 2H), 7.91
(d, J = 8.7 Hz, 2H), 7.38 (d, J = 9.0 Hz, 2H), 2.46 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 167.3, 151.2, 145.3, 137.4, 134.2, 131.8 (2C), 130.0 (2C), 128.4
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(2C), 124.2 (2C), 21.7 ppm.
4-Methyl-N-(2-furanylmethylene)benzenesulfonamide (Imine–1r)
Prepared from 2-furaldehyde (2.10 g, 20.8 mmol, 1.10 equiv), tosyl amide (3.50 g, 18.9 mmol, 1.00
equiv), and Si(OEt)4 (4.34 g, 20.8 mmol, 1.10 equiv) according to General Procedure B at 160 oC for
10 h. Imine–1r was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [138]
Grey hexagon−shaped crystals.
Mp. 99−101 oC (99−102 oC) [138]
Yield: 4.60 g (94%).
1H NMR (CDCl3, 500 MHz): δ = 8.84 (s, 1H), 7.89 (d, J = 8.4 Hz, 2H), 7.76–7.72 (m, 2H), 7.36 (d, J
= 8.4 Hz, 2H), 6.66–6.64 (m, 1H), 2.45 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 155.6, 149.7, 149.1, 144.5, 135.2, 129.8 (2C), 128.0 (2C), 124.6,
113.7, 21.6 ppm.
4-Methyl-N-(2-thienylmethylene)benzenesulfonamide (Imine–1s)
Prepared from 2-thienyl aldehyde (2.32 g, 20.7 mmol, 1.10 equiv), tosyl amide (3.40 g, 18.8 mmol,
1.00 equiv), and Si(OEt)4 (4.34 g, 20.7 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 10 h. Imine–1s was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [54]
Brown hexagon−shaped crystals.
Mp. 99−102 oC (98−103 oC) [54]
Yield: 4.30 g (94%).
1H NMR (CDCl3, 500 MHz): δ = 9.11 (s, 1H), 7.86 (d, J = 8.4 Hz, 2H), 7.77 (d, J = 8.4 Hz, 2H),
7.33–7.30 (m, 2H), 7.20 (t, J = 4.4 Hz, 1H), 2.43 (s, 3H) ppm.




Prepared from 2-pyrrolyl aldehyde (2.09 g, 22.1 mmol, 1.10 equiv), tosyl amide (3.70 g, 20.1 mmol,
1.00 equiv), and Si(OEt)4 (4.63 g, 22.1 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 10 h. Imine–1t was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [54]
Brown wedge−shaped crystals.
Mp. 94−95 oC (93−95 oC) [54]
Yield: 3.83 g (85%).
1H NMR (CDCl3, 500 MHz): δ = 9.65 (s, 1H), 8.15 (d, J = 6.0 Hz, 1H), 7.75 (d, J = 9.0 Hz, 2H), 7.52
(d, J = 6.0 Hz, 1H), 7.33 (d, J = 9.0 Hz, 2H), 6.37–6.36 (m, 1H), 4.82 (br s, NH, 1H), 2.45 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 166.4, 144.3, 138.2, 137.4, 129.7 (2C), 127.6 (2C), 123.5, 111.9,
110.3, 21.3 ppm.
4-Methyl-N-(1H-indol-3-ylmethylene)benzenesulfonamide (Imine–1u)
Prepared from 3-indolyl aldehyde (2.63 g, 18.4 mmol, 1.00 equiv), tosyl amide (2.90 g, 16.8 mmol,
1.00 equiv), and Si(OEt)4 (3.85 g, 18.4 mmol, 1.10 equiv) according to General Procedure B at 160 oC
for 10 h. Imine–1u was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [54]
Red needle−like crystals.
Mp. 131−132 oC (130−132 oC) [54]
Yield: 2.85 g (52%).
1H NMR (CDCl3, 500 MHz): δ = 9.84 (s, 1H), 8.53 (s, 1H), 7.96 (d, J = 8.0, 1H), 7.75 (d, J = 7.9, 1H),
7.64 (d, J = 7.9, 2H), 7.31 (d, J = 7.9, 2H), 7.26 (dd, J = 7.9, 8.0, 1H), 7.17–7.15 (m, 1H), 4.77 (br s,
NH, 1H), 2.46 (s, 3H) ppm.
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13C NMR (CDCl3, 125 MHz): δ = 243.4, 198.9, 185.2, 163.4, 146.6, 138.2, 135.1, 129.9 (2C), 126.7,
126.5 (2C), 124.5, 123.1, 111.4, 21.5 ppm.
4-Methyl-N-(1H-indol-1-carboxlic acid-3-ylmethylene)benzenesulfonamide (Imine–1v)
Prepared from 3-Boc-indolyl aldehyde (1.32 g, 5.50 mmol, 1.10 equiv), tosyl amide (1.40 g, 5.00
mmol, 1.00 equiv), and Si(OEt)4 (1.15 g, 5.50 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 12 h. Imine–1v was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [139]
Yellow needle−like crystals.
Mp. 139−141 oC (139−140 oC) [139]
Yield: 1.21 g (60%).
1H NMR (CDCl3, 500 MHz): δ = 9.16 (s, 1H), 8.28 (s, 1H), 8.14 (d, J = 8.3 Hz, 2H), 7.90 (d, J = 8.3
Hz, 2H), 7.41–7.40 (m, 1H), 7.36–7.30 (m, 3H), 2.42 (s, 3H), 1.70 (s, 9H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 163.2, 152.6, 148.3, 144.0, 137.8, 136.2, 135.9, 129.6, 127.8 (2C),
126.2 (2C), 124.6, 122.7, 116.5, 115.1, 85.9, 27.9 (3C), 21.5 ppm.
4-Methyl-N-(2-pyridinylmethylene)benzenesulfonamide (Imine–1w)
Prepared from 2-pyridinecarbaldehyde (2.26 g, 21.1 mmol, 1.10 equiv), tosyl amide (3.30 g, 19.2
mmol, 1.00 equiv), and Si(OEt)4 (4.42 g, 21.1 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 12 h. Imine–1w was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [140]
Yellow needle−like crystals.
Mp. 120−122 oC (121−122 oC) [140]
Yield: 3.80 g (77%).
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1H NMR (CDCl3, 500 MHz): δ = 9.74 (s, 1H), 8.86 (d, J = 6.0 Hz, 1H), 8.30 (d, J = 9.0 Hz, 1H), 8.04
(dd, J = 6.0, 9.0 Hz, 1H), 7.85 (d, J = 9.0 Hz, 2H), 7.73 (d, J = 9.0 Hz, 2H), 7.32 (d, J = 6.0, 9.0 Hz,
1H), 2.33 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 152.8, 149.7, 146.6, 144.3, 138.2, 137.3, 129.3 (2C), 127.0 (2C),
126.3, 123.4, 21.3 ppm.
4-Methyl-N-(2-pyridinylmethylene)benzenesulfonamide (Imine–1x)
Prepared from 3-pyridinecarbaldehyde (2.26 g, 21.1 mmol, 1.10 equiv), tosyl amide (3.30 g, 19.2
mmol, 1.00 equiv), and Si(OEt)4 (4.42 g, 21.1 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 12 h. Imine–1x was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [140]
Yellow needle−like crystals.
Mp. 129−130 oC (128−131 oC) [140]
Yield: 4.51 g (89%).
1H NMR (CDCl3, 500 MHz): δ = 9.09 (s, 1H), 9.05 (s, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.27 (d, J = 7.8
Hz, 1H), 7.90 (d, J = 7.9 Hz, 2H), 7.45 (dd, J = 4.8, 7.8 Hz, 1H), 7.37 (d, J = 7.9 Hz, 2H), 2.45 (s, 3H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 167.6, 155.1, 152.9, 145.1, 136.9, 134.5, 129.5 (2C), 128.9, 128.3
(2C), 124.1, 21.7 ppm.
4-Methyl-N-(2-pyridinylmethylene)benzenesulfonamide (Imine–1y)
Prepared from 4-pyridinecarbaldehyde (2.26 g, 21.1 mmol, 1.10 equiv), tosyl amide (3.30 g, 19.2
mmol, 1.00 equiv), and Si(OEt)4 (4.42 g, 21.1 mmol, 1.10 equiv) according to General Procedure B at
180 oC for 12 h. Imine–1y was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [140]
Yellow needle−like crystals.
Mp. 138−140 oC (137−141 oC) [140]
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Yield: 2.80 g (72%).
1H NMR (CDCl3, 500 MHz): δ = 9.85 (s, 1H), 8.86 (d, J = 9.0 Hz, 1H), 8.65–8.60 (m, 2H), 8.17 (d, J
= 9.0 Hz, 1H), 7.76 (d, J = 7.9 Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 2.30 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.0, 150.4 (2C), 138.2, 134.1, 131.4, 129.2 (2C), 127.3 (2C),
121.4 (2C), 21.8 ppm.
4-Methyl-N-(3-phenylpropylidene)benzenesulfonamide (Imine–1z)
Prepared from 3-phenyl propionaldehyde (2.56 g, 19.1 mmol, 1.00 equiv), tosyl amide (3.00 g, 17.4
mmol, 1.00 equiv), and Si(OEt)4 (3.98 g, 19.1 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 12 h. Imine–1z was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [141]
Colorless rose−like crystals.
Mp. 123−126 oC (125−126 oC) [141].
Yield: 4.40 g (90%).
1H NMR (CDCl3, 500 MHz): δ = 9.62 (t, J = 7.2 Hz, 1H), 7.70 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz,
2H), 7.29–7.25 (m, 3H), 7.16–7.14 (m, 2H), 3.05–3.03 (m, 2H), 2.81–2.78 (m, 2H), 2.34 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 146.6, 144.2, 138.2 (2C), 131.5, 129.3 (2C), 129.0 (2C), 128.3,
127.4 (2C), 126.8, 30.0, 29.1, 21.3 ppm.
4-Methyl-N-(cyclohexylmethylene)benzenesulfonamide (Imine–1a’)
Prepared from cyclohexanecarbaldehyde (2.32 g, 20.7 mmol, 1.10 equiv), tosyl amide (3.20 g, 18.9
mmol, 1.00 equiv), and Si(OEt)4 (4.31 g, 20.7 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 10 h. Imine–1a’ was recrystallized from EtOAc (10 mL). The obtained analytical data
were in full agreement with the reported data. [140]
Colorless hexagon−shaped crystals.
Mp. 80−82 oC (79−81 oC) [140].
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Yield: 4.40 g (90%).
1H NMR (CDCl3, 500 MHz): δ = 8.48 (d, J = 4.5 Hz, 1H), 7.80 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.3
Hz, 2H), 2.44 (s, 3H), 1.85–1.65 (m, 6H), 1.36–1.12 (m, 5H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 181.0, 144.5, 134.9, 129.8 (2C), 128.1 (2C), 43.7, 28.4 (2C), 25.8
(2C), 25.1, 21.6 ppm.
4-Methyl-N-(2,2-dimethylpropylidene)benzenesulfonamide (Imine–1b’)
Prepared from pivaldehyde (1.97 g, 22.9 mmol, 1.10 equiv), tosyl amide (3.00 g, 20.9 mmol, 1.00
equiv), and Si(OEt)4 (4.77 g, 22.9 mmol, 1.10 equiv) according to General Procedure B at 160 oC for
12 h. Imine–1b’ was recrystallized from EtOAc (10 mL). The obtained analytical data were in full
agreement with the reported data. [141]
Colorless needle−like crystals.
Mp. 67−68 oC (67−69 oC) [141].
Yield: 4.30 g (82%).
1H NMR (CDCl3, 500 MHz): δ = 8.45 (s, 1H), 7.79–7.78 (m, 2H), 7.30–7.28 (m, 2H), 2.37 (s, 3H),
1.10 (s, 9H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.8, 145.1, 129.6 (2C), 129.4 (2C), 127.8, 33.2, 27.8 (3C), 23.4
ppm.
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5.2.4 BAC-catalysed aza-MBH Reactions – eletrophile(imine) test
General Procedure C [imine scope]
To an oven-dried test tube with a magnetic stirring bar in a nitrogen glovebox were added pre-BAC–1
(3.20 mg, 10.0 μmol, 5.00 mol%), the corresponding imine (0.22 mmol, 1.10 equiv), Michael acceptor
MA–1 (16.4 mg, 0.20 mmol, 1.00 equiv), THF (0.66 mL, 0.3 M), and DBU (1.50 mg, 10.0 μmol, 5.00
mol%). The reaction mixture was stirred at 30 °C for 24–48 h, at which point TLC and/or 1H NMR
analysis indicated complete consumption of Michael acceptorMA–1. Volatiles were removed in vacuo,
and the residue was purified by flash column chromatography or PTLC on silica gel (eluent:
EtOAc/PE = 1:2, or DCM/acetone = 100:1) to give the intended products.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(phenyl)methyl]benzenesulfonamide (1–33)[44, 142]
Prepared from Imine–1a (57.0 mg, 0.22 mmol, 1.10 equiv), and MA–1 (16.4 mg, 0.20 mmol, 1.00
equiv) according to general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%), DBU
(1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–33 was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full agreement
with the reported data. [44, 142]
Colorless solid.
Mp. 110−112 oC (111−112 oC) [142]
Yield: 64.2 mg (93%).
1H NMR (CDCl3, 500 MHz): δ = 7.61 (d, J = 8.3 Hz, 2H), 7.37 (t, J = 5.7 Hz, 1H), 7.21-7.16 (m, 7H),
6.12 (d, J = 8.4 Hz, 1H), 5.28 (d, J = 8.4 Hz, 1H), 2.49–2.14 (m, 4H), 2.38 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 160.6, 143.5, 143.2, 138.6, 137.4, 129.4 (2C), 128.6 (2C),
127.8, 127.4 (2C), 126.7 (2C), 55.2, 34.9, 26.7, 21.4 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2-toyl)methyl]benzenesulfonamide (1–39a)
162
Prepared from Imine–1b (60.4 mg, 0.22 mmol, 1.10 equiv), and MA–1 (16.4 mg, 0.20 mmol, 1.00
equiv) according to general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%), DBU
(1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–39a was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless solid (mp 156–157 °C).
Yield: 64.7 mg (91%).
1H NMR (CDCl3, 600 MHz): δ = 7.60 (d, J = 8.4 Hz, 2H), 7.35 (t, J = 6.3 Hz, 1H), 7.18 (d, J = 8.4 Hz,
2H), 7.12–7.03 (m, 4H), 5.82 (d, J = 7.6 Hz, 1H), 5.49 (d, J = 7.6 Hz, 1H), 2.49–2.13 (m, 4H), 2.38 (s,
3H), 2.28 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.3, 160.2, 143.9, 143.2, 137.3, 136.7, 135.7, 130.7, 129.3 (2C),
127.9, 127.4 (2C), 126.9, 126.3, 51.8, 34.9, 26.7, 21.5, 19.4 ppm.
IR (CH2Cl2): ν = 3302, 2958, 1697, 1441, 1339, 1161, 904, 864, 741, 650 cm–1.
HRMS (ESI): calculated for C20H21NaNO3S = [M+Na]+: m/z = 378.1134, found: m/z = 378.1120.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(3-toyl)methyl]benzenesulfonamide (1–39b)
Prepared from Imine–1c (60.4 mg, 0.22 mmol, 1.10 equiv), and MA–1 (16.4 mg, 0.20 mmol, 1.00
equiv) according to general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%), DBU
(1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–39b was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless solid (mp 160–161 °C).
Yield: 63.1 mg (87%).
1H NMR (CDCl3, 600 MHz): δ = 7.61 (d, J = 8.2 Hz, 2H), 7.35 (t, J = 6.1 Hz, 1H), 7.19 (d, J = 8.2 Hz,
2H), 7.12–7.10 (m, 1H), 7.02 (d, J = 7.6 Hz, 1H), 6.93 (d, J = 7.6 Hz, 2H), 6.02 (d, J = 8.4 Hz, 1H),
5.25 (d, J = 8.4 Hz, 1H), 2.50–2.15 (m, 4H), 2.39 (s, 3H), 2.23 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.3, 160.4, 143.6, 143.1, 138.5, 138.3, 137.5, 129.3 (2C), 128.6,
128.5, 127.5, 127.4 (2C), 123.7, 55.4, 34.9, 26.7, 21.4, 21.3 ppm.
IR (CH2Cl2): ν = 3275, 2920, 2849, 1695, 1437, 1330, 1159, 1091, 904, 815, 742, 665 cm–1.
HRMS (ESI): calculated for C20H21NaNO3S = [M+Na]+: m/z = 378.1134, found: m/z = 378.1115.
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4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-toyl)methyl]benzenesulfonamide (1–39c)[44]
Prepared from Imine–1d (60.4 mg, 0.22 mmol, 1.10 equiv), and MA–1 (16.4 mg, 0.20 mmol, 1.00
equiv) according to general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%), DBU
(1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–39c was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full agreement
with the reported data.44
Colorless solid.
Mp. 164−166 oC (164−165 oC) [44]
Yield: 57.9 mg (84%).
1H NMR (CDCl3, 500 MHz): δ = 7.64 (d, J = 8.2 Hz, 2H), 7.36 (t, J = 2.7 Hz, 1H), 7.20 (d, J = 8.2 Hz,
2H), 7.08–7.04 (m, 4H), 5.97 (d, J = 8.4 Hz, 1H), 5.25 (d, J = 8.4 Hz, 1H), 2.54–2.17 (m, 4H), 2.42 (s,
3H), 2.30 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.4, 160.3, 143.6, 143.2, 137.6, 137.5, 135.7, 129.3 (2C), 129.2
(2C), 127.4 (2C), 126.7 (2C), 55.1, 35.0, 26.7, 21.5, 21.0 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2-naphthalenyl)methyl]benzenesulfonamide (1–40a)
Prepared from Imine–1e (68.2 mg, 0.22 mmol, 1.10 equiv), and MA–1 (16.4 mg, 0.20 mmol, 1.00
equiv) according to general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%), DBU
(1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 48 h. 1–40a was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:1).
Colorless solid (mp 176–178 °C).
Yield: 77.2 mg (93%).
1H NMR (CDCl3, 600 MHz): δ = 8.07–8.06 (m, 1H), 7.84–7.82 (m, 1H), 7.76–7.74 (m, 1H), 7.60 (d, J
= 8.2 Hz, 2H), 7.49–7.47 (m, 2H), 7.42–7.41 (t, J = 6.3 Hz, 1H), 7.33–7.30 (m, 2H), 7.14 (d, J = 8.2
Hz, 2H), 6.10 (d, J = 7.8 Hz, 1H), 6.04 (d, J = 7.8 Hz, 1H), 2.46–2.19 (m, 4H), 2.39 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.4, 161.3, 143.4, 143.2, 137.0, 133.9, 130.3, 129.2 (2C), 128.9,
128.8, 127.5 (2C), 126.6, 126.2, 125.8, 125.3, 125.0, 123.1, 51.7, 34.9, 26.7, 21.4 ppm.
IR (CH2Cl2): ν = 3163, 3005, 2943, 1440, 1375, 1037, 918, 748 cm–1.
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HRMS (ESI): calculated for C23H21NaNO3S = [M+Na]+: m/z = 414.1134, found: m/z = 414.1111.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2-naphthalenyl)methyl]benzenesulfonamide (1–40b)
Prepared from Imine–1f (68.2 mg, 0.22 mmol, 1.10 equiv), and MA–1 (16.4 mg, 0.20 mmol, 1.00
equiv) according to general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%), DBU
(1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 48 h. 1–40b was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:1).
Colorless solid (mp 175–179 °C).
Yield: 76.2 mg (92%).
1H NMR (CDCl3, 500 MHz): δ = 7.76–7.75 (m, 1H), 7.70 (d, J = 8.6 Hz, 2H), 7.60 (d, J = 8.2 Hz, 2H),
7.59 (s, 1H), 7.45–7.44 (m, 2H), 7.42 (t, J = 5.4 Hz, 1H), 7.31–7.30 (m, 1H), 7.10 (d, J = 8.2 Hz, 2H),
6.18 (d, J = 8.4 Hz, 1H), 5.45 (d, J = 8.4 Hz, 1H), 2.54–2.20 (m, 4H), 2.30 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.5, 160.8, 139.5, 137.9, 133.7, 133.0, 132.8, 129.7, 129.3 (2C),
128.6, 127.9, 127.5, 127.4 (2C), 126.4, 126.3, 125.7, 125.4, 58.1, 32.5, 26.2, 21.3 ppm.
IR (CH2Cl2): ν = 3165, 3003, 2943, 1701, 1436, 1375, 1161, 1039, 918, 736, 669 cm–1.
HRMS (ESI): calculated for C23H21NaNO3S = [M+Na]+: m/z = 414.1134, found: m/z = 414.1093.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-methoxylphenyl)methyl]benzenesulfonamide (1–41)[44, 142]
Prepared from Imine–1g (63.8 mg, 0.22 mmol, 1.10 equiv), and cyclopentenone MA–1 (16.4 mg,
0.20 mmol, 1.00 equiv) according to general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 oC for 30 h. 1–41 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full
agreement with the reported data. [44, 142]
Colorless solid.
Mp. 119−122 oC (118−120 oC) [142]
Yield: 70.2 mg (92%).
1H NMR (CDCl3, 500 MHz): δ = 7.62 (d, J = 8.3 Hz, 2H), 7.34 (t, J = 5.4 Hz, 1H), 7.22 (d, J = 8.3 Hz,
2H), 7.08 (d, J = 8.8 Hz, 2H), 6.76 (d, J = 8.8 Hz, 2H), 5.93 (d, J = 8.3 Hz, 1H), 5.22 (d, J = 8.3 Hz,
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1H), 3.75 (s, 3H), 2.51–2.16 (m, 4H), 2.39 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.4, 160.3, 159.2, 143.7, 143.1, 137.5, 130.8, 129.3 (2C), 128.0
(2C), 127.4 (2C), 113.8 (2C), 55.2, 54.9, 35.0, 26.7, 21.5 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-dimethylaminophenyl)methyl]benzenesulfon-amide (1–42)[142]
Prepared from Imine–1h (67.1 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 oC for 48 h. 1–42 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full
agreement with the reported data. [142]
Pale−yellow solid.
Mp. 174−176 oC (175−176 oC) [142]
Yield: 72.3 mg (92%).
1H NMR (CDCl3, 500 MHz): δ = 7.64 (d, J = 8.7 Hz, 2H), 7.37 (t, J = 5.0 Hz, 1H), 7.22 (d, J = 8.2 Hz,
2H), 7.00 (d, J = 8.7 Hz, 2H), 6.57 (d, J = 8.2 Hz, 2H), 5.84 (d, J = 8.1 Hz, 1H), 5.19 (d, J = 8.1 Hz,
1H), 2.91 (s, 6H), 2.54–2.14 (m, 4H), 2.42 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 160.4, 144.3, 139.5, 137.9, 130.7, 129.7 (2C), 129.3, 127.6
(2C), 127.4 (2C), 112.9 (2C), 58.1, 40.3 (2C), 32.5, 26.2, 21.3 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-aminophenyl)methyl]benzenesulfonamide (1–43)
Prepared from Imine–1i (60.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–43 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless Solid (mp 157–159 °C).
Yield: 59.2 mg (83%).
1H NMR (CDCl3, 500 MHz): δ = 8.65 (br s, 2H), 7.66 (d, J = 8.1 Hz, 2H), 7.40 (d, J = 8.1 Hz, 2H),
7.26 (t, J = 5.4 Hz, 1H), 7.05 (d, J = 8.2 Hz, 2H), 6.62-6.59 (m, 2H), 5.85 (d, J = 8.2 Hz, 1H), 5.21 (d,
J = 8.2 Hz, 1H), 2.52-2.17 (m, 4H), 2.41 (s, 3H) ppm.
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13C NMR (CDCl3, 125 MHz): δ = 208.3, 151.1, 146.3, 141.5, 139.9, 132.7, 131.7 (2C), 131.2, 129.5
(2C), 129.1 (2C), 116.1 (2C), 60.7, 35.1, 28.8, 23.9 ppm.
IR (CH2Cl2): ν = 3028, 2924, 2835, 2291, 2250, 1705, 1587, 1494, 1346, 1180, 914, 825, 750, 700,
663, 623 cm–1.
HRMS (ESI): calculated for C19H20NaN2O3S = [M+Na]+: m/z = 356.4432, found: m/z = 356.4433.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-hydroxyphenyl)methyl]benzenesulfonamide (1–44)
Prepared from Imine–1j (59.4 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–44 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless Solid (mp 169–170 °C).
Yield: 50.0 mg (70%).
1H NMR (CDCl3, 600 MHz): δ = 7.80 (d, J = 8.3 Hz, 2H), 7.52 (d, J = 8.1 Hz, 2H), 7.45 (t, J = 5.3 Hz,
1H), 7.26 (d, J = 8.3 Hz, 2H), 6.93-6.91 (m, 2H), 6.10 (d, J = 8.4 Hz, 1H), 5.83 (br s, 1H), 5.25 (d, J =
8.4 Hz, 1H), 2.55-2.19 (m, 4H), 2.43 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 157.8, 144.3, 139.5, 137.7, 130.7, 129.8 (2C), 129.5 (2C),
127.6, 125.1 (2C), 115.1 (2C), 58.1, 32.5, 26.2, 21.3 ppm.
IR (CH2Cl2): ν = 3062, 2922, 2835, 2250, 1705, 1647, 1587, 1435, 1346, 180, 750, 698, 611 cm–1.
HRMS (ESI+): calculated for C19H19NaNO4S = [M+Na]+: m/z = 380.5824, found: m/z = 380.5821.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-fluorophenyl)methyl]benzenesulfonamide (1–45)[44]
Prepared from Imine–1k (71.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–45 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full
agreement with the reported data.[44]
Colorless solid.
Mp. 186−187 oC (186−187 oC) [44]
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Yield: 66.3 mg (91%).
1H NMR (CDCl3, 600 MHz): δ = 7.60 (d, J = 8.2 Hz, 2H), 7.33 (t, J = 5.3 Hz, 1H), 7.22 (d, J = 8.2 Hz,
2H), 7.18–7.16 (m, 2H), 6.91–6.88 (m, 2H), 6.05 (d, J = 8.5 Hz, 1H), 5.26 (d, J = 8.5 Hz, 1H), 2.52–
2.16 (m, 4H), 2.39 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 163.0 (d, J = 245.8 Hz), 160.6, 143.3 (d, J = 3.0 Hz), 137.4,
134.5, 129.4 (2C), 128.6 (d, J = 6.6 Hz, 2C), 128.1, 127.4 (2C), 115.5 (d, J = 21.4 Hz, 2C), 54.8, 34.9,
26.8, 21.5 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-chlorophenyl)methyl]benzenesulfonamide (1–46)[44, 142]
Prepared from Imine–1l (64.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–46 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full
agreement with the reported data. [44, 142]
Colorless solid.
Mp. 190−192 oC (190−191 oC) [142]
Yield: 72.3 mg (95%).
1H NMR (CDCl3, 600 MHz): δ = 7.82 (d, J = 8.3 Hz, 1H), 7.59 (t, J = 5.7 Hz, 2H), 7.33–7.30 (m, 2H),
7.20–7.17 (m, 4H), 7.11–7.10 (m, 2H), 6.04 (d, J = 8.5 Hz, 1H), 5.25 (d, J = 8.5 Hz, 1H), 2.51–2.18
(m, 4H), 2.40 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 160.8, 143.4, 143.0, 137.4, 137.1, 129.4 (2C), 128.7 (2C),
128.2 (2C), 127.4 (2C), 126.5, 54.9, 34.9, 26.8, 21.5 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-bromophenyl)methyl]benzenesulfonamide (1–47)[142]
Prepared from Imine–1m (67.4 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–47 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full
agreement with the reported data. [142]
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Colorless solid.
Mp. 197−200 oC (198−201 oC) [142]
Yield: 80.2 mg (94%).
1H NMR (CDCl3, 600 MHz): δ = 7.51 (d, J = 8.3 Hz, 2H), 7.27–7.26 (m, 3H), 7.19 (d, J = 8.0 Hz, 2H),
6.98 (d, J = 8.3 Hz, 2H), 6.02 (d, J = 8.6 Hz, 1H), 5.16 (d, J = 8.6 Hz, 1H), 2.46–2.10 (m, 4H), 2.33 (s,
3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 160.9, 143.5, 142.9, 137.7, 137.3, 131.7 (2C), 129.4 (2C),
128.5 (2C), 127.3 (2C), 121.9, 54.9, 34.9, 26.8, 21.5 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-methoxycarbonylphenyl)methyl]benzene-sulfonamide (1–48)
Prepared from Imine–1n (69.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–48 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless solid (mp 181–183 °C).
Yield: 67.4 mg (94%).
1H NMR (CDCl3, 500 MHz): δ = 7.90 (d, J = 8.4 Hz, 2H), 7.61 (d, J = 8.3 Hz, 2H), 7.36 (t, J = 5.3 Hz,
1H), 7.26 (d, J = 8.3 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 6.12 (d, J = 8.7 Hz, 1H), 5.34 (d, J = 8.7 Hz,
1H), 3.90 (s, 3H), 2.56–2.14 (m, 4H), 2.40 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 207.3, 165.6, 160.0, 142.5, 142.4, 141.8, 136.3, 128.9 (2C), 128.6,
128.4 (2C), 126.3 (2C), 125.7 (2C), 54.2, 51.1, 33.9, 25.9, 20.5 ppm.
IR (CH2Cl2): ν = 3258, 3032, 2917, 1743, 1613, 1431, 1256, 1121, 1099, 910, 812, 732, 654 cm–1.
HRMS (ESI): calculated for C21H21NaNO5S = [M+Na]+: m/z = 422.5612, found: m/z = 466.5619.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-trifluoromethyphenyl)methyl]benzenesulfon-amide (1–49)
Prepared from Imine–1o (72.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–49 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
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Colorless solid (mp 190–192 °C).
Yield: 76.4 mg (85%).
1H NMR (CDCl3, 500 MHz): δ = 7.58 (d, J = 8.2 Hz, 2H), 7.46 (d, J = 8.5 Hz, 2H), 7.37 (t, J = 5.9 Hz,
1H), 7.30 (d, J = 8.5 Hz, 2H), 7.18 (d, J = 8.2 Hz, 2H), 6.19 (d, J = 8.6 Hz, 1H), 5.36 (d, J = 8.6 Hz,
1H), 2.56–2.18 (m, 4H), 2.39 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.4, 161.1, 144.3, 143.5, 142.7, 137.3, 132.0 (q, J = 1.3 Hz, 2C),
130.7 (q, J = 270.3 Hz), 129.4 (2C), 128.9 (q, J = 3.8 Hz, 2C), 127.2 (2C), 125.5 (q, J = 32.5 Hz), 55.2,
34.9, 26.9, 21.4 ppm.
19F NMR (CDCl3, 128 MHz): δ = – 62.7 (s) ppm.
IR (CH2Cl2): ν = 3275, 2916, 2850, 1693, 1436, 1328, 1159, 906, 745, 665 cm–1.
HRMS (ESI): calculated for C20H18F3NaNO3S = [M+Na]+: m/z = 432.0852, found: m/z = 432.0857.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-cyanophenyl)methyl]benzenesulfonamide (1–50)
Prepared from Imine–1p (62.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–50 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless solid (mp 170–172 °C).
Yield: 67.8 mg (91%).
1H NMR (CDCl3, 600 MHz): δ = 7.60 (d, J = 8.3 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 7.34 (t, J = 4.8 Hz,
1H), 7.33 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.3 Hz, 2H), 6.19 (d, J = 8.8 Hz, 1H), 5.33 (d, J = 8.8 Hz,
1H), 2.56–2.20 (m, 4H), 2.41 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.3, 161.4, 143.8, 143.7, 142.3, 137.7, 132.4 (2C), 129.5 (2C),
127.5 (2C), 127.3 (2C), 118.4, 111.8, 55.0, 34.9, 26.9, 21.5 ppm.
IR (CH2Cl2): ν = 3319, 2898, 2819, 2234, 1716, 1672, 1567, 1423, 1398, 1189, 934, 783, 643 cm–1.
HRMS (ESI): calculated for C20H18NaN2O3S = [M+Na]+: m/z = 389.5345, found: m/z = 389.5350.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-nitrophenyl)methyl]benzenesulfonamide (1–51)[44, 142]
Prepared from Imine–1q (67.1 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
170
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) at 30 °C for 24 h. 1–51 was purified by PTLC on silica
gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full agreement with the reported
data.[44, 142]
Pale−yellow solid.
Mp. 187−189 oC (187−188 oC) [142]
Yield: 72.3 mg (93%).
1H NMR (CDCl3, 500 MHz): δ = 8.10 (d, J = 8.7 Hz, 2H), 7.62 (d, J = 8.2 Hz, 2H), 7.40 (d, J = 8.7
Hz, 2H), 7.39 (t, J = 5.0 Hz, 1H), 7.23 (d, J = 8.2 Hz, 2H), 6.18 (d, J = 8.6 Hz, 1H), 5.38 (d, J = 8.6 Hz,
1H), 2.58–2.22 (m, 4H), 2.41 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 161.5, 147.4, 145.7, 143.8, 142.2, 137.1, 129.5 (2C), 127.7
(2C), 127.3 (2C), 123.8 (2C), 54.7, 34.8, 26.5, 21.3 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2-furanyl)methyl]benzenesulfonamide (1–52)[44]
Prepared from Imine–1r (54.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–52 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2). The obtained analytical data were in full
agreement with the reported data. [44]
Yellow solid.
Mp. 154−156 oC (155−156 oC) [44]
Yield: 55.9 mg (83%).
1H NMR (CDCl3, 500 MHz): δ = 7.65 (d, J = 8.1 Hz, 2H), 7.44 (t, J = 6.1 Hz, 1H), 7.24 (d, J = 8.1 Hz,
2H), 7.23–7.21 (m, 1H), 6.22–6.21 (m, 1H), 6.10–6.09 (m, 1H), 5.94 (d, J = 8.5 Hz, 1H), 5.39 (d, J =
8.5 Hz, 1H), 2.52–2.20 (m, 4H), 2.40 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 207.8, 160.9, 150.7, 143.3, 142.3, 141.5, 137.4, 129.4 (2C), 127.3
(2C), 110.5, 107.6, 49.2, 34.8, 26.7, 21.5 ppm.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2-thienyl)methyl]benzenesulfonamide (1–53)
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Prepared from Imine–1s (58.4 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 24 h. 1–53 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Pale-yellow solid (mp 160–164 °C).
Yield: 70.4 mg (92%).
1H NMR (CDCl3, 600 MHz): δ = 7.66 (d, J = 8.1 Hz, 2H), 7.41 (t, J = 5.2 Hz, 1H), 7.24 (d, J = 8.1 Hz,
2H), 7.16–7.15 (m, 1H), 6.86–6.84 (m, 1H), 6.78–6.77 (m, 1H), 6.03 (d, J = 9.0 Hz, 1H), 5.54 (d, J =
9.0 Hz, 1H), 2.56–2.17 (m, 4H), 2.41 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.1, 160.4, 143.4, 143.0, 142.3, 141.9, 137.4, 129.4 (2C), 127.4
(2C), 126.9, 125.4, 51.3, 34.9, 26.3, 21.5 ppm.
IR (CH2Cl2): ν = 3163, 3001, 2943, 1735, 1442, 1375, 1246, 1039, 918, 748 cm–1.
HRMS (ESI): calculated for C17H17NaNO3S2 = [M+Na]+: m/z = 370.0542, found: m/z = 370.0540.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2-pyrrolyl)methyl]benzenesulfonamide (1–54)
Prepared from Imine–1t (54.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) at 30 °C for 48 h. 1–54 was purified by PTLC on silica
gel (eluent: EtOAc/PE = 1:2).
Brown solid (mp 145–147 °C).
Yield: 64.8 mg (88%).
1H NMR (CDCl3, 600 MHz): δ = 8.61 (br s, NH, 1H), 7.67 (d, J = 8.1 Hz, 2H), 7.46 (t, J = 5.6 Hz,
1H), 7.26 (d, J = 8.1 Hz, 2H), 7.25–7.23 (m, 1H), 6.15–6.13 (m, 1H), 6.02–6.01 (m, 1H), 5.86 (d, J =
9.0 Hz, 1H), 5.29 (d, J = 9.0 Hz, 1H), 2.55–2.29 (m, 4H), 2.42 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.8, 144.3, 137.9, 137.5, 130.9, 129.7 (2C), 128.6, 127.5 (2C),
123.5, 111.9, 110.3, 58.3, 32.9, 26.3, 20.9 ppm.
IR (CH2Cl2): ν = 3001, 2941, 2252, 1707, 1440, 1375, 1346, 1182, 916, 754, 702 cm–1.
HRMS (ESI): calculated for C17H18NaN2O3S = [M+Na]+: m/z = 353.5632, found: m/z = 353.5634.
172
4-Methyl-N-[(5-oxocyclopent-1-enyl)(1H-indol-3-yl)methyl]benzenesulfonamide (1–55)
Prepared from Imine–1u (65.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) at 30 °C for 48 h. 1–55 was purified by PTLC on silica
gel (eluent: EtOAc/PE = 1:2).
Colorless solid (mp 175–179 °C).
Yield: 63.2 mg (83%).
1H NMR (CDCl3, 600 MHz): δ = 7.68–7.65 (m, 2H), 7.60 (d, J = 8.1 Hz, 2H), 7.34 (t, J = 5.0 Hz, 1H),
7.31 (d, J = 8.1 Hz, 2H), 7.12–7.08 (m, 1H), 7.00–6.97 (m, 1H), 6.73–6.72 (m, 1H), 6.02 (d, J = 8.4
Hz, 1H), 5.17 (br s, NH, 1H), 4.20 (d, J = 8.4 Hz, 1H), 2.53–2.16 (m, 4H), 2.38 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 146.3, 139.9, 139.0, 132.7, 131.7 (2C), 130.9, 129.8, 129.5
(2C), 127.7, 124.2, 124.1, 122.2, 121.3, 113.6, 60.1, 34.9, 28.6, 23.7 ppm.
IR (CH2Cl2): ν = 2924, 2251, 1703, 1662, 1587, 1346, 1180, 914, 752, 696 cm–1.
HRMS (ESI): calculated for C21H20NaN2O3S = [M+Na]+: m/z = 403.6171, found: m/z = 403.6174.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(1H-indol-1-carboxlic acid-3-yl)methyl]benzene-sulfonamide (1–
56)
Prepared from Imine–1v (87.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–56 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless Solid (mp 189–194 °C).
Yield: 95.4 mg (89%).
1H NMR (CDCl3, 500 MHz): δ = 8.23 (d, J = 8.1 Hz, 1H), 8.02–8.00 (m, 1H), 7.78 (d, J = 8.1 Hz, 2H),
7.66 (d, J = 8.1 Hz, 1H), 7.31 (d, J = 8.1 Hz, 2H), 7.22–7.20 (m, 1H), 7.10–7.08 (m, 1H), 6.73 (t, J =
5.7 Hz, 1H), 6.08 (d, J = 8.4 Hz, 1H), 5.34 (d, J = 8.4 Hz, 1H), 2.54–2.18 (m, 4H), 2.39 (s, 3H), 1.44
(s, 9H) ppm.
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13C NMR (CDCl3, 125 MHz): δ = 206.3, 149.3, 144.3, 139.5, 135.4, 130.7, 129.7 (2C), 129.2, 128.5,
128.1, 127.6 (2C), 126.7, 122.9, 120.2, 119.2, 115.2, 81.4, 58.1, 32.5, 28.2, 26.2, 21.3 ppm.
IR (CH2Cl2): ν = 3061, 3028, 2922, 2833, 2250, 1703, 1574, 1346, 1180, 914, 750, 698 cm–1.
HRMS (ESI): calculated for C26H28NaN2O5S = [M+Na]+: m/z = 503.7325, found: m/z = 503.7330.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2-pyridinyl)methyl]benzenesulfonamide (1–57)
Prepared from Imine–1w (57.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 48 h. 1–57 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Pale-yellow solid (mp 162–164 °C).
Yield: 48.2 mg (64%).
1H NMR (CDCl3, 500 MHz): δ = 8.50–8.47 (m, 1H), 7.62–7.60 (m, 1H), 7.58 (d, J = 8.1 Hz, 2H),
7.31 (t, J = 5.3 Hz, 1H), 7.29 (d, J = 8.1 Hz, 2H), 7.20–7.18 (m, 1H), 6.70 (d, J = 8.1 Hz, 1H), 6.25 (d,
J = 8.4 Hz, 1H), 5.36 (d, J = 8.4 Hz, 1H), 2.61–2.24 (m, 4H), 2.45 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 152.0, 148.5, 144.3, 138.6, 137.9, 130.7, 129.8 (2C), 129.2,
127.6 (2C), 123.4, 122.0, 58.1, 29.8, 23.4, 18.5 ppm.
IR (CH2Cl2): ν = 3252, 3047, 2975, 2836, 2282, 2255, 1874, 1726, 1651, 1590, 1433, 1349, 1184,
1172, 928, 756 cm–1.
HRMS (ESI): calculated for C18H18NaN2O3S = [M+Na]+: m/z = 365.5734, found: m/z = 365.5739.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(3-pyridinyl)methyl]benzenesulfonamide (1–58)
Prepared from Imine–1x (57.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure A using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 48 h. 1–58 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Pale-yellow solid (mp 161–165 °C).
Yield: 59.4 mg (76%).
174
1H NMR (CDCl3, 500 MHz): δ = 8.47–8.45 (m, 2H), 7.74–7.72 (m, 1H), 7.57 (d, J = 8.1 Hz, 2H),
7.37–7.35 (m, 1H), 7.28 (d, J = 8.1 Hz, 2H), 6.69 (t, J = 2.3 Hz, 1H), 6.12 (d, J = 8.4 Hz, 1H), 5.43 (d,
J = 8.4 Hz, 1H), 2.57–2.21 (m, 4H), 2.42 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 149.7, 149.0, 144.3, 138.8, 138.0, 134.6, 130.7, 129.6 (2C),
129.1, 127.3 (2C), 123.9, 58.1, 32.5, 26.2, 21.3 ppm.
IR (CH2Cl2): ν = 3247, 3110, 2943, 2867, 2395, 2197, 1870, 1737, 1658, 1591, 1457, 1328, 1195,
1164, 938, 752, 710 cm–1.
HRMS (ESI): calculated for C18H18NaN2O3S = [M+Na]+: m/z = 365.5734, found: m/z = 365.5741.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(4-pyridinyl)methyl]benzenesulfonamide (1–59)
Prepared from Imine–1y (57.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 48 h. 1–59 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Pale-yellow solid (mp 160–164 °C).
Yield: 71.4 mg (84%).
1H NMR (CDCl3, 500 MHz): δ = 8.55–8.53 (m, 2H), 7.60 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H),
7.20–7.18 (m, 2H), 6.72 (t, J = 5.2 Hz, 1H), 6.02 (d, J = 8.4 Hz, 1H), 5.23 (d, J = 8.4 Hz, 1H), 2.58–
2.22 (m, 4H), 2.40 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 149.8, 144.3, 139.5, 137.9, 130.7, 130.0, 129.7 (2C), 129.4,
129.1, 127.6 (2C), 120.7, 57.9, 32.3, 25.9, 21.1 ppm.
IR (CH2Cl2): ν = 3030, 2924, 2291, 2251, 1703, 1654, 1587, 1438, 1346, 1180, 1165, 914, 750 cm–1.
HRMS (ESI): calculated for C18H18NaN2O3S = [M+Na]+: m/z = 365.5734, found: m/z = 365.5743.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(3-phenylpropyl)methyl]benzenesulfonamide (1–60)
Prepared from Imine–1z (63.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–60 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless solid (mp 178–182 °C).
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Yield: 75.0 mg (92%).
1H NMR (CDCl3, 500 MHz): δ = 7.69 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 7.28–7.25 (m, 2H),
7.17–7.14 (m, 3H), 6.69 (d, J = 5.4 Hz, 1H), 6.12 (d, J = 8.4 Hz, 1H), 4.93 (t, J = 8.4 Hz, 1H), 2.55–
2.50 (m, 2H), 2.42 (s, 3H), 2.38–2.30 (m, 4H), 2.21 (q, J = 7.4 Hz, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.4, 164.3, 144.3, 140.8, 130.8, 129.7 (2C), 129.1, 128.7 (2C),
128.4 (2C), 127.9, 127.5 (2C), 58.1, 32.9, 32.5, 30.7, 26.2, 21.3 ppm.
IR (CH2Cl2): ν = 3324, 2976, 2913, 2876, 2423, 2231, 1897, 1701, 1687, 1512, 1428, 1387, 1176,
1143, 921, 754 cm–1.
HRMS (ESI): calculated for C21H23NaNO3S = [M+Na]+: m/z = 392.2453, found: m/z = 392.2459.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(3-cyclohexyl)methyl]benzenesulfonamide (1–61)
Prepared from Imine–1a’ (58.4 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–61 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Pale-yellow solid (mp 130–132 °C).
Yield: 70.4 mg (91%).
1H NMR (CDCl3, 600 MHz): δ = 7.62 (d, J = 8.1 Hz, 2H), 7.23 (d, J = 8.1 Hz, 2H), 7.00 (t, J = 5.4 Hz,
1H), 5.72 (d, J = 8.9 Hz, 1H), 3.81 (dd, J = 8.9, 9.3 Hz, 1H), 2.40 (s, 3H), 2.39–2.38 (m, 1H), 2.19–
2.18 (m, 1H), 2.09–2.08 (m, 1H), 1.96–1.95 (m, 2H), 1.94–1.92 (m, 4H), 1.42–1.39 (m, 1H), 1.15–
1.10 (m, 3H), 0.90–0.81 (m, 2H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 209.1, 160.6, 142.9, 141.9, 137.9, 129.2 (2C), 127.4 (2C), 57.4,
40.8, 34.8, 29.9, 29.4 (2C), 26.6 (2C), 26.1, 21.4 ppm.
IR (CH2Cl2): ν = 3396, 3176, 2997, 2941, 1597, 1575, 1411, 1375, 1037, 918, 688 cm–1.
HRMS (ESI): calculated for C19H25NaNO3S = [M+Na]+: m/z = 370.1447, found: m/z = 370.1438.
4-Methyl-N-[(5-oxocyclopent-1-enyl)(2,2-dimethylpropyl)methyl]benzenesulfonamide (1–62)
Prepared from Imine–1b’ (52.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone MA–1 (16.4 mg, 0.20
mmol, 1.00 equiv) according to the general procedure C using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00
mol%), DBU (1.50 mg, 10.0 µmol, 5.00 mol%) in THF (0.66 mL, 0.3 M) at 30 °C for 30 h. 1–62 was
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purified by PTLC on silica gel (eluent: EtOAc/PE = 1:2).
Colorless solid (mp 106–110 °C).
Yield: 56.8 mg (78%).
1H NMR (CDCl3, 500 MHz): δ = 7.60 (d, J = 8.1 Hz, 2H), 7.21 (d, J = 8.1 Hz, 2H), 6.99 (t, J = 5.4 Hz,
1H), 5.70 (d, J = 8.1 Hz, 1H), 4.95 (d, J = 8.1 Hz, 1H), 2.50–2.14 (m, 4H), 2.32 (s, 3H), 0.82 (s, 9H)
ppm.
13C NMR (CDCl3, 150 MHz): δ = 206.1, 144.3, 137.9, 130.7, 129.7 (2C), 129.4, 127.5 (2C), 57.8,
35.4, 32.2, 26.3 (3C), 26.2, 20.9 ppm.
IR (CH2Cl2): ν = 3401, 3198, 2978, 2939, 2897, 1603, 1577, 1423, 1398, 1365, 1045, 923, 712, 685
cm–1.
HRMS (ESI): calculated for C17H23NaNO3S = [M+Na]+: m/z = 344.5376, found: m/z = 344.5381.
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5.2.5 BAC-catalysed aza-MBH Reactions – pro-nucleophiles test
General Procedure D [Michael acceptor scope]
To an oven-dried test tube with a magnetic stirring bar in a nitrogen glovebox were added pre-BAC–2
(5.00 mg, 10.0 μmol, 10.0 mol%), imine Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv), the
corresponding Michael acceptor (0.10 mmol, 1.00 equiv), THF (0.33 mL, 0.3 M), and DBU (1.50 mg,
10.0 μmol, 10.0 mol%). The reaction mixture was stirred at 40 °C for 24–72 h, at which point TLC
and/or 1H NMR analysis indicated complete consumption of the corresponding Michael acceptor. The
volatiles were removed in vacuo, and the residue was purified by flash column chromatography or
PTLC on silica gel (eluent: EtOAc/PE = 1:5) to give the intended products.
4-Methyl-N-(2-formyl-1-allyl)benzenesulfonamide (1–63) [133]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and acrolein (6.50 mg, 0.10 mmol, 1.00
equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10 mol%), DBU
(1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 30 h. 1–63 was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement with
the reported data.[133]
Colorless solid.
Mp. 106−108 oC (107−108 oC) [133]
Yield: 32.3 mg (88%).
1H NMR (CDCl3, 500 MHz): δ = 9.39 (s, 1H), 7.66 (d, J = 8.7 Hz, 2H), 7.25 (d, J = 8.7 Hz, 2H),
7.19–7.22 (m, 3H), 7.06–7.09 (m, 2H), 6.54 (s, 1H), 6.12 (s, 1H), 5.49 (d, J = 8.1 Hz, 1H), 5.26 (d, J
= 8.1 Hz, 1H), 2.46 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 192.8, 148.0, 143.5, 138.0, 137.1, 135.9, 129.5 (2C), 128.6 (2C),
127.9 (2C), 127.2 (2C), 126.7, 56.7, 21.5.
4-Methyl-N-(2-formyl-1-allyl)benzenesulfonamide (1–64)
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Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and cinnamaldehyde (10.2 mg, 0.10 mmol,
1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 72 h. 1–64 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[133]
Colorless solid.
Mp. 119−120 oC (118−121 oC) [133]
Yield: 25.6 mg (60%).
1H NMR (CDCl3, 500 MHz): δ = 9.72 (s, 1H), 7.63 (d, J =8.0 Hz, 2H), 7.36–7.35 (m, 1H), 7.42 (d, J
=7.9 Hz, 2H), 7.38 (d, J =7.9 Hz, 2H), 7.31 (d, J =8.0 Hz, 2H), 7.28 (d, J =7.8 Hz, 2H), 7.26 (d, J =7.8
Hz, 2H), 7.23–7.21 (m, 1H), 6.81 (s, 1H), 6.14 (d, J =8.3 Hz, 1H), 5.23 (d, J =8.3 Hz, 1H), 2.32 (s, 3H)
ppm.
13C NMR (CDCl3, 150 MHz): δ = 189.2, 154.2, 144.3, 139.5, 138.7, 137.4, 131.9, 129.7 (2C), 129.6,
129.2 (2C), 128.9, 128.7 (2C), 128.4 (2C), 127.5 (2C), 126.9 (2C), 58.6, 21.4 ppm.
4-Methyl-N-[(inden-1-one)(phenyl)methyl]benzenesulfonamide (1–65)
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and inden-1-one (12.5 mg, 0.10 mmol,
1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 24 h. 1–65 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5).
Colorless solid (mp 172–177 °C).
Yield: 39.1 mg (90%).
1H NMR (CDCl3, 500 MHz): δ = 7.98 (t, J = 5.2 Hz, 1H), 7.77–7.70 (m, 3H), 7.61–7.59 (m, 2H),
7.57-7.54 (m, 1H), 7.32 (d, J = 8.3 Hz, 2H), 7.27–7.19 (m, 5H), 6.15 (d, J = 9.3 Hz, 1H), 5.09 (d, J =
9.3 Hz, 1H), 2.32 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 194.5, 144.3, 143.5, 139.5, 137.9, 133.7, 130.7, 129.7 (2C), 129.2
(2C), 128.9 (2C), 128.6, 128.4, 127.5 (2C), 127.0, 126.9, 126.1, 121.7, 58.1, 21.4 ppm.
IR (CH2Cl2): ν = 3394, 3214, 2989, 2902, 2896, 1954, 1756, 1698, 1585, 1432, 1376, 1389, 1187, 916,
787, 698 cm–1.
HRMS (ESI): calculated for C23H19NaNO3S = [M+Na]+: m/z = 412.2145, found: m/z = 412.2152.
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4-Methyl-N-[(6-oxocyclohex-1-enyl)(phenyl)methyl]benzenesulfonamide (1–34) [44]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and cyclohexenenone (10.4 mg, 0.10
mmol, 1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10
mol%), DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 48 h. 1–34 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[44]
Colorless solid.
Mp. 148−150 oC (148−149 oC) [44]
Yield: 66.7 mg (92%).
1H NMR (CDCl3, 500 MHz): δ = 7.64 (d, J = 8.3 Hz, 2H), 7.24–7.19 (m, 7H), 6.82 (t, J = 5.0 Hz, 1H),
5.94 (d, J = 9.3 Hz, 1H), 5.11 (d, J = 9.3 Hz, 1H), 2.41 (s, 3H), 2.39–1.60 (m, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 195.4, 144.3, 139.5, 129.7 (2C), 129.1, 128.7 (2C), 127.8, 127.5
(2C), 126.9, 126.3 (2C), 126.0, 59.4, 37.2, 25.3, 21.9, 21.3 ppm.
4-Methyl-N-(2-methozoyl-1-benzylallyl)benzenesulfonamide (1–35)[143]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and methyl vinyl ketone (8.20 mg, 0.10
mmol, 1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10
mol%), DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 48 h. 1–35 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[143]
Colorless solid.
Mp. 119−121 oC (120−121 oC) [143]
Yield: 30.8 mg (95%).
1H NMR (CDCl3, 500 MHz): δ = 7.65 (d, J = 8.1 Hz, 2H), 7.23–7.20 (m, 5H), 7.10 (d, J = 8.1 Hz, 2H),
6.09 (s, 1H), 6.08 (s, 1H), 5.75 (d, J = 8.6 Hz, 1H), 5.28 (d, J = 8.6 Hz, 1H), 2.40 (s, 3H), 2.15 (s, 3H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 196.8, 144.3, 139.5, 137.9, 129.7 (2C), 129.2, 128.9, 128.6 (2C),
127.5 (2C), 126.9 (2C), 114.3, 58.1, 29.2, 21.3 ppm.
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4-Methyl-N-(2-benzoyl-1-benzylallyl)benzenesulfonamide (1–66)[144]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and phenyl vinyl ketone (13.1 mg, 0.10
mmol, 1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10
mol%), DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 72 h. 1–66 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[144]
Colorless solid.
Mp. 142−143 oC (141−143 oC) [143]
Yield: 37.4 mg (94%).
1H NMR (CDCl3, 500 MHz): δ = 7.72 (d, J = 8.7 Hz, 2H), 7.56–7.50 (m, 3H), 7.40 (d, J = 8.7 Hz,
2H), 7.25–7.19 (m, 7H), 6.13 (s, 1H), 5.99 (d, J = 8.4 Hz, 1H), 5.75 (s, 1H), 5.49 (d, J = 8.4 Hz, 1H),
2.40 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 182.1, 144.3, 139.4, 138.1, 137.9, 129.7 (2C), 129.1, 128.9 (2C),
128.8 (2C), 128.6 (2C), 128.5, 128.4, 127.5 (2C), 126.9 (2C), 114.3, 59.7, 21.5 ppm.
Methyl-α–Methylene-β-[(p-toluenesulfonyl)-amino]-3-phenylpropionate (1–36)[145,146]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and methyl acrylate (9.32 mg, 0.10 mmol,
1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 72 h. 1–36 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[145,146]
Colorless solid.
Mp. 140−143 oC (142−143 oC) [145, 146]
Yield: 32.1 mg (93%).
1H NMR (CDCl3, 500 MHz): δ = 7.70 (d, J = 8.4 Hz, 2H), 7.58 (d, J = 8.4 Hz, 2H), 7.24 (m, 3H),
7.21–7.18 (m, 2H), 6.24 (s, 1H), 5.85 (s, 1H), 5.72 (d, J = 8.9 Hz, 1H), 5.33 (d, J = 8.9 Hz, 1H), 3.62
(s, 3H), 2.43 (s, 3H) ppm.
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13C NMR (CDCl3, 125 MHz): δ = 165.1, 143.6, 139.5, 137.9, 129.7 (2C), 129.0, 128.6 (2C), 127.6
(2C), 127.2, 126.9 (2C), 114.3, 59.3, 51.9, 21.3 ppm.
1-Naphthyl-2-[phenyl-(toluene-4-sulfonylamino)methyl]acrylate (1–67)[145,146]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and 1-naphthyl acrylate (19.8 mg, 0.10
mmol, 1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10
mol%), DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 48 h. 1–67 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data. [145,146]
Colorless solid.
Mp. 153−155 oC (152−154 oC) [145, 146]
Yield: 41.9 mg (96%).
1H NMR (CDCl3, 500 MHz): δ = 7.84 (d, J = 7.5 Hz, 2H), 7.75 (d, J = 7.5 Hz, 2H), 7.71 (d, J = 9.1
Hz, 1H), 7.46–7.19 (m, 9H), 7.00 (d, J = 7.5 Hz, 2H), 6.59 (s, 1H), 6.14 (s, 1H), 5.55 (d, J = 8.8 Hz,
1H), 5.48 (d, J = 8.8 Hz, 1H), 2.45 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 165.1, 146.8, 144.3, 139.5, 137.9, 134.1, 129.7 (2C), 129.6, 129.4,
128.6 (2C), 128.0, 127.9, 127.5 (2C), 126.9 (2C), 126.6, 126.5, 125.9, 122.8, 122.1, 121.4, 114.3, 59.0,
21.5 ppm.
2-[Phenyl-(toluene-4-sulfonylamino)methyl]-acrylamide (1–68)[147]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and acrylamide (7.12 mg, 0.10 mmol, 1.00
equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10 mol%), DBU
(1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 72 h. 1–68 was purified by
PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[147]
Colorless solid.
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Mp. 200−203 oC (201−203 oC) [145, 146]
Yield: 29.3 mg (88%).
1H NMR (CDCl3, 500 MHz): δ = 7.72 (d, J = 8.8, 2H), 7.48 (d, J = 8.8, 2H), 7.16–7.10 (m, 5H), 7.10
(br s, 2H), 6.58 (s, 1H), 5.93 (d, J = 8.4 Hz, 1H), 5.30 (s, 1H), 4.76 (d, J = 8.4 Hz, 1H), 2.30 (s, 3H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 166.7, 144.3, 139.6, 137.6, 129.7, 129.2, 128.9 (2C), 128.6 (2C),
127.6 (2C), 126.9 (2C), 114.3, 58.1, 21.3 ppm.
2-[Phenyl-(toluene-4-sulfonylmorphlinyl)methyl]acrylamide (1–69)
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and 4-acryloylmorpholine (14.1 mg, 0.10
mmol, 1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10
mol%), DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 72 h. 1–69 was
purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5).
Colorless solid (mp 156–159 °C).
Yield: 33.1 mg (74%).
1H NMR (CDCl3, 500 MHz): δ = 7.60 (d, J = 8.7 Hz, 2H), 7.32 (d, J = 8.7 Hz, 2H), 7.26–7.22 (m,
3H), 7.14–7.11 (m, 2H), 6.26 (d, J = 8.1 Hz, 1H), 6.19 (s, 1H), 5.94 (s, 1H), 5.70 (d, J = 8.1 Hz, 1H),
3.64–3.57 (m, 8H), 2.32 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 166.7, 144.3, 139.6, 137.6, 129.7, 129.2, 128.9 (2C), 128.6 (2C),
127.6 (2C), 126.9 (2C), 114.3, 66.4 (2C), 58.1, 44.1 (2C), 21.3 ppm.
IR (CH2Cl2): ν = 3421, 3100, 3080, 2975, 2635, 1682, 1645, 1523, 1459, 1324, 1130, 990, 910, 720
cm–1.
HRMS (ESI): calculated for C21H24N2O4NaS = [M+Na]+: m/z = 400.4965, found: m/z = 400.4974.
4-methyl-N-(2-Cyano-1-phenylpropen-2-yl)benzenesulfonamide (1–38)[147]
Prepared from Imine–1a (28.5 mg, 0.11 mmol, 1.10 equiv) and acrylonitrile (5.30 mg, 0.10 mmol,
1.00 equiv) according to the general procedure D using pre-BAC–2 (5.00 mg, 10 μmol, 10 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.33 mL, 0.3 M) at 40 °C for 48 h. 1–38 was purified
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by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[147]
Colorless solid.
Mp. 126−128 oC (126−127 oC) [147]
Yield: 30.1 mg (96%).
1H NMR (CDCl3, 500 MHz): δ = 7.70 (d, J = 8.1 Hz, 2H), 7.31–7.28 (m, 5H), 7.12 (d, J = 8.1 Hz, 2H),
6.06 (s, 1H), 6.00 (s, 1H), 5.41 (d, J = 7.8 Hz, 1H), 5.08 (d, J = 7.8 Hz, 1H), 2.44 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 144.2, 139.5, 137.9, 129.9 (2C), 129.4, 128.6 (2C), 127.5 (2C),




To an oven-dried test tube with a magnetic stirring bar in a nitrogen glovebox were added pre-BAC–1
(3.20 mg, 10.0 µmol, 5.00 mol%), diisopropyl azodicarboxylate (DIAD; 87.0 mg, 0.22 mmol, 1.10
equiv), the corresponding Michael acceptor (0.20 mmol, 1.00 equiv), THF (0.2 mL, 1.0 M), and DBU
(1.50 mg, 10.0 µmol, 5.00 mol%). The resulting mixture was stirred at 40 °C for 24 h, at which point
TLC and/or 1H NMR analysis indicated complete consumption of the corresponding Michael acceptor.
The volatiles were removed in vacuo, and the residue was purified by flash column chromatography or
PTLC on silica gel (eluent: EtOAc/PE = 1:5) to give the intended products.
(E)-Diisopropyl-2-(5-oxocyclopenyl)hydrazine-1,2-dicarboxylate (1–70)[60]
Prepared from DIAD (87.0 mg, 0.22 mmol, 1.10 equiv) and cyclohpentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to the general procedure E using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.2 mL, 1.0 M) at 40 °C for 24 h. 1–70 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[60]
Yellow oil.
Yield: 58.5 mg (98%).
1H NMR (CDCl3, 500 MHz): δ = 7.50 (br s, 1H), 7.03 (t, J = 5.1, 1H), 4.81 (septet, J = 5.8, 1H), 4.76
(septet, J = 6.4, 1H), 2.57–2.47 (m, 4H), 1.42 (dd, J = 5.8, 6.4 Hz, 12H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 197.5, 155.2, 150.8, 137.5, 108.6, 72.3, 69.9, 34.0, 30.4, 21.7, 21.6,
21.5, 21.4 ppm.
(E)-Diisopropyl-2-(6-oxocyclohex-1-enyl)hydrazine-1,2-dicarboxylate (1–71)[59,60]
Prepared from DIAD (87.0 mg, 0.22 mmol, 1.10 equiv) and cyclohexenenone (20.8 mg, 0.20 mmol,
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1.00 equiv) according to the general procedure E using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.2 mL, 1.0 M) at 40 °C for 24 h. 1–71 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[59,60]
Yellow oil.
Yield: 54.1 mg (83%).
1H NMR (CDCl3, 500 MHz): δ = 7.00 (br s, 1H), 6.48 (m, 1H), 4.80 (septet, J = 5.8 Hz, 1H), 4.74
(septet, J = 6.4 Hz, 1H), 2.40–2.38 (m, 2H), 2.20–2.18 (m, 2H), 1.89–1.84 (m, 2H), 1.43 (dd, J = 5.8,
6.4 Hz, 12H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 190.6, 155.2, 150.8, 137.5, 108.3, 71.2, 69.6, 38.8, 23.3, 22.6, 22.0,
21.9, 21.8, 21.6 ppm.
(E)-Diisopropyl-2-(1-methylene-2-oxopropyl)hydrazine-1,2-dicarboxylate (1–72)[59]
Prepared from DIAD (87.0 mg, 0.22 mmol, 1.10 equiv) and methyl vinyl ketone (16.4 mg, 0.20 mmol,
1.00 equiv) according to the general procedure E using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.2 mL, 1.0 M) at 40 °C for 24 h. 1–72 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[59]
Colorless oil.
Yield: 48.3 mg (87%).
1H NMR (CDCl3, 500 MHz): δ = 7.30 (br s, 1H), 5.92 (s, 1H), 5.91 (s, 1H), 4.98 (septet, J = 5.8 Hz,
1H), 4.92 (septet, J = 6.4 Hz, 1H), 2.37 (s, 3H), 1.27 (dd, J = 5.8, 6.4 Hz, 12H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 194.8, 162.5, 155.6, 146.6, 118.8, 71.2, 69.7, 25.8, 21.8, 21.7, 21.5,
20.7 ppm.
(E)-Diisopropyl-2-(1-phenyl-2-oxopropyl)hydrazine-1,2-dicarboxylate (1–73)[60]
Prepared from DIAD (87.0 mg, 0.22 mmol, 1.10 equiv) and phenyl vinyl ketone (26.2 mg, 0.20 mmol,
1.00 equiv) according to the general procedure E using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%),
186
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.2 mL, 1.0 M) at 40 °C for 24 h. 1–73 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[60]
Colorless oil.
Yield: 67.9 mg (92%).
1H NMR (CDCl3, 500 MHz): δ = 7.58–7.54 (m, 3H), 7.46–7.42 (m, 2H), 6.92 (br s, 1H), 6.47–6.44
(m, 2H), 4.79 (septet, J = 5.8 Hz, 1H), 4.73 (septet, J = 6.4 Hz, 1H), 1.32 (dd, J = 5.8, 6.4 Hz, 12H)
ppm.
13C NMR (CDCl3, 150 MHz): δ = 181.0, 155.2, 150.8, 137.5, 136.1, 129.5 (2C), 129.1, 128.5 (2C),
107.4, 71.2, 69.9, 21.7, 21.6, 21.5, 21.4 ppm.
(E)-Diisopropyl-2-[1-(methoxycarbonyl)ethenyl]hydrazine-1,2-dicarboxylate (1–74)[59,60]
Prepared from DIAD (87.0 mg, 0.22 mmol, 1.10 equiv) and methyl acrylate (18.6 mg, 0.20 mmol,
1.00 equiv) according to the general procedure E using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.2 mL, 1.0 M) at 40 °C for 24 h. 1–74 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[59,60]
Colorless oil.
Yield: 46.2 mg (78%).
1H NMR (CDCl3, 500 MHz): δ = 7.11 (br s, 1H), 6.17 (s, 1H), 5.98 (s, 1H), 5.05 (septet, J = 5.8 Hz,
1H), 4.96 (septet, J = 6.4 Hz, 1H), 3.80 (s, 3H), 1.27 (dd, J = 5.8, 6.4 Hz, 12H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 163.9, 155.6, 154.2, 138.5, 122.7, 71.1, 69.9, 52.2, 21.8, 21.7, 21.6,
21.5 ppm.
(E)-Diisopropyl 2-(1-cyanoethenyl)hydrazine-1,2-dicarboxylate (1–75)[59,60]
Prepared from DIAD (87.0 mg, 0.22 mmol, 1.10 equiv) and acrylonitrile (10.6 mg, 0.20 mmol, 1.00
equiv) according to the general procedure E using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.2 mL, 1.0 M) at 40 °C for 24 h. 1–75 was purified
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by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[59,60]
Colorless oil.
Yield: 42.4 mg (75%).
1H NMR (CDCl3, 500 MHz): δ = 6.87 (br s, 1H), 6.40 (s, 1H), 6.32 (s, 1H), 4.64 (septet, J = 5.8 Hz,
1H), 4.60 (septet, J = 6.4 Hz, 1H), 1.27 (dd, J = 5.8, 6.4 Hz, 12H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 155.2, 150.8, 137.5, 113.9, 107.4, 71.1, 69.9, 21.8, 21.7, 21.6, 21.5
ppm.
(E)-Diisopropyl 1-(1-nitro-2-phenylvinyl)hydrazine-1,2-dicarboxylate (1–76)[61]
Prepared from DIAD (87.0 mg, 0.22 mmol, 1.10 equiv) and trans-β-styrene (30.2 mg, 0.20 mmol,
1.00 equiv) according to the general procedure E using pre-BAC–1 (3.20 mg, 10.0 µmol, 5.00 mol%),
DBU (1.50 mg, 10.0 μmol, 10.0 mol%) in THF (0.2 mL, 1.0 M) at 40 °C for 24 h. 1–76 was purified
by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement
with the reported data.[61]
Colorless oil.
Yield: 57.9 mg (82%).
1H NMR (CDCl3, 500 MHz): δ = 8.81 (s, 1H), 7.75–7.73 (m, 2H), 7.70–7.68 (m, 1H), 7.47–7.44 (m,
2H), 6.96 (br s, 1H), 4.85 (septet, J = 5.8 Hz, 1H), 4.74 (septet, J = 6.4 Hz, 1H), 1.12 (dd, J = 5.8, 6.4
Hz, 12H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 155.2, 150.8, 133.1, 128.9, 128.8 (2C), 128.1, 127.7 (2C), 119.1,




To an oven-dried test tube with a magnetic stirring bar in a nitrogen glove box were successively
added pre-BAC–1 (1.32 mg, 6.00 µmol, 2.00 mol%), THF (0.1 mL, 1.0 M), the corresponding
Michael acceptor (in molecular sieves, 0.30 mmol, 1.00 equiv), electrophilic halogen reagents (0.33
mmol, 1.10 equiv) and DBU (0.60 mg, 6.00 µmol, 2.00 mol%). The resulting mixture was stirred at
40 °C for 24 h, at which point TLC and/or 1H NMR analysis indicated complete consumption of the
corresponding Michael acceptor. The volatiles were removed in vacuo, and the residue was purified
by flash column chromatography or PTLC on silica gel (eluent: EtOAc/PE = 1:5) to give the intended
products.
2-Chloro-2-cyclopenten-1-one (1–78)[69]
Prepared from N-Chlorosuccinimide (44.1 mg, 0.33 mmol, 1.10 equiv) and cyclopentenone (24.6 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (4.86 mg, 15.0 µmol,
5.00 mol%), DBU (2.58 mg, 15.0 μmol, 5.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h. 1–78
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[69]
Colorless oil.
Yield: 29.8 mg (82%).
1H NMR (CDCl3, 500 MHz): δ = 7.79 (t, J = 3.0 Hz, 1H), 2.71–2.70 (m, 2H), 2.45–2.43 (m, 2H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 194.2, 162.2, 126.7, 34.0, 30.4 ppm.
2-Chloro-2-cyclohexen-1-one (1–80)[69]
Prepared from N-Chlorosuccinimide (44.1 mg, 0.33 mmol, 1.10 equiv) and cyclohexenone (45.2 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (4.86 mg, 15.0 µmol,
5.00 mol%), DBU (2.58 mg, 15.0 μmol, 5.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h. 1–80
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was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[69]
Colorless oil.
Yield: 33.2 mg (81%).
1H NMR (CDCl3, 500 MHz): δ = 7.28 (t, J = 4.4 Hz, 1H), 2.40 (t, J = 6.6 Hz, 2H), 2.29–2.27 (m, 2H),
1.95-1.92 (m, 2H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 190.9, 141.2, 126.6, 38.7, 27.1, 22.6 ppm.
3-Chloro-3-buten-2-one (1–81)[69]
Prepared from N-Chlorosuccinimide (44.1 mg, 0.33 mmol, 1.10 equiv) and methyl vinyl ketone (24.6
mg, 0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (4.86 mg, 15.0
µmol, 5.00 mol%), DBU (2.58 mg, 15.0 μmol, 5.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h.
1–81 was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were
in full agreement with the reported data.[69]
Colorless oil.
Yield: 24.1 mg (73%).
1H NMR (CDCl3, 500 MHz): δ = 3.95 (d, J = 5.4 Hz, 1H), 3.79 (d, J = 5.4 Hz, 1H), 2.39 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 194.5, 145.6, 120.9, 24.5 ppm.
2-Chloro-methylacrylate (1–82)[69]
Prepared from N-Chlorosuccinimide (44.1 mg, 0.33 mmol, 1.10 equiv) and methyl acrylate (41.9 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (4.86 mg, 15.0 µmol,
5.00 mol%), DBU (2.58 mg, 15.0 μmol, 5.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h. 1–82
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[69]
Colorless oil.
Yield: 27.6 mg (65%).
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1H NMR (CDCl3, 500 MHz): δ = 6.85 (d, J = 5.4 Hz, 1H), 6.68 (d, J = 5.4 Hz, 1H), 3.70 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 163.1, 131.8, 126.8, 54.1 ppm.
2-Bromo-2-cyclopenten-1-one (1–77)[68]
Prepared from N-Bromosuccinimide (58.8 mg, 0.33 mmol, 1.10 equiv) and cyclopentenone (24.6 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (1.95 mg, 6.00 µmol,
2.00 mol%), DBU (1.03 mg, 6.00 μmol, 2.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h. 1–77
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[68]
Colorless oil.
Yield: 48.3 mg (98%).
1H NMR (CDCl3, 500 MHz): δ = 7.77 (t, J = 2.9 Hz, 1H), 2.71–2.69 (m, 2H), 2.54–2.53 (m, 2H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 201.6, 161.6, 126.4, 32.4, 27.9 ppm.
2-Bromo-2-cyclohexen-1-one (1–83)[68]
Prepared from N-Bromosuccinimide (58.8 mg, 0.33 mmol, 1.10 equiv) and cyclohexenone (45.2 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (1.95 mg, 6.00 µmol,
2.00 mol%), DBU (1.03 mg, 6.00 μmol, 2.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h. 1–83
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[68]
Colorless oil.
Yield: 51.1 mg (90%).
1H NMR (CDCl3, 500 MHz): δ = 7.40 (t, J = 4.4 Hz, 1H), 2.62 (t, J = 7.2 Hz, 2H), 2.44–2.42 (m, 2H),
2.10–2.04 (m, 2H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 190.8, 150.6, 124.1, 38.4, 28.4, 22.8 ppm.
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3-Bromo-3-buten-2-one (1–84)[68]
Prepared from N-Bromosuccinimide (58.8 mg, 0.33 mmol, 1.10 equiv) and methyl vinyl ketone (24.6
mg, 0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (1.95 mg, 6.00
µmol, 2.00 mol%), DBU (1.03 mg, 6.00 μmol, 2.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h.
1–84 was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were
in full agreement with the reported data.[68]
Colorless oil.
Yield: 39.0 mg (84%).
1H NMR (CDCl3, 500 MHz): δ = 6.52 (d, J = 5.4 Hz, 1H), 6.47 (d, J = 5.4 Hz, 1H), 2.23 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 194.5, 120.1, 114.2, 28.7 ppm.
2-Bromo-methylacrylate (1–85)[68]
Prepared from N-Bromosuccinimide (58.8 mg, 0.33 mmol, 1.10 equiv) and methyl acrylate (41.9 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (1.95 mg, 6.00 µmol,
2.00 mol%), DBU (1.03 mg, 6.00 μmol, 2.00 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 24 h. 1–85
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[68]
Colorless oil.
Yield: 45.0 mg (81%).
1H NMR (CDCl3, 500 MHz): δ = 6.55 (d, J = 5.6 Hz, 1H), 6.45 (d, J = 5.6 Hz, 1H), 3.67 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 162.4, 130.7, 120.9, 53.4 ppm.
2-Iodo-2-cyclopenten-1-one (1–79)[67]
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Prepared from N-Iodosuccinimide (74.2 mg, 0.33 mmol, 1.10 equiv) and cyclopentenone (24.6 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (9.72 mg, 30.0 µmol,
10.0 mol%), DBU (5.15 mg, 30.0 μmol, 10.0 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 48 h. 1–79
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[67]
Purple oil.
Yield: 57.2 mg (91%).
1H NMR (CDCl3, 500 MHz): δ = 8.03 (t, J = 2.9 Hz, 1H), 2.80–2.79 (m, 2H), 2.53–2.51 (m, 2H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 204.1, 169.6, 102.9, 31.3, 30.9 ppm.
2-Iodo-2-cyclohexen-1-one (1–86)[67]
Prepared from N-Iodosuccinimide (74.2 mg, 0.33 mmol, 1.10 equiv) and cyclohexenone (45.2 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (9.72 mg, 30.0 µmol,
10.0 mol%), DBU (5.15 mg, 30.0 μmol, 10.0 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 48 h. 1–86
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[67]
Purple oil.
Yield: 56.8 mg (84%).
1H NMR (CDCl3, 500 MHz): δ = 7.68 (t, J = 4.4 Hz, 1H), 2.55 (t, J = 7.2 Hz, 2H), 2.37-2.36 (m, 2H),
2.02-1.98 (m, 2H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 192.0, 159.7, 103.7, 37.2, 28.9, 22.8 ppm.
3-Iodo-3-buten-2-one (1–87)[67]
Prepared from N-Iodosuccinimide (74.2 mg, 0.33 mmol, 1.10 equiv) and methyl vinyl ketone (24.6 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (9.72 mg, 30.0 µmol,
10.0 mol%), DBU (5.15 mg, 30.0 μmol, 10.0 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 48 h. 1–87
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[67]
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Purple oil.
Yield: 51.4 mg (87%).
1H NMR (CDCl3, 500 MHz): δ = 7.24 (d, J = 2.4 Hz, 1H), 6.85 (d, J = 2.4 Hz, 1H), 2.50 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 192.6, 138.4, 113.2, 24.0 ppm.
2-Iodo-methylacrylate (1–88)[67]
Prepared from N-Iodosuccinimide (74.2 mg, 0.33 mmol, 1.10 equiv) and methyl acrylate (41.9 mg,
0.30 mmol, 1.00 equiv) according to the general procedure F using pre-BAC–1 (9.72 mg, 30.0 µmol,
10.0 mol%), DBU (5.15 mg, 30.0 μmol, 10.0 mol%) in THF (0.3 mL, 1.0 M) at 40 °C for 48 h. 1–88
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data.[67]
Purple oil.
Yield: 54.0 mg (74%).
1H NMR (CDCl3, 500 MHz): δ = 7.55 (d, J = 5.6 Hz, 1H), 6.67 (d, J = 5.6 Hz, 1H), 3.92 (s, 3H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 169.1, 125.9, 91.8, 52.3 ppm.
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5.3 BAC-catalysed ASYMMETRIC AZA-MBH REACTIONS
5.3.1 Preparation of Chiral Bis(dialkylpropylamino)cyclopropenium precursors
Enantiomerically enriched diamine preparation
Two methods were used for the preparation of enantiomerically enriched diamines.[90,135] First,
compound 2–2 was prepared according to the literature procedure.[90]
Succinic anhydride (0.70 g, 7.00 mmol, 1.00 equiv) was dissolved in diethyl ether (10 mL) at room
temperature, and a solution of (S)-phenylethyl amine (0.90 mL, 7.00 mmol, 1.00 equiv) in diethyl
ether (2 mL) was added drop-wise over 10 min. The mixture was stirred at room temperature
overnight. The acid product was purified by column chromatography on silica gel (hexane/EtOAc = 1:1)
and isolated as a colorless solid.
Colorless solid (mp 102–104 °C).
Yield: 1.40 g (95%).
1H NMR (CD3OD, 500 MHz): δ = 10.5 (br s, 1H), 7.32–7.25 (m, 5H), 6.41–6.39 (m, 1H), 5.10 (q, J =
6.6 Hz, 1H), 2.60–2.58 (m, 2H), 2.41–2.39 (m, 2H), 1.40 (d, J = 6.6 Hz, 3H) ppm.
13C NMR (CD3OD, 125.8 MHz): δ = 176.6, 171.5, 142.8, 127.4 (2C), 126.7, 126.1 (2C), 49.2, 30.7,
29.7, 21.8 ppm.
To a stirred solution of the acid (0.44 g, 2.10 mmol, 1.00 equiv) in CH2Cl2 (20 mL) at 0 oC under a
nitrogen atmosphere were successively added DMAP (10.3 g, 2.10 mmol, 1.00 equiv), 1,3-
dicyclohexylcarbodiimide (10.4 g, 2.10 mmol, 1.00 equiv), and (S)-α-phenylethyl amine (0.27 mL,
2.10 mmol, 1.00 equiv). The reaction mixture was stirred at room temperature for 16 h, and filtered to
remove the colorless precipitate. The filtrate was extracted with water and CH2Cl2 (3 x 10 mL). The
organic layer was dried (Na2SO4) and filtered, and volatiles were removed under reduced pressure.
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The residue was purified by column chromatography on silica gel (hexane/EtOAc = 4:1) to obtain
product 2–1 as a colorless solid.
Colorless solid (mp 206–207 °C).
Yield: 0.58 g (80%).
1H NMR (CD3OD, 500 MHz): δ = 7.30–7.20 (m, 10H), 4.82 (q, J =7.0 Hz, 2H), 3.45 (br s, 2H), 2.51-
2.45 (m, 4H), 1.45 (d, J = 7.0 Hz, 6H) ppm.
13C NMR (CD3OD, 125.8 MHz): δ = 172.4 (2C), 144.0 (2C), 129.8 (2C), 128.3 (2C), 127.5 (2C),
126.8 (2C), 125.9 (2C), 48.9 (2C), 31.0 (2C), 21.4 (2C) ppm.
A solution of compound 2–1 (0.23 g, 0.70 mmol, 1.00 equiv) in THF (2 mL) was added slowly to a
vigorously stirred suspension of LiAlH4 (0.13 g, 3.50 mmol, 5.00 equiv) in THF (10 mL) at room
temperature. The resulting mixture was refluxed at 60 oC for 48 h, and quenched by careful addition
of an aqueous solution of sodium hydroxide (10%; 10 mL). The mixture was stirred vigorously for 30
min and filtered. The filtrate was concentrated, dissolved in CH2Cl2 (20 mL), dried over anhydrous
Na2SO4, filtered, and evaporated under reduced pressure. The residue was purified by column
chromatography on silica gel (hexanes/EtOAc = 1:1) to obtain product 2–2 as a colorless oil (0.19 g,
90% yield).
1H NMR (CDCl3, 500 MHz): δ = 7.32–7.21 (m, 10H), 4.54 (br s, 2H), 3.71 (q, J = 6.6 Hz, 2H), 2.40-
2.36 (m, 4H), 1.71-1.70 (m, 2H), 1.67 (d, J = 6.6 Hz, 6H), 1.23-1.21 (m, 2H) ppm.
13C NMR (CDCl3, 125.8 MHz): δ = 143.8 (2C), 134.5 (2C), 130.4 (2C), 128.6 (2C), 127.3 (2C), 126.7
(2C), 58.2 (2C), 46.9 (2C), 27.0 (2C), 23.2 (2C) ppm.
General preparation procedure G [synthesis of enantiomerically enriched diamines]
To an oven-dried flask containing the corresponding enantiomerically enriched amine (2.00 equiv) at
130 oC was added drop-wise 1,3-dibromopropane (1.00 equiv). After one hour at 130 oC, the mixture
was cooled to 80 oC and an aqueous solution of potassium hydroxide (4 M; 5.50 equiv) was added.
After extraction of the reaction mixture with ethyl acetate and concentration of the organic phase, the
residue was fractionally distilled at 2.5 mbar. The corresponding enantiomerically enriched diamines
were obtained at ~155 oC as a colorless liquid.
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N,N’-Bis[(S)-α-phenylethyl]propane-1,3-diamine (Diamine–1)[90]
Prepared from (S)-(–)-α-methylbenzylamine (0.87 mL, 6.8 mmol, 2.00 equiv) and 1,3-
dibromopropane (0.40 mL, 3.90 mmol, 1.00 equiv). Diamine–1 was purified by distillation. The
obtained analytical data were in full agreement with the reported data. [90]
Colorless oil.
Yield: 1.00 g (91%).
1H NMR (CDCl3, 500 MHz): δ = 7.36–7.21 (m, 10H), 3.77 (q, J = 7.0 Hz, 2H), 2.83 (br s, 2H), 2.63–
2.59 (m, 2H), 2.55–2.51 (m, 2H), 1.73–1.69 (m, 2H), 1.40 (d, J = 7.0 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 144.7 (2C), 128.6 (4C), 127.2 (2C), 126.5 (4C), 58.5, 46.6 (2C),
30.3 (2C), 23.9 (2C) ppm.
N,N’-Bis[(S)-α-phenylethyl]ethane-1,3-diamine (Diamine–2) [90]
Prepared from (S)-(–)-α-methylbenzylamine (0.87 mL, 6.8 mmol, 2.00 equiv) and 1,3-dibromoethane
(0.33 mL, 3.90 mmol, 1.00 equiv). Diamine–2 was purified by distillation. The obtained analytical
data were in full agreement with the reported data. [90]
Colorless oil.
Yield: 0.97 g (93%).
1H NMR (CDCl3, 500 MHz): δ = 7.39–7.25 (m, 10H), 3.70 (q, J = 6.3 Hz, 2H), 2.59–2.55 (m, 4H),
2.23 (br s, 2H), 1.39 (d, J = 6.3 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 145.8 (2C), 128.4 (2C), 126.8 (4C), 126.6 (4C), 58.2 (2C), 47.4
(2C), 24.4 (2C) ppm.
N,N’-Bis[(S)-α-benzylethyl]propane-1,3-diamine (Diamine–3) [90]
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Prepared from (S)-(–)-α-ethylbenzylamine (1.96 mL, 13.6 mmol, 4.00 equiv) and 1,3-dibromopropane
(0.40 mL, 3.90 mmol, 1.00 equiv). Diamine–3 was purified by distillation. The obtained analytical
data were in full agreement with the reported data. [90]
Colorless oil.
Yield: 1.11 g (92%).
1H NMR (CDCl3, 500 MHz): δ = 7.36–7.21 (m, 10H), 4.05 (q, J = 7.0 Hz, 2H), 2.64–2.60 (m, 4H),
1.52–1.50 (m, 2H), 1.78 (dq, J = 7.0, 7.7 Hz, 4H), 1.34 (br s, 2H), 0.92 (t, J = 7.7 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 143.9 (2C), 128.9 (2C), 128.6 (4C), 126.7 (4C), 57.2 (2C), 43.1
(2C), 27.6, 26.1 (2C), 10.4 (2C) ppm.
N,N’-Bis[(S)-(1-naphthaleny)lethyl]propane-1,3-diamine (Diamine–4) [90]
Prepared from (S)-(–)-α-(1-naphthyl)ethylamine (2.18 mL, 13.6 mmol, 4.00 equiv) and 1,3-
dibromopropane (0.40 mL, 3.90 mmol, 1.00 equiv). Diamine–4 was purified by PTLC on silica gel
(eluent: EtOAc/PE = 1:5). The obtained analytical data were in full agreement with the reported
data.[90]
Colorless solid.
Mp. 125−126 oC (125−127 oC) [90]
Yield: 1.33 g (89%).
1H NMR (CDCl3, 500 MHz): δ = 7.71–7.52 (m, 14H), 4.38 (q, J = 6.7 Hz, 2H), 2.69–2.65 (m, 4H),
1.53–1.51 (m, 2H), 1.32 (s, 6H), 1.24 (br s, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 132.7 (2C), 130.8 (2C), 130.6 (2C), 129.1 (2C), 128.4 (2C), 126.7
(2C), 126.1 (2C), 125.8 (2C), 124.6 (2C), 122.9 (2C), 51.3 (2C), 43.1 (2C), 27.6, 22.3 (2C) ppm.
N,N’-Bis[(S)-(2-naphthaleny)lethyl]propane-1,3-diamine (Diamine–5) [90]
Prepared from (S)-(–)-α-(2-naphthyl)ethylamine (2.18 mL, 13.6 mmol, 4.00 equiv) and 1,3-
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dibromopropane (0.40 mL, 3.90 mmol, 1.00 equiv). Diamine–5 was purified by PTLC on silica gel
(eluent: EtOAc/PE = 1:2). The obtained analytical data were in full agreement with the reported
data.[90]
Colorless solid.
Mp. 136−138 oC (135−137 oC) [90]
Yield: 1.20 g (87%).
1H NMR (CDCl3, 500 MHz): δ = 7.93–7.69 (m, 14H), 4.31 (q, J = 6.7 Hz, 2H), 2.70–2.65 (m, 4H),
1.53–1.51 (m, 2H), 1.29 (s, 6H), 1.20 (br s, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 139.7 (2C), 133.8 (2C), 133.1 (2C), 128.5 (2C), 128.1 (2C), 127.7
(2C), 127.0 (2C), 126.6 (2C), 126.5 (2C), 125.5 (2C), 51.3 (2C), 43.1 (2C), 27.5, 22.3 (2C) ppm.
N,N’-Bis[(S)-α-benzylethanol]propane-1,3-diamine (Diamine–6) [90]
Prepared from (S)-(+)-2-phenylglycinol (1.87 mg, 13.6 mmol, 4.00 equiv) and 1,3-dibromopropane
(0.40 mL, 3.90 mmol, 1.00 equiv). Diamine–6 was purified by PTLC on silica gel (eluent: EtOAc/PE
= 1:2). The obtained analytical data were in full agreement with the reported data. [90]
Colorless solid.
Mp. 118−121 oC (118−119 oC) [90]
Yield: 1.10 g (90%).
1H NMR (CDCl3, 500 MHz): δ = 7.40–7.20 (m, 10H), 4.21 (q, J = 5.7 Hz, 2H), 3.58 (d, J = 5.7 Hz,
4H), 2.67–2.62 (m, 4H), 2.43 (brs, 2H), 1.52–1.50 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 138.7 (2C), 129.1 (4C), 128.6 (2C), 127.1 (4C), 54.3 (2C), 51.3
(2C), 43.8 (2C), 27.6 ppm.
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General Procedure H [ synthesis of enantiomerically enriched BAC precursors]
Enantiomerically enriched BACs were synthesized according to a slightly modified literature
procedure.[71] Under a nitrogen atmosphere, a pre-cooled solution of the corresponding
enantiomerically enriched diamine (83.0 mg, 0.28 mmol, 1.00 equiv) in CH2Cl2 (0.6 mL) at –78 °C
was slowly added to a solution of tetrachlorocyclopropene (34.0 µL, 0.28 mmol, 1.00 equiv) in
CH2Cl2 (5.0 mL) at –78 °C. After addition of diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv),
the reaction mixture was warmed to room temperature, and stirred under room temperature over three
hours. Then the flask was re-cooled to –78 °C, at which stage polystyrene-bound triphenylphosphine
(3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv) was added in one portion. The reaction mixture was
warmed to room temperature over two hours before successive addition of distilled water (5 mL) and
sodium tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv). The reaction mixture was vigorously
stirred for two days before filtration and transfer of the filtrate to a separating funnel with CH2Cl2.
After phase separation, the organic layer was successively washed with aqueous HCl (0.5 M), aqueous
NaHCO3 (sat), and water. The organic phase was then dried over Na2SO4, filtered, and concentrated in
vacuo. The crude product was purified by flash column chromatography on silica gel (acetone/DCM
= 1:100) to obtain the pure product.
2-(S)-1-Phenylethyl-7-[(S)-1-phenylethyl]-2,7-diazabicyclo[6.1.0]non-1(8)-en-9-yliumtetraphenyl-
borate (pre-BAC*–1)
Prepared from 2–2 (83.0 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28 mmol,
1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL) and sodium
tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. pre-BAC*–1
was purified by PTLC on silica gel (eluent: DCM/acetone = 19:1). The obtained analytical data were
in full agreement with the reported data.[71]
Colorless solid.
Mp. 135−138 oC (135−137 oC) [71]
Yield: 151.1 mg (83%).
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1H NMR (CDCl3, 500 MHz): δ = 7.50 (br s, 8H), 7.40–7.36 (m, 6H), 7.09–7.05 (m, 4H), 7.00 (t, J =
7.0 Hz, 8H), 6.86 (t, J = 7.0 Hz, 4H), 4.95 (s , 1H), 4.41 (q, J = 6.8 Hz, 2H), 2.73 (dd, J = 7.6, 12.0 Hz
2H), 2.61 (dd, J = 7.6, 12.0 Hz, 2H), 1.53–1.50 (m, 2H), 1.46 (d, J = 7.0 Hz ,6 H), 1.36–1.30 (m, 2H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.4 (q, J = 49.1 Hz, 4C), 138.2 (4C), 136.3 (2C), 132.2 (2C),
129.4 (4C), 129.0 (4C), 126.9 (8C), 125.8 (q, J = 2.8 Hz, 8C), 121.9 (2C), 95.5, 63.1 (2C), 48.3 (2C),
23.5 (2C), 18.6 (2C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –5.6 (s) ppm.
2-(S)-1-Phenylethyl-6-[(S)-1-phenylethyl]-2,6-diazabicyclo[5.1.0]non-1(7)-en-8-yliumtetraphenyl-
borate (pre-BAC*–2)
Prepared from Diamine–1 (78.9 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28
mmol, 1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL) and sodium
tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. pre-BAC*–2
was purified by PTLC on silica gel (eluent: DCM/acetone = 19:1).
Colorless solid (mp 130–133 oC).
Yield: 151.1 mg (83%).
1H NMR (CDCl3, 500 MHz): δ = 7.48 (br s, 8H), 7.38–7.35 (m, 6H), 7.08–7.04 (m, 4H), 6.98 (t, J =
7.1 Hz, 8H), 6.78 (t, J = 7.1 Hz, 4H), 4.72 (s , 1H), 4.21 (q, J = 7.0 Hz, 2H), 2.67 (dd, J = 6.5, 14.1 Hz,
2H), 2.64 (dd, J = 6.5, 14.1 Hz, 2H), 1.49 (d, J = 7.0 Hz, 6H), 1.46–1.45 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.5 (q, J = 49.0 Hz, 4C), 138.1 (4C), 136.0 (2C), 132.4 (2C),
129.6 (4C), 129.3 (4C), 127.1 (8C), 125.4 (q, J = 2.6 Hz, 8C), 121.5 (2C), 95.1, 63.3 (2C), 48.0 (2C),
23.4, 17.9 (2C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –6.1 (s) ppm.
IR (CH2Cl2): ν = 3097, 3058, 2987, 2836, 1892, 1610, 945, 732, 710 cm–1.
HRMS (ESI): calculated for C22H26N2+= [M]+: m/z = 318.4625, found: m/z = 318.4628.




Prepared from Diamine–2 (73.4 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28
mmol, 1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL) and sodium
tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. pre-BAC*–3
was purified by PTLC on silica gel (eluent: DCM/acetone = 19:1).
Colorless solid (mp 120–122 oC).
Yield: 139.7 mg (80%).
1H NMR (CDCl3, 500 MHz): δ = 7.68 (br s, 8H), 7.34–7.32 (m, 6H), 7.20–7.19 (m, 4H), 6.95 (t, J =
7.1 Hz, 8H), 6.73 (t, J = 7.1 Hz, 4H), 4.48 (s , 1H), 4.02 (q, J = 6.8 Hz, 2H), 2.11 (dd, J = 7.7, 12.2 Hz,
2H), 2.09 (dd, J = 7.7, 12.2 Hz, 2H), 1.25 (d, J = 6.8 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 163.9 (q, J = 46.3 Hz, 4C), 137.5 (4C), 134.8 (2C), 130.2 (2C),
128.4 (4C), 128.1 (4C), 127.5 (8C), 124.6 (q, J = 2.9 Hz, 8C), 120.7 (2C), 92.3, 47.5 (2C), 42.7 (2C),
19.0 (2C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –5.9 (s) ppm.
IR (CH2Cl2): ν = 3123, 3092, 2992, 1867, 1621, 981, 769, 723 cm–1.
HRMS (ESI): calculated for C21H24N2+= [M]+: m/z = 304.4328, found: m/z = 304.4329.
[α]D25 = –9.0 ° (c = 1.0, CHCl3).
2-(S)-1-Phenylethyl-6-[(S)-1-phenylethyl]-2,6-diazabicyclo[5.1.0]non-1(7)-en-8-ylium tetrafluoro-
borate (pre-BAC*–7)
Prepared from Diamine–1 (78.9 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28
mmol, 1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL) and sodium
tetrafluoroborate (30.7 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. pre-BAC*–7
was purified by PTLC on silica gel (eluent: DCM/acetone = 19:1).
Colorless solid (mp 110–115 oC).
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Yield: 95.3 mg (84%).
1H NMR (CDCl3, 500 MHz): δ = 7.80 (s, 1H), 7.38–7.35 (m, 6H), 7.08–7.04 (m, 4H), 4.19 (q, J = 7.0
Hz, 2H), 2.63–2.60 (m, 4H), 1.50 (d, J = 7.0 Hz, 6H), 1.48–1.46 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 136.3 (2C), 134.6 (4C), 132.2 (4C), 121.8 (2C), 95.5, 63.1 (2C),
48.3 (2C), 23.5, 18.6 (2C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –2.0 (s) ppm.
19F NMR (CDCl3, 128 MHz): δ = –151.8 ~ –151.8 ppm.
IR (CH2Cl2): ν = 3198, 3037, 2876, 2087, 1896, 1623, 984, 736 cm–1.
HRMS (ESI): calculated for C22H26N2+= [M]+: m/z = 318.4625, found: m/z = 318.4630.
[α]D25 = –8.0 ° (c = 1.0, CHCl3).
2-(S)-1-Benzylethyl-6-[(S)-1-benzylethyl]-2,6-diazabicyclo[5.1.0]non-1(7)-en-8-ylium
tetraphenylborate (pre-BAC*–8)
Prepared from Diamine–3 (86.9 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28
mmol, 1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL) and sodium
tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. pre-BAC*–8
was purified by PTLC on silica gel (eluent: DCM/acetone = 19:1).
Colorless solid (mp 150–155 oC).
Yield: 165.9 mg (89%).
1H NMR (CDCl3, 500 MHz): δ = 7.49 (br s, 8H), 7.40–7.38 (m, 6H), 7.09–7.04 (m, 4H), 6.99 (t, J =
7.1 Hz, 8H), 6.75 (t, J = 7.1 Hz, 4H), 4.72 (s, 1H), 4.29 (q, J = 7.3 Hz, 2H), 2.43–2.40 (m, 2H), 2.39–
2.35 (m, 2H), 1.89–1.80 (m, 4H), 1.86–1.83 (m, 2H), 0.82 (t, J = 7.6 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 163.8 (q, J = 49.2 Hz, 4C), 137.2 (4C), 135.9 (2C), 132.8 (2C),
129.9 (4C), 129.5 (4C), 126.7 (8C), 124.8 (q, J = 2.8 Hz, 8C), 120.8 (2C), 95.1, 62.9 (2C), 47.3 (2C),
26.2, 21.5 (2C), 18.4 (2C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –5.8 (s) ppm.
IR (CH2Cl2): ν = 3098, 3052, 2987, 2876, 1887, 1610, 1486, 1376, 723, 710 cm–1.
HRMS (ESI): calculated for C24H30N2+= [M]+: m/z = 346.5187, found: m/z = 346.5191.




Prepared from Diamine–4 (107.1 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28
mmol, 1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL) and sodium
tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. pre-BAC*–9
was purified by PTLC on silica gel (eluent: DCM/acetone = 19:1).
Colorless solid (mp 160–163 oC).
Yield: 171.5 mg (83%).
1H NMR (CDCl3, 500 MHz): δ = 7.95–7.91 (m, 4H), 7.90–7.71 (m, 6H), 7.57–7.54 (m, 4H), 7.50 (br
s, 8H), 7.40–7.36 (m, 6H), 7.09–7.04 (m, 6H), 4.79 (s, 1H), 4.28 (q, J = 7.0 Hz, 2H), 3.46–3.42 (m,
2H), 3.43–3.40 (m, 2H), 1.56–1.55 (m, 2H), 1.46 (d, J = 7.0 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.9 (q, J = 48.0 Hz, 4C), 138.6 (4C), 137.6 (2C), 136.7 (2C),
132.8 (2C), 132.2 (2C), 130.8 (2C), 130.6 (2C), 129.5 (2C), 128.4 (2C), 126.6 (8C), 126.4 (2C), 125.8
(q, J = 2.8 Hz, 8C), 124.1 (2C), 123.2 (2C), 96.5, 63.1, 49.3 (2C), 26.5 (2C), 20.6 (2C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –6.5 (s) ppm.
IR (CH2Cl2): ν = 3098, 2963, 2873, 2564, 1639, 1420, 1387, 983, 716 cm–1.
HRMS (ESI): calculated for C30H30N2+= [M]+: m/z = 418.5764, found: m/z = 418.5768.
[α]D25 = –10.0 ° (c = 1.0, CHCl3).
2-(S)-1-(2-naphthylethyl)-6-[(S)-1-(2-naphthylethyl)]-2,6-diazabicyclo[5.1.0]non-1(7)-en-8-ylium
tetraphenylborate (pre-BAC*–10)
Prepared from Diamine–5 (107.1 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28
mmol, 1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL) and sodium
tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. pre-BAC*–
10 was purified by PTLC on silica gel (eluent: DCM/acetone = 19:1).
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Colorless solid (mp 162–166 oC).
Yield: 170.6 mg (82%).
1H NMR (CDCl3, 500 MHz): δ = 7.95–7.90 (m, 4H), 7.90–7.72 (m, 6H), 7.58–7.54 (m, 4H), 7.52 (br
s, 8H), 7.48–7.39 (m, 6H), 7.08–7.05 (m, 6H), 4.72 (s, 1H), 4.36 (q, J = 7.0 Hz, 2H), 3.42–3.40 (m,
2H), 3.40–3.37 (m, 2H), 1.52–1.49 (m, 2H), 1.45 (d, J = 7.0 Hz, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 165.8 (q, J = 48.2 Hz, 4C), 139.6 (4C), 137.3 (2C), 135.7 (2C),
131.8 (2C), 131.0 (2C), 130.2 (2C), 129.8 (2C), 129.1 (2C), 128.0 (2C), 125.8 (8C), 125.6 (q, J = 2.6
Hz, 8C), 124.7 (2C), 124.0 (2C), 122.1 (2C), 97.5, 63.8, 48.7 (2C), 27.3 (2C), 22.9 (2C) ppm.
11B NMR (CDCl3, 160 MHz): δ = –6.2 (s) ppm.
IR (CH2Cl2): ν = 3108, 2966, 2880, 2568, 1645, 1423, 1389 cm–1.
HRMS (ESI): calculated for C30H30N2+= [M]+: m/z = 418.5765, found: m/z = 418.5769.
[α]D25 = –5.0 ° (c = 1.0, CHCl3).
2-(S)-1-(benzylethanol)-6-[(S)-1-benzylethanol]-2,6-diazabicyclo[5.1.0]non-1(7)-en-8-ylium
tetraphenylborate (pre-BAC*–11)
Prepared from Diamine–6 (88.0 mg, 0.28 mmol, 1.00 equiv), tetrachlorocyclopropene (34.0 µL, 0.28
mmol, 1.00 equiv), diisopropylethylamine (98.0 µL, 0.56 mmol, 2.00 equiv), polystyrene-bound
triphenylphosphine (3.0 mmol/g; 100 mg, 0.56 mmol, 2.00 equiv), distilled water (5 mL), and sodium
tetraphenylborate (98.0 mg, 0.28 mmol, 1.00 equiv) according to General Procedure H. Pre-BAC*–
11 was purified by flash column chromatography on silica gel (eluent: DCM/acetone = 19:1).
Colorless solid (mp 213–218 °C).
Yield: 159 mg (85%).
1H NMR (CDCl3, 500 MHz): δ = 7.45 (br s, 13H), 7.40–7.35 (m, 7H), 7.07–7.04 (m, 4H), 7.01–6.98
(m, 3H), 6.85 (dd, J = 7.1, 7.1 Hz, 3H), 5.61 (br s, OH, 2H), 4.92 (s, 1H), 3.81 (dd, J = 8.1, 4.1 Hz,
2H), 3.73 (dd, J = 10.9, 4.1 Hz, 2H), 3.62 (dd, J = 10.9, 8.1 Hz, 2H), 2.65–2.53 (m, 4H), 1.72–1.67 (m,
2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.5 (q, J = 49.0 Hz, 4C), 138.6 (4C), 136.5 (2C), 133.4 (4C),
129.2 (4C), 128.5 (2C), 127.5 (8C), 125.1 (q, J = 2.8 Hz, 8C), 120.7 (2C), 92.7, 61.9 (2C), 46.4 (2C),
26.8 (2C), 24.7 ppm.
11B NMR (CDCl3, 128 MHz): δ = –6.9 (s) ppm.
IR (neat): ν = 3284, 3065, 2931, 2890, 2865, 2456, 1656, 1640, 1486, 1343, 1107 cm–1.
HRMS (ESI): calculated for C22H25N2O2+= [M]+: m/z = 349.4562, found: m/z = 349.4567.
[α]D25 = –6.0 ° (c = 1.0, CHCl3).
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5.3.2 Preparation of Imine 3a-b’
General Procedure B[54]
To an oven-dried 50 mL round-bottom flask with a magnetic stirring bar under an argon atmosphere
were added 2-naphthalene sulfonamide (1.00 equiv), tetraethyl orthosilicate (1.10 equiv), and the
respective aldehyde (1.00 equiv). The flask was connected to a short distillation head (approximately
3–4 cm long) and a receptor flask. The reaction mixture was heated at 160–170 oC for 8–16 hours,
and the by-product, ethanol, was collected in the receptor flask. After confirming the end-point of the
reaction by 1H NMR spectroscopic analysis, the reaction mixture was cooled to room temperature, and
washed with hexane (10 mL). The mixture was filtered, and volatiles were removed in vacuo to give
the crude imine, which was recrystallized from ethyl acetate to yield the corresponding pure imine,
which was powered and dried over 4Å MS in DCM prior to use in catalysis.
2-Naphthalene-(N-benzylidene)sulfonamide (Imine–3a) [54]
Prepared from benzaldehyde (5.84 g, 55.0 mmol, 1.10 equiv), 2-naphthalene sulfonamide (10.4 g, 50.0
mmol, 1.00 equiv), and Si(OEt)4 (11.5 g, 55.0 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 8 h. Imine–3a was recrystallized from EtOAc (10 mL). The obtained analytical data were
in full agreement with the reported data. [54]
Colorless solid.
Mp. 175−176 oC (174−176 oC) [54]
Yield: 13.9 g (95%).
1H NMR (CDCl3, 500 MHz): δ = 9.12 (s, 1H), 8.61 (s, 1H), 8.01–7.94 (m, 6H), 7.65–7.61 (m, 3H),
7.50–7.49 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 170.5, 135.3, 135.1, 133.6, 132.9, 132.7, 131.4, 130.8, 130.0, 129.7,
129.4, 129.2 (2C), 127.9 (2C), 127.6, 122.9 ppm.
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2-Naphthalene-[N-(2-methylbenzylidene)]sulfonamide (Imine–3b)
Prepared from 2-methylbenzaldehyde (2.17 g, 17.7 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.30 g, 16.1 mmol, 1.00 equiv), and Si(OEt)4 (3.69 g, 17.7 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3b was recrystallized from EtOAc (10 mL).
Colorless solid (mp 176–180 °C).
Yield: 4.82 g (95%).
1H NMR (CDCl3, 500 MHz): δ = 9.45 (s, 1H), 8.63 (s, 1H), 8.06–7.97 (m, 4H), 7.94–7.92 (m, 1H),
7.70–7.68 (m, 1H), 7.63–7.61 (m, 1H), 7.50–7.48 (m, 1H), 7.32–7.29 (m, 2H), 2.64 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.1, 142.4, 135.4, 135.3, 134.7, 132.4, 131.6, 130.8, 130.5, 129.5,
129.4, 129.2, 127.9, 127.6, 126.7, 126.5, 123.0, 19.7 ppm.
IR (CH2Cl2): ν = 3115, 3034, 3021, 2990, 2941, 1894, 1731, 1559, 1433, 1387, 1180, 1162, 1134,
1123, 752, 723, 691 cm–1.
HRMS (ESI): calculated for C18H15NaNO2S = [M+Na]+: m/z = 332.1896, found: m/z = 332.1890.
2-Naphthalene-[N-(3-methylbenzylidene)]sulfonamide (Imine–3c)
Prepared from 3-methylbenzaldehyde (2.17 g, 17.7 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.30 g, 16.1 mmol, 1.00 equiv), and Si(OEt)4 (3.69 g, 17.7 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3c was recrystallized from EtOAc (10 mL).
Colorless solid (mp 175–180 °C).
Yield: 4.72 g (93%).
1H NMR (CDCl3, 500 MHz): δ = 9.48 (s, 1H), 8.62 (s, 1H), 8.02–7.92 (m, 4H), 7.86 (d, J = 8.6 Hz,
2H), 7.70–7.67 (m, 2H), 7.61–7.58 (m, 2H), 2.82 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.3, 146.5, 135.4, 134.9, 134.1, 133.6, 132.3, 130.5, 128.5, 128.4,
128.2, 127.8, 127.6, 127.5, 126.6, 126.5, 123.5, 23.9 ppm.
IR (CH2Cl2): ν = 3120, 3051, 3035, 2987, 2952, 1884, 1743, 1569, 1447, 1392, 1194, 1141, 1138,
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1120, 751, 725, 692 cm–1.
HRMS (ESI): calculated for C18H15NaNO2S = [M+Na]+: m/z = 332.1896, found: m/z = 332.1894.
2-Naphthalene-[N-(4-methylbenzylidene)]sulfonamide (Imine–3d)
Prepared from 4-methylbenzaldehyde (2.17 g, 17.7 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.30 g, 16.1 mmol, 1.00 equiv), and Si(OEt)4 (3.69 g, 17.7 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3d was recrystallized from EtOAc (10 mL).
Colorless solid (mp 175–180 °C).
Yield: 4.74 g (94%).
1H NMR (CDCl3, 500 MHz): δ = 9.04 (s, 1H), 8.62 (s, 1H), 8.03–7.99 (m, 3H), 7.94–7.92 (m, 3H),
7.65 (d, J = 8.4 Hz, 2H), 6.99 (d, J = 8.4 Hz, 2H), 2.66 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 169.6, 145.4, 135.7, 135.2, 133.8, 132.2, 129.3 (2C), 129.1, 129.0
(2C), 127.9, 127.6, 127.5, 125.3, 123.8, 114.7, 25.6 ppm.
IR (CH2Cl2): ν = 3123, 3054, 3040, 2989, 2954, 1891, 1763, 1578, 1421, 1384, 1169, 1139, 1123, 754,
722, 697 cm–1.
HRMS (ESI): calculated for C18H15NaNO2S = [M+Na]+: m/z = 332.1896, found: m/z = 332.1892.
2-Naphthalene-[N-(1-naphthalenyl)methylene]sulfonamide (Imine–3e)
Prepared from 1-naphthaldehyde (2.82 g, 18.0 mmol, 1.10 equiv), 2-naphthalene sulfonamide (3.44 g,
16.4 mmol, 1.00 equiv), and Si(OEt)4 (3.75 g, 18.0 mmol, 1.10 equiv) according to General Procedure
B at 170 oC for 16 h. Imine–3e was recrystallized from EtOAc (10 mL).
Light yellow solid (mp 192–195 °C).
Yield: 5.26 g (92%).
1H NMR (CDCl3, 500 MHz): δ = 9.71 (s, 1H), 9.02 (s, 1H), 8.67–8.65 (m, 1H), 8.18 (d, J = 8.4 Hz,
1H), 8.14 (d, J = 8.2 Hz, 1H), 8.03–7.99 (m, 3H), 7.94 (d, J = 8.4 Hz, 2H), 7.68–7.57 (m, 5H) ppm.
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13C NMR (CDCl3, 125 MHz): δ = 170.2, 136.2, 135.4, 133.6, 132.8, 132.4, 130.8, 130.7, 129.1, 128.3,
128.2, 128.1, 127.8, 127.7, 127.5, 126.7, 126.6, 126.5, 126.4, 124.5, 123.5 ppm.
IR (CH2Cl2): ν = 3120, 3067, 3013, 2978, 2936, 1981, 1741, 1564, 1428, 1378, 1205, 1178, 1137,
1121, 751, 724, 698 cm–1.
HRMS (ESI): calculated for C21H15NaNO2S = [M+Na]+: m/z = 368.5247, found: m/z = 368.5252.
2-Naphthalene-[N-(2-naphthalenyl)methylene]sulfonamide (Imine–3f)
Prepared from 2-naphthaldehyde (2.82 g, 18.0 mmol, 1.10 equiv), 2-naphthalene sulfonamide (3.44 g,
16.4 mmol, 1.00 equiv), and Si(OEt)4 (3.75 g, 18.0 mmol, 1.10 equiv) according to General Procedure
B at 170 oC for 16 h. Imine–3f was recrystallized from EtOAc (10 mL).
Light yellow solid (mp 193–195 °C).
Yield: 5.32 g (94%).
1H NMR (CDCl3, 500 MHz): δ = 9.26 (s, 1H), 8.65 (s, 1H), 8.36 (s, 1H), 8.08–8.03 (m, 2H), 7.97–
7.87 (m, 5H), 7.68–7.62 (m, 3H), 7.60–7.57 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 170.5, 136.6, 136.3, 135.3, 135.2, 132.7, 132.2, 130.1, 129.7, 129.6,
129.5, 129.4, 129.3, 129.2, 128.1, 127.9, 127.8, 127.6, 127.3, 124.2, 123.0 ppm.
IR (CH2Cl2): ν = 3119, 3074, 3025, 2991, 2974, 2924, 1985, 1747, 1558, 1436, 1371, 1214, 1184,
1169, 1114, 759, 736, 691 cm–1.
HRMS (ESI): calculated for C21H15NaNO2S = [M+Na]+: m/z = 368.5247, found: m/z = 368.5250.
2-Naphthalene-[N-(2-methoxybenzylidene)]sulfonamide (Imine–3g)
Prepared from 2-methoxy benzaldehyde (2.59 g, 19.0 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.65 g, 17.3 mmol, 1.00 equiv), and Si(OEt)4 (3.96 g, 19.0 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3g was recrystallized from EtOAc (10 mL).
Colorless solid (mp 184–187 °C).
Yield: 5.17 g (90%).
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1H NMR (CDCl3, 500 MHz): δ = 9.64 (s, 1H), 8.60 (s, 1H), 8.06–8.04 (m, 1H), 7.98–7.95 (m, 3H),
7.90–7.88 (m, 1H), 7.64–7.60 (m, 2H), 7.59–7.57 (m, 1H), 6.97–6.95 (m, 2H), 3.93 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 166.7, 161.8, 142.3, 136.9, 135.6, 135.1, 132.2, 131.9, 130.5, 129.4,
129.3, 129.0, 127.9, 123.0, 121.0, 120.9, 111.5, 55.7 ppm.
IR (CH2Cl2): ν = 3123, 3062, 3037, 2989, 2971, 2936, 1989, 1752, 1564, 1440, 1381, 1246, 1219,
1191, 1175, 1123, 1051, 753, 739, 695 cm–1.
HRMS (ESI): calculated for C18H15NaNO3S = [M+Na]+: m/z = 348.2808, found: m/z = 348.2814.
2-Naphthalene-[N-(2-hydroxybenzylidene)]sulfonamide (Imine–3h)
Prepared from 2-hydroxy benzaldehyde (2.33 g, 19.0 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.77 g, 18.2 mmol, 1.00 equiv), and Si(OEt)4 (3.96 g, 19.0 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3h was recrystallized from EtOAc (10 mL).
Colorless solid (mp 171–175 °C).
Yield: 5.03 g (89%).
1H NMR (CDCl3, 500 MHz): δ = 10.8 (s, 1H), 9.16 (s, 1H), 8.59 (s, 1H), 7.99–7.97 (m, 2H), 7.92–
7.90 (m, 2H), 7.67-7.64 (m, 2H), 7.56-7.51 (m, 2H), 7.01-6.98 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 171.8, 162.3, 137.5, 135.5, 135.4, 134.9, 132.2, 129.8, 129.7, 129.5,
129.4, 128.0, 127.8, 122.5, 120.4, 118.0, 116.7 ppm.
IR (CH2Cl2): ν = 3121, 3058, 3042, 2993, 2982, 2931, 1875, 1739, 1569, 1434, 1381, 1356, 1246,
1182, 1154, 1130, 750, 723, 696 cm–1.
HRMS (ESI): calculated for C17H13NaNO3S = [M+Na]+: m/z = 357.1568, found: m/z = 357.1572.
2-Naphthalene-[N-(2-fluorobenzylidene)]sulfonamide (Imine–3i)
Prepared from 2-fluoro benzaldehyde (0.24 g, 2.04 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(0.38 g, 1.85 mmol, 1.00 equiv), and Si(OEt)4 (0.43 g, 2.04 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3i was recrystallized from EtOAc (10 mL).
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Colorless solid (mp 168–171 °C).
Yield: 0.56 g (96%).
1H NMR (CDCl3, 500 MHz): δ = 9.45 (s, 1H), 8.62 (s, 1H), 8.10–8.08 (m, 1H), 8.03–8.01 (m, 2H),
8.00–7.98 (m, 1H), 7.93 (d, J = 7.7 Hz, 1H), 7.70–7.60 (m, 3H), 7.22–7.17 (m, 1H), 7.16–7.15 (m, 1H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 165.2, 164.0 (d, J = 238.3 Hz), 163.5, 137.1 (d, J = 9.2 Hz), 135.4,
134.7, 132.2, 129.8, 129.5 (d, J = 6.4 Hz), 129.4, 129.3, 127.9, 127.7, 124.9 (d, J = 17.0 Hz), 122.9,
120.5 (d, J = 8.6 Hz), 116.4 (d, J = 20.6 Hz) ppm.
19F NMR (CDCl3, 128 MHz): δ = –116.0 ~ –115.9 (m) ppm.
IR (CH2Cl2): ν = 3122, 3059, 3026, 2981, 2939, 1880, 1737, 1568, 1438, 1355, 1188, 1157, 1138,
1118, 1058, 1031, 750, 721, 696 cm–1.
HRMS (ESI): calculated for C17H12FNaNO2S = [M+Na]+: m/z = 336.2168, found: m/z = 336.2174.
2-Naphthalene-[N-(2-chlorobenzylidene)]sulfonamide (Imine–3j)
Prepared from 2-chloro benzaldehyde (2.32 g, 19.7 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.74 g, 17.9 mmol, 1.00 equiv), and Si(OEt)4 (4.11 g, 19.7 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3j was recrystallized from EtOAc (10 mL).
Colorless solid (mp 178–181 °C).
Yield: 5.50 g (93%).
1H NMR (CDCl3, 500 MHz): δ = 9.59 (s, 1H), 8.62 (s, 1H), 8.16–8.14 (m, 1H), 8.00–7.98 (m, 2H),
7.96–7.92 (m, 1H), 7.87 (d, J = 8.6 Hz, 1H), 7.68–7.64 (m, 2H), 7.52–7.50 (m, 1H), 7.48–7.47 (m, 1H),
7.32–7.30 (m, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 167.2, 139.1, 135.7, 135.4, 134.9, 133.7, 132.7, 132.4, 129.5, 129.3,
129.1, 128.3, 128.2, 128.0, 127.7, 127.4, 123.0 ppm.
IR (CH2Cl2): ν = 3125, 3069, 3031, 2994, 2943, 1878, 1754, 1561, 1434, 1352, 1197, 1151, 1136, 756,
727, 698 cm–1.
HRMS (ESI): calculated for C17H12ClNaNO2S = [M+Na]+: m/z = 352.1396, found: m/z = 352.1394.
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2-Naphthalene-[N-(2-cyanobenzylidene)]sulfonamide (Imine–3k)
Prepared from 2-cyano benzaldehyde (2.16 g, 18.2 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.53 g, 16.5 mmol, 1.00 equiv), and Si(OEt)4 (3.79 g, 18.2 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3k was recrystallized from EtOAc (10 mL).
Colorless solid (mp 170–173 °C).
Yield: 4.54 g (85%).
1H NMR (CDCl3, 500 MHz): δ = 9.82 (s, 1H), 8.45 (s, 1H), 8.09–8.00 (m, 3H), 7.96 (d, J = 8.4 Hz,
2H), 7.87 (d, J = 8.4 Hz, 1H), 7.81 (d, J = 8.4 Hz, 1H), 7.78–7.73 (m, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.4, 143.5, 136.1, 135.4, 133.6, 132.4, 130.3, 130.1, 129.9, 129.6,
128.3, 127.8, 127.7, 127.5, 126.5, 123.5, 116.0, 112.5 ppm.
IR (CH2Cl2): ν = 3126, 3058, 3047, 2984, 2936, 2234, 1857, 1739, 1559, 1458, 1350, 1189, 1156,
1139, 752, 721, 697 cm–1.
HRMS (ESI): calculated for C18H12NaN2O2S = [M+Na]+: m/z = 343.2654, found: m/z = 343.2659.
2-Naphthalene-[N-(4-hydroxybenzylidene)]sulfonamide (Imine–3l)
Prepared from 4-hydroxy benzaldehyde (2.33 g, 19.0 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.77 g, 18.2 mmol, 1.00 equiv), and Si(OEt)4 (3.96 g, 19.0 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3l was recrystallized from EtOAc (10 mL).
Colorless solid (mp 171–175 °C).
Yield: 5.16 g (90%).
1H NMR (CDCl3, 500 MHz): δ = 9.10 (s, 1H), 8.47 (s, 1H), 7.96 (d, J = 8.4 Hz, 1H), 7.91 (d, J = 8.4
Hz, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.76 (d, J = 7.8 Hz, 1H), 7.74–7.72 (m, 1H), 7.70–7.68 (m, 1H),
7.51–7.49 (m, 2H), 7.13–7.12 (m, 2H), 6.91 (br s, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.3, 157.8, 135.4, 133.6, 132.8, 132.4, 128.7, 128.4 (2C), 128.2,
127.7, 127.5 (2C), 126.7, 126.5, 123.5, 115.0 ppm.
IR (CH2Cl2): ν = 3123, 3055, 3039, 2987, 2980, 2678, 1874, 1785, 1543, 1497, 1374, 1349, 1251,
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1190, 1147, 1133, 755, 734, 692 cm–1.
HRMS (ESI): calculated for C17H13NaNO3S = [M+Na]+: m/z = 357.1568, found: m/z = 357.1570.
2-Naphthalene-[N-(4-fluorobenzylidene)]sulfonamide (Imine–3m)
Prepared from 4-fluoro benzaldehyde (0.24 g, 2.04 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(0.38 g, 1.85 mmol, 1.00 equiv), and Si(OEt)4 (0.43 g, 2.04 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3m was recrystallized from EtOAc (10 mL).
Colorless solid (mp 170–172 °C).
Yield: 0.61 g (97%).
1H NMR (CDCl3, 500 MHz): δ = 9.07 (s, 1H), 8.60 (s, 1H), 8.00–7.94 (m, 3H), 7.91 (d, J = 8.4 Hz,
2H), 7.79 (d, J = 8.4 Hz, 2H), 7.68–7.66 (m, 2H), 7.62–7.61 (m, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.9, 167.8 (d, J = 245.3 Hz), 135.3, 135.0, 133.9 (d, J = 21.0 Hz,
2C), 132.2, 129.7, 129.5, 129.4 (d, J = 3.3 Hz), 129.3, 127.9, 127.6, 126.4, 123.5, 116.5 (d, J = 7.7 Hz,
2C) ppm.
19F NMR (CDCl3, 128 MHz): δ = –115.5 ~ –115.0 (m) ppm.
IR (CH2Cl2): ν = 3121, 3062, 3027, 2980, 2936, 1884, 1740, 1567, 1439, 1358, 1190, 1159, 1137,
1120, 1056, 1034, 752, 727, 694 cm–1.
HRMS (ESI): calculated for C17H12FNaNO2S = [M+Na]+: m/z = 336.2168, found: m/z = 336.2170.
2-Naphthalene-[N-(4-chlorobenzylidene)]sulfonamide (Imine–3n)
Prepared from 4-chloro benzaldehyde (2.32 g, 19.7 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.74 g, 17.9 mmol, 1.00 equiv), and Si(OEt)4 (4.11 g, 19.7 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3n was recrystallized from EtOAc (10 mL).
Colorless solid (mp 177–181 °C).
Yield: 5.55 g (93%).
1H NMR (CDCl3, 500 MHz): δ = 9.07 (s, 1H), 8.61 (s, 1H), 8.01–8.00 (m, 2H), 7.98–7.96 (m, 2H),
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7.90–7.88 (m, 2H), 7.68 (d, J = 8.6 Hz, 2H), 7.48 (d, J = 8.6 Hz, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 167.2, 139.1, 135.7, 135.4, 134.9, 133.7, 132.7, 132.4, 129.5 (2C),
129.3, 128.3, 128.2, 127.7 (2C), 127.4, 123.0 ppm.
IR (CH2Cl2): ν = 3122, 3068, 3035, 2991, 2956, 1884, 1769, 1557, 1467, 1358, 1191, 1155, 1139, 754,
721, 695 cm–1.
HRMS (ESI): calculated for C17H12ClNaNO2S = [M+Na]+: m/z = 352.1396, found: m/z = 352.1399.
2-Naphthalene-[N-(4-bromobenzylidene)]sulfonamide (Imine–3o)
Prepared from 4-bromo benzaldehyde (1.30 g, 6.50 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(1.31 g, 5.90 mmol, 1.00 equiv), and Si(OEt)4 (1.36 g, 6.50 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3o was recrystallized from EtOAc (10 mL).
Colorless solid (mp 187–189 °C).
Yield: 2.12 g (96%).
1H NMR (CDCl3, 500 MHz): δ = 9.10 (s, 1H), 8.58 (s, 1H), 8.05 (d, J = 8.5 Hz, 2H), 7.95 (d, J = 8.5
Hz, 2H), 7.91 (d, J = 7.5 Hz, 1H), 7.78 (d, J = 8.4 Hz, 1H), 7.75 (dd, J = 7.5, 7.8 Hz, 1H), 7.73 (dd, J
= 7.5, 7.8 Hz, 1H), 7.70 (d, J = 7.8 Hz, 1H), 7.58 (d, J = 8.4 Hz, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.1, 141.3, 135.5, 133.6, 132.7, 132.4, 131.9, 129.3, 128.8 (2C),
128.2, 127.7, 127.5 (2C), 126.5, 124.0, 123.4 ppm.
IR (CH2Cl2): ν = 3121, 3063, 3038, 3001, 2961, 1890, 1767, 1569, 1464, 1361, 1199, 1157, 1145, 756,
727, 693 cm–1.
HRMS (ESI): calculated for C17H12BrNaNO2S = [M+Na]+: m/z = 396.0841, found: m/z = 396.0845.
2-Naphthalene-[N-(4-cyanobenzylidene)]sulfonamide (Imine–3p)
Prepared from 4-cyano benzaldehyde (2.16 g, 18.2 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.53 g, 16.5 mmol, 1.00 equiv), and Si(OEt)4 (3.79 g, 18.2 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3p was recrystallized from EtOAc (10 mL).
Colorless solid (mp 171–175 °C).
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Yield: 4.86 g (87%).
1H NMR (CDCl3, 500 MHz): δ = 9.85 (s, 1H), 8.59 (s, 1H), 8.18 (d, J = 8.4 Hz, 2H), 8.10 (d, J = 8.4
Hz, 1H), 8.00 (d, J = 7.4 Hz, 1H), 7.97 (d, J = 8.4 Hz, 1H), 7.81 (d, J = 8.4 Hz, 2H), 7.78 (dd, J = 7.4,
7.9 Hz, 1H), 7.72 (d, J = 7.9 Hz, 1H), 7.55 (dd, J = 7.4, 7.9 Hz, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.2, 142.3, 140.1, 135.4, 133.6, 133.1, 132.7, 132.3, 128.3, 128.1,
127.8 (2C), 127.7, 127.5, 126.5 (2C), 123.5, 118.6 ppm.
IR (CH2Cl2): ν = 3123, 3061, 3049, 2991, 2939, 2240, 1856, 1741, 1567, 1459, 1356, 1162, 1151,
1137, 756, 722, 695 cm–1.
HRMS (ESI): calculated for C18H12NaN2O2S = [M+Na]+: m/z = 343.2654, found: m/z = 343.2658.
2-Naphthalene-[N-(4-methoxycarbonyl)benzylidene)]sulfonamide (Imine–3q)
Prepared from methyl 4-formylbenzoate (1.11 g, 6.80 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(1.36 g, 6.20 mmol, 1.00 equiv), and Si(OEt)4 (1.42 g, 6.80 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 12 h. Imine–3q was recrystallized from EtOAc (10 mL).
Colorless solid (mp 192–195 °C).
Yield: 2.06 g (93%).
1H NMR (CDCl3, 500 MHz): δ = 9.14 (s, 1H), 8.62 (s, 1H), 8.14 (d, J = 8.4 Hz, 2H), 8.03–7.98 (m,
3H), 7.95 (d, J = 8.4 Hz, 2H), 7.69–7.61 (m, 3H), 3.94 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 166.1, 163.0, 143.2, 135.4, 133.6, 132.7, 132.4, 130.7, 128.4, 128.2,
127.8 (2C), 127.7, 127.4, 126.4 (2C), 125.9, 123.5, 52.3 ppm.
IR (CH2Cl2): ν = 3121, 3058, 3046, 2989, 2937, 1878, 1746, 1737, 1562, 1454, 1352, 1280, 1167,
1159, 1138, 751, 728, 693 cm–1.
HRMS (ESI): calculated for C19H15NaNO4S = [M+Na]+: m/z = 376.2745, found: m/z = 376.2749.
2-Naphthalene-[N-(4-trifluoromethylbenzylidene)]sulfonamide (Imine–3r)
Prepared from 4-trifluoromethyl benzaldehyde (0.99 g, 5.70 mmol, 1.00 equiv), 2-naphthalene
sulfonamide (1.14 g, 5.20 mmol, 1.00 equiv), and Si(OEt)4 (1.19 g, 5.70 mmol, 1.10 equiv) according
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to General Procedure B at 160 oC for 12 h. Imine–3r was recrystallized from EtOAc (10 mL).
Colorless solid (mp 198–200 °C).
Yield: 1.74 g (92%).
1H NMR (CDCl3, 500 MHz): δ = 9.19 (s, 1H), 8.69 (s, 1H), 8.05 (d, J = 8.4 Hz, 2H), 8.00 (d, J = 7.5
Hz, 1H), 7.98 (d, J = 8.4 Hz, 1H), 7.96 (d, J = 8.4 Hz, 2H), 7.81 (d, J = 8.4 Hz, 1H), 7.79 (d, J = 7.4
Hz, 1H), 7.76 (dd, J = 7.4, 7.5 Hz, 1H), 7.73–7.72 (m, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.2, 153.2, 144.7, 135.4, 134.6 (q, J = 271.1 Hz), 133.7, 133.5,
132.8, 131.9 (q, J = 1.3 Hz), 130.4, 129.7 (q, J = 3.9 Hz, 2C), 128.4, 127.9, 125.4 (q, J = 17.8 Hz, 2C),
120.6 (q, J = 32.3 Hz), 120.0 ppm.
19F NMR (CDCl3, 128 MHz): δ = –71.9 (s) ppm.
IR (CH2Cl2): ν = 3124, 3062, 3028, 2982, 2943, 1882, 1741, 1570, 1479, 1458, 1365, 1323, 1162,
1153, 1062, 1043, 723, 697 cm–1.
HRMS (ESI): calculated for C18H12F3NaNO2S = [M+Na]+: m/z = 386.2546, found: m/z = 386.2551.
2-Naphthalene-[N-(4-nitrobenzylidene)]sulfonamide (Imine–3s)
Prepared from 4-nitro benzaldehyde (2.76 g, 18.1 mmol, 1.10 equiv), 2-naphthalene sulfonamide (3.47
g, 16.5 mmol, 1.00 equiv), and Si(OEt)4 (3.78 g, 18.1 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3s was recrystallized from EtOAc (10 mL).
Colorless solid (mp 195–198 °C).
Yield: 5.14 g (91%).
1H NMR (CDCl3, 500 MHz): δ = 9.26 (s, 1H), 8.49 (s, 1H), 8.17 (d, J = 8.8 Hz, 2H), 8.09–8.07 (m,
1H), 8.01 (d, J = 7.5 Hz, 1H), 8.00 (d, J = 7.4 Hz, 1H), 7.97 (d, J = 8.8 Hz, 2H), 7.81–7.79 (m, 1H),
7.79 (dd, J = 7.4, 7.5 Hz, 1H), 7.76–7.74 (m, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 163.8, 148.0, 135.8, 133.6, 132.7, 132.4, 130.6, 129.1, 128.5, 128.2,
127.7, 127.5 (2C), 125.9 (2C), 124.0, 123.5 ppm.
IR (CH2Cl2): ν = 3122, 3057, 3030, 2984, 2938, 1878, 1739, 1559, 1548, 1471, 1459, 1365, 1354,
1331, 1160, 1157, 1062, 1046, 728, 692 cm–1.
HRMS (ESI): calculated for C17H12NaN2O4S = [M+Na]+: m/z = 363.1568, found: m/z = 363.1572.
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2-Naphthalene-[N-(2-furanylmethylene)]sulfonamide (Imine–3t)
Prepared from 2-furaldehyde (2.10 g, 20.8 mmol, 1.10 equiv), 2-naphthalene sulfonamide (3.92 g,
18.9 mmol, 1.00 equiv), and Si(OEt)4 (4.34 g, 20.8 mmol, 1.10 equiv) according to General Procedure
B at 160 oC for 10 h. Imine–3t was recrystallized from EtOAc (10 mL).
Grey solid (mp 168–170 °C).
Yield: 5.10 g (95%).
1H NMR (CDCl3, 500 MHz): δ = 9.24 (s, 1H), 8.63 (s, 1H), 8.21 (d, J = 1.8 Hz, 1H), 7.96–7.94 (m,
1H), 7.91 (d, J = 8.6 Hz, 1H), 7.89 (d, J = 8.6 Hz, 1H), 7.85–7.83 (m, 1H), 7.78–7.76 (m, 1H), 7.72–
7.70 (m, 1H), 7.65 (d, J = 3.5 Hz, 1H), 6.62 (dd, J = 1.8, 3.5 Hz, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.5, 150.6, 146.6, 143.3, 135.4, 133.6, 132.3, 128.3, 128.1, 127.7,
127.3, 126.5, 123.5, 112.4, 109.5 ppm.
IR (CH2Cl2): ν = 3120, 3057, 2981, 2954, 1876, 1742, 1545, 1478, 1462, 1369, 1358, 1340, 1158,
1069, 1048, 735, 691 cm–1.
HRMS (ESI): calculated for C15H11NaNO3S = [M+Na]+: m/z = 308.2514, found: m/z = 308.2519.
2-Naphthalene-[N-(2-thienylmethylene)]sulfonamide (Imine–3u)
Prepared from 2-thienyl aldehyde (2.32 g, 20.7 mmol, 1.10 equiv), 2-naphthalene sulfonamide (3.88 g,
18.8 mmol, 1.00 equiv), and Si(OEt)4 (4.34 g, 20.7 mmol, 1.10 equiv) according to General Procedure
B at 160 oC for 10 h. Imine–3u was recrystallized from EtOAc (10 mL).
Grey solid (mp 174–178 °C).
Yield: 5.06 g (90%).
1H NMR (CDCl3, 500 MHz): δ = 9.20 (s, 1H), 8.60 (s, 1H), 8.01–7.99 (m, 2H), 7.95–7.92 (m, 2H),
7.80 (d, J = 7.9 Hz, 1H), 7.78 (d, J = 7.3 Hz, 1H), 7.68–7.61 (m, 2H), 7.22 (dd, J = 7.3, 7.9 Hz, 1H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 163.2, 146.6, 143.7, 135.5, 133.6, 132.4, 131.9, 130.2, 128.5, 128.2,
127.8, 127.6, 127.5, 126.5, 123.5 ppm.
IR (CH2Cl2): ν = 3123, 3003, 2943, 1879, 1740, 1564, 1440, 1375, 1156, 1142, 748, 724, 694 cm–1.
217
HRMS (ESI): calculated for C15H11NaNO2S2 = [M+Na]+: m/z = 324.2256, found: m/z = 324.2260.
2-Naphthalene-[N-(1H-pyrrol-2-ylmethylene)]sulfonamide (Imine–3v)
Prepared from 2-pyrrolyl aldehyde (2.12 g, 22.1 mmol, 1.10 equiv), 2-naphthalene sulfonamide (4.26
g, 20.1 mmol, 1.00 equiv), and Si(OEt)4 (4.63 g, 22.1 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3v was recrystallized from EtOAc (10 mL).
Grey solid (mp 167–169 °C).
Yield: 4.86 g (85%).
1H NMR (CDCl3, 500 MHz): δ = 9.22 (s, 1H), 8.65 (s, 1H), 8.01 (d, J = 2.1 Hz, 1H), 7.95–7.94 (m,
1H), 7.91 (d, J = 8.6 Hz, 1H), 7.88 (d, J = 8.6 Hz, 1H), 7.83 (d, J = 7.9 Hz, 1H), 7.77 (d, J = 7.3 Hz,
1H), 7.48 (d, J = 3.5 Hz, 1H), 7.73 (dd, J = 7.3, 7.9 Hz, 1H), 6.36 (dd, J = 2.1, 3.5 Hz, 1H), 6.21 (br s,
1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 162.3, 146.7, 137.5, 135.4, 133.6, 132.4, 128.4, 128.2, 127.8, 127.5,
126.8, 123.5, 123.4, 111.9, 110.3 ppm.
IR (CH2Cl2): ν = 3121, 3012, 2954, 1883, 1754, 1569, 1441, 1379, 1161, 1148, 754, 721, 696 cm–1.
HRMS (ESI): calculated for C15H12NaN2O2S = [M+Na]+: m/z = 307.2696, found: m/z = 306.2694.
2-Naphthalene-[N-(2-pyridinylmethylene)]sulfonamide (Imine–3w)
Prepared from 2-pyridinecarbaldehyde (2.26 g, 21.1 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.91 g, 19.2 mmol, 1.00 equiv), and Si(OEt)4 (4.42 g, 21.1 mmol, 1.10 equiv) according to General
Procedure B at 180 oC for 12 h. Imine–3w was recrystallized from EtOAc (10 mL).
Yellow solid (mp 174–179 °C).
Yield: 4.31 g (77%).
1H NMR (CDCl3, 500 MHz): δ = 9.20 (s, 1H), 8.85 (d, J = 8.1 Hz, 1H), 8.68 (s, 1H), 8.28 (d, J = 8.2
Hz, 1H), 8.04 (dd, J = 8.1, 8.2 Hz, 1H), 8.02 (d, J = 7.5 Hz, 1H), 8.00 (d, J = 7.9 Hz, 1H), 7.97 (d, J =
8.4 Hz, 1H), 7.85–7.84 (m, 1H), 7.81 (d, J = 8.4 Hz, 1H), 7.79 (dd, J = 7.5, 7.9 Hz, 1H), 7.76–7.74 (m,
1H) ppm.
218
13C NMR (CDCl3, 125 MHz): δ = 164.5, 162.1, 152.8, 149.7, 146.7, 137.3, 135.4, 133.6, 132.4, 128.3,
127.7, 127.5, 126.6, 126.3, 123.5, 123.3 ppm.
IR (CH2Cl2): ν = 3124, 3054, 2982, 2924, 1886, 1756, 1738, 1571, 1437, 1376, 1354, 1189, 1152,
1136, 751, 729, 698 cm–1.
HRMS (ESI): calculated for C16H12NaN2O2S = [M+Na]+: m/z = 319.2712, found: m/z = 319.2716.
2-Naphthalene-[N-(3-pyridinylmethylene)]sulfonamide (Imine–3x)
Prepared from 3-pyridinecarbaldehyde (2.26 g, 21.1 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.91 g, 19.2 mmol, 1.00 equiv), and Si(OEt)4 (4.42 g, 21.1 mmol, 1.10 equiv) according to General
Procedure B at 180 oC for 12 h. Imine–3x was recrystallized from EtOAc (10 mL).
Light yellow solid (mp 173–176 °C).
Yield: 4.74 g (82%).
1H NMR (CDCl3, 500 MHz): δ = 9.17 (s, 1H), 9.07 (s, 1H), 8.82–8.81 (m, 1H), 8.62 (s, 1H), 8.28–
8.26 (m, 1H), 8.01 (d, J = 8.4 Hz, 1H), 7.97–7.93 (m, 3H), 7.70–7.66 (m, 2H), 7.45–7.43 (m, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.2, 164.1, 149.8, 145.3, 135.4, 133.6, 133.1, 132.4, 129.1, 128.4,
128.2, 127.7, 127.5, 126.5, 123.5, 123.3 ppm.
IR (CH2Cl2): ν = 3123, 3051, 2985, 2931, 1890, 1758, 1735, 1572, 1436, 1378, 1359, 1181, 1150,
1142, 752, 730, 694 cm–1.
HRMS (ESI): calculated for C16H12NaN2O2S = [M+Na]+: m/z = 319.2712, found: m/z = 319.2714.
2-Naphthalene-[N-(4-pyridinylmethylene)]sulfonamide (Imine–3y)
Prepared from 4-pyridinecarbaldehyde (2.26 g, 21.1 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.91 g, 19.2 mmol, 1.00 equiv), and Si(OEt)4 (4.42 g, 21.1 mmol, 1.10 equiv) according to General
Procedure B at 180 oC for 12 h. Imine–3y was recrystallized from EtOAc (10 mL).
Light yellow solid (mp 174–178 °C).
Yield: 4.45 g (78%).
1H NMR (CDCl3, 500 MHz): δ = 9.10 (s, 1H), 8.80–8.78 (m, 2H), 8.62 (s, 1H), 8.02 (d, J = 7.5 Hz,
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1H), 7.96–7.89 (m, 3H), 7.75–7.72 (m, 2H), 7.66–7.62 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 168.9, 163.9, 150.4, 145.6, 135.4, 134.1, 133.6, 132.4, 130.5, 128.4,
128.2, 127.7, 127.5, 126.4, 123.5, 121.4 ppm.
IR (CH2Cl2): ν = 3124, 3050, 2987, 2930, 1893, 1757, 1736, 1578, 1431, 1379, 1364, 1183, 1156,
1136, 756, 732, 691 cm–1.
HRMS (ESI): calculated for C16H12NaN2O2S = [M+Na]+: m/z = 319.2712, found: m/z = 319.2715.
2-Naphthalene-[N-(3-phenylpropylidene)]sulfonamide (Imine–3z)
Prepared from 3-phenylpropionaldehyde (2.56 g, 19.1 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.64 g, 17.4 mmol, 1.00 equiv), and Si(OEt)4 (3.98 g, 19.1 mmol, 1.10 equiv) according to General
Procedure B at 170 oC for 12 h. Imine–3z was recrystallized from EtOAc (10 mL).
Light yellow solid (mp 184–188 °C).
Yield: 5.02 g (90%).
1H NMR (CDCl3, 500 MHz): δ = 9.13 (s, 1H), 8.61 (s, 1H), 8.11 (d, J = 7.5 Hz, 1H), 8.02 (d, J = 7.9
Hz, 1H), 7.98 (d, J = 8.2 Hz, 1H), 7.83 (d, J = 8.2 Hz, 1H), 7.81 (dd, J = 7.5, 7.9 Hz, 1H), 7.79–7.77
(m, 1H), 7.31 (d, J = 7.8 Hz, 2H), 7.27–7.25 (m, 1H), 7.19 (d, J = 7.8 Hz, 2H), 4.85 (t, J = 7.2 Hz, 2H),
2.81–2.79 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 165.4, 145.6, 139.2, 135.4, 133.6, 132.4, 128.9, 128.7 (2C), 128.5,
128.3, 128.0, 127.7, 127.5 (2C), 124.6, 123.5, 30.0, 29.1 ppm.
IR (CH2Cl2): ν = 3122, 3063, 3031, 2984, 2931, 2865, 1892, 1740. 1572, 1362, 1327, 1186, 1163,
1167, 1112, 767, 745, 723, 694, 683, 652 cm–1.
HRMS (ESI+): calculated for C19H17NaNO2S = [M+Na]+: m/z = 346.5436, found: m/z = 346.5440.
2-Naphthalene-[N-(cyclohexylmethylene)]sulfonamide (Imine–3a’)
Prepared from cyclohexanecarbaldehyde (2.32 g, 20.7 mmol, 1.10 equiv), 2-naphthalene sulfonamide
(3.93 g, 18.9 mmol, 1.00 equiv), and Si(OEt)4 (4.31 g, 20.7 mmol, 1.10 equiv) according to General
Procedure B at 160 oC for 8 h. Imine–3a’ was recrystallized from EtOAc (10 mL).
Colorless solid (mp 151–155 °C).
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Yield: 4.52 g (79%).
1H NMR (CDCl3, 500 MHz): δ = 9.19 (s, 1H), 8.64 (s, 1H), 8.05 (d, J = 7.4 Hz, 1H), 8.03 (d, J = 7.9
Hz, 1H), 7.98 (d, J = 8.2 Hz, 1H), 7.83 (d, J = 8.2 Hz, 1H), 7.82 (dd, J = 7.4, 7.9 Hz, 1H), 7.79–7.77
(m, 1H), 2.88–2.87 (m, 1H), 1.84–1.79 (m, 4H), 1.55–1.43 (m, 4H), 1.34–1.31 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 162.3, 146.7, 135.4, 133.6, 132.4, 128.3, 128.0, 127.7, 127.5, 127.0,
123.5, 36.2, 29.9 (2C), 26.3 (2C), 25.6 ppm.
IR (CH2Cl2): ν = 3120, 3034, 2926, 1880, 1736. 1561, 1355, 1188, 1154, 1136, 769, 756, 747, 695,
680, 645, 581, 516 cm–1.
HRMS (ESI): calculated for C17H19NaNO2S = [M+Na]+: m/z = 324.3156, found: m/z = 324.3159.
2-Naphthalene-[N-(cyclohexylmethylene)]sulfonamide (Imine–3b’)
Prepared from pivaldehyde (1.97 g, 22.9 mmol, 1.10 equiv), 2-naphthalene sulfonamide (4.36 g, 20.9
mmol, 1.00 equiv), and Si(OEt)4 (4.77 g, 22.9 mmol, 1.10 equiv) according to General Procedure B at
160 oC for 8 h. Imine–3b’ was recrystallized from EtOAc (10 mL).
Colorless solid (mp 138–141 °C).
Yield: 4.65 g (80%).
1H NMR (CDCl3, 500 MHz): δ = 9.17 (s, 1H), 8.65 (s, 1H), 8.05 (d, J = 7.4 Hz, 1H), 8.02 (d, J = 7.9
Hz, 1H), 7.98 (d, J = 8.2 Hz, 1H), 7.83 (d, J = 8.2 Hz, 1H), 7.81 (dd, J = 7.4, 7.9 Hz, 1H), 7.78–7.76
(m, 1H), 1.31 (s, 9H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 164.2, 147.6, 135.4, 133.6, 132.4, 128.4, 128.2, 127.8, 127.5, 124.6,
123.5, 36.2, 27.0 (3H) ppm.
IR (CH2Cl2): ν = 3121, 3052, 2954, 1882, 1738. 1567, 1351, 1164, 1158, 1139, 766, 745, 682, 645,
582 cm–1.
HRMS (ESI): calculated for C15H17NaNO2S = [M+Na]+: m/z = 298.3219, found: m/z = 298.3224.
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5.3.3 BAC-catalysed asymmetric aza-MBH Reactions
General Procedure I
To an oven-dried 2 mL-test tube with a magnetic stirring bar in a nitrogen glove box were added pre-
BAC*–8 (3.20 mg, 10.0 µmol, 5.00 mol% ), the corresponding N-nasyl imine (0.22 mmol, 1.10 equiv),
cyclopentenone (in molecular sieves, 16.4 mg, 0.20 mmol, 1.00 equiv), THF (2.00 mL, 0.1 M), and
Cs2CO3 (3.60 mg, 11.0 µmol, 5.50 mol%). The reaction mixture was stirred at 35 oC for 24 h, at which
point TLC or 1H NMR analysis indicated complete consumption of cyclopentenone. The solvent was
removed in vacuo and the residue was purified by flash column chromatography or PTLC on silica gel
(EtOAc/PE = 1:1, or DCM/acetone = 100:1) to give the desired product.
General Procedure J
To an oven-dried 2 mL-test tube with a magnetic stirring bar in a nitrogen glove box were added pre-
BAC*–11 (3.30 mg, 10.0 µmol, 5.00 mol%), Cs2CO3 (3.60 mg, 11.0 µmol, 5.50 mol%) and THF (100
µL). The pre-catalyst mixture was pre-stirred at 35 oC for 20 h before cooling to –20 oC, at which
stage a stock solution of the corresponding N-nasyl imine (0.22 mmol, 1.10 equiv) and cyclopentenone
(16.4 mg, 0.20 mmol, 1.00 equiv) in THF (1.90 mL) was added to the pre-catalyst mixture. The
reaction mixture was stirred at –20 oC for 72 h, at which point TLC or 1H NMR analysis indicated
complete consumption of cyclopentenone. The solvent was removed in vacuo and the residue was
purified by flash column chromatography or PTLC on silica gel (EtOAc/PE = 1:1, or DCM/acetone =
100:1) to give the desired product.
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(phenyl)methyl]sulfonamide (2–4)
Prepared from Imine–3a (65.6 mg, 0.22 mmol, 1.10 equiv) and cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–4 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice). The obtained analytical data fit accurately with the reported data.[54]
Colorless solid (mp 186–188 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 64.9 mg (86%), 89% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 72.4 mg (96%), 93% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.27 (s, 1H), 7.89-7.84 (m, 3H), 7.72–7.70 (m, 1H), 7.64–7.57 (m,
2H), 7.25 (t, J = 5.2 Hz, 1H), 7.18–7.11 (m, 4H), 7.08–7.07 (m, 1H), 6.27 (d, J = 8.9 Hz, 1H), 5.36 (d,
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J = 8.9 Hz, 1H), 2.28–1.90 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.4, 160.6, 143.0, 138.4, 137.1, 134.6, 131.9, 129.1, 129.0, 128.9,
128.7, 128.6 (2C), 127.8, 127.7, 127.6, 126.7 (2C), 122.6, 55.5, 34.8, 26.6 ppm.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 11.8 min, tr (R)
= 14.9 min.
[α]D25 = +31.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-toyl)methyl]sulfonamide (2–7)
Prepared from Imine–3b (68.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–7 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 192–196 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 71.9 mg (92%), 76% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 71.2 mg (91%), 90% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.27 (s, 1H), 7.90–7.86 (m, 3H), 7.71–7.69 (m, 1H), 7.63–7.56 (m,
2H), 7.26 (t, J = 5.3 Hz, 1H), 7.10 (d, J = 7.8 Hz, 1H), 7.00 (d, J = 7.8 Hz, 1H), 6.95–6.92 (m, 2H),
6.14 (d, J = 8.1 Hz, 1H), 5.60 (d, J = 8.1 Hz, 1H), 2.33 (s, 3H), 2.25–1.91 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 160.3, 143.4, 136.9, 136.6, 135.7, 134.6, 131.9, 130.7, 129.1,
129.0, 128.9, 128.8, 127.9, 127.7, 127.4, 126.8, 126.2, 122.6, 51.8, 34.8, 26.5, 19.4 ppm.
IR (CH2Cl2): ν = 3269, 3054, 2918, 2869, 2254, 1693, 1436, 1327, 1159, 906, 745, 665 cm–1.
HRMS (ESI): calculated for C23H21NaNO3S = [M+Na]+: m/z = 414.1134, found: m/z = 414.1137.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.7 mL/min; 220 nm, 25 oC): tr (S) = 12.1 min, tr (R)
= 14.8 min.
[α]D25 = +42.0 ° (c = 1.0, CHCl3).
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(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(3-toyl)methyl]sulfonamide (2–6)
Prepared from Imine–3c (68.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–6 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 194–197 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 71.9 mg (92%), 74% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 69.6 mg (89%), 89% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.20 (s, 1H), 7.82-7.79 (m, 3H), 7.78 (dd, J = 7.4, 7.5 Hz, 1H), 7.58
(d, J = 7.8 Hz, 1H), 7.54 (d, J = 7.5 Hz, 1H), 7.22 (t, J = 5.2 Hz, 1H), 7.02 (d, J = 7.4 Hz, 1H), 6.97–
6.95 (m, 2H), 6.91–6.89 (m, 1H), 6.08 (d, J = 8.1 Hz, 1H), 5.53 (d, J = 8.1 Hz, 1H), 2.25 (s, 3H),
2.23–1.90 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.8, 162.3, 143.4, 139.5, 135.4, 134.9, 133.7, 132.4, 130.6, 129.2,
128.4, 128.2, 127.7, 127.6, 127.5, 127.0, 126.6, 126.5, 123.5, 58.1, 32.5, 26.2, 20.9 ppm.
IR (CH2Cl2): ν = 3163, 2918, 2848, 2252, 1735, 1701, 1438, 1375, 1163, 1039, 916, 732, 661 cm–1.
HRMS (ESI): calculated for C23H21NaNO3S = [M+Na]+: m/z = 414.1134, found: m/z = 414.1150.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.7 mL/min; 220 nm, 25 oC): tr (S) = 11.6 min, tr (R)
= 14.9 min.
[α]D25 = +41.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-toyl)methyl]sulfonamide (2–13)
Prepared from Imine–3d (68.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–13 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 193–197 °C).
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1st generation pre-BAC*–8: +35 oC, 48 h; yield: 68.8 mg (88%), 59% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 64.1 mg (82%), 79% ee.
1H NMR (CDCl3, 600 MHz): δ = 8.25 (s, 1H), 7.89–7.85 (m, 3H), 7.77–7.72 (m, 3H), 7.27 (t, J = 5.6
Hz, 1H), 7.06 (d, J = 8.0 Hz, 2H), 6.95 (d, J = 8.0 Hz, 2H), 6.24 (d, J = 8.4 Hz, 1H), 5.33 (d, J = 8.4
Hz, 1H), 2.34–1.95 (m, 4H), 2.19 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.5, 160.5, 143.3, 137.7, 137.2, 135.4, 132.4, 130.7, 129.6, 129.2
(2C), 128.3, 128.1, 127.9, 127.8, 127.5, 126.7 (2C), 123.5, 55.4, 34.9, 26.6, 20.9 ppm.
IR (CH2Cl2): ν = 3271, 2918, 2848, 2554, 1695, 1327, 1159, 904, 742, 663, 648 cm–1.
HRMS (ESI): calculated for C23H21NaNO3S = [M+Na]+: m/z = 414.1134, found: m/z = 414.1153.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 11.9 min, tr (R)
= 14.8 min.
[α]D25 = +47.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(naphthalen-1-yl)methyl]sulfonamide (2–5)
Prepared from Imine–3e (51.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–5 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Light yellow solid (mp 208–211 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 76.0 mg (89%), 84% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 78.6 mg (92%), 93% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.22 (s, 1H), 8.09 (d, J = 8.4 Hz, 1H), 7.96 (d, J = 7.4 Hz, 1H), 7.92
(d, J = 7.8 Hz, 1H), 7.91 (d, J = 7.8 Hz, 1H), 7.90 (d, J = 7.4 Hz, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.77
(dd, J = 7.4, 7.8 Hz, 1H), 7.75 (dd, J = 7.4, 7.8 Hz, 1H), 7.72 (d, J = 6.9 Hz, 1H), 7.58 (dd, J = 6.9, 8.4
Hz, 1H), 7.53 (d, J = 8.4 Hz, 1H), 7.50–7.49 (m, 1H), 7.27 (t, J = 5.3 Hz, 1H), 7.19–7.18 (m, 1H), 6.30
(d, J = 8.8 Hz, 1H), 6.17 (d, J = 8.8 Hz, 1H), 2.19–1.92 (m, 4H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.4, 161.3, 143.2, 136.8, 133.6, 132.8, 132.4, 130.8, 130.7, 130.6,
129.3, 129.2, 128.9, 128.8, 128.1, 127.7, 127.5, 126.7, 126.6, 124.5, 124.4, 123.5, 122.9, 58.1, 32.5,
26.3 ppm.
IR (CH2Cl2): ν = 3271, 2918, 2848, 2554, 1695, 1327, 1159, 904, 742, 663, 648 cm–1.
HRMS (ESI): calculated for C23H21NaNO3S = [M+Na]+: m/z = 414.1134, found: m/z = 414.1153.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
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column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 12.8 min, tr (R)
= 15.9 min.
[α]D25 = +75.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-naphthalenyl)methyl]sulfonamide (2–40)
Prepared from Imine–3f (51.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–40 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Light yellow solid (mp 209–211 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 78.6 mg (92%), 80% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 75.2 mg (88%), 85% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.26 (s, 1H), 8.12 (d, J = 7.4 Hz, 1H), 7.96 (d, J = 8.4 Hz, 1H), 7.92
(d, J = 7.8 Hz, 1H), 7.90 (d, J = 8.4 Hz, 1H), 7.87 (d, J = 7.8 Hz, 1H), 7.80 (d, J = 7.4 Hz, 1H), 7.79
(dd, J = 7.4, 7.8 Hz, 1H), 7.72 (dd, J = 7.4, 7.8 Hz, 1H), 7.64 –7.62 (m, 1H), 7.55–7.54 (m, 1H), 7.45
(d, J = 8.1 Hz, 1H), 7.35 (d, J = 8.1 Hz, 1H), 7.31 (t, J = 5.3 Hz, 1H), 7.23–7.20 (m, 1H), 6.33 (d, J =
8.6 Hz, 1H), 5.56 (d, J = 8.6 Hz, 1H), 2.19–1.93 (m, 4H) ppm.
13C NMR (CDCl3, 150 MHz): δ = 208.4, 163.4, 143.8, 139.5, 135.4, 133.7, 133.6, 133.0, 132.4, 132.1,
131.6, 131.0, 130.8, 129.2, 128.6, 128.3, 128.1, 127.5, 125.5, 126.9, 126.6, 125.5, 123.5, 58.1, 32.5,
26.2 ppm.
IR (CH2Cl2): ν = 3265, 2941, 2876, 2254, 1694, 1436, 1375, 1028, 912, 729, 664, 648 cm–1.
HRMS (ESI): calculated for C26H21NaNO3S = [M+Na]+: m/z = 450.1134, found: m/z = 450.1129.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 12.3 min, tr (R)
= 15.9 min.
[α]D25 = +74.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-methoxylphenyl)methyl]sulfonamide (2–8)
Prepared from Imine–3g (71.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
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1.00 equiv) according to General Procedure I or J. 2–8 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 196–200 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 70.8 mg (87%), 67% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 72.5 mg (89%), 83% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.28 (s, 1H), 7.90–7.84 (m, 2H), 7.78–7.77 (m, 1H), 7.69–7.68 (m,
1H), 7.65–7.61 (m, 2H), 7.39–7.38 (m, 1H), 7.18 (t, J = 5.3 Hz, 1H), 6.70 (d, J = 7.6 Hz, 1H), 6.62 (dd,
J = 7.6, 8.3 Hz, 1H), 6.60 (d, J = 8.3 Hz, 1H), 6.38 (d, J = 7.6 Hz, 1H), 5.60 (d, J = 7.6 Hz, 1H), 3.66
(s, 3H), 2.29–2.12 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.0, 159.5, 155.8, 143.3, 137.2, 131.9, 130.7, 129.2, 128.9, 128.8,
128.6, 128.2, 128.0, 127.7, 127.3, 123.5, 122.6, 120.7, 110.5, 55.2, 51.1, 34.8, 26.4 ppm.
IR (CH2Cl2): ν = 3269, 2918, 1689, 1436, 1325, 1157, 1091, 906, 745, 663 cm–1.
HRMS (ESI): calculated for C23H21NaNO4S = [M+Na]+: m/z = 430.1084, found: m/z = 430.1119.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 12.1 min, tr (R)
= 14.5 min.
[α]D25 = +26.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-hydroxyphenyl)methyl]sulfonamide (2–9)
Prepared from Imine–3h (35.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–9 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 185–187 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 66.8 mg (85%), 93% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 69.2 mg (88%), 97% ee.
1H NMR (CDCl3, 500 MHz): δ = 10.5 (br s, 1H), 8.30 (d, J = 8.3 Hz, 1H), 7.72–7.70 (m, 2H), 7.64–
7.63 (m, 2H), 7.41–7.39 (m, 1H), 7.38–7.35 (m, 1H), 7.26 (t, J = 5.3 Hz, 1H), 7.23–7.21 (m, 2H),
6.72–6.70 (m, 2H), 6.23 (d, J = 8.4 Hz, 1H), 5.47 (d, J = 8.4 Hz, 1H), 2.03–1.68 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 167.8, 148.2, 135.4, 133.6, 132.4, 131.9, 130.7, 129.2, 128.4,
128.2, 128.0, 127.7, 127.6, 127.3, 126.5, 126.0, 123.5, 107.2, 58.1, 32.6, 27.9 ppm.
IR (CH2Cl2): ν = 3248, 2941, 2252, 1701, 1375, 1256, 1163, 912, 729, 669, 648 cm–1.
HRMS (ESI): calculated for C22H19NaNO4S = [M+Na]+: m/z = 416.0927, found: m/z = 416.0938.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
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column (eluent: hexane/iPrOH = 70:30; flow rate: 0.5 mL/min; 220 nm, 25 oC): tr (S) = 12.3 min, tr (R)
= 15.2 min.
[α]D25 = +64.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-fluorophenyl)methyl]sulfonamide (2–10)
Prepared from Imine–3i (69.0 mg, 0.22 mmol, 1.10 equiv) and cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–10 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 196–198 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 75.1 mg (95%), 84% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 76.6 mg (97%), 87% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.28 (s, 1H), 7.82–7.80 (m, 1H), 7.80–7.76 (m, 2H), 7.71–7.70 (m,
1H), 7.60–7.55 (m, 2H), 7.36 (d, J = 8.0 Hz, 1H), 7.29 (d, J = 8.0 Hz, 1H), 7.03–7.01 (m, 1H), 6.88 (d,
J = 8.4 Hz, 1H), 6.79 (t, J = 5.3 Hz, 1H), 6.46 (d, J = 8.4 Hz, 1H), 5.64 (d, J = 8.4 Hz, 1H), 2.29–2.01
(m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 160.5, 160.3 (d, J = 237.5 Hz), 142.3, 136.9, 134.6, 131.9,
130.2, 129.5 (d, J = 6.4 Hz), 129.1, 128.8 (d, J = 3.2 Hz), 128.6, 127.7, 127.5 (d, J = 36.5 Hz), 124.2,
122.5, 121.4, 115.4 (d, J = 14.7 Hz), 115.2 (d, J = 17.0 Hz), 49.8, 34.8, 26.6 ppm.
19F NMR (CDCl3, 128 MHz): δ = –111.4 ~ –110.9 (m) ppm.
IR (CH2Cl2): ν = 3325, 2916, 2848, 2291, 2252, 1735, 1707, 1452, 1438, 1373, 1163, 1029, 916, 732,
700 cm–1.
HRMS (ESI): calculated for C22H18FNaNO3S = [M+Na]+: m/z = 418.0636, found: m/z = 418.0638.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 11.3 min, tr (R)
= 14.2 min.
[α]D25 = +96.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-chlorophenyl)methyl]sulfonamide (2–11)
228
Prepared from Imine–3j (69.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–11 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 200–202 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 80.6 mg (98%), 85% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 78.9 mg (96%), 92% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.26 (s, 1H), 7.86–7.84 (m, 1H), 7.80–7.79 (m, 2H), 7.74–7.72 (m,
1H), 7.62–7.58 (m, 2H), 7.42–7.37 (m, 2H), 7.12 (t, J = 5.3 Hz, 1H), 6.97–6.94 (m, 2H), 6.58 (d, J =
8.0 Hz, 1H), 5.81 (d, J = 8.0 Hz, 1H), 2.37–2.04 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.7, 161.3, 141.6, 136.8, 136.2, 135.9, 133.0, 132.4, 129.4, 129.1,
129.0, 128.8, 128.7, 128.4, 127.9, 127.7, 127.5, 127.4, 122.5, 52.5, 34.8, 26.6 ppm.
IR (CH2Cl2): ν = 3234, 2925, 1814, 1754, 1636, 1455, 1258, 1115, 917, 736, 689, 645 cm–1.
HRMS (ESI): calculated for C22H18ClNaNO3S = [M+Na]+: m/z = 434.5745, found: m/z = 434.5752.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 70:30; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 11.6 min, tr (R)
= 14.1 min.
[α]D25 = +87.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-cyanophenyl)methyl]sulfonamide (2–12)
Prepared from Imine–3k (70.4 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–12 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 192–194 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 59.5 mg (74%), 89% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 66.7 mg (83%), 94% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.61 (s, 1H), 8.01–7.99 (m, 2H), 7.98–7.96 (m, 2H), 7.92–7.91 (m,
1H), 7.67–7.66 (m, 1H), 7.64 (d, J = 8.0 Hz, 1H), 7.31–7.27 (m, 3H), 7.19 (t, J = 5.2 Hz, 1H), 6.22 (d,
J = 8.4 Hz, 1H), 5.68 (d, J = 8.4 Hz, 1H), 2.15–1.87 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.8, 165.2, 143.6, 133.2, 133.1, 132.4, 130.8, 130.7, 129.9, 129.3,
128.3, 128.1, 127.7, 127.5, 126.5, 126.1, 123.4, 122.9, 116.0, 112.6, 58.2, 32.5, 26.1 ppm.
IR (CH2Cl2): ν = 3269, 2967, 2252, 1954, 1878, 1753, 1686, 1498, 1237, 1059, 931, 722, 639 cm–1.
HRMS (ESI): calculated for C23H18NaN2O3S = [M+Na]+: m/z = 425.4587, found: m/z = 425.4596.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
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column (eluent: hexane/iPrOH = 80:40; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 11.1 min, tr (R)
= 14.5 min.
[α]D25 = +69.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-hydroxyphenyl)methyl]sulfonamide (2–14)
Prepared from Imine–3l (71.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol, 1.00
equiv) according to General Procedure I or J. 2–14 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 184–187 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 58.2 mg (74%), 81% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 66.8 mg (85%), 91% ee.
1H NMR (CDCl3, 500 MHz): δ = 9.10 (br s, 1H), 8.63 (s, 1H), 8.03–7.95 (m, 4H), 7.94 (d, J = 8.4 Hz,
2H), 7.67–7.65 (m, 1H), 7.30–7.28 (m, 1H), 7.18 (d, J = 8.4 Hz, 2H), 7.09 (t, J = 5.3 Hz, 1H), 6.07 (d,
J = 8.8 Hz, 1H), 5.49 (d, J = 8.8 Hz, 1H), 2.22–1.94 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 157.6, 139.5, 135.4, 133.6, 132.4, 130.7, 129.2, 128.4, 128.3,
127.7, 127.5, 126.8, 126.4 (2C), 125.0 (2C), 123.5, 115.0, 58.2, 32.6, 26.4 ppm.
IR (CH2Cl2): ν = 3232, 2915, 2345, 1796, 1345, 1265, 1204, 915, 730, 664, 652 cm–1.
HRMS (ESI): calculated for C22H19NaNO4S = [M+Na]+: m/z = 416.0927, found: m/z = 416.0935.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 70:30; flow rate: 0.5 mL/min; 220 nm, 25 oC): tr (S) = 12.1 min, tr (R)
= 15.0 min.
[α]D25 = +56.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-fluorophenyl)methyl]sulfonamide (2–15)
Prepared from Imine–3m (69.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–15 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
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Colorless solid (mp 197–200 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 76.6 mg (97%), 75% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 75.1 mg (95%), 86% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.26 (s, 1H), 7.92–7.89 (m, 2H), 7.78–7.74 (m, 2H), 7.67–7.64 (m,
2H), 7.26 (t, J = 5.3 Hz, 1H), 7.19 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.8 Hz, 2H), 6.21 (d, J = 8.8 Hz,
1H), 5.32 (d, J = 8.8 Hz, 1H), 2.36–1.89 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.5, 163.0 (d, J = 245.5 Hz), 160.8, 142.9, 137.0, 133.6, 131.9,
129.2 (d, J = 3.3 Hz), 129.1, 128.7, 128.5 (d, J = 20.5 Hz, 2C), 127.9, 127.8 (d, J = 7.6 Hz, 2C), 127.7,
122.5, 115.5, 115.4, 54.9, 34.9, 26.6 ppm.
19F NMR (CDCl3, 128 MHz): δ = –100.8 ~ –99.9 (m) ppm.
IR (CH2Cl2): ν = 3282, 2924, 2850, 2254, 1747, 1712, 1697, 1402, 1334, 1161, 1036, 904, 741, 650,
619 cm–1.
HRMS (ESI): calculated for C22H18FNaNO3S = [M+Na]+: m/z = 418.0636, found: m/z = 418.0642.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 11.5 min, tr (R)
= 14.3 min.
[α]D25 = +98.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-chlorophenyl)methyl]sulfonamide (2–16)
Prepared from Imine–3n (69.0 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–16 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 199–202 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 78.1 mg (95%), 78% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 78.9 mg (96%), 81% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.26 (s, 1H), 7.89 (d, J = 8.4 Hz, 1H), 7.88–7.87 (m, 2H), 7.71–7.67
(m, 3H), 7.26 (t, J = 5.4 Hz, 1H), 7.13 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 6.26 (d, J = 8.0 Hz,
1H), 5.33 (d, J = 8.0 Hz, 1H), 2.26–1.94 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.6, 160.7, 139.5, 135.7, 135.4, 133.6, 132.4, 131.4, 130.7, 129.4,
128.6, 128.1 (2C), 127.9, 127.8, 127.5, 126.4 (2C), 123.5, 58.3, 32.7, 26.4 ppm.
IR (CH2Cl2): ν = 3314, 3254, 3019, 2905, 2079, 1953, 1865, 1758, 1634, 1532, 1198, 1102, 921, 754,
689, 618 cm–1.
HRMS (ESI): calculated for C22H18ClNaNO3S = [M+Na]+: m/z = 434.5745, found: m/z = 434.5750.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 70:30; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 11.3 min, tr (R)
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= 14.5 min.
[α]D25 = +80.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-bromophenyl)methyl]sulfonamide (2–17)
Prepared from Imine–3o (72.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–17 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 205–208 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 77.3 mg (85%), 74% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 82.8 mg (91%), 85% ee.
1H NMR (CDCl3, 600 MHz): δ = 8.63 (s, 1H), 8.04–8.02 (m, 2H), 7.96–7.94 (m, 2H), 7.92–7.90 (m,
2H), 7.61 (d, J = 8.2 Hz, 2H), 7.52 (d, J = 8.2 Hz, 2H), 7.31 (t, J = 5.3 Hz, 1H), 6.51 (d, J = 7.9 Hz,
1H), 5.68 (d, J = 7.9 Hz, 1H), 2.33–2.06 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.5, 164.3, 143.8, 139.5, 133.6, 132.4, 131.5 (2C), 131.2, 130.9,
130.1, 128.8 (2C), 128.5, 128.0, 127.7, 126.6, 124.0, 123.5, 57.9, 32.3, 25.9 ppm.
IR (CH2Cl2): ν = 3258, 3187, 3021, 2857, 2831, 1947, 1878, 1732, 1667, 1514, 1207, 1184, 912, 764,
741, 626 cm–1.
HRMS (ESI): calculated for C22H18BrNaNO3S = [M+Na]+: m/z = 478.3245, found: m/z = 478.3254.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 70:30; flow rate: 0.9 mL/min; 220 nm, 25 oC): tr (S) = 11.7 min, tr (R)
= 14.9 min.
[α]D25 = +60.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-cyanophenyl)methyl]sulfonamide (2–18)
Prepared from Imine–3p (70.4 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–18 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
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Colorless solid (mp 193–196 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 54.7 mg (68%), 71% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 63.5 mg (79%), 81% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.56 (s, 1H), 7.94–7.92 (m, 1H), 7.88 (d, J = 8.6 Hz, 1H), 7.80–7.77
(m, 2H), 7.60 (d, J = 8.6 Hz, 2H), 7.27 (t, J = 5.3 Hz, 1H), 7.23–7.20 (m, 3H), 6.37 (d, J = 8.8 Hz, 1H),
5.47 (d, J = 8.8 Hz, 1H), 2.21–1.96 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 165.2, 142.9, 139.4, 135.4, 133.6, 132.9, 130.7, 129.2, 128.4,
128.3, 127.8 (2C), 127.7, 126.6, 126.3 (2C), 123.5, 118.6, 112.2, 58.2, 32.6, 26.5 ppm.
IR (CH2Cl2): ν = 3267, 2874, 2250, 1983, 1837, 1798, 1612, 1438, 1284, 1049, 912, 775, 648 cm–1.
HRMS (ESI): calculated for C23H18NaN2O3S = [M+Na]+: m/z = 425.4587, found: m/z = 425.4593.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:40; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 11.8 min, tr (R)
= 14.2 min.
[α]D25 = +78.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-methoxycarbonylphenyl)methyl]sulfonamide
(2–19)
Prepared from Imine–3q (77.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–19 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 208–213 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 82.7 mg (95%), 84% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 84.4 mg (97%), 92% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.26 (s, 1H), 7.90–7.88 (m, 2H), 7.84–7.80 (m, 2H), 7.75–7.73 (m,
2H), 7.21 (d, J = 8.6 Hz, 2H), 7.25 (t, J = 5.2 Hz, 1H), 7.09 (d, J = 8.6 Hz, 2H), 6.11 (d, J = 8.8 Hz,
1H), 5.48 (d, J = 8.8 Hz, 1H), 3.88 (s, 3H), 2.39–1.96 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.4, 166.4, 161.1, 143.2, 142.4, 136.6, 134.6, 131.7, 129.8 (2C),
129.2, 128.9, 128.2, 127.8, 127.5, 127.1, 126.9, 126.7 (2C), 122.5, 55.4, 52.1, 34.8, 26.7 ppm.
IR (CH2Cl2): ν = 3245, 3029, 2947, 1856, 1648, 1439, 1265, 1134, 1084, 915, 876, 798, 732, 634 cm–1.
HRMS (ESI): calculated for C24H21NaNO5S = [M+Na]+: m/z = 458.4156, found: m/z = 458.4162.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.6 mL/min; 220 nm, 25 oC): tr (S) = 12.1 min, tr (R)
= 15.2 min.




Prepared from Imine–3r (79.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.8 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–20 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Colorless solid (mp 218–221 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 81.9 mg (92%), 69% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 84.6 mg (95%), 82% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.22 (s, 1H), 7.86–7.83 (m, 3H), 7.62–7.60 (m, 2H), 7.26–7.24 (m,
1H), 7.21 (t, J = 5.6 Hz, 1H), 7.06 (d, J = 8.6 Hz, 2H), 6.65 (d, J = 8.6 Hz, 2H), 6.13 (d, J = 9.0 Hz,
1H), 5.29 (d, J = 9.0 Hz, 1H), 2.30–1.95 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.4, 162.3, 145.6, 139.5, 135.4, 134.4, 133.6, 132.4, 130.7 (q, J =
269.7 Hz), 129.2 (q, J = 2.1 Hz, 2C), 128,4, 128.2, 127.9 (q, J = 3.4 Hz, 2C), 127.7, 127.5, 125.5 (q, J
= 37.2 Hz), 124.0, 123.5, 58.1, 32.5, 26.3 ppm.
19F NMR (CDCl3, 128 MHz): δ = – 60.9 (s) ppm.
IR (CH2Cl2): ν = 3298, 3198, 3057, 2927, 2889, 1723, 1658, 1567, 1432, 1398, 1201, 912, 747, 732,
643, 621 cm–1.
HRMS (ESI): calculated for C23H18F3NaNO3S = [M+Na]+: m/z = 468.4871, found: m/z = 468.4877.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:40; flow rate: 0.5 mL/min; 220 nm, 25 oC): tr (S) = 11.8 min, tr (R)
= 15.4 min.
[α]D25 = +28.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-nitrophenyl)methyl]sulfonamide (2–21)
Prepared from Imine–3s (74.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.8 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–21 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
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Yellow solid (mp 195–197 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 68.3 mg (81%), 90% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 71.8 mg (85%), 92% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.62 (s, 1H), 8.03–8.00 (m, 2H), 7.95–7.92 (m, 2H), 7.69–7.67 (m,
2H), 7.62 (d, J = 8.6 Hz, 2H), 7.24 (t, J = 5.3 Hz, 1H), 7.00 (d, J = 8.6 Hz, 2H), 6.28 (d, J = 8.8 Hz,
1H), 5.43 (d, J = 8.8 Hz, 1H), 2.38–2.11 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.5, 165.9, 150.2, 141.7, 137.6, 135.8, 133.6, 132.8, 132.4, 131.8
(2C), 129.6, 129.2, 129.0, 128.9, 128.7 (2C), 125.9, 125.7, 60.2, 34.7, 28.3 ppm.
IR (CH2Cl2): ν = 3241, 3059, 2938, 2873, 1838, 1683, 1546, 1438, 1373, 1161, 1037, 908, 751, 727,
648, 639 cm–1.
HRMS (ESI): calculated for C22H18NaN2O5S = [M+Na]+: m/z = 445.0829, found: m/z = 445.0830.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 11.5 min, tr (R)
= 14.2 min.
[α]D25 = +19.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-furanyl)methyl]sulfonamide (2–22)
Prepared from Imine–3t (62.8 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–22 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Yellow solid (mp 172–177 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 71.2 mg (97%), 90% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 72.7 mg (99%), 94% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.60 (s, 1H), 8.13–8.11 (m, 1H), 8.02–7.99 (m, 2H), 7.96–7.93 (m,
2H), 7.80 (d, J = 7.4 Hz, 1H), 7.67 (dd, J = 7.4, 7.5 Hz, 1H), 7.58 (d, J = 7.5 Hz, 1H), 7.33–7.32 (m,
1H), 7.22 (t, J = 5.7 Hz, 1H), 6.00 (d, J = 8.6 Hz, 1H), 5.18 (d, J = 8.6 Hz, 1H), 2.61–2.41 (m, 4H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.6, 160.2, 151.5, 142.4, 135.4, 133.6, 132.4, 130.7, 129.3, 128.3,
128.2, 127.6, 127.5, 126.5, 123.5, 110.5, 107.8, 58.1, 32.5, 26.2 ppm.
IR (CH2Cl2): ν = 3264, 3076, 2972, 2954, 1823, 1739, 1596, 1503, 1421, 1376, 1249, 1118, 1032, 918,
748, 721, 693, 612 cm–1.
HRMS (ESI): calculated for C20H17NaNO4S = [M+Na]+: m/z = 390.3987, found: m/z = 390.3994.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 70:30; flow rate: 0.6 mL/min; 220 nm, 25 oC): tr (S) = 11.0 min, tr (R)
= 14.2 min.
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[α]D25 = –23.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-thienyl)methyl]sulfonamide (2–23)
Prepared from Imine–3u (66.4 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–23 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Yellow solid (mp 182–185 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 76.6 mg (>99%), 91% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 75.9 mg (>99%), 96% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.30 (s, 1H), 8.10–8.09 (m, 1H), 7.71–7.68 (m, 2H), 7.66–7.63 (m,
2H), 7.50 (d, J = 7.4 Hz, 1H), 7.47 (dd, J = 7.4, 7.5 Hz, 1H), 7.32 (d, J = 7.5 Hz, 1H), 6.95 (t, J = 5.3
Hz, 1H), 6.93–6.92 (m, 1H), 6.03 (d, J = 8.6 Hz, 1H), 5.21 (d, J = 8.6 Hz, 1H), 2.21–2.19 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.4, 161.2, 152.7, 141.4, 133.6, 132.4, 130.7, 129.2, 128.7, 128.3,
127.8, 127.5, 126.9, 126.3, 125.6, 125.3, 123.5, 58.1, 32.6, 26.2 ppm.
IR (CH2Cl2): ν = 3265, 3001, 2916, 2848, 1962, 1845, 1703, 1685, 1593, 1440, 1375, 1037, 916, 731,
650 cm–1.
HRMS (ESI): calculated for C20H17NaNO3S2 = [M+Na]+: m/z = 406.0542, found: m/z = 406.0492.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 90:10; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 11.3 min, tr (R)
= 14.5 min.
[α]D25 = –17.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-pyrrol)methyl]sulfonamide (2–24)
Prepared from Imine–3v (62.6 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–24 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Brown solid (mp 167–173 °C).
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1st generation pre-BAC*–8: +35 oC, 48 h; yield: 61.5 mg (84%), 91% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 65.9 mg (90%), 94% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.56 (s, 1H), 7.97–7.94 (m, 2H), 7.86–7.82 (m, 2H), 7.77–7.75 (m,
2H), 7.67–7.65 (m, 1H), 7.60–7.58 (m, 1H), 7.28 (t, J = 5.2 Hz, 1H), 7.20–7.18 (m, 1H), 6.20 (d, J =
8.1 Hz, 1H), 5.78 (br s, NH, 1H), 5.22 (d, J = 8.1 Hz, 1H), 2.30–2.02 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 206.3, 162.3, 153.8, 137.5, 135.4, 133.6, 130.7, 129.2, 129.1, 128.3,
127.3, 127.0, 126.8, 126.2, 123.4, 111.9, 110.3, 58.3, 32.7, 26.3 ppm.
IR (CH2Cl2): ν = 3223, 3012, 2989, 2812, 2298, 1985, 1839, 1567, 1371, 1182, 913, 768, 623 cm–1.
HRMS (ESI): calculated for C20H18NaN2O3S = [M+Na]+: m/z = 389.3254, found: m/z = 389.3261.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.6 mL/min; 220 nm, 25 oC): tr (S) = 11.6 min, tr (R)
= 14.9 min.
[α]D25 = –44.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2-pyridinyl)methyl]sulfonamide (2–25)
Prepared from Imine–3w (65.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–25 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Yellow solid (mp 178–183 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 63.5 mg (84%), 89% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 67.3 mg (89%), 92% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.61 (s, 1H), 8.51 (s, 1H), 8.26–8.25 (m, 1H), 8.06 (d, J = 8.4 Hz,
1H), 7.47–7.44 (m, 2H), 7.41–7.39 (m, 2H), 7.23 (t, J = 5.2 Hz, 1H), 7.15–7.13 (m, 1H), 7.08–7.06 (m,
1H), 6.89 (d, J = 8.4 Hz, 1H), 6.27 (d, J = 8.1 Hz, 1H), 5.63 (d, J = 8.1 Hz, 1H), 2.21–1.95 (m, 4H)
ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 169.2, 152.0, 149.0, 138.6, 133.6, 132.4, 129.2, 128.9, 128.3,
128.2, 127.7, 127.5, 127.0, 126.4, 123.5, 123.4, 122.0, 58.2, 32.6, 26.3 ppm.
IR (CH2Cl2): ν = 3257, 3028, 2964, 2098, 1974, 1846, 1701, 1654, 1582, 1431, 1343, 1134, 1109, 912,
713, 625 cm–1.
HRMS (ESI): calculated for C21H18NaN2O3S = [M+Na]+: m/z = 401.1573, found: m/z = 401.1580.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:40; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 11.6 min, tr (R)
= 14.8 min.
[α]D25 = –17.0 ° (c = 1.0, CHCl3).
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(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(3-pyridinyl)methyl]sulfonamide (2–26)
Prepared from Imine–3x (65.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–26 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Yellow solid (mp 177–181 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 61.3 mg (81%), 82% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 65.8 mg (87%), 89% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.74 (s, 1H), 8.50 (s, 1H), 8.03–8.01 (m, 2H), 7.93 (d, J = 7.5 Hz,
1H), 7.82 (d, J = 7.5 Hz, 1H), 7.78 (d, J = 8.4 Hz, 1H), 7.63–7.61 (m, 1H), 7.55–7.54 (m, 1H), 7.24 (t,
J = 5.3 Hz, 1H), 7.10–7.08 (m, 1H), 7.01 (d, J = 8.4 Hz, 1H), 6.68 (d, J = 8.4 Hz, 1H), 5.84 (d, J = 8.4
Hz, 1H), 2.36–2.23 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.6, 169.6, 149.8, 149.0, 138.8, 135.4, 134.9, 134.6, 133.8, 132.4,
130.9, 129.5, 128.3, 127.4, 127.1, 126.5, 123.9, 123.5, 58.6, 32.4, 26.3 ppm.
IR (CH2Cl2): ν = 3349, 3027, 2952, 2187, 2036, 1895, 1745, 1582, 1436, 1351, 1254, 1139, 918, 746,
725, 693 cm–1.
HRMS (ESI): calculated for C21H18NaN2O3S = [M+Na]+: m/z = 401.1573, found: m/z = 401.1578.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:40; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 11.3 min, tr (R)
= 14.5 min.
[α]D25 = –18.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(4-pyridinyl)methyl]sulfonamide (2–27)
Prepared from Imine–3y (32.6 mg, 0.11 mmol, 1.10 equiv), cyclopentenone (8.20 mg, 0.10 mmol,
1.00 equiv) according to General Procedure I or J. 2–27 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Yellow solid (mp 179–182 °C).
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1st generation pre-BAC*–8: +35 oC, 48 h; yield: 54.4 mg (72%), 77% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 60.5 mg (80%), 87% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.64 (s, 1H), 8.50 (s, 1H), 7.93–7.90 (m, 2H), 7.91–7.88 (m, 1H),
7.83 (d, J = 8.4 Hz, 1H), 7.60–7.58 (m, 1H), 7.54 (d, J = 8.4 Hz, 1H), 7.42–7.41 (m, 1H), 7.40–7.38
(m, 1H), 7.25 (t, J = 5.3 Hz, 1H), 7.20–7.18 (m, 1H), 6.12 (d, J = 8.4 Hz, 1H), 5.34 (d, J = 8.4 Hz, 1H),
2.20–1.88 (m, 4H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.5, 168.4, 154.8, 141.2, 139.5, 133.7, 132.4, 130.7, 129.2, 128.3,
128.1, 127.7, 127.4, 126.6, 126.5, 125.4, 123.6, 120.7, 57.9, 32.4, 26.1 ppm.
IR (CH2Cl2): ν = 3269, 3027, 2952, 2187, 2036, 1895, 1745, 1582, 1436, 1351, 1254, 1139, 918, 746,
721, 646 cm–1.
HRMS (ESI): calculated for C21H18NaN2O3S = [M+Na]+: m/z = 401.1573, found: m/z = 401.1581.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:40; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 11.4 min, tr (R)
= 14.8 min.
[α]D25 = –9.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(3-phenylpropyl)methyl]sulfonamide (2–28)
Prepared from Imine–3z (71.2 mg, 0.22 mmol, 1.10 equiv), cyclopentenone (16.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–28 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Yellow solid (mp 198–200 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 38.9 mg (48%), 55% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 46.9 mg (58%), 78% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.30 (s, 1H), 7.90–7.86 (m, 3H), 7.75 (d, J = 7.8 Hz, 1H), 7.68–7.66
(m, 1H), 7.65–7.64 (m, 1H), 7.28 (d, J = 7.8 Hz, 1H), 7.20–7.16 (m, 4H), 7.15 (t, J = 5.3 Hz, 1H), 6.29
(d, J = 8.1 Hz, 1H), 4.92 (t, J = 8.1 Hz, 1H), 2.65–2.62 (m, 2H), 2.52–2.49 (m, 2H), 2.30–2.28 (m, 2H),
2.28–2.26 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 162.0, 140.8, 135.4, 133.6, 132.4, 130.7, 129.2, 128.9, 128.7
(2C), 128.5, 128.3, 128.2, 127.7, 127.5, 126.5 (2C), 123.5, 58.2, 33.0, 32.6, 30.8, 26.3 ppm.
IR (CH2Cl2): ν = 3312, 2987, 2923, 2819, 2463, 2276, 1953, 1758, 1617, 1557, 1381, 1249, 1142, 911,
784, 748, 652 cm–1.
HRMS (ESI): calculated for C24H23NaNO3S = [M+Na]+: m/z = 428.1453, found: m/z = 428.1447.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 12.3 min, tr (R)
= 15.1 min.
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[α]D25 = +19.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(3-cyclohexyl)methyl]sulfonamide (2–29)
Prepared from Imine–3a’ (33.2 mg, 0.11 mmol, 1.10 equiv), cyclopentenone (8.20 mg, 0.10 mmol,
1.00 equiv) according to General Procedure I or J. 2–29 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
Yellow solid (mp 164–169 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 52.9 mg (69%), 36% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 55.9 mg (73%), 59% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.52 (s, 1H), 8.02–8.00 (m, 2H), 7.96–7.93 (m, 2H), 7.69–7.66 (m,
2H), 6.99 (t, J = 5.2 Hz, 1H), 6.12 (d, J = 8.1 Hz, 1H), 4.71 (t, J = 8.1 Hz, 1H), 2.20–1.93 (m, 4H),
1.73–1.58 (m, 4H), 1.35–1.34 (m, 1H), 1.27–1.25 (m, 1H), 1.20–1.08 (m, 3H), 0.91–0.78 (m, 2H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.3, 161.3, 142.3, 135.4, 133.6, 132.4, 130.7, 129.2, 128.3, 127.7,
127.5, 126.6, 123.5, 58.1, 38.9, 32.5, 28.8 (2C), 26.3 (2C), 26.2, 25.8 ppm.
IR (CH2Cl2): ν = 3325, 3195, 3021, 2947, 1874, 1769, 1605, 1598, 1457, 1389, 1123, 919, 851, 796,
752, 742, 687, 623 cm–1.
HRMS (ESI): calculated for C22H25NaNO3S = [M+Na]+: m/z = 406.1649, found: m/z = 406.1658.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 10.4 min, tr (R)
= 12.1 min.
[α]D25 = –40.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(5-oxocyclopent-1-enyl)(2,2-dimethylpropyl)methyl]sulfonamide (2–30)
Prepared from Imine–3b’ (30.3 mg, 0.11 mmol, 1.10 equiv), cyclopentenone (8.20 mg, 0.10 mmol,
1.00 equiv) according to General Procedure I or J. 2–30 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:2; eluted twice).
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Yellow solid (mp 144–146 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 44.3 mg (62%), 65% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 56.4 mg (79%), 84% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.45 (s, 1H), 7.95–7.93 (m, 2H), 7.86–7.85 (m, 2H), 7.62–7.60 (m,
1H), 7.58–7.56 (m, 1H), 7.17 (t, J = 5.2 Hz, 1H), 6.17 (d, J = 8.1 Hz, 1H), 4.92 (d, J = 8.1 Hz, 1H),
2.12-1.86 (m, 4H), 0.84 (s, 9H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 208.7, 160.2, 143.6, 135.4, 133.6, 132.4, 130.7, 129.2, 128.4, 127.7,
127.5, 126.5, 123.5, 58.1, 35.4, 32.5, 29.3, 26.2 (3C) ppm.
IR (CH2Cl2): ν = 3423, 3245, 2973, 2845, 2758, 1646, 1573, 1436, 1349, 1313, 1158, 916, 784, 736,
688, 631, 592 cm–1.
HRMS (ESI): calculated for C20H23NaNO3S = [M+Na]+: m/z = 380.4425, found: m/z = 380.4434.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 9.4 min, tr (R)
= 11.3 min.
[α]D25 = –30.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(2-formyl-1-allyl)(2-hydroxyphenyl)methyl]sulfonamide (2–31)
Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and acrolein (13.0 mg, 0.20 mmol, 1.00
equiv) according to General Procedure I or J. 2–31 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 152–156 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 65.3 mg (81%), 81% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 68.5 mg (85%) 91% ee.
1H NMR (CDCl3, 500 MHz): δ = 9.58 (s, 1H), 8.27 (br s, 1H), 8.21–8.20 (m, 1H), 7.93–7.81 (m, 3H),
7.72 (d, J = 7.6 Hz, 1H), 7.25–7.23 (m, 1H), 7.22–7.19 (m, 3H), 7.05 (d, J = 8.0 Hz, 1H), 6.90 (dd, J
= 7.6, 8.0 Hz, 1H ), 6.12 (s, 1H), 5.99 (d, J = 8.1 Hz, 1H), 5.75 (s, 1H), 5.48 (d, J = 8.1 Hz, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 189.2, 154.6, 141.3, 135.4, 133.6, 132.4, 131.9, 129.2, 128.3, 128.2,
128.0, 127.7, 127.5, 126.6, 123.5, 123.3, 122.5, 114.7, 114.3, 58.1 ppm.
IR (CH2Cl2): ν = 3432, 3356, 2854, 2728, 1703, 1685, 1639, 1320, 1284, 1225, 730, 698 cm–1.
HRMS (ESI): calculated for C20H17NaNO4S = [M+Na]+: m/z = 390.5286, found: m/z = 390.5289.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 90:10; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 12.5 min, tr (R)
= 20.3 min.
[α]D25 = +10.0 ° (c = 1.0, CHCl3).
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(R)-2-Naphthalene-N-[(2-formyl-1-phenylallyl)(2-hydroxyphenyl)methyl]sulfonamide (2–32)
Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and cinnamaldehyde (20.4 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–32 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 160–163 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 60.4 mg (68%), 76% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 70.2 mg (79%) 88% ee.
1H NMR (CDCl3, 500 MHz): δ = 9.74 (s, 1H), 8.31–8.30 (m, 1H), 7.93–7.81 (m, 3H), 7.74–7.72 (m,
3H), 7.51–7.46 (m, 2H), 7.43 (d, J = 7.9 Hz, 2H), 7.39 (d, J = 7.9 Hz, 2H), 7.36 (d, J = 7.9 Hz, 2H),
7.23–7.03 (m, 2H), 6.08 (s, 1H), 5.64 (d, J = 8.4 Hz, 1H), 4.88 (d, J = 8.4 Hz, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 189.3, 154.6, 140.2, 135.4, 133.6, 132.4, 131.9, 131.8, 130.5, 129.6,
129.2, 128.9, 128.7 (2C), 128.3, 128.2, 128.0, 127.7, 127.5 (2C), 126.6, 123.5, 123.3, 122.5, 114.8,
58.1 ppm.
IR (CH2Cl2): ν = 3456, 3302, 2864, 2731, 1712, 1683, 1598, 1326, 1284, 1215, 728, 690 cm–1.
HRMS (ESI): calculated for C26H21NaNO4S = [M+Na]+: m/z = 466.6128, found: m/z = 466.6134.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 90:10; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 12.8 min, tr (R)
= 21.9 min.
[α]D25 = +3.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(6-oxocyclohex-1-enyl)(2-hydroxyphenyl)methyl]sulfonamide (2–34)
Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and cyclohexenenone (20.8 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–34 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 167–172 °C).
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1st generation pre-BAC*–8: +35 oC, 48 h; yield: 63.5 mg (78%), 78% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 67.6 (83%), 94% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.21 (s, 1H), 7.93–7.81 (m, 3H), 6.08 (br s, 1H), 7.77–7.72 (m, 4H),
7.25 (dd, J = 7.6, 8.3 Hz, 1H), 6.95 (dd, J = 7.0, 7.6 Hz, 1H), 6.41 (t, J = 3.7 Hz, 1H), 6.00 (d, J = 8.3
Hz, 1H), 5.74 (d, J = 8.6 Hz, 1H), 5.34 (d, J = 8.6 Hz, 1H), 2.45–1.81 (m, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 195.4, 154.6, 141.2, 135.4, 133.6, 132.4, 131.9, 129.2, 128.3, 128.2,
128.1, 127.7, 127.5, 126.6, 126.0, 123.5, 123.3, 122.5, 114.7, 58.1, 37.2, 25.3, 22.0 ppm.
IR (CH2Cl2): ν = 3425, 3310, 2931, 2845, 1698, 1675, 1487, 1328, 1245, 1224, 731, 695 cm–1.
HRMS (ESI): calculated for C23H21NaNO4S = [M+Na]+: m/z = 430.5843, found: m/z = 430.5847.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 13.5 min, tr (R)
= 19.8 min.
[α]D25 = +23.0 ° (c = 1.0, CHCl3).
(R)-2-Naphthalene-N-[(2-methozoyl)-1-(2-hydroxylbenzylallyl)]sulfonamide (2–35)
Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and methyl vinyl ketone (16.8 mg, 0.20
mmol, 1.00 equiv) according to General Procedure I or J. 2–35 was purified by PTLC on silica gel
(eluent: EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 156–162 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 63.7 mg (76%), 83% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 77.1 mg (92%), 91% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.32 (s, 1H), 7.96–7.81 (m, 3H), 7.75–7.70 (m, 4H), 7.20–6.82 (m,
3H), 6.18 (br s, 1H), 6.11 (s, 1H), 6.02 (s, 1H), 5.70 (d, J = 8.1 Hz, 1H), 5.24 (d, J = 8.1 Hz, 1H), 2.23
(s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 196.8, 154.6, 143.5, 135.4, 133.6, 132.4, 131.9, 129.2, 128.3, 128.2,
128.0, 127.7, 127.5, 126.5, 123.5, 123.3, 122.5, 114.7, 114.3, 58.1, 29.5 ppm.
IR (CH2Cl2): ν = 3419, 3397, 2964, 2825, 1701, 1664, 1367, 1318, 1275, 1210, 731, 704 cm–1.
HRMS (ESI): calculated for C21H19NaNO4S = [M+Na]+: m/z = 404.5612, found: m/z = 404.5617.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 100:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 14.6 min, tr
(R) = 21.4 min.




Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and methyl acrylate (18.6 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–36 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 169–174 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 56.4 mg (71%), 70% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 58.8 mg (74%), 83% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.25 (s, 1H), 7.95–7.78 (m, 3H), 7.76–7.72 (m, 4H), 7.24–6.99 (m,
3H), 7.24 (br s, 1H), 6.25 (s, 1H), 5.87 (s, 1H), 5.80 (d, J = 8.1 Hz, 1H), 5.21 (d, J = 8.1 Hz, 1H), 3.78
(s, 3H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 165.1, 154.6, 145.2, 135.4, 133.6, 132.4, 131.9, 129.2, 128.3, 128.2,
128.0, 127.7, 127.5, 126.6, 123.4, 123.2, 122.5, 114.7, 114.3, 58.1, 51.9 ppm.
IR (CH2Cl2): ν = 3426, 3356, 2958, 2837, 1694, 1662, 1381, 1310, 1289, 1214, 1168, 720, 693 cm–1.
HRMS (ESI): calculated for C21H19NaNO5S = [M+Na]+: m/z = 420.9735, found: m/z = 420.9737.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 100:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 13.2 min, tr
(R) = 22.6 min.
[α]D25 = +5.0 ° (c = 1.0, CHCl3).
(R)-1-Naphthyl-2-[(2-hydroxyphenyl)-(2-naphthalenesulfonylamino)methyl]acrylate (2–37)
Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and α-naphthyl acrylate (39.6 mg, 0.20
mmol, 1.00 equiv) according to General Procedure I or J. 2–37 was purified by PTLC on silica gel
(eluent: EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 187–194 °C).
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1st generation pre-BAC*–8: +35 oC, 48 h; yield: 75.6 mg (74%), 72% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 97.1 mg (95%), 94% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.45–8.44 (m, 1H), 7.92 (d, J = 8.2 Hz, 1H), 7.91 (d, J = 7.6 Hz,
1H), 7.90 (d, J = 7.6 Hz, 1H), 7.80 (d, J = 8.2 Hz, 1H), 7.76–7.72 (m, 3H), 7.66–7.61 (m, 3H), 7.38–
7.32 (m, 2H), 7.25 (dd, J = 7.6, 8.2 Hz, 2H), 7.06 (d, J = 8.0 Hz, 1H), 6.95 (dd, J = 7.6, 8.2 Hz, 2H),
6.68 (s, 1H), 6.43 (s, 1H), 6.09 (d, J = 8.4 Hz, 1H), 5.87 (d, J = 8.4 Hz, 1H), 5.65 (br s, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 165.2, 154.6, 146.8, 142.3, 135.4, 134.6, 133.6, 132.4, 131.9, 130.5,
129.2, 128.3, 128.2, 128.1, 128.0, 127.7, 127.6, 127.5, 126.7, 126.6, 123.5, 123.3, 122.5, 122.1, 121.4,
120.4, 114.7, 125.9, 118.7, 58.0 ppm.
IR (CH2Cl2): ν = 3429, 3346, 1698, 1665, 1580, 1320, 1287, 1256, 1211, 1189, 728, 693 cm–1.
HRMS (ESI): calculated for C30H23NaNO5S = [M+Na]+: m/z = 532.6715, found: m/z = 532.6718.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.8 mL/min; 220 nm, 25 oC): tr (S) = 15.6 min, tr (R)
= 17.5 min.
[α]D25 = +38.0 ° (c = 1.0, CHCl3).
(R)-2-[(2-hydroxyphenyl)-(2-naphthalenesulfonylamino)methyl]-acrylamide (2–38)
Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and acrylamide (14.2 mg, 0.20 mmol, 1.00
equiv) according to General Procedure I or J. 2–38 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 135–139 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 45.9 mg (60%), 66% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 57.4 mg (75%), 82% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.15 (s, 1H), 7.82–7.80 (m, 3H), 7.77–7.72 (m, 4H), 7.34 (br s, 2H),
7.11 (d, J = 8.0 Hz, 1H), 7.05–7.03 (m, 2H), 6.48 (s, 1H), 5.70 (d, J = 8.1 Hz, 1H), 5.68 (br s, 1H),
5.29 (s, 1H), 5.02 (d, J = 8.1 Hz, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 166.7, 154.6, 142.3, 133.6, 135.4, 131.9, 130.8, 129.2, 128.3, 128.2,
128.0, 127.5, 125.6, 124.3, 123.6, 123.3, 122.5, 114.7, 114.3, 58.4 ppm.
IR (CH2Cl2): ν = 3401, 3346, 3319, 1689, 1656, 1660, 1535, 1320, 1294, 1238, 1216, 1182, 722, 694,
678 cm–1.
HRMS (ESI): calculated for C20H18NaN2O4S = [M+Na]+: m/z = 405.6347, found: m/z = 405.6354.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 11.2 min, tr (R)
= 16.5 min.
[α]D25 = +9.0 ° (c = 1.0, CHCl3).
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(R)-2-Naphthalene-N-[2-cyano-1-(2-hydroxyphenyl)propen-2-yl]sulfonamide (2–39)
Prepared from Imine 3h (68.4 mg, 0.22 mmol, 1.10 equiv) and acrylonitrile (10.6 mg, 0.20 mmol,
1.00 equiv) according to General Procedure I or J. 2–39 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5; eluted twice).
Colorless solid (mp 148–154 °C).
1st generation pre-BAC*–8: +35 oC, 48 h; yield: 60.5 mg (83%),75% ee.
2nd generation pre-BAC*–11: –20 oC, 72 h; yield: 65.6 mg (90%), 84% ee.
1H NMR (CDCl3, 500 MHz): δ = 8.32 (s, 1H), 7.90-7.80 (m, 3H), 7.77-7.72 (m, 2H), 7.14-7.12 (m,
1H), 7.06 (d, J = 8.0 Hz, 1H), 7.00-6.68 (m, 3H), 6.47 (br s, 1H), 6.11 (s, 1H), 5.92 (s, 1H), 5.46 (d, J
= 8.1 Hz, 1H), 5.10 (d, J = 8.1 Hz, 1H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 154.6, 140.3, 135.4, 133.6, 132.4, 131.9, 129.2, 128.3, 128.2, 128.0,
127.7, 127.5, 124.6, 123.5, 123.3, 122.5, 115.9, 114.7, 114.3, 58.1 ppm.
IR (CH2Cl2): ν = 3342, 3301, 2206, 1657, 1639, 1528, 1276, 765, 687 cm–1.
HRMS (ESI): calculated for C20H16NaN2O3S = [M+Na]+: m/z = 387.5246, found: m/z = 387.5249.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 80:20; flow rate: 0.4 mL/min; 220 nm, 25 oC): tr (S) = 15.5 min, tr (R)
= 18.9 min.
[α]D25 = +18.0 ° (c = 1.0, CHCl3).
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5.4 TOWARDS BAC-catalysed ASYMMETRIC BORYLATION
5.4.1 BAC-catalysed Conjugate Borylation
General Procedure K [synthesis of conjugate borylated products]
To an oven-dried test tube with a magnetic stirring bar in a nitrogen glovebox were added pre-BAC–1
(3.20 mg, 10.0 µmol, 10.0 mol%), (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv), different
Michael acceptors (0.10 mmol, 1.00 equiv), THF (0.33 mL, 0.3 M), and DBU (1.50 mg, 10.0 µmol,
10.0 mol%). In the cases of 3–3 and 3–4, an additional amount of methanol (6.40 mg, 0.20 mmol,
2.00 equiv) was added. The reaction mixture was stirred at 40 oC for 24 h, at which point TLC and/or
1H NMR analysis indicated complete consumption of Michael acceptor. The reaction was quenched
by the addition of water (0.3 mL) and the mixture was allowed to stir for an additional 20 min. The
aqueous layer was washed with diethyl ether (3 x 2 mL). Volatiles were removed in vacuo, and the
residue was purified by flash column chromatography or PTLC on silica gel (eluent: EtOAc/PE = 1:5)
to give the intended products.
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexanone (3-1)[109]
Prepared from (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv) and cyclohexenone (10.4 mg,
0.10 mmol, 1.00 equiv) according to Procedure K. 3–1 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5). The obtained analytical data were in full agreement with the reported data. [109]
Colorless oil.
Yield: 20.2 mg (89%).
1H NMR (CDCl3, 500 MHz): δ = 2.37–2.22 (m, 4H), 2.08–2.00 (m, 1H), 1.87–1.81 (m, 1H), 1.77–
1.66 (m, 1H), 1.64–1.54 (m, 1H), 1.46–1.38 (m, 1H), 1.20 (s, 12H) ppm.




Prepared from (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv) and cyclopentenone (8.20 mg,
0.10 mmol, 1.00 equiv) according to Procedure K. 3–2 was purified by PTLC on silica gel (eluent:
EtOAc/PE = 1:5). The obtained analytical data were in full agreement with the reported data. [109]
Colorless oil.
Yield: 18.3 mg (82%).
1H NMR (CDCl3, 500 MHz): δ = 2.33–2.20 (m, 2H), 2.19–2.07 (m, 3H), 1.90–1.81 (m, 1H), 1.68–
1.59 (m, 1H), 1.25 (s, 12H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 221.2, 83.7, 40.3, 39.1, 30.5, 25.4 (2C), 24.9 (2C), 22.3 (2C) ppm.
4-phenyl-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one (3-3)[111]
Prepared from (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv) and trans-4-phenyl-3-buten-2-
one (14.6 mg, 0.10 mmol, 1.00 equiv), methanol (6.40 mg, 0.20 mmol, 2.00 equiv) according to
Procedure K. 3–3 was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical
data were in full agreement with the reported data. [111]
Colorless oil.
Yield: 18.9 mg (65%).
1H NMR (CDCl3, 500 MHz): δ = 7.45–7.43 (m, 2H), 7.25–7.21 (m, 3H), 3.05 (dd, J = 20.0, 12.0 Hz,
1H), 2.85 (dd, J = 20.0, 4.0 Hz, 1H), 2.71 (dd, J = 12.0, 4.0 Hz, 1H), 1.94 (s, 3H), 1.29 (s, 12H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 205.9, 130.6, 128.9, 127.8 (2C), 127.5 (2C), 83.4, 30.5, 29.9 (2C),
25.1 (2C), 24.8 (2C), 22.8 ppm.
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4-phenyl-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)butan-2-one (3-4) [111]
Prepared from (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv) and 1,3-diphenyl-2-propenone
(20.8 mg, 0.10 mmol, 1.00 equiv), methanol (6.40 mg, 0.20 mmol, 2.00 equiv) according to Procedure
K. 3–4 was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were
in full agreement with the reported data. [111]
Colorless oil.
Yield: 26.4 mg (76%).
1H NMR (CDCl3, 500 MHz): δ = 7.97–7.94 (m, 2H), 7.55–7.50 (m, 1H), 7.44–7.40 (m, 2H), 7.31–
7.24 (m, 4H), 7.17–7.13 (m, 1H), 3.54 (dd, J = 18.4, 10.8 Hz, 1H), 3.41 (dd, J = 18.4, 5.2 Hz, 1H),
2.79 (dd, J = 10.8, 5.2 Hz, 1H), 1.23 (s, 6H), 1.15 (s, 6H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 199.2, 134.5, 130.7, 129.7, 128.9, 128.6 (2C), 128.4 (2C), 127.8
(2C), 127.6 (2C), 83.2, 30.5, 25.0 (2C), 24.8 (2C), 22.3 (2C) ppm.
5.4.2 Towards an Asymmetric Version
General Procedure L [asymmetric borylation]
To an oven-dried test tube with a magnetic stirring bar in a nitrogen glovebox were added pre-BAC*–
8 (3.20 mg, 10.0 µmol, 10.0 mol%), DBU (1.50 mg, 10.0 µmol, 10.0 mol%) and THF (0.17 mL). The
pre-catalyst mixture was pre-stirred at 35 oC for 20 h before cooling to –20 oC, at which stage a stock
solution of (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv), corresponding Michael acceptors
(0.10 mmol, 1.00 equiv), dried methanol (80.1 mg, 2.50 mmol, 25.0 equiv) and THF (0.33 mL) was
added to the pre-catalyst mixture. The reaction mixture was stirred at –20 oC for 48 h, at which point
TLC and/or 1H NMR analysis indicated complete consumption of Michael acceptor. The reaction was
quenched by the addition of water (0.3 mL) and the mixture was allowed to stir for an additional 20
min. The aqueous layer was washed with diethyl ether (3 x 2 mL). Volatiles were removed in vacuo,
and the residue was purified by flash column chromatography or PTLC on silica gel (eluent:
EtOAc/PE = 1:5) to give the intended products.
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(R)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohexanone (3-5) [111]
Prepared from (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv), cyclohexenone (10.4 mg, 0.10
mmol, 1.00 equiv), and methanol (80.1 mg, 2.50 mmol, 25.0 equiv) according to Procedure K. 3–5
was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in full
agreement with the reported data. [111]
Colorless oil.
1st generation pre-BAC*–8, –20 oC, 48 h; yield: 10.1 mg (45%), 69% ee.
1H NMR (CDCl3, 500 MHz): δ = 2.39–2.24 (m, 4H), 2.09–2.03 (m, 1H), 1.89–1.84 (m, 1H), 1.79–
1.70 (m, 1H), 1.66–1.57 (m, 1H), 1.45–1.42 (m, 1H), 1.23 (s, 12H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 210.9, 82.7, 41.7, 40.9, 27.8, 26.5, 24.5 (2C), 21.8 (2C), 20.9 (2C)
ppm.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 98:2; flow rate: 0.3 mL/min; 220 nm, 25 oC): tr (S) = 11.1 min, tr (R)
= 12.8 min.
(R)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopentanone (3-6) [111]
Prepared from (pin)B–B(pin) (B–5) (27.9 mg, 0.11 mmol, 1.10 equiv) and cyclopentenone (8.40 mg,
0.10 mmol, 1.00 equiv), and methanol (80.1 mg, 2.50 mmol, 25.0 equiv) according to Procedure K.
3–6 was purified by PTLC on silica gel (eluent: EtOAc/PE = 1:5). The obtained analytical data were in
full agreement with the reported data. [111]
Colorless oil.
1st generation pre-BAC*–8, –20 oC, 48 h; yield: 9.66 mg (46%), 63% ee.
1H NMR (CDCl3, 500 MHz): δ = 2.31-2.18 (m, 2H), 2.15-2.06 (m, 3H), 1.88-1.79 (m, 1H), 1.67-1.56
(m, 1H), 1.24 (s, 12H) ppm.
13C NMR (CDCl3, 125 MHz): δ = 220.4, 85.2, 42.5, 38.1, 29.8, 25.1 (2C), 24.8 (2C), 21.6 (2C) ppm.
The enantiomeric excess was determined by chiral HPLC analysis using a DAICEL Chiracel IB
column (eluent: hexane/iPrOH = 98:2; flow rate: 0.3 mL/min; 220 nm, 25 oC): tr (S) = 12.4 min, tr
(R)= 14.7 min.
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5.5 THE CHEMISTRYOF CARBONES
5.5.1 Preparation of Carbone Precursors 4–28 and a Carbone 4–5
To a 50-mL two-neck, round-bottomed flask fitted with Dean-Sttark apparatus and additional funnel
was placed the N-methyl-1,2-phenylenediamine (1.20 g, 9.30 mmol, 2.00 equiv) in 1,6-
dichlorotoluene (5.00 mL). The solution was heated to 170 oC, and then diethyl malonate (1.00 g, 4.60
mmol, 1.00 equiv) was added drop-wise to the reaction flask over 90 min. The temperature gradually
increased to 185 oC during the addition process and maintained around 185 oC to 190 oC for 2 hours.
The ending point of the reaction can be monitored by 1H NMR analysis. The resulting mixture was
cooled down to ambient temperature. After filtration, the solid was washed with benzene (3 x 5 mL)
and methanol (5 mL), and then dried in vacuo to afford the product 4–26 as a pale beige solid (8.05 g,
70% yield; mp 207–209°C). The obtained analytical data fit accurately with the reported data.[129]
1H NMR (CDCl3, 400 MHz): δ = 7.76–7.71 (m, 2H), 7.33–7.22 (m, 6H), 4.69 (s, 2H), 3.90 (s, 6H)
ppm.
13C NMR (CDCl3, 100 MHz) δ = 149.8 (2C), 142.9 (2C), 136.7 (2C), 123.3 (2C), 122.7 (2C), 120.0
(2C), 109.9 (2C), 31.0, 29.1 (2C) ppm.
In a 50-mL, two-necked, round-bottomed flask was placed 4–26 (3.00 g, 10.9 mmol, 1.00 equiv) in
anhydrous acetonitrile (10.0 mL). Methyl trifluoromethansulfonate (4.00 mL, 35.3 mmol, 3.50 equiv)
was added dropwise to the reaction flask. The resulting mixture was then stirred at room temperature
for one hour and then added diethyl ether (60.0 mL) to provide white precipitate. The white
precipitate was then washed with CH2Cl2 (2 x 15 mL), and dried in vacuo to afford the product 4–27
as a colourless solid (1.22 g, 65% yield; mp 246–250 °C). The obtained analytical data fit accurately
with the reported data.[117]
1H NMR (CD3CN, 400 MHz) δ = 7.95–7.90 (m, 4H), 7.80–7.76 (m, 4H), 5.37 (s, 2H), 3.95 (s, 12H)
ppm.
13C NMR (CD3CN, 100 MHz): δ = 144.7 (2C), 133.5 (4C), 129.1 (4C), 126.5 (4C), 114.8 (q, J =
264.6 Hz), 34.2, 22.9 (4C) ppm.
Preparation of 4–28[124]
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Prepared from 4–27 (0.50 g, 0.60 mmol, 1.00 equiv) and base (2.0 equiv) in anhydrous DCE (5.00 mL)
at room temperature for 6 h. 4–28 was washed with hexane (10 mL). The obtained analytical data
were in full agreement with the reported data.[124]
Colorless solid.
Mp. 152−155 oC (153−155 oC) [124]
Ag2O; yield: 91.1 mg (20%); KHMDS; yield: 273 mg (60%); NaOMe; yield: 410 mg (90%).
1H NMR (CD2Cl2, 500 MHz): δ = 7.42–7.32 (m, 8H), 4.55 (s, 1H), 3.57 (s, 12H) ppm.
13C NMR (CD2Cl2, 150 MHz): δ = 153.1, 140.2, 137.6 (2C), 134.2 (2C), 132.9 (2C), 130.1 (2C),
128.7 (2C), 126.4 (2C), 124.3, 112.5 (q, J = 262.8 Hz), 32.2 (4C) ppm.
Bis(1,3-methyl-benzimidazol-2-ylidene)methane (4–5)[117]
Prepared from 4–28 (1.00 g, 1.50 mmol, 1.00 equiv) and KHMDS (0.37 g, 1.82 mmol, 1.10 equiv) in
THF (6.70 mL) at room temperature for 3 h. 4–5 was washed with Et2O (10 mL). The obtained
analytical data were in full agreement with the reported data.[117]
Colorless solid.
Mp. 151−152 oC (150−152 oC) [117]
Yield: 0.64 g (80%).
1H NMR (C6D6, 400 MHz): δ = 6.96–6.94 (m, 4H), 6.84–6.82 (m, 4H), 3.13 (s, 12H) ppm.
13C NMR (C6D6, 100 MHz): δ = 144.8 (2C), 135.9 (4C), 132.4 (4C), 130.5 (4C), 110.2, 29.7 (4C) ppm.
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Preparation of 4–29
A 50 ml two-necked round-bottomed flask fitted with an efficient condenser was charged with
diethylether (15.0 ml), cyclohexane carbonyl chloride (1.10 g, 7.50 mmol, 1.00 equiv) and
ethoxyacetylene (2.10 g, 50%w/w in hexanes, 15.0 mmol, 2.00 equiv). The stirred solution was then
treated dropwise at toom temperature with triethylamine (1.50 ml, 11.2 mmol, 1.50 equiv). After 30
min the suspension was heated to reflux at 60 oC and stirred for a further 24 h. The resulting turbid
mixture was allowed to cool prior to removal of triethlammonium chloride by filtration and the filtrate
was concentrated in vacuo. The obtained analytical data fit accurately with the reported data.[128]
Brown oil.
Yield: 0.93 g (81%).
1H NMR (C6D6, 400 MHz): δ = 5.37 (s, 1H), 4.25 (q, J = 7.9 Hz, 2H), 1.77–1.72 (m, 4H), 1.53–1.49
(m, 4H), 1.36–1.33 (m, 2H), 1.28 (t, J = 7.9 Hz, 3H) ppm.
13C NMR (C6D6, 100 MHz): δ = 194.5, 155.7, 119.1, 66.5, 42.4 (2C), 35.4 (2C), 25.8, 22.2, 14.7 ppm.
Preparation of 4–30
A CHCl3 solution (20.0 mL) of Et3O+ -BF4 (3.10 g, 16.6 mmol) was added at room temperature to a
CHCl3 solution (30.0 mL) of 4–29 (2.00 g, 11.1 mmol). After stirring at 50 °C for 2 hours, and
evaporation of the solvent, the residue was washed with dry ether (2 x 20 ml), and dissolved in
dichloromethane (20 mL). Piperidine (3.85 mL, 33.0 mmol) was added at 0 °C, and the solution is
stirred for 1 hour at room temperature. The solution was filtered through neutral alumina and the
solvent removed under vacuum. Salt 4–30 was obtained from a concentrated solution of acetonitrile at
–20 oC. The obtained analytical data fit accurately with the reported data.[128]
Light yellow solid.
Mp. 169−171 oC (168−171 oC) [128]
Yield: 0.65 g (72%).
1H NMR (CDCl3, 500 MHz): δ = 5.17 (s, 1H), 3.62–3.58 (m, 4H), 3.42–3.39 (m, 4H), 1.92–1.87 (m,
4H), 1.69–1.60 (m, 8H), 1.64–1.56 (m, 8H), 1.52–1.50 (m, 2H) ppm.
13C NMR (CDCl3, 100 MHz): δ = 171.7 (2C), 92.8, 57.5, 50.1, 49.9, 35.6, 29.0 (2C), 26.0 (2C), 25.4
(2C), 23.1 (2C), 23.0 (2C), 21.9 (2C) ppm.
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